Disease on EC 3.4.21.120 - oviductin
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abetalipoproteinemia
Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia.
Abnormalities, Multiple
Fetal echogenic bowel: parameters to be considered in differential diagnosis.
Abortion, Spontaneous
Alpha-fetoprotein (AFP) levels in maternal serum in 115 patients with spontaneous abortion.
Abortion, Spontaneous
Alpha-fetoprotein levels in amniotic fluids from spontaneous abortions.
Abortion, Spontaneous
Low VEGF expression in conceptus material and maternal serum AFP and ?-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages.
Abortion, Spontaneous
Miscarriage determination in first trimester based on alpha-fetoprotein extracted from sanitary pads.
Abortion, Spontaneous
Placental lakes, absent umbilical artery diastolic flow and poor fetal growth in early pregnancy.
Abortion, Spontaneous
Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.
Abortion, Spontaneous
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Abortion, Spontaneous
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Abortion, Spontaneous
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Abortion, Spontaneous
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
Abortion, Spontaneous
[Discolored amniotic fluid--results of prenatal diagnosis and clinical significance]
Abortion, Threatened
Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
Abortion, Threatened
Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound.
Abortion, Threatened
[Changes in the blood level of alpha-fetoprotein in threatened abortion]
Abruptio Placentae
Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Abruptio Placentae
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Abruptio Placentae
Malignant placental site trophoblastic tumor associated with placental abruption, fetal distress, and elevated CA-125.
Abruptio Placentae
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Abruptio Placentae
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Abruptio Placentae
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Abruptio Placentae
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Abruptio Placentae
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Abruptio Placentae
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Abruptio Placentae
Ultrasonically dense amniotic fluid in early pregnancy in asymptomatic women without vaginal bleeding. A report of two cases.
Acidosis, Lactic
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
Acidosis, Lactic
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Acquired Immunodeficiency Syndrome
Defective uptake of alpha-fetoprotein (AFP) and transferrin (Tf) by PHA-activated peripheral blood lymphocytes from patients with AIDS and related syndromes.
Acquired Immunodeficiency Syndrome
Expression of alpha-fetoprotein and interleukin 2 receptors and impairment of membrane fluidity in peripheral blood mononuclear cells from AIDS and related syndromes.
Acquired Immunodeficiency Syndrome
[Prenatal diagnosis of Meckel-Gruber's syndrome by ultrasound (author's transl(]
Acromegaly
Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
Acute-On-Chronic Liver Failure
Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.
Acute-On-Chronic Liver Failure
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
Acute-On-Chronic Liver Failure
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Acute-On-Chronic Liver Failure
[Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
acyl-coa dehydrogenase deficiency
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Adenocarcinoma
A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
Adenocarcinoma
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Adenocarcinoma
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Adenocarcinoma
Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
Adenocarcinoma
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Adenocarcinoma
Alpha-fetoprotein and carbohydrate antigen 19-9 producing advanced adenocarcinoma of renal pelvis and ureter.
Adenocarcinoma
Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Adenocarcinoma
Alpha-fetoprotein producing Barrett's esophageal adenocarcinoma: a case report.
Adenocarcinoma
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Adenocarcinoma
Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions.
Adenocarcinoma
Alpha-fetoprotein-producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation.
Adenocarcinoma
Alpha-fetoprotein-producing esophageal adenocarcinoma: a mimicker of hepatocellular carcinoma.
Adenocarcinoma
Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
Adenocarcinoma
Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Adenocarcinoma
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Adenocarcinoma
An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report.
Adenocarcinoma
An Extremely Rare Presentation of an Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma.
Adenocarcinoma
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Adenocarcinoma
Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine endometrial adenocarcinoma.
Adenocarcinoma
Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
Adenocarcinoma
Carcinosarcoma of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma: a report of two cases.
Adenocarcinoma
Clear-Cell Adenocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature.
Adenocarcinoma
Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Adenocarcinoma
Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Adenocarcinoma
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Adenocarcinoma
Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.
Adenocarcinoma
Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Adenocarcinoma
Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Adenocarcinoma
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas.
Adenocarcinoma
Education and Imaging. Gastrointestinal: brain metastasis of alpha-fetoprotein producing gastric adenocarcinoma.
Adenocarcinoma
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Adenocarcinoma
Esophageal adenocarcinoma with enteroblastic differentiation arising in ectopic gastric mucosa in the cervical esophagus: a case report and literature review.
Adenocarcinoma
Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Adenocarcinoma
Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Adenocarcinoma
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Adenocarcinoma
Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma.
Adenocarcinoma
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Adenocarcinoma
Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Adenocarcinoma
Forkhead box protein A2, a pioneer factor for hepatogenesis, is involved in the expression of hepatic phenotype of alpha-fetoprotein-producing adenocarcinoma.
Adenocarcinoma
Gastric cancer with adenocarcinoma and yolk sac tumor components: A rare entity.
Adenocarcinoma
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Adenocarcinoma
Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma.
Adenocarcinoma
Gastric hepatoid adenocarcinoma and familial investigation: does it always produce alpha-fetoprotein?
Adenocarcinoma
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Adenocarcinoma
Hepatic carcinosarcoma with heterogeneous carcinomatous and sarcomatous elements: report of a case and review of the literature.
Adenocarcinoma
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Adenocarcinoma
Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production.
Adenocarcinoma
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Adenocarcinoma
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Adenocarcinoma
Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy.
Adenocarcinoma
Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment.
Adenocarcinoma
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Adenocarcinoma
Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
Adenocarcinoma
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Adenocarcinoma
Hepatoid adenocarcinoma of the stomach: report of five cases and review of the literature.
Adenocarcinoma
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Adenocarcinoma
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
Adenocarcinoma
Heterotransplantation of ovarian serous adenocarcinoma with functioning stroma to nude mice. Disappearance of functioning stroma in transplanted tumor.
Adenocarcinoma
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Adenocarcinoma
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Adenocarcinoma
Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
Adenocarcinoma
In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer.
Adenocarcinoma
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Adenocarcinoma
Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma.
Adenocarcinoma
Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
Adenocarcinoma
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Adenocarcinoma
Non-?-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Adenocarcinoma
Primary adenocarcinoma of the female urethra with three histologic patterns and partial AFP positivity.
Adenocarcinoma
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Adenocarcinoma
Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis: an unusual association.
Adenocarcinoma
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Adenocarcinoma
Pulmonary adenocarcinomas of the fetal lung type: a clinicopathologic study indicating differences in histology, epidemiology, and natural history of low-grade and high-grade forms.
Adenocarcinoma
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Adenocarcinoma
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
Adenocarcinoma
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Adenocarcinoma
Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Adenocarcinoma
Synchronous presentation of hepatoid alpha-fetoprotein-producing lung cancer and colorectal adenocarcinoma.
Adenocarcinoma
The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
Adenocarcinoma
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Adenocarcinoma
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
Adenocarcinoma
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
Adenocarcinoma
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Adenocarcinoma
Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.
Adenocarcinoma
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Adenocarcinoma
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Adenocarcinoma
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
Adenocarcinoma
[Hepatoid adenocarcinoma of the lung with negative alpha-fetoprotein: a case report].
Adenocarcinoma
[Hepatoid adenocarcinoma of the stomach. Case report and review of the literature]
Adenocarcinoma
[Ovarian serous adenocarcinoma with functioning stroma and production of estrogen and alpha-fetoprotein]
Adenocarcinoma
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Adenocarcinoma of Lung
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.
Adenocarcinoma of Lung
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Adenocarcinoma of Lung
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Adenocarcinoma of Lung
Spontaneous hepatic rupture due to metastatic tumor of lung adenocarcinoma.
Adenocarcinoma, Clear Cell
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Adenocarcinoma, Papillary
Alpha-fetoprotein-producing papillary adenocarcinoma originating from a uterine body. A case report.
Adenoma
A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Adenoma
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Adenoma
Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
Adenoma
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Adenoma, Bile Duct
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Adenoma, Liver Cell
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
Adenoma, Liver Cell
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Adrenal Insufficiency
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Adrenocortical Carcinoma
Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma - Long survival with various therapeutic strategies including a lung resection: Report of a case.
Amniotic Band Syndrome
A stillborn fetus with amniotic band syndrome and elevated levels of alpha-fetoprotein plus beta-human chorionic gonadotropin: a case report.
Amniotic Band Syndrome
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Anaplasia
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Anaplasia
[The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients]
Androgen-Insensitivity Syndrome
Yolk sac tumor in a case of testicular feminization syndrome.
Anemia
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Anemia
Cuba's Salgen: a provincial informatics network for genetic services to pregnant women and newborns.
Anemia
Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Anemia
Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.
Anemia
Maternal serum alpha-fetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia.
Anemia
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
Anemia
Prenatal diagnosis and management of fetal anemia secondary to a large chorioangioma.
Anemia
Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection.
Anemia
Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Anemia
Successful resection of a ruptured hepatoblastoma prior to chemotherapy: report of a case.
Anemia
Successful treatment of advanced pancreatoblastoma by a pylorus-preserving pancreatoduodenectomy after radiation and high-dose chemotherapy.
Anemia, Aplastic
Serum alpha-fetroprotein concentration in adult patients under corticoid, estroprogestative or androgen therapy.
Anemia, Iron-Deficiency
Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Anemia, Neonatal
The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use.
Anemia, Sickle Cell
Cuba's Salgen: a provincial informatics network for genetic services to pregnant women and newborns.
Anencephaly
Alpha-fetoprotein levels in amniotic fluid in normal pregnancy and in pregnancy complicated by anencephaly.
Anencephaly
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Anencephaly
Amniotic fluid alpha-fetoprotein levels in anencephaly and open spina bifida: validation of median cut-off limits.
Anencephaly
Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy.
Anencephaly
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Anencephaly
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Anencephaly
Biamnial elevated alpha-fetoprotein and positive acetylcholinesterase in twins, one with anencephaly.
Anencephaly
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Anencephaly
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.
Anencephaly
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Anencephaly
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Anencephaly
Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
Anencephaly
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Anencephaly
Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Anencephaly
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Anencephaly
Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid.
Anencephaly
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Anencephaly
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Anencephaly
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
Anencephaly
The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
Anencephaly
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Anencephaly
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
Anencephaly
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
Anencephaly
[Prenatal diagnosis of anencephaly and open spina bifida by combined use of amniotic or maternal serum alpha-fetoprotein and maternal urine estrogen/creatinine ratio (author's transl)]
Anovulation
Alpha-Fetoprotein Controls Female Fertility and Prenatal Development of the Gonadotropin-Releasing Hormone Pathway through an Antiestrogenic Action.
Antiphospholipid Syndrome
Biochemical and Doppler predictors of poor perinatal outcome in a fetus with four umbilical vessels.
Anus, Imperforate
Maternal serum alpha-fetoprotein in fetal anal atresia and other gastro-intestinal obstructions.
Appendicitis
[Unusual clinical presentation of hepatic yolk sac tumour in periappendical region. A case report and review of the literature]
Apraxias
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Apraxias
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Apraxias
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Apraxias
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Apraxias
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Apraxias
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Apraxias
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Apraxias
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Apraxias
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Apraxias
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.
Arteriovenous Fistula
Combined use of alpha-fetoprotein and ultrasound in the prenatal diagnosis of arteriovenous fistula in the brain.
Arthritis
Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.
Arthritis, Rheumatoid
A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Elevated serum alpha-fetoprotein in a pregnant woman with rheumatoid arthritis.
Arthritis, Rheumatoid
High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
Arthritis, Rheumatoid
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Arthritis, Rheumatoid
Serum alpha-fetroprotein concentration in adult patients under corticoid, estroprogestative or androgen therapy.
arylsulfatase (type i) deficiency
Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis.
Ataxia
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Ataxia
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Ataxia
Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation.
Ataxia
Ataxia-telangiectasia: linkage analysis in highly inbred Arab and Druze families and differentiation from an ataxia-microcephaly-cataract syndrome.
Ataxia
Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
Ataxia
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Ataxia
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Ataxia
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Ataxia
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Ataxia
Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia.
Ataxia
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Ataxia
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Ataxia
Progressive Ataxia with Elevated Alpha-Fetoprotein: Diagnostic Issues and Review of the Literature.
Ataxia
Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.
Ataxia Telangiectasia
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
Ataxia Telangiectasia
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Ataxia Telangiectasia
Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation.
Ataxia Telangiectasia
Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.
Ataxia Telangiectasia
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
Ataxia Telangiectasia
ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome.
Ataxia Telangiectasia
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Ataxia Telangiectasia
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Ataxia Telangiectasia
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Ataxia Telangiectasia
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Ataxia Telangiectasia
Tissue of origin of elevated alpha-fetoprotein in ataxia-telangiectasia.
Autoimmune Diseases
Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
Autoimmune Diseases
Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization.
Autoimmune Diseases
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Autoimmune Diseases
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
Autoimmune Diseases
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Barrett Esophagus
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Beckwith-Wiedemann Syndrome
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Beckwith-Wiedemann Syndrome
Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Beckwith-Wiedemann Syndrome
Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
Beckwith-Wiedemann Syndrome
The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Biliary Atresia
Chubby face and the biochemical parameters for the early diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency.
Biliary Atresia
Liver transplantation for biliary atresia associated with malignant hepatic tumors.
Biliary Atresia
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ).
Biliary Atresia
The role of alpha-fetoprotein in the differentiation of neonatal hepatitis and biliary atresia.
Blister
Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk.
Brain Diseases
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Brain Diseases
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Brain Diseases
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Brain Diseases
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Brain Diseases
Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report.
Brain Neoplasms
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Brain Neoplasms
Genes Encoding Mammalian Oviductal Proteins Involved in Fertilization are Subjected to Gene Death and Positive Selection.
Brain Neoplasms
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1.
Brain Neoplasms
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Branchio-Oto-Renal Syndrome
The branchio-oto-renal (BOR) syndrome: report of bilateral renal agenesis in three sibs.
Breast Diseases
Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum.
Breast Neoplasms
A comparative study of four serological tumor markers for the detection of breast cancer.
Breast Neoplasms
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
Breast Neoplasms
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Breast Neoplasms
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Breast Neoplasms
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Breast Neoplasms
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Breast Neoplasms
Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Breast Neoplasms
Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk".
Breast Neoplasms
Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride.
Breast Neoplasms
Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Breast Neoplasms
Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum.
Breast Neoplasms
Estrogen action: A historic perspective on the implications of considering alternative approaches.
Breast Neoplasms
Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
Breast Neoplasms
Ethnic differences in breast cancer risk: a possible role for pregnancy levels of alpha-fetoprotein?
Breast Neoplasms
Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Breast Neoplasms
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Breast Neoplasms
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
Breast Neoplasms
Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Breast Neoplasms
Levels and correlates of alpha-fetoprotein in normal pregnancies among Caucasian and Chinese women.
Breast Neoplasms
Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.
Breast Neoplasms
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Breast Neoplasms
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Breast Neoplasms
Monoclonal antibodies against a component related to soluble estrogen receptor.
Breast Neoplasms
Plausible interaction of an alpha-fetoprotein cyclopeptide with the G-protein-coupled receptor model GPR30: docking study by molecular dynamics simulated annealing.
Breast Neoplasms
Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Breast Neoplasms
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Breast Neoplasms
Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility.
Breast Neoplasms
Serum tumor markers for detection of bone metastasis in breast cancer patients.
Breast Neoplasms
Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
Breast Neoplasms
Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.
Breast Neoplasms
Structural Analysis of AFP-like Peptides with Anti-breast Cancer Properties.
Breast Neoplasms
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
Breast Neoplasms
The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
Breast Neoplasms
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Breast Neoplasms
Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Breast Neoplasms
Vimentin and alpha-fetoprotein expression in breast cancer smears: relationship with various prognostic factors.
Breast Neoplasms
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.
Breast Neoplasms, Male
Alpha-fetoprotein-producing male breast cancer accompanied with hepatocellular carcinoma: assessment by lectin-affinity profile.
Budd-Chiari Syndrome
Budd-Chiari syndrome as an initial presentation of hepatocellular carcinoma: a case report.
Budd-Chiari Syndrome
Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma?
Budd-Chiari Syndrome
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Carcinogenesis
Alpha-fetoprotein (AFP) and alpha 2-macroglobulin (alpha 2-M) as the markers of distinct responses of hepatocytes to carcinogens in the rat: carcinogenesis.
Carcinogenesis
alpha-Fetoprotein and albumin genes of rats: no evidence for amplification-deletion or rearrangement in rat liver carcinogenesis.
Carcinogenesis
alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis.
Carcinogenesis
alpha-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration.
Carcinogenesis
alpha-Fetoprotein levels and hepatic alterations during chemical carcinogenesis in C57BL/6N mice.
Carcinogenesis
Alpha-fetoprotein molecular heterogeneity. Physiologic correlations with normal growth, carcinogenesis and tumor growth.
Carcinogenesis
Alpha-fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Carcinogenesis
Antibodies to alpha-fetoprotein disrupt histogenesis in cultured chick retinae.
Carcinogenesis
Cell adhesion proteins and alpha-fetoprotein. Similar structural motifs as prerequisites for common functions.
Carcinogenesis
Cell lineages in liver carcinogenesis: possible clues from studies of the distribution of alpha-fetoprotein RNA sequences in cell populations isolated from normal, regenerating, and preneoplastic rat livers.
Carcinogenesis
Correlation of deoxycytidylate deaminase activity with cell proliferation during hepatocarcinogenesis and tumour growth in transplantable rat hepatomas.
Carcinogenesis
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Carcinogenesis
Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases.
Carcinogenesis
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.
Carcinogenesis
Maternal risk of breast cancer following multiple births: a nationwide study in Sweden.
Carcinogenesis
Modifications of the expression of liver-specific and non-specific messenger RNAs during azo-dye hepatocarcinogenesis.
Carcinogenesis
On the synthesis of alpha-fetoprotein during liver carcinogenesis by N-2-fluorenylacetamide and its relationships with the intracellular localization of the carcinogen.
Carcinogenesis
Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts.
Carcinogenesis
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Carcinogenesis
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Carcinogenesis
Relationship between alpha-fetoprotein positive cells and precancerous lesions in rat liver during 3'-methyl-4-dimethylaminoazobenzene carcinogenesis.
Carcinogenesis
RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element.
Carcinogenesis
Sequence content of alpha-fetoprotein, albumin and fibrinogen polypeptide mRNAs in different organs, developing tissues and in liver during carcinogenesis in rats.
Carcinogenesis
Sequence requirements for Afr-2 regulation of alpha-fetoprotein gene expression during liver regeneration.
Carcinogenesis
Sequence requirements for alpha-fetoprotein gene expression during liver regeneration.
Carcinogenesis
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Carcinogenesis
Sex steroid hormones levels and testicular activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
Carcinogenesis
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
Carcinogenesis
Structural basis for alpha fetoprotein-mediated inhibition of caspase-3 activity in hepatocellular carcinoma cells.
Carcinogenesis
The effects of growth inhibitory peptide on follicular thyroid cancer cell growth, migration, and invasion.
Carcinogenesis
The expression of alpha-fetoprotein and albumin genes in rat liver during chemical carcinogenesis.
Carcinogenesis
The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
Carcinogenesis
Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia.
Carcinogenesis
[Characteristics of alpha-fetoprotein synthesis in the early stages of hepatic carcinogenesis in mice with a various sensitivity to ortho-aminoazotoluene]
Carcinogenesis
[Concentration of carcinoembryonic antigen, alpha-fetoprotein and beta-subunit of human chorionic gonadotropin in serum of workers employed directly in the production of coke]
Carcinogenesis
[Possibilities for the spread of alpha-fetoprotein and heterologous antibodies in mother and fetus during transplacental carcinogenesis]
Carcinogenesis
[Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter]
Carcinogenesis
[Transitory cell antigens of rat liver. 3. The reappearance of alpha-fetoprotein during chemical carcinogenesis (author's transl)]
Carcinoid Tumor
Histochemical studies of dense-core granulated tumors of the lung. Neuron-specific enolase as a marker for granulated cells.
Carcinoid Tumor
Primary carcinoid tumor of the testis: immunohistochemical, ultrastructural and DNA flow cytometric study of two cases.
Carcinoid Tumor
Pulmonary atypical carcinoid tumor with marked alphafetoprotein production and features of an adenocarcinoma differentiation.
Carcinoid Tumor
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Carcinoma
'5-5-500' - yet another extended criteria for HCC or a truly innovative development?
Carcinoma
A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA).
Carcinoma
A case of gastric carcinoma whose serum was positive for alpha-fetoprotein, variant alkaline phosphatase and CEA (author's transl)]
Carcinoma
A channel-resolved approach coupled with magnet-captured technique for multianalyte chemiluminescent immunoassay.
Carcinoma
A disposable multianalyte electrochemical immunosensor array for automated simultaneous determination of tumor markers.
Carcinoma
A distinctive antigen present in liver carcinomas induced by 3'-methyl-p-dimethylaminoazobenzene.
Carcinoma
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Carcinoma
A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor.
Carcinoma
A Portable Microfluidic System for Point-of-Care Detection of Multiple Protein Biomarkers.
Carcinoma
A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
Carcinoma
A rational route to hybrid aptamer-molecularly imprinted magnetic nanoprobe for recognition of protein biomarkers in human serum.
Carcinoma
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Carcinoma
Activation of an alpha-fetoprotein (AFP)/receptor autocrine loop in HT-29 human colon carcinoma cells.
Carcinoma
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
Carcinoma
Adenoendocrine cell carcinoma of the gallbladder producing a high level of alpha-fetoprotein.
Carcinoma
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Carcinoma
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Carcinoma
AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.
Carcinoma
AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.
Carcinoma
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.
Carcinoma
Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Carcinoma
Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?
Carcinoma
Alpha-fetoprotein and carcinoembryonic antigen in a case of gastric carcinoma metastatic to the liver.
Carcinoma
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Carcinoma
Alpha-fetoprotein in patients of gastric carcinoma with or without liver metastasis.
Carcinoma
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Carcinoma
Alpha-fetoprotein producing carcinoma of the gallbladder associated with anomalous arrangement of the pancreaticobiliary ductal system--early detection through an attack of acute pancreatitis.
Carcinoma
alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes.
Carcinoma
Alpha-fetoprotein producing mucin-producing carcinoma of the pancreas: a case report with immunohistochemical study and lectin-affinity profile.
Carcinoma
Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: A case report.
Carcinoma
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Carcinoma
Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor.
Carcinoma
alpha-Fetoprotein-producing adenocarcinoma of the pancreas presenting focal hepatoid differentiation.
Carcinoma
Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature.
Carcinoma
Alpha-fetoprotein-producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation.
Carcinoma
Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
Carcinoma
Alpha-fetoprotein-producing gastric carcinoma: biological properties of a cultured cell line.
Carcinoma
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Carcinoma
Alpha-fetoprotein-producing pancreatic cancer--a case report and review of 28 cases.
Carcinoma
Alpha-fetoprotein-producing pancreatic carcinoma: case report and review of the Japanese literature.
Carcinoma
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Carcinoma
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Carcinoma
Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report.
Carcinoma
An autopsy case of hepatoid carcinoma of the ovary with PIVKA-II production: immunohistochemical study and literature review.
Carcinoma
An unusual case, in Italy, of hepatocarcinoma characterized by portal hypertension and absence of cirrhosis.
Carcinoma
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Carcinoma
Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.
Carcinoma
Anti-Cytokeratin CAM 5.2 (Becton Dickinson) is not synonymous with CK8/18 monoclonal antibody. Comment on "Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 42:167-174".
Carcinoma
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Carcinoma
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Carcinoma
Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver.
Carcinoma
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma.
Carcinoma
Clear-Cell Adenocarcinoma of the Gallbladder with Alpha-Fetoprotein Production: A Case Report and Review of the Literature.
Carcinoma
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Carcinoma
Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC.
Carcinoma
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Carcinoma
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Carcinoma
Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Carcinoma
Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Carcinoma
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Carcinoma
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Carcinoma
Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases.
Carcinoma
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Carcinoma
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Carcinoma
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Carcinoma
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Carcinoma
Different characteristics of hepatoid and non-hepatoid alpha-fetoprotein-producing gastric carcinomas: an experimental study using xenografted tumors.
Carcinoma
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.
Carcinoma
Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.
Carcinoma
Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component.
Carcinoma
Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.
Carcinoma
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement.
Carcinoma
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Carcinoma
Enhanced liver metastatic potential of alpha-fetoprotein-producing human gastric carcinoma after carbon tetrachloride-induced liver damage in nude mice.
Carcinoma
Establishment and characterization of HEPFT, a cell line derived from hepatoid carcinoma of the fallopian tube, with special reference to alpha-fetoprotein, lectin affinity and histogenesis.
Carcinoma
Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
Carcinoma
Establishment of a testicular carcinoma cell line producing alpha-fetoprotein.
Carcinoma
Establishment of an alpha-fetoprotein-producing human gastric carcinoma in nude mice.
Carcinoma
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Carcinoma
Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinoma.
Carcinoma
Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.
Carcinoma
Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Carcinoma
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Carcinoma
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Carcinoma
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Carcinoma
Ferritin, alpha-fetoprotein and carcinoembryonic antigen concentration in the serum of mammary carcinoma patients.
Carcinoma
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
Carcinoma
Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, CEA and alpha-fetoprotein.
Carcinoma
Gastrointestinal Obstruction due to Solitary Lymph Node Recurrence of Alpha-Fetoprotein-Producing Gastric Carcinoma with Enteroblastic Differentiation.
Carcinoma
Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
Carcinoma
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Carcinoma
Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Carcinoma
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Carcinoma
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Carcinoma
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Carcinoma
Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma.
Carcinoma
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Carcinoma
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Carcinoma
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Carcinoma
Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).
Carcinoma
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
Carcinoma
Hepatoid carcinoma with serous component of the fallopian tube: a case report with immunohistochemical and ultrastructural studies.
Carcinoma
Heterotransplantation of an alpha-fetoprotein-producing human gallbladder carcinoma into nude mice.
Carcinoma
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Carcinoma
Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma.
Carcinoma
Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Carcinoma
Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein.
Carcinoma
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Carcinoma
Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
Carcinoma
Immunofluorescent localization of alpha fetoprotein in yolk sac carcinomas of the rat.
Carcinoma
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Carcinoma
Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
Carcinoma
In vitro upconverting/downshifting luminescent detection of tumor markers based on Eu3+-activated core-shell-shell lanthanide nanoprobes.
Carcinoma
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Carcinoma
Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases.
Carcinoma
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Carcinoma
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Carcinoma
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Carcinoma
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Carcinoma
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Carcinoma
miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
Carcinoma
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Carcinoma
Nanogram per milliliter-level immunologic detection of alpha-fetoprotein with integrated rotating-resonance microcantilevers for early-stage diagnosis of heptocellular carcinoma.
Carcinoma
Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report.
Carcinoma
Ovarian hepatoid carcinoma without staining for alpha-fetoprotein in the primary site.
Carcinoma
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Carcinoma
Pathological studies on primary carcinoma of the liver. A study of 89 cases among 3890 necropsies and a study of alpha-fetoprotein in the serum of 17 cases.
Carcinoma
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Carcinoma
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Carcinoma
Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Carcinoma
Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma.
Carcinoma
Propensity of ectopic liver to hepatocarcinogenesis: case reports and a review of the literature.
Carcinoma
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Carcinoma
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Carcinoma
Quantitative screening of serum protein biomarkers by reverse phase protein arrays.
Carcinoma
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Carcinoma
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Carcinoma
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Carcinoma
Sampling-resolution strategy for one-way multiplexed immunoassay with sequential chemiluminescent detection.
Carcinoma
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Carcinoma
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Carcinoma
Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Carcinoma
Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests.
Carcinoma
Solitary intraperitoneal recurrence of alpha-fetoprotein-producing gastric carcinoma: report of a case.
Carcinoma
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Carcinoma
The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Carcinoma
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
Carcinoma
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Carcinoma
The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth.
Carcinoma
The Research of No-Touch Isolation Technique on the Prevention of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma after Hepatectomy.
Carcinoma
The use of radioiodinated alpha-fetoprotein for the scintigraphic detection of mouse mammary carcinomas.
Carcinoma
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Carcinoma
The value of ultrasound in the diagnosis and treatment of small hepatocellular carcinoma.
Carcinoma
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Carcinoma
Transformation of an AFP-positive yolk sac carcinoma into an AFP-negative neoplasm. Evidence for in vivo cloning of the human parietal yolk sac carcinoma.
Carcinoma
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Carcinoma
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Carcinoma
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Carcinoma
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Carcinoma
Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Carcinoma
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Carcinoma
Undetected hepatocellular carcinoma in patients undergoing liver transplantation: is associated with favorable outcome.
Carcinoma
Uninfluenced alpha-fetoprotein and treatment of liver primary carcinoma by lobaplatin in combination with 5-fluorouracil and doxorubicin via chemoembolization and transarterial chemoembolization.
Carcinoma
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Carcinoma
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Carcinoma
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Carcinoma
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Carcinoma
[76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type]
Carcinoma
[A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma]
Carcinoma
[A case of alpha-fetoprotein-producing gastric carcinoma with histologic features of embryonal carcinoma]
Carcinoma
[A case of clear cell carcinoma of the hepatic bile duct with production of alpha-fetoprotein (AFP)]
Carcinoma
[A case of IgA-lambda producing gastric plasmacytoma associated with alpha-fetoprotein producing gastric carcinoma]
Carcinoma
[Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck]
Carcinoma
[An alpha-fetoprotein and PIVKA-II producing carcinoma of the colon: report of a case]
Carcinoma
[An autopsied case of alpha-fetoprotein (AFP) producing large cell carcinoma of the lung (author's transl)]
Carcinoma
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
Carcinoma
[An immunohistological study on an autopsy case of duodenal carcinoma associated with marked increasing of alpha-fetoprotein in the serum (author's transl)]
Carcinoma
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
Carcinoma
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]
Carcinoma
[Cytodiagnosis of primary liver cell carcinoma with reference to alpha-fetoprotein (author's transl)]
Carcinoma
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
Carcinoma
[Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
Carcinoma
[Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system]
Carcinoma
[Elevated serum alpha-fetoprotein in a case of rectum carcinoma with liver cirrhosis (author's transl)]
Carcinoma
[Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure]
Carcinoma
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
Carcinoma
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Carcinoma
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
Carcinoma
[Positive alpha-fetoprotein in a case of metastatic gastric carcinoma, Borrmann type 3]
Carcinoma
[Preliminary data on possibilities for the early detection of risk for primary liver carcinoma in chronic HBsAg carriers]
Carcinoma
[Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency]
Carcinoma
[Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Carcinoma
[Significance of serum golgi protein 73 (GP73), alpha-fetoprotein (AFP) and lectin-reactive alpha-fetoprotein (AFP-L3) expresssion in primary hepatic carcinoma].
Carcinoma
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
Carcinoma
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Carcinoma
[The immunohistological study of alpha-fetoprotein on carcinoma of digestive organs (author's transl)]
Carcinoma
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice]
Carcinoma
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
Carcinoma
[Three-dimensional conformal radiation therapy for malignant tumors (report of 1,024 cases)]
Carcinoma, Acinar Cell
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Carcinoma, Acinar Cell
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
Carcinoma, Acinar Cell
AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.
Carcinoma, Acinar Cell
Alpha-fetoprotein-positive carcinoma of the pancreas: a case report.
Carcinoma, Acinar Cell
Alpha-fetoprotein-producing pancreatic cancer--a case report and review of 28 cases.
Carcinoma, Acinar Cell
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Carcinoma, Acinar Cell
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
Carcinoma, Acinar Cell
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
Carcinoma, Adenosquamous
Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients.
Carcinoma, Embryonal
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Carcinoma, Embryonal
A suprasellar embryonal carcinoma producing alpha-fetoprotein and human chorionic gonadotropin; treated with combined chemotherapy followed by radiotherapy.
Carcinoma, Embryonal
Alpha-fetoprotein and human chorionic gonadotropin in embryonal carcinoma of the ovary. An 8-year survival case.
Carcinoma, Embryonal
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Carcinoma, Embryonal
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Carcinoma, Embryonal
Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
Carcinoma, Embryonal
Enhancement of reporter gene de novo methylation by DNA fragments from the alpha-fetoprotein control region.
Carcinoma, Embryonal
Expression of the alpha-fetoprotein gene in pluripotent and committed cells.
Carcinoma, Embryonal
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Carcinoma, Embryonal
Immunohistochemistry of alpha-fetoprotein in testicular embryonal carcinoma.
Carcinoma, Embryonal
Improved staging for testicular cancer using biologic tumor markers: a prospective study.
Carcinoma, Embryonal
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Carcinoma, Embryonal
Intracranial mixed germ cell tumor with syncytiotrophoblastic giant cells and precocious puberty.
Carcinoma, Embryonal
Long-term follow-up of germinoma after stereotactic biopsy and brain radiotherapy: a cell kinetics study.
Carcinoma, Embryonal
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Carcinoma, Embryonal
Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Carcinoma, Embryonal
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Carcinoma, Embryonal
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Carcinoma, Embryonal
Suspected extragonadal germ-cell cancer syndrome presenting with an orbital mass and elevation of serum CEA, CA 19-9 and CA50 levels.
Carcinoma, Embryonal
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Carcinoma, Embryonal
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
Carcinoma, Embryonal
The capacity for differentiation and production of human chorionic gonadotropin and alpha-fetoprotein in human embryonal carcinoma cell lines.
Carcinoma, Embryonal
The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene.
Carcinoma, Embryonal
Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line.
Carcinoma, Embryonal
VAB-4 combination chemotherapy in the treatment of metastatic testis tumors.
Carcinoma, Embryonal
[A case of alpha-fetoprotein producing embryonal carcinoma of the stomach]
Carcinoma, Embryonal
[A case of alpha-fetoprotein producing primary intracranial embryonal carcinoma treated with combination chemotherapy with cis-platinum, vinblastine and bleomycin (author's transl)]
Carcinoma, Embryonal
[Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases]
Carcinoma, Embryonal
[Significance of tumor markers in the treatment of patients with ovarian malignancies]
Carcinoma, Endometrioid
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Carcinoma, Endometrioid
Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary.
Carcinoma, Endometrioid
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Carcinoma, Endometrioid
Pseudoglandular hepatoid differentiation in endometrioid carcinoma of the ovary simulates oxyphilic cell change.
Carcinoma, Endometrioid
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Carcinoma, Hepatocellular
240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
Carcinoma, Hepatocellular
68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
Carcinoma, Hepatocellular
8-Quinolineboronic acid as a potential phosphorescent molecular switch for the determination of alpha-fetoprotein variant for the prediction of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
9-cis-retinoic acid is more effective than all-trans-retinoic acid in upregulating expression of the alpha-fetoprotein gene.
Carcinoma, Hepatocellular
A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
Carcinoma, Hepatocellular
A case of hepatocellular carcinoma with the sign of Leser-Trelat: a possible role of a cutaneous marker for internal malignancy.
Carcinoma, Hepatocellular
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
Carcinoma, Hepatocellular
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
Carcinoma, Hepatocellular
A Case-Control Study of Correlation between Preoperative Serum AFP and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy.
Carcinoma, Hepatocellular
A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Carcinoma, Hepatocellular
A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks.
Carcinoma, Hepatocellular
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
Carcinoma, Hepatocellular
A fluorometric aptamer nanoprobe for alpha-fetoprotein by exploiting the FRET between 5-carboxyfluorescein and palladium nanoparticles.
Carcinoma, Hepatocellular
A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Carcinoma, Hepatocellular
A lectin-based monoclonal enzyme immunoassay to distinguish fucosylated and non-fucosylated alpha-fetoprotein molecular variants.
Carcinoma, Hepatocellular
A malignant, stem cell-like somatic hybrid between a mouse teratocarcinoma and a rat ascitic hepatoma is differentiation competent.
Carcinoma, Hepatocellular
A Markov model for analysing cancer markers and disease states in survival studies.
Carcinoma, Hepatocellular
A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity.
Carcinoma, Hepatocellular
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
Carcinoma, Hepatocellular
A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
Carcinoma, Hepatocellular
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
Carcinoma, Hepatocellular
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Carcinoma, Hepatocellular
A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
Carcinoma, Hepatocellular
A new restriction fragment length polymorphism of the human alpha-fetoprotein gene in Japanese individuals: detection of loss of heterozygosity in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells.
Carcinoma, Hepatocellular
A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
Carcinoma, Hepatocellular
A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.
Carcinoma, Hepatocellular
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Carcinoma, Hepatocellular
A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
Carcinoma, Hepatocellular
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
Carcinoma, Hepatocellular
A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma.
Carcinoma, Hepatocellular
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol ester.
Carcinoma, Hepatocellular
A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Carcinoma, Hepatocellular
A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.
Carcinoma, Hepatocellular
A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma.
Carcinoma, Hepatocellular
A Rare Presentation of Hepatocellular Carcinoma in a Young Adult: A Case Report.
Carcinoma, Hepatocellular
A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Carcinoma, Hepatocellular
A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Carcinoma, Hepatocellular
A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Carcinoma, Hepatocellular
A specific alpha-fetoprotein gene binding protein in alpha-fetoprotein producing rat hepatomas.
Carcinoma, Hepatocellular
A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.
Carcinoma, Hepatocellular
A-G Score Associated With Outcomes in Solitary Hepatocellular Carcinoma Patients After Hepatectomy.
Carcinoma, Hepatocellular
Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembryonic antigen.
Carcinoma, Hepatocellular
Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
Carcinoma, Hepatocellular
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Absolute Quantification of N-Glycosylation of Alpha-Fetoprotein Using Parallel Reaction Monitoring with Stable Isotope-Labeled N-Glycopeptide as an Internal Standard.
Carcinoma, Hepatocellular
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Carcinoma, Hepatocellular
Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression.
Carcinoma, Hepatocellular
Activation of alpha-fetoprotein synthesis in rat hepatoma cells with reduced sensitivity to dexamethasone.
Carcinoma, Hepatocellular
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Carcinoma, Hepatocellular
Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
Carcinoma, Hepatocellular
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Carcinoma, Hepatocellular
AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.
Carcinoma, Hepatocellular
AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
Carcinoma, Hepatocellular
AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein.
Carcinoma, Hepatocellular
AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Carcinoma, Hepatocellular
Ag/SiO2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools.
Carcinoma, Hepatocellular
Age-distribution of alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Albumin and alpha-fetoprotein gene expression and DNA methylation in rat hepatoma cell lines.
Carcinoma, Hepatocellular
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.
Carcinoma, Hepatocellular
Aldolase A isoenzyme levels in serum and tissues of patients with liver diseases.
Carcinoma, Hepatocellular
Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.
Carcinoma, Hepatocellular
Allomyrina dichotoma lectin-nonreactive alpha-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I.
Carcinoma, Hepatocellular
Alpha Fetoprotein-Secreting Gastric Cancer in the Setting of Chronic Hepatitis B: The Role of Endoscopy.
Carcinoma, Hepatocellular
Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience.
Carcinoma, Hepatocellular
Alpha-fetoprotein (AFP) expression in clones of McA-RH 7777 rat hepatoma: correlation with the occurrence of homogeneously staining regions on chromosome 14.
Carcinoma, Hepatocellular
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Carcinoma, Hepatocellular
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary.
Carcinoma, Hepatocellular
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Carcinoma, Hepatocellular
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Carcinoma, Hepatocellular
Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
Carcinoma, Hepatocellular
Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.
Carcinoma, Hepatocellular
Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Carcinoma, Hepatocellular
Alpha-fetoprotein and albumin produced by subclonal cell population of the ascites hepatoma AH-66 in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.
Carcinoma, Hepatocellular
Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Carcinoma, Hepatocellular
Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Carcinoma, Hepatocellular
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Carcinoma, Hepatocellular
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Carcinoma, Hepatocellular
Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Carcinoma, Hepatocellular
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Carcinoma, Hepatocellular
Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization.
Carcinoma, Hepatocellular
Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.
Carcinoma, Hepatocellular
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Carcinoma, Hepatocellular
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Carcinoma, Hepatocellular
alpha-Fetoprotein detected in rat transplantable hepatomas by radioimmunoassay.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Carcinoma, Hepatocellular
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein expression in hepatocellular carcinoma: a clinical study.
Carcinoma, Hepatocellular
Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
Carcinoma, Hepatocellular
alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.
Carcinoma, Hepatocellular
alpha-Fetoprotein gene methylation and hepatocarcinogenesis in rats fed a choline-devoid diet.
Carcinoma, Hepatocellular
Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration.
Carcinoma, Hepatocellular
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Carcinoma, Hepatocellular
Alpha-fetoprotein impairs APC function and induces their apoptosis.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma with an abnormal electrophoretic alpha-1-fraction.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
Carcinoma, Hepatocellular
Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.
Carcinoma, Hepatocellular
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Carcinoma, Hepatocellular
Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in tumor-bearing mice assayed by particle agglutination inhibition.
Carcinoma, Hepatocellular
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Carcinoma, Hepatocellular
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.
Carcinoma, Hepatocellular
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Carcinoma, Hepatocellular
Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy.
Carcinoma, Hepatocellular
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Carcinoma, Hepatocellular
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Carcinoma, Hepatocellular
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.
Carcinoma, Hepatocellular
Alpha-Fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risks.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Carcinoma, Hepatocellular
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Carcinoma, Hepatocellular
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
Carcinoma, Hepatocellular
Alpha-fetoprotein mRNA: variation of half-life in rat hepatoma cell lines and destabilization by sodium butyrate.
Carcinoma, Hepatocellular
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
Carcinoma, Hepatocellular
Alpha-fetoprotein on human peripheral blood lymphocytes does not block complement-dependent lymphocytotoxicity.
Carcinoma, Hepatocellular
Alpha-fetoprotein producing clones derived from ascites hepatoma AH70B culture.
Carcinoma, Hepatocellular
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Carcinoma, Hepatocellular
Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
Carcinoma, Hepatocellular
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-?B (P65) Pathway in Hepatocellular Carcinoma Cells.
Carcinoma, Hepatocellular
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival.
Carcinoma, Hepatocellular
Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis.
Carcinoma, Hepatocellular
Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
Carcinoma, Hepatocellular
alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Carcinoma, Hepatocellular
alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Carcinoma, Hepatocellular
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Carcinoma, Hepatocellular
Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells.
Carcinoma, Hepatocellular
Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Carcinoma, Hepatocellular
Alpha-fetoprotein testing is still necessary for the detection of small hepatocellular carcinomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Carcinoma, Hepatocellular
alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
Carcinoma, Hepatocellular
Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Carcinoma, Hepatocellular
Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Carcinoma, Hepatocellular
Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing capacity, chromosomal and morphological properties in human hepatoma cells treated with various chemotherapeutic agents.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing male breast cancer accompanied with hepatocellular carcinoma: assessment by lectin-affinity profile.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Carcinoma, Hepatocellular
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Carcinoma, Hepatocellular
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.
Carcinoma, Hepatocellular
Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: A novel model for dual modality longitudinal imaging of tumorigenesis in liver.
Carcinoma, Hepatocellular
Alpha-fetoprotein/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells.
Carcinoma, Hepatocellular
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Carcinoma, Hepatocellular
Alpha-fetoprotein: diagnostic and prognostic use in patients with hepatomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Carcinoma, Hepatocellular
Alpha-fetoprotein: its immunofluorescent localization in human fetal liver and hepatoma.
Carcinoma, Hepatocellular
alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756.
Carcinoma, Hepatocellular
Alpha-Fetoprotein: The Predictor of Microvascular Invasion in Solitary Small Hepatocellular Carcinoma and Criterion for Anatomic or Non-Anatomic Hepatic Resection.
Carcinoma, Hepatocellular
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Carcinoma, Hepatocellular
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Carcinoma, Hepatocellular
Altered dynamics of alpha-fetoprotein production following pyridoxine and adenosine 5'-triphosphate administration to cirrhotic patients with or without primary hepatomas and to liver-injured and hepatoma-bearing rats.
Carcinoma, Hepatocellular
Altered glycosylation of alpha-fetoprotein in hepadnavirus-induced hepatocellular carcinoma of the woodchuck.
Carcinoma, Hepatocellular
An acute form of tyrosinemia type I with multiple intrahepatic mass lesions.
Carcinoma, Hepatocellular
An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
Carcinoma, Hepatocellular
An analysis of the UNOS liver transplant registry: High serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Carcinoma, Hepatocellular
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Carcinoma, Hepatocellular
An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein.
Carcinoma, Hepatocellular
An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma.
Carcinoma, Hepatocellular
An fluorescent aptasensor for sensitive detection of tumor marker based on the FRET of a sandwich structured QDs-AFP-AuNPs.
Carcinoma, Hepatocellular
An immuno-electron microscopic study on intra and extracellular localization of alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Carcinoma, Hepatocellular
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Carcinoma, Hepatocellular
Analysis and optimization of nonequilibrium capillary electrophoresis of alpha-fetoprotein isoforms.
Carcinoma, Hepatocellular
Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
Carcinoma, Hepatocellular
Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Carcinoma, Hepatocellular
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
Carcinoma, Hepatocellular
Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Analytical and Clinical Performance Evaluation of the Abbott Architect PIVKA Assay.
Carcinoma, Hepatocellular
Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and alpha-fetoprotein expression status.
Carcinoma, Hepatocellular
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Carcinoma, Hepatocellular
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Carcinoma, Hepatocellular
Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway.
Carcinoma, Hepatocellular
Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody.
Carcinoma, Hepatocellular
Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in alpha-fetoprotein-producing human liver cancer cells.
Carcinoma, Hepatocellular
Apolipoproteinemia A and alpha-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: several interpretations.
Carcinoma, Hepatocellular
Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Appearance of alpha-fetoprotein in rat serum during induction of primary hepatoma with regard to development of histological changes in liver tissue.
Carcinoma, Hepatocellular
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
Carcinoma, Hepatocellular
Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options.
Carcinoma, Hepatocellular
Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Carcinoma, Hepatocellular
Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide.
Carcinoma, Hepatocellular
ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Carcinoma, Hepatocellular
Assessment of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma in Middle Eastern Patients.
Carcinoma, Hepatocellular
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs.
Carcinoma, Hepatocellular
Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.
Carcinoma, Hepatocellular
Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Carcinoma, Hepatocellular
Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.
Carcinoma, Hepatocellular
Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
Carcinoma, Hepatocellular
Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Carcinoma, Hepatocellular
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Autoantibody signature in hepatocellular carcinoma using seromics.
Carcinoma, Hepatocellular
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Carcinoma, Hepatocellular
Beta2-microglobulin levels of serum and ascites in malignant diseases.
Carcinoma, Hepatocellular
Bile acid synthesis by long-term cultured cell line established from human hepatoblastoma.
Carcinoma, Hepatocellular
Biliary alkaline phosphatase measured by mini-column chromatography on DEAE-cellulose: application to detection of hepatobiliary diseases.
Carcinoma, Hepatocellular
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
Carcinoma, Hepatocellular
Boronate affinity chromatography of gamma-glutamyltransferase in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature.
Carcinoma, Hepatocellular
Budd-Chiari syndrome as an initial presentation of hepatocellular carcinoma: a case report.
Carcinoma, Hepatocellular
c-Ha-ras down regulates the alpha-fetoprotein gene but not the albumin gene in human hepatoma cells.
Carcinoma, Hepatocellular
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Carcinoma, Hepatocellular
Cancer in Bangladesh: a model for some problems and proposed solutions in the Third World.
Carcinoma, Hepatocellular
Capillary electrochromatography immunoassay for alpha-fetoprotein based on poly(guanidinium ionic liquid) monolithic material.
Carcinoma, Hepatocellular
Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives.
Carcinoma, Hepatocellular
Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
Carcinoma, Hepatocellular
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Carcinoembryonic character of gamma-glutamyltranspeptidase in primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Carcinoma, Hepatocellular
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Carcinoma, Hepatocellular
Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.
Carcinoma, Hepatocellular
Change of alpha-fetoprotein content during cell cycle of human hepatoma cells in vitro: flow cytometric analysis.
Carcinoma, Hepatocellular
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Carcinoma, Hepatocellular
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Carcinoma, Hepatocellular
Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.
Carcinoma, Hepatocellular
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Carcinoma, Hepatocellular
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Carcinoma, Hepatocellular
Characterization and nucleotide sequences of the variable regions of a monoclonal antibody against alpha-fetoprotein.
Carcinoma, Hepatocellular
Characterization of alpha-fetoprotein secreted from cultured reuber H-35 hepatoma cells.
Carcinoma, Hepatocellular
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Carcinoma, Hepatocellular
Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells.
Carcinoma, Hepatocellular
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
Carcinoma, Hepatocellular
Chromosome analysis of hepatocellular carcinoma 7777 and correlation with alpha-fetoprotein production.
Carcinoma, Hepatocellular
Chronological change in alpha-fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus.
Carcinoma, Hepatocellular
Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence.
Carcinoma, Hepatocellular
Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Carcinoma, Hepatocellular
Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.
Carcinoma, Hepatocellular
Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
Carcinoma, Hepatocellular
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
Carcinoma, Hepatocellular
Clinical Application of Determining Serum AFP-IgM Complexes for Diagnosis of Small Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Carcinoma, Hepatocellular
Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
Carcinoma, Hepatocellular
Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Carcinoma, Hepatocellular
Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
Carcinoma, Hepatocellular
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Carcinoma, Hepatocellular
Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Carcinoma, Hepatocellular
Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: Comparison in mice and humans.
Carcinoma, Hepatocellular
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.
Carcinoma, Hepatocellular
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Carcinoma, Hepatocellular
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical evaluation of serum alpha-fetoprotein-IgM immune complexes on the diagnosis of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.
Carcinoma, Hepatocellular
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Carcinoma, Hepatocellular
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Carcinoma, Hepatocellular
Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical outcomes of patients with a high alpha-fetoprotein level but without evident recurrence on CT or MRI in surveillance after curative-intent treatment for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical role of combining alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study.
Carcinoma, Hepatocellular
Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
Carcinoma, Hepatocellular
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Alpha-Fetoprotein mRNA in Peripheral Blood in Liver Resection for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of mrp gene in primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.
Carcinoma, Hepatocellular
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Carcinoma, Hepatocellular
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20?ng/mL.
Carcinoma, Hepatocellular
Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
Carcinoma, Hepatocellular
Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
Carcinoma, Hepatocellular
Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.
Carcinoma, Hepatocellular
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-?-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Carcinoma, Hepatocellular
Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
Carcinoma, Hepatocellular
Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Carcinoma, Hepatocellular
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Carcinoma, Hepatocellular
Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Carcinoma, Hepatocellular
Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.
Carcinoma, Hepatocellular
Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.
Carcinoma, Hepatocellular
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Carcinoma, Hepatocellular
Coagulation assays as diagnostic markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Coexistence of expressed and non-expressed alpha-fetoprotein genes in somatic cell hybrids.
Carcinoma, Hepatocellular
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combination of alpha-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence.
Carcinoma, Hepatocellular
Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases.
Carcinoma, Hepatocellular
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Carcinoma, Hepatocellular
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation.
Carcinoma, Hepatocellular
Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Carcinoma, Hepatocellular
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
Carcinoma, Hepatocellular
Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome.
Carcinoma, Hepatocellular
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Carcinoma, Hepatocellular
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Carcinoma, Hepatocellular
Combined measurement of preoperative ?-fetoprotein and des-?-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Carcinoma, Hepatocellular
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.
Carcinoma, Hepatocellular
Comment on Alpha-Fetoprotein Decrease from > 1.000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Carcinoma, Hepatocellular
Comparative analysis of core-fucose-binding lectins from Lens culinaris and Pisum sativum using frontal affinity chromatography.
Carcinoma, Hepatocellular
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein???400 ng/mL: A Matching-Adjusted Indirect Comparison.
Carcinoma, Hepatocellular
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Carcinoma, Hepatocellular
Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Carcinoma, Hepatocellular
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Carcinoma, Hepatocellular
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone.
Carcinoma, Hepatocellular
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Comparison of the acute phase response of cultured Morris hepatoma 7777 cells and of rat hepatocytes.
Carcinoma, Hepatocellular
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Carcinoma, Hepatocellular
Comparison of ultrasound guided versus CT guided radiofrequency ablation on liver function, serum PIVKA-II, AFP levels and recurrence in patients with primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Computational intelligence identifies alkaline phosphatase (ALP), alpha-fetoprotein (AFP), and hemoglobin levels as most predictive survival factors for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Concanavalin A affinity molecular variants of alpha-fetoprotein in neonatal rat serum and in the serum of rats bearing hepatomas.
Carcinoma, Hepatocellular
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Carcinoma, Hepatocellular
Concanavalin-A-affinity molecular heterogeneity of human hepatoma AFP and cord-serum AFP.
Carcinoma, Hepatocellular
Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Conditions required for activation of the mouse albumin or alpha-fetoprotein gene in hybrids between mouse lymphoblastoma and rat hepatoma cells.
Carcinoma, Hepatocellular
Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium.
Carcinoma, Hepatocellular
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Carcinoma, Hepatocellular
Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Control of albumin and alpha-fetoprotein expression in rat liver and in some transplantable hepatocellular carcinomas.
Carcinoma, Hepatocellular
Control of serum protein production in hepatocyte hybridomas: immortalization and expression of normal hepatocyte genes.
Carcinoma, Hepatocellular
Coordinate secretion of mouse alphafetoprotein, mouse albumin and rat albumin by mouse hepatoma-rat hepatoma hybrid cells.
Carcinoma, Hepatocellular
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.
Carcinoma, Hepatocellular
Correlating serum alpha-fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere).
Carcinoma, Hepatocellular
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
Carcinoma, Hepatocellular
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Carcinoma, Hepatocellular
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico.
Carcinoma, Hepatocellular
Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines.
Carcinoma, Hepatocellular
Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Carcinoma, Hepatocellular
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
Carcinoma, Hepatocellular
CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
Carcinoma, Hepatocellular
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Carcinoma, Hepatocellular
Culturing of human hepatocellular carcinoma. A simple and reproducible method.
Carcinoma, Hepatocellular
Current role of local ablative treatments for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cytophotometric measurements of nuclear DNA content in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells.
Carcinoma, Hepatocellular
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Carcinoma, Hepatocellular
Cytotoxic effects of daunomycin-fatty acid complexes on rat hepatoma cells.
Carcinoma, Hepatocellular
Cytotoxicity induced by monoclonal antibody to alpha-fetoprotein coadministered with spleen cells of nude mice.
Carcinoma, Hepatocellular
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
Carcinoma, Hepatocellular
Datura stramonium agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors.
Carcinoma, Hepatocellular
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Carcinoma, Hepatocellular
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Carcinoma, Hepatocellular
Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir.
Carcinoma, Hepatocellular
Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Carcinoma, Hepatocellular
Delineation of antigenic pathways of ethionine-induced liver cancer in the rat.
Carcinoma, Hepatocellular
Demonstration of a novel cellular retinol-binding protein, F-type, in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Carcinoma, Hepatocellular
Depressed immune function in patients with cirrhosis before emergence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Des-?-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Carcinoma, Hepatocellular
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Carcinoma, Hepatocellular
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Carcinoma, Hepatocellular
Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Carcinoma, Hepatocellular
Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor.
Carcinoma, Hepatocellular
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Carcinoma, Hepatocellular
Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit.
Carcinoma, Hepatocellular
Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.
Carcinoma, Hepatocellular
Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
Carcinoma, Hepatocellular
Detection of messenger RNAs of alpha-fetoprotein and albumin in a human hepatoma cell line by in situ hybridization.
Carcinoma, Hepatocellular
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Carcinoma, Hepatocellular
Detection, Isolation, and Characterization of alpha-fetoprotein-specific T Cell Populations and Clones Using MHC Class I Multimer Magnetic Sorting.
Carcinoma, Hepatocellular
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use.
Carcinoma, Hepatocellular
Determination of alpha-fetoprotein in human serum by a quartz crystal microbalance-based immunosensor.
Carcinoma, Hepatocellular
Determination of optimum cutoff levels of plasma des-gamma-carboxy prothrombin and serum alpha-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves.
Carcinoma, Hepatocellular
Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Carcinoma, Hepatocellular
Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort.
Carcinoma, Hepatocellular
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Carcinoma, Hepatocellular
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Carcinoma, Hepatocellular
Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer.
Carcinoma, Hepatocellular
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Carcinoma, Hepatocellular
Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Carcinoma, Hepatocellular
Development of on-chip fully automated immunoassay system "?TASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dexamethasone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Carcinoma, Hepatocellular
Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Carcinoma, Hepatocellular
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.
Carcinoma, Hepatocellular
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Carcinoma, Hepatocellular
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Carcinoma, Hepatocellular
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Carcinoma, Hepatocellular
Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis.
Carcinoma, Hepatocellular
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
Carcinoma, Hepatocellular
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Carcinoma, Hepatocellular
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
Carcinoma, Hepatocellular
Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Carcinoma, Hepatocellular
Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Carcinoma, Hepatocellular
Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Carcinoma, Hepatocellular
Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Carcinoma, Hepatocellular
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.
Carcinoma, Hepatocellular
Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Carcinoma, Hepatocellular
Diagnostic value of serum tumor markers in asymptomatic individuals.
Carcinoma, Hepatocellular
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Carcinoma, Hepatocellular
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients.
Carcinoma, Hepatocellular
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Carcinoma, Hepatocellular
Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Differential effects of dimethyl sulfoxide and sodium butyrate on alpha-fetoprotein, albumin, and transferrin production by rat hepatomas in culture.
Carcinoma, Hepatocellular
Differential Expression of Glypican-3 and InsulinLike Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
Carcinoma, Hepatocellular
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
Carcinoma, Hepatocellular
Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differential regulation of albumin gene expression by heparin-binding epidermal growth factor-like growth factor in alpha-fetoprotein-producing and -nonproducing human hepatoma cells.
Carcinoma, Hepatocellular
Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
Carcinoma, Hepatocellular
Diffuse intrahepatic recurrence after resection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Carcinoma, Hepatocellular
Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Carcinoma, Hepatocellular
Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.
Carcinoma, Hepatocellular
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Carcinoma, Hepatocellular
Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.
Carcinoma, Hepatocellular
Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Carcinoma, Hepatocellular
Distribution of alpha-fetoprotein-producing cells and proliferating cells in human hepatoma cells transplanted into athymic mice.
Carcinoma, Hepatocellular
Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.
Carcinoma, Hepatocellular
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice.
Carcinoma, Hepatocellular
Do overexpressed oncoproteins cause malignant growth of cancer cells?--Studied by antisense oligonucleotides.
Carcinoma, Hepatocellular
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Carcinoma, Hepatocellular
Does the Preoperative Alpha-fetoprotein Predict the recurrence and mortality after Hepatectomy for Hepatocellular Carcinoma without macrovascular invasion in patients with normal liver function?
Carcinoma, Hepatocellular
Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Carcinoma, Hepatocellular
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Carcinoma, Hepatocellular
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
Carcinoma, Hepatocellular
Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells.
Carcinoma, Hepatocellular
DR-70 immunoassay for the surveillance of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Dracocephalum: novel anticancer plant acting on liver cancer cell mitochondria.
Carcinoma, Hepatocellular
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Carcinoma, Hepatocellular
Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Duplex pulsed Doppler sonography of hepatocellular carcinoma treated with transcatheter arterial embolization.
Carcinoma, Hepatocellular
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Dynamics of alpha-fetoprotein production compared to alpha 2-macroglobulin during induction of primary hepatoma with 4-dimethylaminoazobenzene in rats.
Carcinoma, Hepatocellular
Dynamics of serum alpha-fetoprotein during spontaneous hepatocellular carcinoma development in mice.
Carcinoma, Hepatocellular
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
Carcinoma, Hepatocellular
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Carcinoma, Hepatocellular
Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Carcinoma, Hepatocellular
Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report.
Carcinoma, Hepatocellular
Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
Carcinoma, Hepatocellular
Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients.
Carcinoma, Hepatocellular
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Carcinoma, Hepatocellular
Early diagnosis of hepatocellular carcinoma with lectin electrophoresis of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Early on-treatment predictions of clinical outcomes using AFP and DCP responses in patients with advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Carcinoma, Hepatocellular
Effect of alpha-fetoprotein and albumin on the uptake of polyunsaturated fatty acids by rat hepatoma cells and fetal rat hepatocytes.
Carcinoma, Hepatocellular
Effect of alpha-fetoprotein and other serum factors derived from hepatoma-bearing rats on the mixed lymphocyte response.
Carcinoma, Hepatocellular
Effect of alpha-interferon on anti-alpha-fetoprotein-monoclonal-antibody targeting of hepatoma.
Carcinoma, Hepatocellular
Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetoprotein-producing hepatoma cells in vitro.
Carcinoma, Hepatocellular
Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effect of BCG on hepatocarcinogenesis of the rat induced by 3'-methyl-4-(dimethylamino)azobenzene.
Carcinoma, Hepatocellular
Effect of cross-reactivity of alpha-fetoprotein monoclonal antibody on quantitation of serum AFP and radioimmunodetection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effect of cyclic AMP and related substances on the production of alpha-fetoprotein by ascites hepatoma AH-66 cells in culture.
Carcinoma, Hepatocellular
Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines.
Carcinoma, Hepatocellular
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Carcinoma, Hepatocellular
Effect of insulin on the growth of a human hepatoma cell line PLC/PRF/5: a possible role of insulin receptor.
Carcinoma, Hepatocellular
Effect of phorbol esters and hormones on rat hepatoma cells producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Effect of pre- and post-treatment ?-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Carcinoma, Hepatocellular
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Carcinoma, Hepatocellular
Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Carcinoma, Hepatocellular
Effect of simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on alpha-fetoprotein gene expression through interaction with the ras-mediated pathway.
Carcinoma, Hepatocellular
Effect of sodium butyrate on alpha-fetoprotein gene expression in rat hepatoma cells in vitro.
Carcinoma, Hepatocellular
Effect of specific immunotherapy with preimmunization against alpha-fetoprotein on a mouse transplantable hepatoma.
Carcinoma, Hepatocellular
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer.
Carcinoma, Hepatocellular
Effects of alpha-difluoromethyl ornithine on alpha-fetoprotein and albumin secretion in human hepatoma cell line, PLC/PRF/5.
Carcinoma, Hepatocellular
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Carcinoma, Hepatocellular
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines.
Carcinoma, Hepatocellular
Effects of dexamethasone and insulin on the acute phase response of Morris hepatoma cells and of rat hepatocytes in culture.
Carcinoma, Hepatocellular
Effects of dibutyryl adenosine 3'-5' cyclic monophosphate on the ultrastructure of rat ascites hepatoma cells and on the intracellular localization of alpha-fetoprotein.
Carcinoma, Hepatocellular
Effects of hexamethylene bisacetamide on alpha-fetoprotein, albumin, and transferrin production by two rat hepatoma cell lines.
Carcinoma, Hepatocellular
Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Effects of serum and serum-derived factors on the growth and production of alpha-fetoprotein and albumin by human hepatoma cell lines.
Carcinoma, Hepatocellular
Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
Carcinoma, Hepatocellular
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials.
Carcinoma, Hepatocellular
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
Carcinoma, Hepatocellular
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Carcinoma, Hepatocellular
Efficiency of whole-body 18F-FDG PET CT in detecting the cause of rising serum AFP level in post-therapeutic follow-up for HCC patients.
Carcinoma, Hepatocellular
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Carcinoma, Hepatocellular
Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.
Carcinoma, Hepatocellular
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Carcinoma, Hepatocellular
Elevated serum alpha-fetoprotein level of nude mice bearing hepatoma cells by treatment with monoclonal antibodies to alpha-fetoprotein.
Carcinoma, Hepatocellular
Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis.
Carcinoma, Hepatocellular
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement.
Carcinoma, Hepatocellular
Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance.
Carcinoma, Hepatocellular
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Endoscopic injection sclerotherapy for esophageal varices associated with concomitant portal venous thrombus of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.
Carcinoma, Hepatocellular
Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
Carcinoma, Hepatocellular
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Carcinoma, Hepatocellular
Epidermal growth factor stimulates proliferation of rat hepatoma cells producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
Carcinoma, Hepatocellular
Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carcinoma, Hepatocellular
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Carcinoma, Hepatocellular
Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.
Carcinoma, Hepatocellular
Establishment and characterization of primary canine hepatocellular carcinoma cell lines producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Establishment of an AFP-producing serum-independent culture cell line of human liver cancer and changes in protein synthesis associated with the absence of serum (second part).
Carcinoma, Hepatocellular
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Carcinoma, Hepatocellular
Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
Carcinoma, Hepatocellular
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Carcinoma, Hepatocellular
Evaluation of a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Carcinoma, Hepatocellular
Evaluation of CA 125 as a serum marker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of click chemistry microarrays for immunosensing of alpha-fetoprotein (AFP).
Carcinoma, Hepatocellular
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Carcinoma, Hepatocellular
Evaluation of cytokeratin-1 in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Carcinoma, Hepatocellular
Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.
Carcinoma, Hepatocellular
Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Carcinoma, Hepatocellular
Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Carcinoma, Hepatocellular
Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)-Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis.
Carcinoma, Hepatocellular
Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Carcinoma, Hepatocellular
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Carcinoma, Hepatocellular
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Carcinoma, Hepatocellular
Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease.
Carcinoma, Hepatocellular
Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
Carcinoma, Hepatocellular
Expression and methylation of the mouse alpha-fetoprotein gene in embryonic, adult, and neoplastic tissues.
Carcinoma, Hepatocellular
Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression of ?-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Carcinoma, Hepatocellular
Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression of alpha fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4 oxalysine on the expression.
Carcinoma, Hepatocellular
Expression of alpha-fetoprotein and albumin genes in a rat hepatoma cell line SY/1/80: evidence for the need of species specific serum factors.
Carcinoma, Hepatocellular
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Carcinoma, Hepatocellular
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Carcinoma, Hepatocellular
Expression of alpha1-6 fucosyltransferase in rat tissues and human cancer cell lines.
Carcinoma, Hepatocellular
Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis.
Carcinoma, Hepatocellular
Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome.
Carcinoma, Hepatocellular
Expression of miR-20a: A serum biomarker in the diagnostic approach for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Carcinoma, Hepatocellular
Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
Carcinoma, Hepatocellular
External validation of an individual prognostic calculator after trans-arterial chemo-embolization for hepatocellular carcinoma.
Carcinoma, Hepatocellular
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
Carcinoma, Hepatocellular
External validation of the French alpha-fetoprotein model for hepatocellular carcinoma liver transplantation in a recent unicentric cohort - a retrospective study.
Carcinoma, Hepatocellular
Extinction of alpha-fetoprotein gene expression in somatic cell hybrids involves cis-acting DNA elements.
Carcinoma, Hepatocellular
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Carcinoma, Hepatocellular
Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma.
Carcinoma, Hepatocellular
Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection.
Carcinoma, Hepatocellular
Fabrication of Carboxylated Silicon Nitride Sensor Chips for Detection of Antigen-Antibody Reaction Using Microfluidic Reflectometric Interference Spectroscopy.
Carcinoma, Hepatocellular
Facile Synthesis of Water-Soluble Zn-Doped AgIn5S8/ZnS Core/Shell Fluorescent Nanocrystals and Their Biological Application.
Carcinoma, Hepatocellular
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Carcinoma, Hepatocellular
Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Carcinoma, Hepatocellular
Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment.
Carcinoma, Hepatocellular
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Carcinoma, Hepatocellular
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
Carcinoma, Hepatocellular
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
Carcinoma, Hepatocellular
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Carcinoma, Hepatocellular
Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
Carcinoma, Hepatocellular
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.
Carcinoma, Hepatocellular
Fluorescence analysis with quantum dot probes for hepatoma under one- and two-photon excitation.
Carcinoma, Hepatocellular
Fluorescence Immunoassay System via Enzyme-Enabled in Situ Synthesis of Fluorescent Silicon Nanoparticles.
Carcinoma, Hepatocellular
Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
Carcinoma, Hepatocellular
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Carcinoma, Hepatocellular
Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Carcinoma, Hepatocellular
Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment.
Carcinoma, Hepatocellular
Fucosylated Fraction of Alpha-fetoprotein as a Serological Marker of Early Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
Fucosylation is a promising target for cancer diagnosis and therapy.
Carcinoma, Hepatocellular
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.
Carcinoma, Hepatocellular
Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer.
Carcinoma, Hepatocellular
Further resolution of alpha-fetoprotein glycoforms by two-dimensional isoelectric focusing and lectin affinity electrophoresis.
Carcinoma, Hepatocellular
GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Carcinoma, Hepatocellular
Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.
Carcinoma, Hepatocellular
Gallium scanning in the diagnosis of hepatocellular carcinoma: a clinicopathological study of 45 patients.
Carcinoma, Hepatocellular
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Carcinoma, Hepatocellular
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Gene expression in clonally derived cell lines produced by in vitro transformation of rat fetal hepatocytes: isolation of cell lines which retain liver-specific markers.
Carcinoma, Hepatocellular
Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Carcinoma, Hepatocellular
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Carcinoma, Hepatocellular
Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Carcinoma, Hepatocellular
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Carcinoma, Hepatocellular
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Carcinoma, Hepatocellular
Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Carcinoma, Hepatocellular
Gene therapy vectors harboring AFP regulatory sequences. Preparation of an adenoviral vector.
Carcinoma, Hepatocellular
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.
Carcinoma, Hepatocellular
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Carcinoma, Hepatocellular
Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Carcinoma, Hepatocellular
Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.
Carcinoma, Hepatocellular
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Carcinoma, Hepatocellular
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Carcinoma, Hepatocellular
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection.
Carcinoma, Hepatocellular
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Carcinoma, Hepatocellular
Gold nanoparticles and polyethylene glycols functionalized conducting polyaniline nanowires for ultrasensitive and low fouling immunosensing of alpha-fetoprotein.
Carcinoma, Hepatocellular
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis.
Carcinoma, Hepatocellular
Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Growth and hepatospecific gene expression of human hepatoma cells in a defined medium.
Carcinoma, Hepatocellular
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
HBP1-mediated transcriptional repression of AFP inhibits hepatoma progression.
Carcinoma, Hepatocellular
Heat shock protein 70 chaperoned alpha-fetoprotein in human hepatocellular carcinoma cell line BEL-7402.
Carcinoma, Hepatocellular
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
Carcinoma, Hepatocellular
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Carcinoma, Hepatocellular
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatic Resection for "BCLC Stage A" Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Carcinoma, Hepatocellular
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire.
Carcinoma, Hepatocellular
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
Carcinoma, Hepatocellular
Hepatocarcinogenesis in the mouse. Combined morphologic-stereologic studies.
Carcinoma, Hepatocellular
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
Carcinoma, Hepatocellular
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in HBsAg-negative chronic active hepatitis.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Carcinoma, Hepatocellular
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Carcinoma, Hepatocellular
Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
Carcinoma, Hepatocellular
Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.
Carcinoma, Hepatocellular
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Carcinoma, Hepatocellular
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Carcinoma, Hepatocellular
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
Carcinoma, Hepatocellular
Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Carcinoma, Hepatocellular
Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells.
Carcinoma, Hepatocellular
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Carcinoma, Hepatocellular
Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Carcinoma, Hepatocellular
Hepatoid pancoast tumor. A case report and review of the literature.
Carcinoma, Hepatocellular
Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Carcinoma, Hepatocellular
Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Carcinoma, Hepatocellular
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Carcinoma, Hepatocellular
Hepatomas seen on follow-up angiograms in patients with liver cirrhosis.
Carcinoma, Hepatocellular
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
Carcinoma, Hepatocellular
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Carcinoma, Hepatocellular
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
Carcinoma, Hepatocellular
Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
Carcinoma, Hepatocellular
Heterogeneous hepatic venous pressures in patients with liver cancer.
Carcinoma, Hepatocellular
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Carcinoma, Hepatocellular
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Carcinoma, Hepatocellular
High expression of alpha-1-6 fucosyltransferase during rat hepatocarcinogenesis.
Carcinoma, Hepatocellular
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
Carcinoma, Hepatocellular
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
Carcinoma, Hepatocellular
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
Carcinoma, Hepatocellular
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Carcinoma, Hepatocellular
High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver.
Carcinoma, Hepatocellular
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.
Carcinoma, Hepatocellular
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
High-yield and high-degree purification of human alpha-fetoprotein produced by adaptation of the human hepatoma cell line Hep G2 in a serum-free medium.
Carcinoma, Hepatocellular
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Carcinoma, Hepatocellular
Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
Carcinoma, Hepatocellular
Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.
Carcinoma, Hepatocellular
Histopathology and immunohistochemistry of large hepatocellular carcinoma with undetectable or low serum levels of alpha-fetoprotein.
Carcinoma, Hepatocellular
Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.
Carcinoma, Hepatocellular
Hormonal regulation during secretion of alpha-fetoprotein in hepatoma cells grown in synthetic medium.
Carcinoma, Hepatocellular
HSP90? combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity.
Carcinoma, Hepatocellular
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Carcinoma, Hepatocellular
Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Carcinoma, Hepatocellular
Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of alpha-fetoprotein-P4 sugar chain as alpha 2-->6 monosialylated biantennary complex-type oligosaccharides with an exposed galactose on the mannose alpha 1-->6 arm by two-dimensional extended agarose gel-lectin affinity electrophoresis.
Carcinoma, Hepatocellular
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Carcinoma, Hepatocellular
Identification of Key Hydroxymethylated Genes and Transcription Factors Associated with Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients.
Carcinoma, Hepatocellular
Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy.
Carcinoma, Hepatocellular
Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.
Carcinoma, Hepatocellular
Immunobiologic studies in hepatoma-bearing mice passively immunized to alpha-fetoprotein.
Carcinoma, Hepatocellular
Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors.
Carcinoma, Hepatocellular
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Carcinoma, Hepatocellular
Immunoelectronmicroscopic study of alpha-fetoprotein synthesis in hepatoma cells.
Carcinoma, Hepatocellular
Immunohistochemical and affinity electrophoretic studies of alpha-fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space.
Carcinoma, Hepatocellular
Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Carcinoma, Hepatocellular
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Carcinoma, Hepatocellular
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Carcinoma, Hepatocellular
Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunolocalization of alpha-fetoprotein and albumin in Morris 7777 hepatoma cells grown in vivo.
Carcinoma, Hepatocellular
Immunoprecipitation assay of alpha-fetoprotein synthesis by cultured mouse hepatoma cells treated with estrogens and glucocorticoids.
Carcinoma, Hepatocellular
Immunoradioautographic study of alpha-fetoprotein in hepatoma cells.
Carcinoma, Hepatocellular
Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice.
Carcinoma, Hepatocellular
Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Carcinoma, Hepatocellular
Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
Carcinoma, Hepatocellular
Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
Carcinoma, Hepatocellular
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Carcinoma, Hepatocellular
Impact of hepatitis C virus infection on schistosomal liver disease.
Carcinoma, Hepatocellular
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Carcinoma, Hepatocellular
Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
Carcinoma, Hepatocellular
Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.
Carcinoma, Hepatocellular
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
Carcinoma, Hepatocellular
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase.
Carcinoma, Hepatocellular
Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Carcinoma, Hepatocellular
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Carcinoma, Hepatocellular
In vitro alpha-fetoprotein synthesis by monkey hepatocellular carcinoma.
Carcinoma, Hepatocellular
In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector.
Carcinoma, Hepatocellular
In vitro cloning of a rat ascites hepatoma cell line, AH66, with special reference to alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.
Carcinoma, Hepatocellular
In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.
Carcinoma, Hepatocellular
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
Carcinoma, Hepatocellular
In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
Carcinoma, Hepatocellular
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.
Carcinoma, Hepatocellular
Incorporating alpha-fetoprotein within dimensional criteria for hepatocellular carcinoma transplantation.
Carcinoma, Hepatocellular
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Carcinoma, Hepatocellular
Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Carcinoma, Hepatocellular
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Carcinoma, Hepatocellular
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Carcinoma, Hepatocellular
Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis.
Carcinoma, Hepatocellular
Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
Carcinoma, Hepatocellular
Increased histone acetylation and deacetylation in rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
Carcinoma, Hepatocellular
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Carcinoma, Hepatocellular
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Carcinoma, Hepatocellular
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Carcinoma, Hepatocellular
Indications and outcome of liver transplantation in tyrosinaemia type 1.
Carcinoma, Hepatocellular
Inducible protein in rat hepatomas with expression alternative to alpha-fetoprotein.
Carcinoma, Hepatocellular
Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
Carcinoma, Hepatocellular
Induction of apoptosis in human hepatoma cells by alpha-fetoprotein.
Carcinoma, Hepatocellular
Induction of hepatomas secreting large amounts of alpha-fetoprotein.
Carcinoma, Hepatocellular
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Carcinoma, Hepatocellular
Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
Carcinoma, Hepatocellular
Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines.
Carcinoma, Hepatocellular
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells.
Carcinoma, Hepatocellular
Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma.
Carcinoma, Hepatocellular
Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Inhibition of alpha-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues.
Carcinoma, Hepatocellular
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Carcinoma, Hepatocellular
Inhibition of synthesis of alpha-fetoprotein by glucocorticoids in cultured hepatoma cells.
Carcinoma, Hepatocellular
Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells.
Carcinoma, Hepatocellular
Integrated analysis of the rhesus monkey liver transcriptome during development and human primary HCC AFP-related gene expression.
Carcinoma, Hepatocellular
Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
Carcinoma, Hepatocellular
Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes.
Carcinoma, Hepatocellular
Interaction of lectins with their ligand carbohydrate of alpha-fetoprotein: analysis by mixed-lectin affinity electrophoresis.
Carcinoma, Hepatocellular
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Intracellular alpha-fetoprotein level in cultured ascites hepatoma cells of the rat determined as alpha-fetoprotein-negative.
Carcinoma, Hepatocellular
Intracellular synthesis of alpha-fetoprotein and fibrinogen without secretion by Zajdela rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Investigation of Alpha-Fetoprotein Antibody Modified Fluorescent Magnetic Probe on HepG? Cell and Cancer Model Mouse.
Carcinoma, Hepatocellular
Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC.
Carcinoma, Hepatocellular
Involvement of an AFP1-binding site in cell-specific transcription of the pre-S1 region of the human hepatitis B virus surface antigen gene.
Carcinoma, Hepatocellular
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Carcinoma, Hepatocellular
Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Carcinoma, Hepatocellular
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
Carcinoma, Hepatocellular
IS RESECTION OF HEPATOCELLULAR CARCINOMA IN THE ERA OF LIVER TRANSPLANTATION WORTHWILE? A single center experience.
Carcinoma, Hepatocellular
Is Serum Alpha-Fetoprotein Useful for Predicting Recurrence and Mortality Specific to Hepatocellular Carcinoma After Hepatectomy? A Test Based on Propensity Scores and Competing Risks Analysis.
Carcinoma, Hepatocellular
Isolation and characterization of alpha-fetoprotein from the mouse hepatoma BW7756.
Carcinoma, Hepatocellular
Isolation of alpha-fetoprotein messenger ribonucleic acid from AH-66 ascites hepatoma cells.
Carcinoma, Hepatocellular
Knockdown of alpha-fetoprotein expression inhibits HepG2 cell growth and induces apoptosis.
Carcinoma, Hepatocellular
Lack of correlation among gamma-glutamyltranspeptidase activity, production of alpha-fetoprotein, and transplantability in rat liver epithelial-like cell cultures.
Carcinoma, Hepatocellular
Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Carcinoma, Hepatocellular
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Carcinoma, Hepatocellular
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Carcinoma, Hepatocellular
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Carcinoma, Hepatocellular
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Carcinoma, Hepatocellular
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Carcinoma, Hepatocellular
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Carcinoma, Hepatocellular
Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection.
Carcinoma, Hepatocellular
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Carcinoma, Hepatocellular
Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor ?B in Liver Cancer Cells.
Carcinoma, Hepatocellular
Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma.
Carcinoma, Hepatocellular
Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
Carcinoma, Hepatocellular
Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study.
Carcinoma, Hepatocellular
Liver transplantation (lt) for hepatocellular carcinoma (hcc): relationship between alpha-fetoprotein (afp) and outcome.
Carcinoma, Hepatocellular
Liver Transplantation for Extended Criteria Hepatocellular Carcinoma Using Stable Response to Locoregional Therapy and Alpha-Fetoprotein as Selection Criteria.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma: alpha-fetoprotein should be included in selection criteria.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5.
Carcinoma, Hepatocellular
Liver Transplantation for Hepatocellular carcinoma: Evaluation of the AFP model in a multicenter cohort from Latin America.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma: one center's experience, 1987-1994.
Carcinoma, Hepatocellular
Living related donor liver transplantation for preoperative alpha-fetoprotein mRNA-positive patients of hepatocellular carcinoma: description of five cases.
Carcinoma, Hepatocellular
Local regional therapy before liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Localization of alpha-fetoprotein by immunofluorescent method during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
Carcinoma, Hepatocellular
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Carcinoma, Hepatocellular
Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
Carcinoma, Hepatocellular
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.
Carcinoma, Hepatocellular
Long-term impact of hepatitis B, C virus infection on renal transplantation.
Carcinoma, Hepatocellular
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Carcinoma, Hepatocellular
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Carcinoma, Hepatocellular
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carcinoma, Hepatocellular
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.
Carcinoma, Hepatocellular
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Macroregenerative nodules in cirrhosis are not associated with elevated serum or stainable tissue alpha-fetoprotein.
Carcinoma, Hepatocellular
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Major chromatin changes accompany extinction of alpha-fetoprotein gene in hepatoma x fibroblast hybrids.
Carcinoma, Hepatocellular
Malignancy-related ascites and ascitic fluid "humoral tests of malignancy".
Carcinoma, Hepatocellular
Management of patients with cirrhosis in southern california: results of a practitioner survey.
Carcinoma, Hepatocellular
Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Carcinoma, Hepatocellular
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Carcinoma, Hepatocellular
Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan--a dried blood spot method.
Carcinoma, Hepatocellular
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
Carcinoma, Hepatocellular
Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Measuring fucosylated alpha-fetoprotein in hepatocellular carcinoma: A comparison of ?TAS and parallel reaction monitoring.
Carcinoma, Hepatocellular
Mechanism of the dexamethasone effect on alpha-fetoprotein gene expression in McA-RH8994 rat hepatoma cells.
Carcinoma, Hepatocellular
Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Mechanisms of alpha-fetoprotein synthesis in hepatoma cells. Combined electron microscopic immunocytochemistry and autoradiography.
Carcinoma, Hepatocellular
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Carcinoma, Hepatocellular
Metastasis of hepatocellular carcinoma to the proximal jejunum manifested by occult gastrointestinal bleeding.
Carcinoma, Hepatocellular
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Carcinoma, Hepatocellular
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Carcinoma, Hepatocellular
Methylation of the alpha-fetoprotein gene in isogenic rat hepatoma and liver cell lines.
Carcinoma, Hepatocellular
Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Carcinoma, Hepatocellular
Microchip-based ELISA strategy for the detection of low-level disease biomarker in serum.
Carcinoma, Hepatocellular
Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Microwave ablation with cooled-tip electrode for liver cancer: An analysis of 160 cases.
Carcinoma, Hepatocellular
miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
Carcinoma, Hepatocellular
miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
Carcinoma, Hepatocellular
miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Carcinoma, Hepatocellular
Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
Carcinoma, Hepatocellular
Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Carcinoma, Hepatocellular
Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Carcinoma, Hepatocellular
Molecular heterogeneity of alpha-fetoprotein secreted by primary and transplantable hepatocellular carcinomas.
Carcinoma, Hepatocellular
Molecular mechanism of extinction of liver-specific functions in mouse hepatoma x rat fibroblast hybrids: extinction of the albumin gene.
Carcinoma, Hepatocellular
Molecular mechanisms of extinction of liver-specific functions in mouse hepatoma rat fibroblast hybrids: extinction of alpha-fetoprotein gene.
Carcinoma, Hepatocellular
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials.
Carcinoma, Hepatocellular
Monitoring hepatocellular carcinoma by using a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Carcinoma, Hepatocellular
Monitoring of lectin-reactive alpha-fetoproteins in patients with hepatocellular carcinoma treated using transcatheter arterial embolization.
Carcinoma, Hepatocellular
Morphological and biological changes of a hepatocellular carcinoma cell line cultured in a three-dimensional matrix of collagen.
Carcinoma, Hepatocellular
Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.
Carcinoma, Hepatocellular
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Carcinoma, Hepatocellular
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.
Carcinoma, Hepatocellular
Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer.
Carcinoma, Hepatocellular
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Carcinoma, Hepatocellular
Multiple antigens as marker substances in germinal tumors of the testis.
Carcinoma, Hepatocellular
Multiple echogenic liver masses from multifocal nodular steatosis in a 55-year-old male with chronic hepatitis C.
Carcinoma, Hepatocellular
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Carcinoma, Hepatocellular
Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy.
Carcinoma, Hepatocellular
N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study.
Carcinoma, Hepatocellular
Nanohoneycomb Surface-Enhanced Raman Spectroscopy-Active Chip for the Determination of Biomarkers of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Carcinoma, Hepatocellular
Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus.
Carcinoma, Hepatocellular
New application of human tumor clonogenic assay to in vitro evaluation of tumor-targeting efficiency of immunoconjugates.
Carcinoma, Hepatocellular
New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Carcinoma, Hepatocellular
New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Carcinoma, Hepatocellular
Nodular transformation of the liver, alpha-fetoprotein, and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Carcinoma, Hepatocellular
Non-invasive diagnostic criteria for hepatocellular carcinoma: the value of contrast washout at imaging and the death of alpha-fetoprotein.
Carcinoma, Hepatocellular
Non-specificity of messenger RNA of alpha-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans.
Carcinoma, Hepatocellular
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
Carcinoma, Hepatocellular
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
Carcinoma, Hepatocellular
Novel and sensitive enzyme immunoassay (immune-complex-transfer enzyme immunoassay) for alpha-fetoprotein from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines.
Carcinoma, Hepatocellular
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha-fetoprotein score: a new prognostic risk factor.
Carcinoma, Hepatocellular
Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
Carcinoma, Hepatocellular
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.
Carcinoma, Hepatocellular
Oesophageal hepatoid carcinoma with liver metastasis, a diagnostic dilemma.
Carcinoma, Hepatocellular
On the Electrochemical Detection of Alpha-Fetoprotein Using Aptamers: DNA Isothermal Amplification Strategies to Improve the Performance of Weak Aptamers.
Carcinoma, Hepatocellular
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Carcinoma, Hepatocellular
Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
Carcinoma, Hepatocellular
Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Organization of the albumin and alpha-fetoprotein genes in fetal and adult rat tissues, and rat hepatomas.
Carcinoma, Hepatocellular
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Carcinoma, Hepatocellular
Overcoming effect of antibody against rat alpha-fetoprotein (AFP) on the growth of daunorubicin-resistant mutant rat ascites hepatoma cell line AH66.
Carcinoma, Hepatocellular
Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
Carcinoma, Hepatocellular
P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study.
Carcinoma, Hepatocellular
p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.
Carcinoma, Hepatocellular
p55PIK regulates alpha-fetoprotein expression through the NF-?B signaling pathway.
Carcinoma, Hepatocellular
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis.
Carcinoma, Hepatocellular
Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.
Carcinoma, Hepatocellular
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.
Carcinoma, Hepatocellular
Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
Carcinoma, Hepatocellular
Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population.
Carcinoma, Hepatocellular
Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Carcinoma, Hepatocellular
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
Carcinoma, Hepatocellular
Personalized treatment of patients with very early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Carcinoma, Hepatocellular
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.
Carcinoma, Hepatocellular
Phenotypic variability of cultured rat hepatoma cell population in respect to alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
Plasma abnormal prothrombin levels in patients with small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Carcinoma, Hepatocellular
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Carcinoma, Hepatocellular
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients.
Carcinoma, Hepatocellular
Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.
Carcinoma, Hepatocellular
Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.
Carcinoma, Hepatocellular
Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis.
Carcinoma, Hepatocellular
Postoperative changes in protein-induced vitamin K absence or antagonist II levels after hepatectomy in patients with hepatocellular carcinoma: relationship to prognosis.
Carcinoma, Hepatocellular
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Posttranscriptional regulation of albumin and alpha-fetoprotein messenger RNA by transforming growth factor-beta 1 requires de novo RNA and protein synthesis.
Carcinoma, Hepatocellular
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Carcinoma, Hepatocellular
Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.
Carcinoma, Hepatocellular
Pre and postoperative changes of alpha-fetoprotein and human chorionic gonadotropin in hepatoma of children.
Carcinoma, Hepatocellular
Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.
Carcinoma, Hepatocellular
Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
Carcinoma, Hepatocellular
Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin.
Carcinoma, Hepatocellular
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Carcinoma, Hepatocellular
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.
Carcinoma, Hepatocellular
Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin.
Carcinoma, Hepatocellular
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Carcinoma, Hepatocellular
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort.
Carcinoma, Hepatocellular
Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.
Carcinoma, Hepatocellular
Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
Carcinoma, Hepatocellular
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Carcinoma, Hepatocellular
Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preliminary observation on human saliva alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
Carcinoma, Hepatocellular
Preoperative Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma in Non-Cirrhotic Patients After Surgical Resection.
Carcinoma, Hepatocellular
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Carcinoma, Hepatocellular
Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Preoperative investigation and indication for operation in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preventive strategies in chronic liver disease: part II. Cirrhosis.
Carcinoma, Hepatocellular
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Carcinoma, Hepatocellular
Primary hepatocellular carcinoma and hepatitis B infection during childhood.
Carcinoma, Hepatocellular
Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.
Carcinoma, Hepatocellular
Primary hepatoma presenting with central abdominal pain and diagnosed from a raised serum alpha-fetoprotein level.
Carcinoma, Hepatocellular
Primary liver cell carcinoma. New insight for a more correct approach to its classification.
Carcinoma, Hepatocellular
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Carcinoma, Hepatocellular
Proceedings: Serum alpha-fetoprotein and Ga67 citrate uptake in hepatoma.
Carcinoma, Hepatocellular
Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology.
Carcinoma, Hepatocellular
Production of alpha-fetoprotein by cultured rat ascites hepatoma cells determined in vivo as alpha-fetoprotein-negative.
Carcinoma, Hepatocellular
Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Carcinoma, Hepatocellular
Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases.
Carcinoma, Hepatocellular
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Carcinoma, Hepatocellular
Prognostic Impact of Alpha Fetoprotein at Diagnosis on Overall Survival of Single Small Hepatocellular Carcinomas.
Carcinoma, Hepatocellular
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Carcinoma, Hepatocellular
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.
Carcinoma, Hepatocellular
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.
Carcinoma, Hepatocellular
Prognostic role of serial alpha-fetoprotein levels in hepatocellular carcinoma treated with locoregional therapy.
Carcinoma, Hepatocellular
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.
Carcinoma, Hepatocellular
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization.
Carcinoma, Hepatocellular
Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
Carcinoma, Hepatocellular
Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
Carcinoma, Hepatocellular
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic value of ?-fetoprotein and des-?-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Carcinoma, Hepatocellular
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence.
Carcinoma, Hepatocellular
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.
Carcinoma, Hepatocellular
Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation.
Carcinoma, Hepatocellular
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Carcinoma, Hepatocellular
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Carcinoma, Hepatocellular
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.
Carcinoma, Hepatocellular
Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Carcinoma, Hepatocellular
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Carcinoma, Hepatocellular
Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.
Carcinoma, Hepatocellular
Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin.
Carcinoma, Hepatocellular
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Carcinoma, Hepatocellular
Prussian blue nanoparticle-labeled aptasensing platform on graphene oxide for voltammetric detection of ?-fetoprotein in hepatocellular carcinoma with target recycling.
Carcinoma, Hepatocellular
Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Carcinoma, Hepatocellular
Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells.
Carcinoma, Hepatocellular
Pylephlebitis and liver abscess mimicking hepatocellular carcinoma.
Carcinoma, Hepatocellular
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Carcinoma, Hepatocellular
Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Carcinoma, Hepatocellular
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Carcinoma, Hepatocellular
Quantitative screening of serum protein biomarkers by reverse phase protein arrays.
Carcinoma, Hepatocellular
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Carcinoma, Hepatocellular
Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
Carcinoma, Hepatocellular
Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy.
Carcinoma, Hepatocellular
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
Carcinoma, Hepatocellular
Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein.
Carcinoma, Hepatocellular
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety across two global randomized Phase 3 studies (REACH-2 and REACH).
Carcinoma, Hepatocellular
Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH).
Carcinoma, Hepatocellular
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2.
Carcinoma, Hepatocellular
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
Carcinoma, Hepatocellular
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Carcinoma, Hepatocellular
Rat alpha-macrofetoprotein (acute-phase alpha 2-macroglobulin) during hepatocarcinogenesis.
Carcinoma, Hepatocellular
Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy.
Carcinoma, Hepatocellular
Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.
Carcinoma, Hepatocellular
Recombinant heat shock protein 70 functional peptide and alpha-fetoprotein epitope peptide vaccine elicits specific anti-tumor immunity.
Carcinoma, Hepatocellular
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Carcinoma, Hepatocellular
Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.
Carcinoma, Hepatocellular
Regenerative nodule mimicking hepatocellular carcinoma in a cirrhotic child due to hepatitis B: an imaging dilemma.
Carcinoma, Hepatocellular
Regression of hepatocellular carcinoma during vitamin K administration.
Carcinoma, Hepatocellular
Regulation effect of zinc fingers and homeoboxes 2 on alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Regulation of albumin and alpha-fetoprotein gene expression by colloid osmotic pressure in human hepatoma cells.
Carcinoma, Hepatocellular
Regulation of alpha-fetoprotein and transferrin synthesis and secretion in mouse hepatoma cells.
Carcinoma, Hepatocellular
Regulation of rat alpha-fetoprotein production by methionine during ethionine-hepatocarcinogenesis.
Carcinoma, Hepatocellular
Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
Carcinoma, Hepatocellular
Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone.
Carcinoma, Hepatocellular
Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
Carcinoma, Hepatocellular
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses.
Carcinoma, Hepatocellular
Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Carcinoma, Hepatocellular
Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
Carcinoma, Hepatocellular
Report of hereditary persistence of alpha-fetoprotein in a Spanish family: molecular basis and clinical concerns.
Carcinoma, Hepatocellular
Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
Carcinoma, Hepatocellular
Resected case of hepatocellular carcinoma associated with lupoid hepatitis.
Carcinoma, Hepatocellular
Resection versus Ablation for Alpha-fetoprotein Positive Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis.
Carcinoma, Hepatocellular
Response of alpha-fetoprotein to chemotherapy in patients with hepatomas.
Carcinoma, Hepatocellular
Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis B.
Carcinoma, Hepatocellular
Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
Carcinoma, Hepatocellular
Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors.
Carcinoma, Hepatocellular
Retraction: Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell.
Carcinoma, Hepatocellular
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Carcinoma, Hepatocellular
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Carcinoma, Hepatocellular
Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Carcinoma, Hepatocellular
Reversing hepatocellular carcinoma progression by using networked biological therapies.
Carcinoma, Hepatocellular
Review of the clinicopathologic features of fibrolamellar carcinoma.
Carcinoma, Hepatocellular
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Carcinoma, Hepatocellular
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Carcinoma, Hepatocellular
Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Carcinoma, Hepatocellular
Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis.
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it?
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of superoxide dismutase in hepatitis B virus-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of the alpha-fetoprotein response in immune checkpoint inhibitor-based treatment of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.
Carcinoma, Hepatocellular
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.
Carcinoma, Hepatocellular
RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element.
Carcinoma, Hepatocellular
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Carcinoma, Hepatocellular
Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver.
Carcinoma, Hepatocellular
Sarcopenia and Alpha-fetoprotein Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: In Response.
Carcinoma, Hepatocellular
Screening methods for early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology?
Carcinoma, Hepatocellular
Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm.
Carcinoma, Hepatocellular
Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Carcinoma, Hepatocellular
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Carcinoma, Hepatocellular
Semi-quantitative Measurement of a Specific Glycoform Using a DNA-tagged Antibody and Lectin Affinity Chromatography for Glyco-biomarker Development.
Carcinoma, Hepatocellular
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Carcinoma, Hepatocellular
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
Carcinoma, Hepatocellular
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Carcinoma, Hepatocellular
Sequence analysis of the proximal promoter region of the human alpha-fetoprotein gene in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Sequence content of alpha-fetoprotein, albumin and fibrinogen polypeptide mRNAs in different organs, developing tissues and in liver during carcinogenesis in rats.
Carcinoma, Hepatocellular
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
Sequential study of serum glycoprotein fucosylation in acute hepatitis.
Carcinoma, Hepatocellular
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Carcinoma, Hepatocellular
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Carcinoma, Hepatocellular
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Serum alpha 1-antitrypsin in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
Carcinoma, Hepatocellular
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in experimental hepatocellular carcinomas in rats.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in the relatively early stages of hepatocellular carcinoma and its relationship to gross anatomical types.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level independently predicts post-transplantation survival in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Carcinoma, Hepatocellular
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Carcinoma, Hepatocellular
Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Carcinoma, Hepatocellular
Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Carcinoma, Hepatocellular
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.
Carcinoma, Hepatocellular
Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Carcinoma, Hepatocellular
Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Carcinoma, Hepatocellular
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.
Carcinoma, Hepatocellular
Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening.
Carcinoma, Hepatocellular
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Carcinoma, Hepatocellular
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
Carcinoma, Hepatocellular
Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Carcinoma, Hepatocellular
Sgo1 is a potential therapeutic target for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Carcinoma, Hepatocellular
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Carcinoma, Hepatocellular
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Carcinoma, Hepatocellular
Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Carcinoma, Hepatocellular
Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinical auto-analyzer.
Carcinoma, Hepatocellular
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Carcinoma, Hepatocellular
Simultaneous multicentric occurrence of early hepatocellular carcinoma in a patient with persistent alpha-fetoprotein elevation.
Carcinoma, Hepatocellular
Simultaneous voltammetric immunodetection of alpha-fetoprotein and glypican-3 using a glassy carbon electrode modified with magnetite-conjugated dendrimers.
Carcinoma, Hepatocellular
Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Carcinoma, Hepatocellular
Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Carcinoma, Hepatocellular
Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.
Carcinoma, Hepatocellular
Soluble CD25 as a predictor of hepatocellular carcinoma compared with alpha-fetoprotein.
Carcinoma, Hepatocellular
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Carcinoma, Hepatocellular
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Carcinoma, Hepatocellular
Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Carcinoma, Hepatocellular
Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Specific uptake of alpha-fetoprotein and albumin by rat Morris 7777 hepatoma cells.
Carcinoma, Hepatocellular
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Sphingosine kinase regulates hepatoma cell differentiation: roles of hepatocyte nuclear factor and retinoid receptor.
Carcinoma, Hepatocellular
Spiral computed tomography versus ultrasound in the follow-up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study.
Carcinoma, Hepatocellular
Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus.
Carcinoma, Hepatocellular
Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver.
Carcinoma, Hepatocellular
Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells.
Carcinoma, Hepatocellular
Streamline phenomena in liver metastasis of gastrointestinal tumor - an experimental-study using rats.
Carcinoma, Hepatocellular
Studies on human alpha-fetoprotein. Isolation and characterization of monomeric and polymeric forms and amino-terminal sequence analysis.
Carcinoma, Hepatocellular
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Carcinoma, Hepatocellular
Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Carcinoma, Hepatocellular
Successful treatment of hepatocellular carcinoma with percutaneous ethanol injection therapy and local hyperthermia.
Carcinoma, Hepatocellular
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Carcinoma, Hepatocellular
Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment.
Carcinoma, Hepatocellular
Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
Carcinoma, Hepatocellular
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Carcinoma, Hepatocellular
Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
Carcinoma, Hepatocellular
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.
Carcinoma, Hepatocellular
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Carcinoma, Hepatocellular
Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on 18F-FDG PET/CT
Carcinoma, Hepatocellular
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Synthesis and secretion of alpha-fetoprotein and acute-phase alpha 2-macroglobulin by Zajdela rat ascites hepatoma.
Carcinoma, Hepatocellular
Synthesis of alpha-fetoprotein by membrane-bound polysomes of rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Systematic review: the prognostic role of alpha-fetoprotein following liver transplant for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?
Carcinoma, Hepatocellular
Tandem arrangement of the albumin and alpha-fetoprotein genes in the human genome.
Carcinoma, Hepatocellular
Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Carcinoma, Hepatocellular
TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Carcinoma, Hepatocellular
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.
Carcinoma, Hepatocellular
The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.
Carcinoma, Hepatocellular
The alpha1-6-fucosyltransferase gene and its biological significance.
Carcinoma, Hepatocellular
The antagonistic effect of dexamethasone and insulin on alpha-fetoprotein secretion by cultured H4-II-E-C3 cells derived from the Reuber H-35 hepatoma.
Carcinoma, Hepatocellular
The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis.
Carcinoma, Hepatocellular
The c-jun proto-oncogene down-regulates the rat alpha-fetoprotein promoter in HepG2 hepatoma cells without binding to DNA.
Carcinoma, Hepatocellular
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The control of serum protein synthesis in hepatoma-fibroblast hybrids.
Carcinoma, Hepatocellular
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The development of laboratory tests for cancer in Japan with special reference to carcinoembryonic proteins.
Carcinoma, Hepatocellular
The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Carcinoma, Hepatocellular
The E2F Transcription Factor 1 Transactives Stathmin 1 in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The effect of anti-alpha-fetoprotein-adriamycin conjugate on a human hepatoma.
Carcinoma, Hepatocellular
The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Carcinoma, Hepatocellular
The effects of dexamethasone on alpha-fetoprotein and albumin synthesis in cultured hepatoma 7777 cells.
Carcinoma, Hepatocellular
The effects of retinoic acid on the expression of alpha-fetoprotein and albumin genes in rat hepatoma cell lines.
Carcinoma, Hepatocellular
The EIIAPA Chimeric Promoter for Tumor Specific Gene Therapy of Hepatoma.
Carcinoma, Hepatocellular
The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
Carcinoma, Hepatocellular
The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Carcinoma, Hepatocellular
The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera.
Carcinoma, Hepatocellular
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes.
Carcinoma, Hepatocellular
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Carcinoma, Hepatocellular
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
Carcinoma, Hepatocellular
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.
Carcinoma, Hepatocellular
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.
Carcinoma, Hepatocellular
The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
Carcinoma, Hepatocellular
The inhibitory effects of horse anti-rat AFP antiserum on the uptake of 2-deoxy-D-glucose by AFP-producing rat hepatoma cells.
Carcinoma, Hepatocellular
The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
The mechanism of the bidirectional regulation of the rat alpha-fetoprotein gene by glucocorticoid hormone.
Carcinoma, Hepatocellular
The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).
Carcinoma, Hepatocellular
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
Carcinoma, Hepatocellular
The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome.
Carcinoma, Hepatocellular
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Carcinoma, Hepatocellular
The Predictive Power of Serum ?-Fetoprotein and Des-?-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.
Carcinoma, Hepatocellular
The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.
Carcinoma, Hepatocellular
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Carcinoma, Hepatocellular
The role of alpha-fetoprotein in hepatocellular carcinoma drug resistance.
Carcinoma, Hepatocellular
The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
Carcinoma, Hepatocellular
The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The role of methylation in regulating the expression of the alpha-fetoprotein gene in developing rat liver and hepatoma cell lines.
Carcinoma, Hepatocellular
The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
Carcinoma, Hepatocellular
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.
Carcinoma, Hepatocellular
The Significance of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in the Early Postoperative Recurrence Monitoring and Prognosis Prediction of AFP-Negative Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Carcinoma, Hepatocellular
The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.
Carcinoma, Hepatocellular
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The use of tissue polypeptide specific antigen as a marker in liver diseases.
Carcinoma, Hepatocellular
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Carcinoma, Hepatocellular
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Carcinoma, Hepatocellular
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
The value of serum tissue polypeptide specific antigen in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: X. Correlation of the induceability of hepatomas and alpha-fetoprotein gene activity.
Carcinoma, Hepatocellular
Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats.
Carcinoma, Hepatocellular
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Carcinoma, Hepatocellular
Thorotrast-induced hepatic angiosarcoma, and combined hepatocellular and cholangiocarcinoma in a single patient.
Carcinoma, Hepatocellular
Thyroid hormone effect on alpha-fetoprotein and albumin coordinate expression by a human hepatoma cell line.
Carcinoma, Hepatocellular
Thyroxine-binding globulin in elderly patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Carcinoma, Hepatocellular
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Carcinoma, Hepatocellular
Tissular immunoenzymatic detection of hepatic alphafetoprotein in human hepatomas.
Carcinoma, Hepatocellular
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Carcinoma, Hepatocellular
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Carcinoma, Hepatocellular
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Carcinoma, Hepatocellular
Transcription factor AP-2 functions as a repressor that contributes to the liver-specific expression of serum amyloid A1 gene.
Carcinoma, Hepatocellular
Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells.
Carcinoma, Hepatocellular
Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Carcinoma, Hepatocellular
Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Carcinoma, Hepatocellular
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Carcinoma, Hepatocellular
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.
Carcinoma, Hepatocellular
Ultrastructural observation of alpha-fetoprotein producing cells in human hepatocellular carcinoma using immunoperoxidase methods--comparison with fetal liver.
Carcinoma, Hepatocellular
Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation.
Carcinoma, Hepatocellular
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Carcinoma, Hepatocellular
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells.
Carcinoma, Hepatocellular
Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Carcinoma, Hepatocellular
Usefulness of a new inflammation-based scoring system for prognostication of patients with hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of Alpha-fetoprotein Response in Patients Treated with Sorafenib for Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Carcinoma, Hepatocellular
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation.
Carcinoma, Hepatocellular
Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Carcinoma, Hepatocellular
Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
Carcinoma, Hepatocellular
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study.
Carcinoma, Hepatocellular
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
Carcinoma, Hepatocellular
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Validation of a novel model for the early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
Carcinoma, Hepatocellular
Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies.
Carcinoma, Hepatocellular
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.
Carcinoma, Hepatocellular
Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Variety and Dynamics of Proteoforms in the Human Proteome: Aspects of Markers for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Carcinoma, Hepatocellular
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Carcinoma, Hepatocellular
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Carcinoma, Hepatocellular
Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.
Carcinoma, Hepatocellular
ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines.
Carcinoma, Hepatocellular
[131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells]
Carcinoma, Hepatocellular
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]
Carcinoma, Hepatocellular
[76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type]
Carcinoma, Hepatocellular
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]
Carcinoma, Hepatocellular
[A clinicopathological study of primary liver cancer associated with alcoholic liver injury]
Carcinoma, Hepatocellular
[A new method of preparation of doxorubicin-in-oil suspension using ultrasonificator attached with Cuphorn]
Carcinoma, Hepatocellular
[Alpha 1-proteinase inhibitor deficiency and isolated liver cirrhosis without pulmonary emphysema in a 53-year-old female patient]
Carcinoma, Hepatocellular
[Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Alpha-fetoprotein synthesis in clonogenic cells of rat hepatoma McA-RH 7777]
Carcinoma, Hepatocellular
[Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy].
Carcinoma, Hepatocellular
[Antigen showing alternative to alpha-fetoprotein expression in rat hepatomas]
Carcinoma, Hepatocellular
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
Carcinoma, Hepatocellular
[Application of alpha-fetoprotein determination by radioimmunoassay to the diagnosis of primary hepatoma]
Carcinoma, Hepatocellular
[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
Carcinoma, Hepatocellular
[Changes in the rhythms of the alpha-fetoprotein content of the blood serum of mice with hepatoma 22A and of tumor cell proliferation depending on the time of cyclophosphane administration]
Carcinoma, Hepatocellular
[Characteristics of contrast-enhanced ultrasound in alpha-fetoprotein-negative recurrent small hepatocellular carcinoma].
Carcinoma, Hepatocellular
[Clinical application studies on AFP-L3 detected by micro-spin column method].
Carcinoma, Hepatocellular
[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)]
Carcinoma, Hepatocellular
[Clinical Significance of Serum GPDA-F Determined by Immunoelectrophoresis in Diagnosis of Hepatocellular Carcinoma.]
Carcinoma, Hepatocellular
[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Comparative evaluation of ultrasonography, computerized tomography, angiography and lipiodol CT in defining extent of hepatocarcinoma. A multicenter study]
Carcinoma, Hepatocellular
[Comparison of scintigraphy, CT and serum alpha-fetoprotein in patients with hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma]
Carcinoma, Hepatocellular
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
Carcinoma, Hepatocellular
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]
Carcinoma, Hepatocellular
[Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?]
Carcinoma, Hepatocellular
[Cytodiagnosis of primary liver cell carcinoma with reference to alpha-fetoprotein (author's transl)]
Carcinoma, Hepatocellular
[Dendritic cell vaccine modified by murine mAFP gene enhances immunoprotective effect on liver carcinogenesis and tumor development in mice]
Carcinoma, Hepatocellular
[Detection and comparison of transcriptional activities of tumor-specific survivin and alpha-fetoprotein promoters in human hepatocellular carcinoma cells]
Carcinoma, Hepatocellular
[Detection of GGT-II by dot-ELISA with monoclonal antibody in the diagnosis of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Carcinoma, Hepatocellular
[Distribution of alpha-fetoprotein and albumin in paraffin sections of cells of Zaidel's ascitic hepatoma]
Carcinoma, Hepatocellular
[Distribution of alpha-fetoprotein and albumin-positive cells in hepatocellular carcinoma as well as their surrounding liver tissue]
Carcinoma, Hepatocellular
[DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
Carcinoma, Hepatocellular
[Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein]
Carcinoma, Hepatocellular
[Early determination of the effect of preoperative TAE by observation of serum AFP changes in patients with hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro]
Carcinoma, Hepatocellular
[Effect of antibody to rat alpha-fetoprotein (AFP) on protein and DNA synthesis of rat ascites hepatoma AH66 cells]
Carcinoma, Hepatocellular
[Effect of cyclophosphamide on alpha-fetoprotein content in the blood serum of mice with hepatoma 22a depending upon the period of tumor development]
Carcinoma, Hepatocellular
[Effects of alpha-fetoprotein on the expression of TRAIL death receptor-2 and its role on resisting the cytotoxicity of TRAIL in hepatoma cells].
Carcinoma, Hepatocellular
[Effects of oxidative stress on the proliferation, differentiation and apoptosis in the human hepatoma cells]
Carcinoma, Hepatocellular
[Effects of oxygen free radicals on cell growth and productions of alpha-fetoprotein (AFP) and albumin (ALB) by human hepatoma cell line (HH2-6)]
Carcinoma, Hepatocellular
[Epidemiology of hepatocellular carcinoma in the department of Calvados]
Carcinoma, Hepatocellular
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
Carcinoma, Hepatocellular
[Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Experimental studies in vitro on the alpha-fetoprotein-specific promoter mediated target gene therapy of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody]
Carcinoma, Hepatocellular
[Expression of alpha-fetoprotein and hepatocyte nuclear factors in rat hepatoma clones: effect of retinoic acid]
Carcinoma, Hepatocellular
[Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
Carcinoma, Hepatocellular
[Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis]
Carcinoma, Hepatocellular
[Hepatocellular carcinoma as a rare cause of excessive rise in alpha-fetoprotein in pregnancy]
Carcinoma, Hepatocellular
[Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas]
Carcinoma, Hepatocellular
[Independence of alpha-fetoprotein expression from production of adult rat serum proteins in hepatoma McA-RH7777]
Carcinoma, Hepatocellular
[Induction of alpha-fetoprotein synthesis in highly differentiated spontaneous hepatomas in mice]
Carcinoma, Hepatocellular
[Inhibition of alpha-fetoprotein synthesis in hepatocytes of adult mice by dextran sulfate in vivo and in vitro]
Carcinoma, Hepatocellular
[Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Killing effect of PNP/MeP-dR suicide gene system driven by an AFP promoter AF0.3 on AFP-positive hepatoma cells]
Carcinoma, Hepatocellular
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
Carcinoma, Hepatocellular
[Massive venous thrombosis with cardiac invasion as primary manifestation of hepatocarcinoma]
Carcinoma, Hepatocellular
[Measurement of alpha-fetoprotein with L3 fraction in the early diagnosis of patients with hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Measurement of radioimmunoassay of alpha-fetoprotein in dried blood samples on paper for mass screening of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Metastatic pancreatic endocrine tumor with elevation of alpha-fetoprotein]
Carcinoma, Hepatocellular
[Microspectrophotometric analysis of nuclear DNA contents related to the presence of alpha-fetoprotein in human hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Molecular markers for the monitoring of malignant transformation of hepatocytes and early diagnosis of liver cancer].
Carcinoma, Hepatocellular
[Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis]
Carcinoma, Hepatocellular
[Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma: Using ROC Curve.]
Carcinoma, Hepatocellular
[Ploidy level and alpha-fetoprotein production in spontaneous murine hematomas in relation to the degree of histological differentiation]
Carcinoma, Hepatocellular
[Portal thrombosis and liver cirrhosis. Value of ultrasound-guided puncture-biopsy of the thrombus]
Carcinoma, Hepatocellular
[Production of an Anti-PIVKA-II Recombinant Single-Chain-Antibody in Escherichia Coli].
Carcinoma, Hepatocellular
[Prognostic marker of serum alpha-fetoprotein levels in hepatocellular carcinoma: retrospective analysis of 230 patients]
Carcinoma, Hepatocellular
[Prognostic value of pre- and postoperative alpha-fetoprotein in the follow-up of patients with surgically-treated hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin]
Carcinoma, Hepatocellular
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Reconstruction of transcriptional regulatory elements of human alpha-fetoprotein gene]
Carcinoma, Hepatocellular
[Research progress of alpha-fetoprotein vaccine in hepatocellular carcinoma].
Carcinoma, Hepatocellular
[Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
Carcinoma, Hepatocellular
[Retroviral-mediated transcriptional regulatory elements of alpha-fetoprotein gene directed specific expression of interleukin-2 in murine hepatoma]
Carcinoma, Hepatocellular
[Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
Carcinoma, Hepatocellular
[Serological examinations in children with hepatoma and teratoma of alpha-fetoprotein and alpha-2-H-globulin and the diagnostic and prognostic value (author's transl)]
Carcinoma, Hepatocellular
[Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)]
Carcinoma, Hepatocellular
[Serum concentrations of prolactin, growth hormone, and alpha-fetoprotein under long-term administration of an oral contraceptive containing cyproterone acetate (author's transl)]
Carcinoma, Hepatocellular
[Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Carcinoma, Hepatocellular
[Small hepatocellular carcinoma. New concepts on intrahepatic recurrence after hepatectomy in orthotopic liver transplantation]
Carcinoma, Hepatocellular
[Small unilocular hepatocellular carcinoma (0 < 5 cm) in patients with liver cirrhosis. Early diagnosis, surgical indications, resection and prognosis]
Carcinoma, Hepatocellular
[Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient]
Carcinoma, Hepatocellular
[Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
Carcinoma, Hepatocellular
[Structure and expression of alpha-fetoprotein gene--current progress in research]
Carcinoma, Hepatocellular
[Studies on AFP-producing capacity and some other properties of human hepatoma cells treated with various anticancer drugs]
Carcinoma, Hepatocellular
[Study on the evaluation of recurrence of HCC and the effect after transcatheter hepatic arterial embolization--fluctuations in AFP values]
Carcinoma, Hepatocellular
[Suppression of alpha-fetoprotein gene expression in somatic hybrids of AFP-positive and AFP-negative clones of rat hepatoma]
Carcinoma, Hepatocellular
[Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis]
Carcinoma, Hepatocellular
[Synergic Effect of Adenoviral Vector-encoding Human Alpha-fetoprotein and Interferon-gamma on Immunity against Hepatocellular Carcinoma in Mice.]
Carcinoma, Hepatocellular
[Synthesis of alpha-fetoprotein, albumin and transferrin by long-term cultured cells of murine hepatoma]
Carcinoma, Hepatocellular
[The anti-apoptotic effect of cytoplasmic alpha-fetoprotein in hepatoma cells induced by all-trans retinoic acid involves activation of the PI3K/AKT signaling pathway].
Carcinoma, Hepatocellular
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
Carcinoma, Hepatocellular
[The clinical significance of PIVKA-II in hepatocellular carcinoma: a comparative study with alpha-fetoprotein: preliminary report]
Carcinoma, Hepatocellular
[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].
Carcinoma, Hepatocellular
[The degree of methylation of alpha-fetoprotein in rat hepatoma cell lines and their clones producing and not producing this protein]
Carcinoma, Hepatocellular
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
Carcinoma, Hepatocellular
[The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery]
Carcinoma, Hepatocellular
[The role of interleukin-1 beta in the regulation of liver-specific gene expression in human hepatoblastoma cells]
Carcinoma, Hepatocellular
[The studies on clinical value of AFP-L3 detected by microspincolum method for judgment of treatment response in patients with HCC undergoing TACE].
Carcinoma, Hepatocellular
[The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Triplet anti-tumor therapy based on thymosin ?-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].
Carcinoma, Hepatocellular
[Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]
Carcinoma, Hepatocellular
[Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without hcc development]
Carcinoma, Hepatocellular
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Carcinoma, Hepatocellular
[Value of ultrasonography in the early diagnosis of hepatocellular carcinoma]
Carcinoma, Islet Cell
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
Carcinoma, Large Cell
[An autopsied case of alpha-fetoprotein (AFP) producing large cell carcinoma of the lung (author's transl)]
Carcinoma, Medullary
Human mammary tumor cell proliferation: primary role of platelet-derived growth factor and possible synergism with human alpha-fetoprotein.
Carcinoma, Neuroendocrine
Alpha-fetoprotein Secreting Neuroendocrine Carcinoma of the Liver: a Case Report and Literature Review.
Carcinoma, Neuroendocrine
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Carcinoma, Neuroendocrine
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
Carcinoma, Neuroendocrine
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Carcinoma, Neuroendocrine
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Carcinoma, Non-Small-Cell Lung
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
Carcinoma, Ovarian Epithelial
Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Carcinoma, Ovarian Epithelial
Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+? in epithelial ovarian cancer patients.
Carcinoma, Ovarian Epithelial
Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
Carcinoma, Renal Cell
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Carcinoma, Renal Cell
Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma.
Carcinoma, Renal Cell
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Carcinoma, Renal Cell
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Carcinoma, Renal Cell
[A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma]
Carcinoma, Renal Cell
[A case of renal carcinoma with bone metastasis, producing alpha-fetoprotein]
Carcinoma, Renal Cell
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
Carcinoma, Small Cell
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Carcinoma, Small Cell
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Carcinoma, Squamous Cell
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
Carcinoma, Squamous Cell
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Carcinoma, Squamous Cell
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Carcinoma, Squamous Cell
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Carcinoma, Squamous Cell
Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.
Carcinoma, Squamous Cell
Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Carcinoma, Squamous Cell
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Carcinoma, Squamous Cell
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Carcinoma, Squamous Cell
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma.
Carcinoma, Squamous Cell
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Carcinoma, Squamous Cell
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Carcinoma, Squamous Cell
Impact of chronic kidney disease on serum tumor markers concentrations.
Carcinoma, Squamous Cell
Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Carcinoma, Squamous Cell
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Carcinoma, Squamous Cell
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Carcinoma, Transitional Cell
Alpha-fetoprotein-producing transitional cell carcinoma of the urinary bladder: a case report.
Carcinoma, Transitional Cell
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Carcinosarcoma
Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: Report of a case.
Carcinosarcoma
Carcinosarcoma of the stomach with alpha-fetoprotein-producing hepatoid adenocarcinoma: an unexpected combination of two rare subtypes of gastric cancer in one tumor.
Carcinosarcoma
Carcinosarcoma of the Uterine Corpus on 18F-FDG PET/CT in a Postmenopausal Woman With Elevated AFP.
Carcinosarcoma
Carcinosarcoma of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma: a report of two cases.
Carcinosarcoma
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Cardiomegaly
Prenatal diagnosis of partial monosomy 13q associated with occipital encephalocoele in a fetus.
Central Nervous System Diseases
Alpha-fetoprotein and the prenatal diagnosis of central nervous system disorders. A review.
Cerebellar Ataxia
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
Cerebellar Ataxia
A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Cerebellar Ataxia
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
Cerebellar Ataxia
Autosomal Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker.
Cerebellar Ataxia
Autosomal-Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha-Fetoprotein.
Cerebellar Ataxia
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Cerebellar Ataxia
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Cerebellar Ataxia
Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
Cerebellar Ataxia
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Cerebellar Ataxia
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Cerebellar Ataxia
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Cerebellar Ataxia
Reply to: "Autosomal-Recessive Cerebellar Ataxias With Elevated Alpha-Fetoprotein: Uncommon Diseases, Common Biomarker".
Cerebellar Ataxia
SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
Chemical and Drug Induced Liver Injury
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Chickenpox
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.
Cholangiocarcinoma
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Cholangiocarcinoma
Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
Cholangiocarcinoma
Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
Cholangiocarcinoma
An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Cholangiocarcinoma
Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Cholangiocarcinoma
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Cholangiocarcinoma
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Cholangiocarcinoma
Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
Cholangiocarcinoma
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Cholangiocarcinoma
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Cholangiocarcinoma
Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
Cholangiocarcinoma
HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Cholangiocarcinoma
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Cholangiocarcinoma
Human chorionic gonadotropin and alpha-fetoprotein in cholangiocarcinoma in relation to the expression of ras p21: an immunohistochemical study.
Cholangiocarcinoma
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.
Cholangiocarcinoma
Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?
Cholangiocarcinoma
Primary liver cell carcinoma. New insight for a more correct approach to its classification.
Cholangitis
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Cholestasis
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
Cholestasis
Progressive familial intrahepatic cholestasis - farnesoid X receptor deficiency due to NR1H4 mutation: A case report.
Cholestasis
[The noninvasive evaluation of degree of expression of fibrosis of liver and significance of polymorphism of gene of hyaluronic acid under chronic hepatitis C].
Cholestasis, Intrahepatic
Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy.
Cholestasis, Intrahepatic
Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Cholestasis, Intrahepatic
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Cholestasis, Intrahepatic
Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong.
Choriocarcinoma
alpha-Fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and its beta subunit in metastatic choriocarcinoma: short-term follow-up and determinations of resistance during chemotherapy.
Choriocarcinoma
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Choriocarcinoma
Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma.
Choriocarcinoma
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Choriocarcinoma
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Choriocarcinoma
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Choriocarcinoma
Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta.
Choriocarcinoma
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Choriocarcinoma
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Choriocarcinoma
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Choriocarcinoma
Radioimmunoassay of alpha-fetoprotein: a contribution to the diagnosis of choriocarcinoma and hydatidiform mole.
Choriocarcinoma
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Choriocarcinoma
Serum alpha-fetoprotein in hydatidiform mole, choriocarcinoma, and twin pregnancy.
Choriocarcinoma
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
Choriocarcinoma
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Choriocarcinoma, Non-gestational
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Chromosome Disorders
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Chromosome Disorders
First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal Diagnosis.
Chromosome Disorders
First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
Chromosome Disorders
[Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women]
Coinfection
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colonic Neoplasms
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Colonic Neoplasms
Carcinoembryonic antigen and alpha-fetoprotein in the diagnosis of gastric and colonic cancer: a comparative clinical evaluation.
Colonic Neoplasms
Colon cancer in pregnancy with elevated maternal serum alpha-fetoprotein level at presentation.
Colonic Neoplasms
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Colonic Neoplasms
The fucose-specific lectin ANL from Aspergillus niger possesses anti-cancer activity by inducing the intrinsic apoptosis pathway in hepatocellular and colon cancer cells.
Colonic Neoplasms
[Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case]
Colonic Neoplasms
[The evaluation of the efficiency in the detection of embryonal cancer and tumor-related antigens as tumor markers in gastrointestinal cancer]
Colorectal Neoplasms
Alpha-fetoprotein-producing colon cancer with atypical bulky lymph node metastasis.
Colorectal Neoplasms
Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA 19.9 and CA 125 in advanced colorectal cancer (ACC).
Colorectal Neoplasms
Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis.
Colorectal Neoplasms
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Colorectal Neoplasms
The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.
Colorectal Neoplasms
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization]
Coma
A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure.
Communicable Diseases
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Congenital Abnormalities
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Congenital Abnormalities
Acute reactive hepatitis in pregnancy induced by alpha-methyldopa.
Congenital Abnormalities
Alpha-fetoprotein concanavalin A-binding variants in the diagnosis of neural tube defects and other communicating fetal abnormalities.
Congenital Abnormalities
Alpha-fetoprotein content of amniotic fluid in normal and abnormal pregnancies.
Congenital Abnormalities
Amniotic fluid alpha-fetoprotein concentrations in twin gestations: dependence on placental membrane anatomy.
Congenital Abnormalities
An apparent dimerization motif in the third domain of alpha-fetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily.
Congenital Abnormalities
Antepartum evaluation of the high-risk fetus: problems and prospects.
Congenital Abnormalities
Anxiety concerning fetal malformations in pregnant women exposed or not exposed to an antenatal serum alpha-fetoprotein screening program.
Congenital Abnormalities
Assessment of equine alpha-fetoprotein levels in mares and newborn foals in the periparturient period.
Congenital Abnormalities
Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test.
Congenital Abnormalities
Biological roles of alpha-fetoprotein during pregnancy and perinatal development.
Congenital Abnormalities
Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?
Congenital Abnormalities
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Congenital Abnormalities
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Congenital Abnormalities
Comparison of amniotic fluid alpha-fetoprotein reactivity to Lens culinaris agglutinin and concanavalin A in crossed-affinity immunoelectrophoresis: ancillary tests in the prenatal diagnosis of severe fetal malformations.
Congenital Abnormalities
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Congenital Abnormalities
Concanavalin A--non-reactive alpha-fetoprotein and communicating fetal malformation.
Congenital Abnormalities
Editorial: Alpha-fetoprotein and prenatal diagnosis of congenital abnormalities.
Congenital Abnormalities
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Congenital Abnormalities
Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome.
Congenital Abnormalities
Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
Congenital Abnormalities
Fetal malformation and serum alpha-fetoprotein concentration of diabetic mothers.
Congenital Abnormalities
Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors.
Congenital Abnormalities
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Congenital Abnormalities
Management of epilepsy in women of childbearing age: practical recommendations.
Congenital Abnormalities
Maternal serum alpha-fetoprotein is a marker for fetal anomalies in pediatric surgery.
Congenital Abnormalities
Maternal serum alpha-fetoprotein screening: further consideration of low-volume testing.
Congenital Abnormalities
Maternal-serum-alphafetoprotein screening for fetal malformations in 28 062 pregnancies. A four-year experience from a low-risk area.
Congenital Abnormalities
Open fetal malformations in incorrectly dated pregnancies with initially low maternal serum alpha-fetoprotein.
Congenital Abnormalities
Outcomes in patients with unusually high maternal serum alpha-fetoprotein levels.
Congenital Abnormalities
Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome.
Congenital Abnormalities
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Congenital Abnormalities
Prospective study of an inverse relationship between maternal glycosylated hemoglobin and serum alpha-fetoprotein concentrations in pregnant women with diabetes.
Congenital Abnormalities
Raised alpha-fetoprotein levels associated with minor congenital defect.
Congenital Abnormalities
Raised maternal serum alpha-fetoprotein levels not associated with fetal malformations. A case report.
Congenital Abnormalities
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A in relation to gestational age: clinical implications.
Congenital Abnormalities
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformations.
Congenital Abnormalities
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
Congenital Abnormalities
Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
Congenital Abnormalities
Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein.
Congenital Abnormalities
Routine prenatal screening policy of fetal malformations by both maternal serum alpha-fetoprotein and ultrasound in eastern Hungary.
Congenital Abnormalities
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Congenital Abnormalities
The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
Congenital Abnormalities
The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects.
Congenital Abnormalities
Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin).
Congenital Abnormalities
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Congenital Abnormalities
Zinc and alpha-fetoprotein in amniotic fluid from early pregnancies with fetal malformations.
Congenital Abnormalities
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
Congenital Abnormalities
[Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)]
Congenital Hypothyroidism
Serum alpha-fetoprotein--a biochemical indicator of prenatal hypothyroidism.
Cough
[Mediastinal dissection of hepatocellular carcinoma with bilateral hilar and mediastinal lymph node metastasis]
Craniopharyngioma
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
Crohn Disease
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Cryptorchidism
Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
Cryptorchidism
The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.
Cryptorchidism
Yolk sac tumor in a patient with transverse testicular ectopia: a case report.
Cystadenocarcinoma, Mucinous
Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
Cystadenocarcinoma, Mucinous
Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. A case report.
Cystadenocarcinoma, Papillary
Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
Cystadenocarcinoma, Serous
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Cystic Adenomatoid Malformation of Lung, Congenital
Type III congenital cystic adenomatoid malformation associated with elevated maternal serum alpha-fetoprotein.
Cystic Fibrosis
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Cystic Fibrosis
Carcinoembryonic antigen, alpha 1-antitrypsin, and alpha-fetoprotein in the pancreas of patients with cystic fibrosis.
Cystic Fibrosis
Letter: Serum alpha-fetoprotein in cystic fibrosis.
Cystic Fibrosis
Prolactin, growth hormone and alpha-fetoprotein in children with cystic fibrosis.
Cystic Fibrosis
Serum alpha - fetoprotein levels in patients with cystic fibrosis and their parents and siblings.
Cystic Fibrosis
The direct early diagnosis of cystic fibrosis by the detection of the delta F508 CFTR gene mutation in a prematurely delivered boy.
Cystic Fibrosis
Timing and sequence of differentiation of embryonic rat hepatocytes along the biliary epithelial lineage.
Cystic Fibrosis
[The diagnostic potentialities of determining alpha-fetoprotein in the blood of patients with mucoviscidosis]
Cysts
Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation.
Cysts
CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Cysts
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Cysts
Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
Cysts
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Cysts
Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta.
Cysts
Serum and Cyst Fluid Tumor Marker Levels in the Differential Diagnosis of Benign Ovarian Cysts
Cysts
Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.
Cytomegalovirus Infections
Elevated second trimester maternal serum alpha-fetoprotein and cytomegalovirus infection.
Cytomegalovirus Infections
Increased serum alpha-fetoprotein levels in cytomegalovirus infections.
Decompression Sickness
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Denys-Drash Syndrome
Elevated maternal serum and amniotic fluid alpha-fetoprotein levels in the Denys-Drash syndrome.
Dermatomyositis
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Diabetes Insipidus, Neurogenic
Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline.
Diabetes Insipidus, Neurogenic
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Diabetes Mellitus
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
Diabetes Mellitus
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs.
Diabetes Mellitus
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.
Diabetes Mellitus
Early detection of hepatocellular carcinoma in patients with diabetes mellitus.
Diabetes Mellitus
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
Diabetes Mellitus
Maternal serum alpha-fetoprotein and diabetes mellitus.
Diabetes Mellitus
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
Diabetes Mellitus
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.
Diabetes Mellitus
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Diabetes Mellitus
Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
Diabetes Mellitus
Relationship of hepatitis B virus infection to the recurrence of hepatocellular carcinoma after direct acting antivirals.
Diabetes Mellitus
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Diabetes Mellitus
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.
Diabetes Mellitus
[Factors linked to 5-year survival after hepatectomy for hepatocellular carcinoma: univariate and multivariate analyses of 312 patients]
Diabetes Mellitus, Type 1
A prenatal diagnostic center's first-year experience with the California alpha-Fetoprotein Screening Program.
Diabetes Mellitus, Type 1
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Diabetes Mellitus, Type 1
Cord serum alpha-fetoprotein and maternal insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Diabetes Mellitus, Type 1
Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
Diabetes, Gestational
Correlation and diagnostic value of maternal serum alpha-fetoprotein level, predelivery age and body mass with gestational diabetes mellitus.
Diabetes, Gestational
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Diabetes, Gestational
Maternal serum alpha-fetoprotein levels in pregnant women with gestational diabetes.
Diabetes, Gestational
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
Diabetes, Gestational
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Digestive System Diseases
Alpha-fetoprotein in infantile obstructive jaundice in comparison with the normal ranges.
Digestive System Neoplasms
"Humors from tumors": carcinoembryonic antigen, alpha-fetoprotein, and digestive system cancer.
Diphtheria
Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human alpha-fetoprotein gene.
Diphtheria
Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Disorder of Sex Development, 46,XY
Elevated maternal serum and amniotic fluid alpha-fetoprotein levels in the Denys-Drash syndrome.
Diverticulum
Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro.
Down Syndrome
2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome.
Down Syndrome
A novel method for the detection of Down syndrome with the use of four serum markers.
Down Syndrome
A prenatal trisomy 21 screening program using alpha-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood.
Down Syndrome
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Down Syndrome
A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Down Syndrome
A six year study of the antenatal detection of fetal abnormality in six Scottish health boards.
Down Syndrome
ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Down Syndrome
Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Down Syndrome
Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers.
Down Syndrome
Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
Down Syndrome
All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
Down Syndrome
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Down Syndrome
Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome.
Down Syndrome
Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Down Syndrome
Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
Down Syndrome
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Down Syndrome
Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Down Syndrome
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Down Syndrome
Amniotic fluid alpha-fetoprotein levels and prenatal diagnosis of autosomal trisomies.
Down Syndrome
Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
Down Syndrome
Amniotic fluid alpha-fetoprotein subfractions in fetal Trisomy 21 affected pregnancies.
Down Syndrome
An alpha-fetoprotein radioimmunoassay for use in maternal serum screening for Down's syndrome: limitations and improvements.
Down Syndrome
An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
Down Syndrome
Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Down Syndrome
Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities.
Down Syndrome
Between-pregnancy biological variability of maternal serum alpha-fetoprotein and free beta hCG: implications for Down syndrome screening in subsequent pregnancies.
Down Syndrome
Biochemical screening for Down syndrome in pregnancies following renal transplantation.
Down Syndrome
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters.
Down Syndrome
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Down Syndrome
Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Down Syndrome
Collaborative study of Down syndrome screening using maternal serum alpha-fetoprotein and maternal age.
Down Syndrome
Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
Down Syndrome
Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Down Syndrome
Combining maternal age and serum alpha-fetoprotein to predict the risk of Down syndrome.
Down Syndrome
Combining maternal age and serum alpha-fetoprotein to predict the risk of Down's syndrome.
Down Syndrome
Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening.
Down Syndrome
Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Down Syndrome
Concanavalin A variants of alpha-fetoprotein in first trimester fetuses with trisomy 21 and with normal karyotypes.
Down Syndrome
Congenital pulmonary airway malformation (congenital cystic adenomatoid malformation) with multiple extrapulmonary anomalies: autopsy report of a fetus at 19 weeks of gestation.
Down Syndrome
Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Down Syndrome
Current difficulties in use of maternal serum alpha-fetoprotein levels in counseling mid-trimester older pregnant women regarding risk of a Down syndrome fetus.
Down Syndrome
Cutis marmorata telangiectatica congenita associated with an elevated maternal serum human chorionic gonadotrophin level and transitory isolated fetal ascites.
Down Syndrome
Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
Down Syndrome
Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Down Syndrome
Diagnostic and therapeutic technology assessment. Maternal serum alpha-fetoprotein testing and Down's syndrome.
Down Syndrome
Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
Down Syndrome
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
Down Syndrome
Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
Down Syndrome
Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Down Syndrome
Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Down Syndrome
Effect of incorrect gestational dating on Down's syndrome and neural tube risk assessment.
Down Syndrome
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Down Syndrome
Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Down Syndrome
Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997.
Down Syndrome
Elevated human chorionic gonadotropin levels in pregnancies with sex chromosome abnormalities.
Down Syndrome
Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
Down Syndrome
Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Down Syndrome
Elevated second-trimester maternal serum hCG in patients undergoing haemodialysis.
Down Syndrome
Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
Down Syndrome
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.
Down Syndrome
Evaluating health and maturation of the unborn: the role of the clinical laboratory.
Down Syndrome
Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
Down Syndrome
Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Down Syndrome
Evaluation of multiple-marker screening for Down syndrome in a statewide population.
Down Syndrome
Evaluation of the impact of vasa previa on feto-placental hormonal synthesis and fetal growth.
Down Syndrome
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Down Syndrome
Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Down Syndrome
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Down Syndrome
First trimester maternal serum alpha-fetoprotein screening for Down syndrome and other aneuploidies.
Down Syndrome
First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
Down Syndrome
First-trimester maternal serum alpha-fetoprotein screening for chromosome defects.
Down Syndrome
First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome.
Down Syndrome
Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
Down Syndrome
Genetic conditions among patients receiving genetic services in middle Tennessee.
Down Syndrome
Gestational age at maternal serum alpha-fetoprotein screening and the detection of Down syndrome.
Down Syndrome
Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
Down Syndrome
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Down Syndrome
Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first.
Down Syndrome
Implications of 'low' maternal serum alpha-fetoprotein levels: are maternal age risk criteria obsolete?
Down Syndrome
Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses.
Down Syndrome
Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome.
Down Syndrome
Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes.
Down Syndrome
Insulin-like growth factor binding protein-3 in the detection of fetal Down syndrome pregnancies.
Down Syndrome
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Down Syndrome
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Down Syndrome
Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome.
Down Syndrome
Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.
Down Syndrome
Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene.
Down Syndrome
Low maternal serum alpha-fetoprotein at 10 weeks gestation and fetal Down's syndrome.
Down Syndrome
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
Down Syndrome
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Down Syndrome
Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Down Syndrome
Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization.
Down Syndrome
Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.
Down Syndrome
Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older.
Down Syndrome
Maternal serum alpha-fetoprotein screening for Down syndrome and repeat testing.
Down Syndrome
Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations.
Down Syndrome
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
Down Syndrome
Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics.
Down Syndrome
Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling.
Down Syndrome
Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
Down Syndrome
Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
Down Syndrome
Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study.
Down Syndrome
Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
Down Syndrome
Maternal serum screening for down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an asian population. a prospective study.
Down Syndrome
Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong.
Down Syndrome
Maternal serum screening for down syndrome in pregnancies conceived by intra-uterine insemination.
Down Syndrome
Maternal serum screening for Down syndrome in the United States: a 1995 survey.
Down Syndrome
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Down Syndrome
Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.
Down Syndrome
Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Down Syndrome
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
Down Syndrome
Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Down Syndrome
Measuring quantitative serum human chorionic gonadotropin. Variations in levels between kits.
Down Syndrome
Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.
Down Syndrome
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Down Syndrome
New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Down Syndrome
Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Down Syndrome
Nuchal translucence incorporated into a one-stage multifactorial screening model for Down syndrome prediction at second-trimester pregnancy.
Down Syndrome
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.
Down Syndrome
Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
Down Syndrome
Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3-->q31.3) associated with Gorlin syndrome.
Down Syndrome
Poor pregnancy outcome associated with elevated maternal serum alpha-fetoprotein in combination with increased risk for Down syndrome.
Down Syndrome
Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy.
Down Syndrome
Precise gaussian distribution functions of maternal serum alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin for trisomy 21 screening: improved accuracy for patient counseling.
Down Syndrome
Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels.
Down Syndrome
Predictive value of the triple screening test for the phenotype of Down syndrome.
Down Syndrome
Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
Down Syndrome
Prenatal diagnosis of de novo t(2;18;14)(q33.1;q12.2;q31.2), dup(5)(q34q34), del(7)(p21.1p21.1), and del(10)(q25.3q25.3) and a review of the prenatally ascertained de novo apparently balanced complex and multiple chromosomal rearrangements.
Down Syndrome
Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus.
Down Syndrome
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
Down Syndrome
Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Down Syndrome
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Down Syndrome
Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.
Down Syndrome
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
Down Syndrome
Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
Down Syndrome
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Down Syndrome
Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels.
Down Syndrome
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Down Syndrome
Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome.
Down Syndrome
Replacing Alpha-Fetoprotein With Alpha-Fetoprotein-L3 Increases the Sensitivity of Prenatal Screening for Trisomy 21.
Down Syndrome
Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
Down Syndrome
Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
Down Syndrome
Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Down Syndrome
Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
Down Syndrome
Screening for Down's syndrome in older women based on maternal serum alpha-fetoprotein levels and age: preliminary results.
Down Syndrome
Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
Down Syndrome
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
Down Syndrome
Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
Down Syndrome
Screening for fetal Down's syndrome with maternal serum markers--an experience in Italy.
Down Syndrome
Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Down Syndrome
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Down Syndrome
Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Down Syndrome
Second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein levels in normal twin and singleton pregnancies: a report of local Chinese population.
Down Syndrome
Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women.
Down Syndrome
Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Down Syndrome
Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Down Syndrome
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Down Syndrome
Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Down Syndrome
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Down Syndrome
Selection and validation of alpha-fetoprotein assay kits for the screening of Down syndrome.
Down Syndrome
Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
Down Syndrome
Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome.
Down Syndrome
Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia.
Down Syndrome
Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Down Syndrome
Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Down Syndrome
Sonographic scoring index for prenatal detection of chromosomal abnormalities.
Down Syndrome
The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy.
Down Syndrome
The effect of estimating gestational age by ultrasound cephalometry on the sensitivity of alpha-fetoprotein screening for Down's syndrome.
Down Syndrome
The effect of fetal gender on the false-positive rate of Down syndrome by maternal serum screening.
Down Syndrome
The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters.
Down Syndrome
The effect of gestational age on maternal serum alpha-fetoprotein levels in pregnancies with Down syndrome.
Down Syndrome
The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening.
Down Syndrome
The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Down Syndrome
The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free beta-hCG.
Down Syndrome
The Influence of Maternal Weight Correction Formulas in Asian Down Syndrome Screening Using alpha-Fetoprotein and Free beta-Human Chorionic Gonadotropin
Down Syndrome
The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Down Syndrome
The second-trimester fetus with Down syndrome: detection using sonographic features.
Down Syndrome
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Down Syndrome
The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome.
Down Syndrome
The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
Down Syndrome
The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
Down Syndrome
Total alpha-fetoprotein and Lens culinaris agglutinin-reactive alpha-fetoprotein in fetal chromosomal abnormalities.
Down Syndrome
Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan.
Down Syndrome
Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Down Syndrome
Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Down Syndrome
Ultrasonographic dating of pregnancy causes significant errors in Down syndrome risk assessment that may be minimized by use of biparietal diameter-based means.
Down Syndrome
Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy.
Down Syndrome
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome.
Down Syndrome
Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome.
Down Syndrome
Variability in predicted rates of Down syndrome associated with elevated maternal serum alpha-fetoprotein levels in older women.
Down Syndrome
Weights of fetuses with autosomal trisomies at termination of pregnancy: an investigation of the etiologic factors of low serum alpha-fetoprotein values.
Down Syndrome
[A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay]
Down Syndrome
[Concanavalin A reactivity of alpha-fetoprotein in the amniotic fluid in autosomal trisomies of the fetus]
Down Syndrome
[Decreased alpha fetoprotein in maternal serum in relation to increased alpha fetoprotein in amniotic fluid in a case of fetal trisomy 21 associated with esophageal atresia]
Down Syndrome
[Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study]
Down Syndrome
[Maternal serum AFP determination in the 2d trimester: a suitable screening method for detection of fetuses with Down's syndrome in young females?]
Down Syndrome
[Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome]
Down Syndrome
[Maternal serum screening: possibilities of using in the complex diagnosis of fetal malformation]
Down Syndrome
[Serum Ca-125 levels in aneuploidy screening in first pregnancy trimester. Authors' experience]
Down Syndrome
[The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]
Duodenal Obstruction
First-trimester diagnosis of duodenal stenosis associated with oesophageal atresia.
Dysarthria
Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy.
Dysgerminoma
A case of mixed-type dysgerminoma with a high serum concentration of both human chorionic gonadotropin and alpha-fetoprotein in a child.
Dysgerminoma
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Dysgerminoma
Human chorionic gonadotropin and alpha-fetoprotein in sera and tumor cells of a patient with pure dysgerminoma of the ovary. A case report with radio-immunoassay and immunoperoxidase.
Dysgerminoma
Large mononuclear cells in seminoma--an immunohistochemical analysis of 21 cases.
Dysgerminoma
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Dysgerminoma
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Dysgerminoma
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Dyslipidemias
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Dyslipidemias
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
Dyslipidemias
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Dystonia
Clinical characteristics of ataxia-telangiectasia presenting dystonia as a main manifestation.
Echinococcosis
Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
Echinococcosis
[Cystic echinococcosis and hepatocellular carcinoma--a coincidence? A case report].
Ectodermal Dysplasia
Aplasia Cutis Congenita in a Setting of Fetus Papyraceus Associated with Small Fetal Abdominal Circumference and High Alpha-Fetoprotein and Amniotic Acetylcholinesterase.
Ectodermal Dysplasia
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
Ectodermal Dysplasia
Aplasia cutis congenita: a rare cause of elevated alpha-fetoprotein levels.
Ectodermal Dysplasia
Epidermolysis bullosa in association with aplasia cutis congenita and pyloric atresia.
Ectodermal Dysplasia
Increased amniotic acetylcholinesterase activity with a fetus papyraceus and aplasia cutis congenita.
Ectodermal Dysplasia
Report of a case with aplasia cutis congenita, elevated amniotic fluid alpha-fetoprotein, and positive acetylcholinesterase band.
Ectodermal Dysplasia
The association of congenital skin disorders with acetylcholinesterase in amniotic fluid.
Ectromelia
[Sirenomelia in a dead fetus in utero, discovered by a rise in maternal serum alpha-fetoprotein]
Embolism
Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
Embolism
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Embolism
[A case report of distal gastrectomy with thrombectomy after NAC for Gastric cancer].
Embolism
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]
Encephalocele
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Encephalocele
Prenatal diagnosis and perinatal management of frontoethmoidal meningoencephalocele.
Encephalocele
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Encephalomyelitis, Autoimmune, Experimental
Alpha-fetoprotein suppresses experimental allergic encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein.
End Stage Liver Disease
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
Endodermal Sinus Tumor
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
Endodermal Sinus Tumor
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Endodermal Sinus Tumor
Adult hepatic cavernous haemangioma with highly elevated alpha-fetoprotein.
Endodermal Sinus Tumor
Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein.
Endodermal Sinus Tumor
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
Endodermal Sinus Tumor
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Endodermal Sinus Tumor
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Endodermal Sinus Tumor
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
Endodermal Sinus Tumor
alpha-Fetoprotein and other serum proteins synthesized by endodermal sinus tumor transplanted into nude mice.
Endodermal Sinus Tumor
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Endodermal Sinus Tumor
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Endodermal Sinus Tumor
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Endodermal Sinus Tumor
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Endodermal Sinus Tumor
Alpha-fetoprotein, prealbumin, albumin, alpha-1-antitrypsin and transferrin as diagnostic and therapeutic markers for endodermal sinus tumors.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Endodermal Sinus Tumor
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Endodermal Sinus Tumor
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Endodermal Sinus Tumor
Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor.
Endodermal Sinus Tumor
Clinical and Computed Tomography Features of Female Pelvic Malignant Germ Cell Tumors in Children and Adolescents: A Series of 30 Cases.
Endodermal Sinus Tumor
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Endodermal Sinus Tumor
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Endodermal Sinus Tumor
Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Endodermal Sinus Tumor
Combination chemotherapy in the management of ovarian germ cell malignancies.
Endodermal Sinus Tumor
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Endodermal Sinus Tumor
Developmental alterations of alpha-fetoprotein sugar chain in amniotic fluids analyzed by lectin affinity electrophoresis.
Endodermal Sinus Tumor
Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors: An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3.
Endodermal Sinus Tumor
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Endodermal Sinus Tumor
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Endodermal Sinus Tumor
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Endodermal Sinus Tumor
Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report.
Endodermal Sinus Tumor
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
Endodermal Sinus Tumor
Epidemiological and clinical behavior of prepubertal testicular tumors in Korea.
Endodermal Sinus Tumor
Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.
Endodermal Sinus Tumor
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Endodermal Sinus Tumor
Fine needle aspiration cytology of primary mediastinal germ cell tumors.
Endodermal Sinus Tumor
Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
Endodermal Sinus Tumor
Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors.
Endodermal Sinus Tumor
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Endodermal Sinus Tumor
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Endodermal Sinus Tumor
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Endodermal Sinus Tumor
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Endodermal Sinus Tumor
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Endodermal Sinus Tumor
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Endodermal Sinus Tumor
Human endodermal sinus tumour in nude mice and its markers for diagnosis and management.
Endodermal Sinus Tumor
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Endodermal Sinus Tumor
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Endodermal Sinus Tumor
Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor).
Endodermal Sinus Tumor
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Endodermal Sinus Tumor
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Endodermal Sinus Tumor
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Endodermal Sinus Tumor
Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
Endodermal Sinus Tumor
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Endodermal Sinus Tumor
Intracardiac yolk sac tumor and dysrhythmia as an etiology of pediatric syncope.
Endodermal Sinus Tumor
Intracranial germ-cell tumors. Immunohistochemical study of three autopsy cases.
Endodermal Sinus Tumor
Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Endodermal Sinus Tumor
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Endodermal Sinus Tumor
Juvenile granulosa cell tumor of the testis:: contemporary clinical management and pathological diagnosis.
Endodermal Sinus Tumor
Malignant müllerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor.
Endodermal Sinus Tumor
Malignant ovarian germ cell tumours: experience in the National University Hospital of Singapore.
Endodermal Sinus Tumor
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Endodermal Sinus Tumor
Management of advanced endodermal sinus tumor of the ovary with preservation of reproductive function.
Endodermal Sinus Tumor
Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience.
Endodermal Sinus Tumor
Microcystic Leydig cell tumors mimicking yolk sac tumor: a report of four cases.
Endodermal Sinus Tumor
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Endodermal Sinus Tumor
Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Endodermal Sinus Tumor
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Endodermal Sinus Tumor
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Endodermal Sinus Tumor
Ovarian mucinous cystadenocarcinoma with yolk sac tumor in a 71-year-old woman.
Endodermal Sinus Tumor
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Endodermal Sinus Tumor
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Endodermal Sinus Tumor
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Endodermal Sinus Tumor
Perforating abomasal ulcer caused by yolk sac tumor in a Holstein calf.
Endodermal Sinus Tumor
Peritoneal implantation of endodermal sinus tumor of the pineal region via a ventriculoperitoneal shunt. Cytodiagnosis with immunocytochemical demonstration of alpha-fetoprotein.
Endodermal Sinus Tumor
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumor.
Endodermal Sinus Tumor
Postchemotherapy retroperitoneal residual mass in infantile yolk sac tumor.
Endodermal Sinus Tumor
Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum.
Endodermal Sinus Tumor
Primary intracranial yolk sac tumor: immunofluorescent demonstration of alpha-fetoprotein synthesis.
Endodermal Sinus Tumor
Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
Endodermal Sinus Tumor
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Endodermal Sinus Tumor
Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice.
Endodermal Sinus Tumor
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Endodermal Sinus Tumor
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
Endodermal Sinus Tumor
Pure Primary Extragonadal Retroperitoneal Yolk Sac Tumour in a Young Child: A Case Report.
Endodermal Sinus Tumor
Raised maternal serum alpha-fetoprotein levels during pregnancy following treatment of an endodermal sinus tumour. Case report.
Endodermal Sinus Tumor
Residual retroperitoneal mass following chemotherapy for infantile yolk sac tumor.
Endodermal Sinus Tumor
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Endodermal Sinus Tumor
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Endodermal Sinus Tumor
Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.
Endodermal Sinus Tumor
Serial serum determination on alpha-fetoprotein as a marker of the effect of postoperative chemotherapy in ovarian endodermal sinus tumor.
Endodermal Sinus Tumor
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Endodermal Sinus Tumor
Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour.
Endodermal Sinus Tumor
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Endodermal Sinus Tumor
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Endodermal Sinus Tumor
Synthesis of alpha-fetoprotein by human yolk sac tumor transplanted into nude mice.
Endodermal Sinus Tumor
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
Endodermal Sinus Tumor
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
Endodermal Sinus Tumor
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
Endodermal Sinus Tumor
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
Endodermal Sinus Tumor
Ultrastructure and immunohistochemical staining of a transplanted endodermal sinus tumor.
Endodermal Sinus Tumor
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
Endodermal Sinus Tumor
Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases.
Endodermal Sinus Tumor
Yolk sac tumor and alpha-fetoprotein: clinicopathological study of four cases.
Endodermal Sinus Tumor
Yolk sac tumor of the anterior mediastinum. Case report with light- and electron-microscopic examination and immunohistochemical study of alpha-fetoprotein.
Endodermal Sinus Tumor
Yolk sac tumor of the anterior mediastinum: the role of palliative surgery.
Endodermal Sinus Tumor
Yolk sac tumor of the stomach with an adenocarcinomatous component: a case report with immunohistochemical analysis.
Endodermal Sinus Tumor
Yolk sac tumor of the testicle: is retroperitoneal lymph node dissection necessary?
Endodermal Sinus Tumor
[An experimental study on alpha-fetoprotein producing yolk sac tumor (author's transl)]
Endodermal Sinus Tumor
[Anti-tumor activity of an anti-human alpha-fetoprotein antibody-human serum albumin-mitomycin C conjugate against human yolk sac tumor maintained in vitro and in nude mice in vivo]
Endodermal Sinus Tumor
[Case of yolk sac tumor of the anterior mediastinum with superior vena cava syndrome]
Endodermal Sinus Tumor
[Combined treatment with resection, intraoperative hypotonic and post-operative systemic chemotherapy using cis-platinum for a mediastinal yolk sac tumor: a case report]
Endodermal Sinus Tumor
[Effect of anti-human alpha-fetoprotein serum on human endodermal sinus tumor transplanted in nude mice (author's transl)]
Endodermal Sinus Tumor
[Molecular heterogeneity of alpha-fetoprotein in ovarian or extragonadal yolk sac tumor]
Endodermal Sinus Tumor
[Yolk sac tumor by fetectomy in the rat: histopathological characteristics and histogenesis (author's transl)]
Endometrial Neoplasms
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Endometrial Neoplasms
Predictive power of sexual hormones and tumor markers in endometrial cancer.
Endometriosis
Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: A case report.
Endometriosis
Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.
Endometriosis
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Endometriosis
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Eosinophilia
Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.
Ependymoma
Case report: a preterm infant with an extradural myxopapillary ependymoma component of a teratoma and high levels of alpha-fetoprotein.
Epidermal Cyst
[Clinical and ultrasonographic features of testis tumor in children of different ages].
Epidermolysis Bullosa
Epidermolysis bullosa in association with aplasia cutis congenita and pyloric atresia.
Epidermolysis Bullosa
Genetic counseling of high-risk isolated populations: A worldwide challenge.
Epidermolysis Bullosa
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
Association of generalized dystrophic epidermolysis bullosa with positive acetylcholinesterase and markedly elevated maternal serum and amniotic fluid alpha-fetoprotein.
Epidermolysis Bullosa Dystrophica
Markedly elevated alpha-fetoprotein and positive acetylcholinesterase in amniotic fluid from a pregnancy affected with dystrophic epidermolysis bullosa.
Epidermolysis Bullosa Dystrophica
The association of congenital skin disorders with acetylcholinesterase in amniotic fluid.
Epidermolysis Bullosa, Junctional
Alpha-fetoprotein and acetylcholinesterase are not predictive of fetal junctional epidermolysis bullosa, Herlitz variant.
Epidermolysis Bullosa, Junctional
Alpha-fetoprotein and acetylcholinesterase are not predictors of fetal junctional epidermolysis bullosa, Herlitz variant.
Epidermolysis Bullosa, Junctional
Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein.
Epidermolysis Bullosa, Junctional
Role of elevated alpha-fetoprotein in prenatal diagnosis of junctional epidermolysis bullosa and pyloric atresia.
Epididymitis
Hereditary persistence of alpha-fetoprotein mimicking testicular cancer in a patient with acute epididymitis.
Epilepsy
Alpha-fetoprotein concentrations in sera from epileptic patients with immunodeficiency.
Epilepsy
First and Second Trimester Biochemical Markers in Maternal Epilepsy: A Case-Control Study.
Epilepsy
[Observations on the development of pregnancy in women with epilepsy based on analysis of protein placental hormones and alpha fetoprotein]
Erythema Infectiosum
Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Erythema Infectiosum
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Erythema Infectiosum
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Esophageal and Gastric Varices
Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.
Esophageal and Gastric Varices
Endoscopic injection sclerotherapy for esophageal varices associated with concomitant portal venous thrombus of hepatocellular carcinoma.
Esophageal and Gastric Varices
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Esophageal and Gastric Varices
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Esophageal and Gastric Varices
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Esophageal and Gastric Varices
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Esophageal Atresia
[Decreased alpha fetoprotein in maternal serum in relation to increased alpha fetoprotein in amniotic fluid in a case of fetal trisomy 21 associated with esophageal atresia]
Esophageal Neoplasms
An enzyme immunoassay for galactosyltransferase isoenzyme II, and its clinical application to cancer diagnosis.
Esophageal Neoplasms
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Esophageal Neoplasms
Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Esophageal Neoplasms
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Fanconi Anemia
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Fanconi Anemia
Intermethod discordance for alpha-fetoprotein measurements in Fanconi anemia.
Fanconi Anemia
Maternal serum alpha-fetoprotein levels are normal in Fanconi anemia: Can it be a lack of postnatal inhibition of AFP gene resulting in the elevation?
Fanconi Anemia
Serum alpha-fetoprotein level in Fanconi's anemia: evaluation of 33 Turkish patients.
Fanconi Syndrome
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Fatty Liver
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Fatty Liver
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Fatty Liver
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.
Fatty Liver
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Fatty Liver
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
Fatty Liver
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Fatty Liver
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
Fetal Alcohol Spectrum Disorders
Alpha-fetoprotein, human placental lactogen, and pregnancy-specific beta 1-glycoprotein in pregnant women who drink: relation to fetal alcohol syndrome.
Fetal Death
Biochemical and Doppler predictors of poor perinatal outcome in a fetus with four umbilical vessels.
Fetal Death
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Fetal Death
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Fetal Death
Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester?
Fetal Death
Elevated maternal alpha-fetoprotein levels with subsequent fetal exsanguination.
Fetal Death
Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
Fetal Death
Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Fetal Death
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Fetal Death
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Fetal Death
Letter: Alpha-fetoprotein in amniotic fluid in early normal pregnancy and intrauterine fetal death.
Fetal Death
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Fetal Death
Mechanisms of fetal demise in pregnant mice immunized to murine alpha-fetoprotein.
Fetal Death
Persistently elevated AFP and AChE in amniotic fluid from a normal fetus following demise of its twin.
Fetal Death
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Fetal Death
Prediction of pregnancy outcome with single versus serial maternal serum alpha-fetoprotein tests.
Fetal Death
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Fetal Death
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Fetal Death
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Fetal Death
Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Fetal Death
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Fetal Death
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Fetal Death
The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum alpha-fetoprotein levels.
Fetal Death
The Kleihauer-Betke test. Clinical utility, indication, and correlation in patients with placental abruption and cocaine use.
Fetal Death
Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Fetal Death
Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Fetal Death
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
Fetal Death
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
Fetal Growth Retardation
A discrepancy between gestational age estimated by last menstrual period and biparietal diameter may indicate an increased risk of fetal death and adverse pregnancy outcome.
Fetal Growth Retardation
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Fetal Growth Retardation
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Fetal Growth Retardation
Antepartum evaluation of the high-risk fetus: problems and prospects.
Fetal Growth Retardation
Association of low maternal serum alpha-fetoprotein levels and intrauterine growth retardation.
Fetal Growth Retardation
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Fetal Growth Retardation
Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
Fetal Growth Retardation
Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
Fetal Growth Retardation
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Fetal Growth Retardation
Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia.
Fetal Growth Retardation
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Fetal Growth Retardation
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Fetal Growth Retardation
Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.
Fetal Growth Retardation
Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses.
Fetal Growth Retardation
Midtrimester diagnosis and anomalies in the dup(22q) syndrome: correlation of aneuploidy with low maternal serum alpha-fetoprotein and oligohydramnios.
Fetal Growth Retardation
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
Fetal Growth Retardation
Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Fetal Growth Retardation
Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration.
Fetal Growth Retardation
Postnatal placental confirmation of trisomy 2 and trisomy 16 detected at chorionic villus sampling: a possible association with intrauterine growth retardation and elevated maternal serum alpha-fetoprotein.
Fetal Growth Retardation
Prenatal diagnosis of an infant with mosaic trisomy 16 of paternal origin.
Fetal Growth Retardation
Prenatal diagnosis of congenital anomalies in an intrauterine growth retarded fetus.
Fetal Growth Retardation
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Fetal Growth Retardation
Prenatal diagnosis of partial monosomy 13q associated with occipital encephalocoele in a fetus.
Fetal Growth Retardation
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Fetal Growth Retardation
Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.
Fetal Growth Retardation
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Fetal Growth Retardation
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Fetal Growth Retardation
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Fetal Growth Retardation
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Fetal Growth Retardation
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
Fetal Growth Retardation
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Fetal Growth Retardation
The association of early-onset fetal growth restriction, elevated maternal serum alpha-fetoprotein, and the development of severe pre-eclampsia.
Fetal Growth Retardation
The effect of fetomaternal bleeding on the risk of adverse pregnancy outcome in patients with elevated second-trimester maternal serum alpha-fetoprotein levels.
Fetal Growth Retardation
The use of biochemical markers in prenatal diagnosis of intrauterine growth retardation: insulin-like growth factor I, Leptin, and alpha-fetoprotein.
Fetal Growth Retardation
Uterine torsion and subsequent rupture in a gravid bicornuate uterus associated with an elevated alpha-fetoprotein.
Fetal Growth Retardation
[Radioimmunological assay of alpha-fetoprotein in maternal serum and intrauterine fetal growth retardation]
Fetal Hypoxia
Cord blood alpha-fetoprotein concentrations in term newborns of smoking mothers.
Fetomaternal Transfusion
Detecting fetomaternal hemorrhage after first-trimester abortion with the Kleihauer-Betke test and rise in maternal serum alpha-fetoprotein.
Fetomaternal Transfusion
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Fetomaternal Transfusion
Fetomaternal transfusion and pregnancy outcome after cordocentesis.
Fetomaternal Transfusion
Fetomaternal transfusion depends on amount of chorionic villi aspirated but not on method of chorionic villus sampling.
Fetomaternal Transfusion
Measurement of alpha-fetoprotein and fetal erythrocyte levels for detecting fetomaternal hemorrhage.
Fetomaternal Transfusion
Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha-fetoprotein levels. A case report.
Fetomaternal Transfusion
Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
Fibrocystic Breast Disease
CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Focal Nodular Hyperplasia
Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
Focal Nodular Hyperplasia
Focal nodular hyperplasia masquerading as malignancy in an infant with elevated alpha-fetoprotein: A case report with literature review.
Focal Nodular Hyperplasia
Focal nodular hyperplasia of the liver and elevated alpha fetoprotein level in an infant with isolated hemihyperplasia.
Focal Nodular Hyperplasia
High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver.
Focal Nodular Hyperplasia
Telangiectatic focal nodular hyperplasia of the liver in an infant with spontaneous regression: a case report.
Gallbladder Neoplasms
Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9-producing gallbladder cancer.
Ganglioglioma
Pineal ganglioglioma in a patient with familial basal ganglia calcification and elevated serum alpha-fetoprotein: case report.
Gastric Dilatation
Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein.
Gastric Dilatation
Prenatal findings in epidermolysis bullosa with pyloric atresia in a family not known to be at risk.
Gastritis, Atrophic
Tumor markers in carcinoma and premalignant states of the stomach in humans.
Gastrointestinal Diseases
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Gastrointestinal Diseases
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Gastrointestinal Diseases
Letter: Radioimmunoassay of alpha-fetoprotein in gastrointestinal diseases.
Gastrointestinal Diseases
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Gastrointestinal Diseases
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Gastrointestinal Neoplasms
Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases.
Gastrointestinal Neoplasms
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Gastrointestinal Neoplasms
Immunologic tests for the detection of gastrointestinal cancers: status report on carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP).
Gastrointestinal Neoplasms
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.
Gastrointestinal Neoplasms
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
Gastroschisis
Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis.
Gastroschisis
Fetal protein loss in gastroschisis as an explanation of associated morbidity.
Gastroschisis
Impact of demographic factors on prenatal diagnosis and elective pregnancy termination because of abdominal wall defects, Hawaii, 1986-1997.
Gastroschisis
Prenatal diagnosis and management of anterior abdominal wall defects in the west of Scotland.
Gastroschisis
Prenatal diagnosis of two cases of gastroschisis following alpha-fetoprotein (AFP) screening.
Gastroschisis
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Gastroschisis
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Gastroschisis
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Gastroschisis
The omega-6 fatty acid linoleic acid is associated with risk of gastroschisis: A novel dietary risk factor.
Gastroschisis
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
Genetic Diseases, Inborn
A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: A possible link between twelve autism risk factors and the autism 'epidemic'
Genetic Diseases, Inborn
Alpha-fetoprotein values in maternal serum and amniotic fluid for prenatal screening of genetic disorders.
Genetic Diseases, Inborn
Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
Genetic Diseases, Inborn
Unusual prenatal sonographic findings without an elevated maternal serum alpha-fetoprotein level in a fetus with epidermolysis bullosa.
Genital Diseases, Female
Multiple biochemical markers in patients with gynecologic malignancies.
Genital Neoplasms, Female
[Carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in malignant female genital neoplasms]
Germinoma
Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar Region.
Germinoma
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Germinoma
Germ cell tumor presenting as sellar mass with suprasellar extension and long history of hypopituitarism.
Germinoma
Improved outcome of central nervous system germ cell tumors: implications for the role of risk-adapted intensive chemotherapy.
Germinoma
Intracranial multiple midline germinomas: is histological verification crucial for therapy?
Germinoma
Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus.
Germinoma
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
Germinoma
Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
Germinoma
Synchronous mixed germ cell tumor of the pineal gland and suprasellar region with a predominant angiomatous component: a diagnostic challenge.
Germinoma
Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Germinoma
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Germinoma
[Highly sensitive test for alpha-fetoprotein in the differential diagnosis of germinomas of the testis and in evaluating the effectiveness of their treatment]
Glycogen Storage Disease
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.
Glycogen Storage Disease Type I
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature.
Gonadal Dysgenesis
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
Gout
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
Granulosa Cell Tumor
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Granulosa Cell Tumor
Juvenile granulosa cell tumour with hepatocyte-like cells and raised serum alpha-fetoprotein.
Gynecomastia
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Hamartoma
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Hamartoma
Stromal-predominant mesenchymal hamartoma of the liver with elevated serum alpha-fetoprotein level.
Heart Defects, Congenital
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
Heart Diseases
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Heart Failure
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
HELLP Syndrome
Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome.
Hemangioendothelioma
Elevated alpha-fetoprotein in a neonate with a benign hemangioendothelioma of the liver.
Hemangioendothelioma
Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level.
Hemangioendothelioma
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Hemangioendothelioma
Solitary hepatic hemangioendothelioma with extensive cystic necrosis and markedly elevated alpha-fetoprotein.
Hemangioendothelioma
[Infantile hemangioendothelioma with increased serum alpha-fetoprotein]
Hemangioma
A giant cord hemangioma with extramedullary hematopoiesis and elevated maternal serum human chorionic gonadotropin: a case report and review of the literature.
Hemangioma
Chorioangioma: a new inclusion in the prospective and retrospective evaluation of elevated maternal serum alpha-fetoprotein.
Hemangioma
Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor.
Hemangioma
Giant congenital right atrial epithelioid-capillary hemangioma with prolonged QT interval: Case report and practical surgical treatment strategy for primary cardiac tumors in children based on 25-year review of 299 cases.
Hemangioma
Not all chorioangiomas are associated with elevated maternal serum alpha-fetoprotein.
Hemangioma
Placental chorioangioma: a rare cause of elevated amniotic fluid alpha-fetoprotein.
Hemangioma
Prenatal diagnosis and management of fetal anemia secondary to a large chorioangioma.
Hemangioma
Rare causes of elevated maternal serum alpha-fetoprotein. A report of three cases.
Hemangioma
Umbilical cord hemangioma associated with extremely high alpha-fetoprotein levels.
Hemangioma
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
Hemochromatosis
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Hemochromatosis
Detection of treatable neonatal liver disease by expanded newborn screening.
Hemochromatosis
Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Hemochromatosis
High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.
Hemochromatosis
Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure.
Hemoperitoneum
A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult.
Hemoperitoneum
A rare case of a spontaneously ruptured secondary hepatic malignant lymphoma.
Hemoperitoneum
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Hemoperitoneum
Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
Hemoptysis
[Usefulness of carcinoembryonic antigen and other markers in patients with hemoptysis]
Hepatic Encephalopathy
A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure.
Hepatic Encephalopathy
Cytochrome c is a possible new marker for fulminant hepatitis in humans.
Hepatic Encephalopathy
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Hepatic Encephalopathy
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Hepatic Encephalopathy
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
Hepatic Encephalopathy
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
Hepatic Encephalopathy
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
Hepatic Encephalopathy
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Hepatic Encephalopathy
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Hepatitis
A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients.
Hepatitis
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Hepatitis
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Hepatitis
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Hepatitis
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Hepatitis
Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.
Hepatitis
Alpha-fetoprotein in adult normals, bilharzial hepatic fibrosis and viral hepatitis in Egypt.
Hepatitis
Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
Hepatitis
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Hepatitis
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Hepatitis
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Hepatitis
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era.
Hepatitis
Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
Hepatitis
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Hepatitis
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Hepatitis
Blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic HBV hepatitis patients as hepatocellular cancer appears.
Hepatitis
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Hepatitis
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Hepatitis
Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years.
Hepatitis
Chubby face and the biochemical parameters for the early diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency.
Hepatitis
Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
Hepatitis
Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma.
Hepatitis
Clinical predictors of liver fibrosis in patients with chronic hepatitis B virus infection from children to adults.
Hepatitis
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Hepatitis
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Hepatitis
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Hepatitis
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Hepatitis
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Hepatitis
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Hepatitis
Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C.
Hepatitis
Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Hepatitis
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Hepatitis
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Hepatitis
Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma.
Hepatitis
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Hepatitis
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.
Hepatitis
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Hepatitis
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Hepatitis
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Hepatitis
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Hepatitis
Hepatitis B surface antigen, hepatitis B surface antibody and alpha-fetoprotein in urban endemic hepatitis at Aurangabad.
Hepatitis
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Hepatitis
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
Hepatitis
Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan.
Hepatitis
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Hepatitis
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Hepatitis
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Hepatitis
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Hepatitis
Impact of interferon-alpha therapy on the serum level of alpha-fetoprotein in patients with chronic viral hepatitis.
Hepatitis
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Hepatitis
Indocyanine green clearance test in non-cirrhotic hepatitis patients: a comparison and analysis between conventional blood sampling method and Finger Piece Monitoring method.
Hepatitis
Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
Hepatitis
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Hepatitis
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Hepatitis
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Hepatitis
Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma.
Hepatitis
Liver with hypoechoic nodular pattern as a risk factor for hepatocellular carcinoma.
Hepatitis
Living-Donor Liver Transplant for Fibrolamellar Hepatocellular Carcinoma With Hilar Lymph Node Metastasis: A Case Report.
Hepatitis
Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Hepatitis
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Hepatitis
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Hepatitis
Pedunculated Hepatocellular Carcinoma Mimicking Right Adrenal Tumor on FDG PET/CT.
Hepatitis
Preoperative predictors of survival after resection of small hepatocellular carcinomas.
Hepatitis
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Hepatitis
Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma.
Hepatitis
Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
Hepatitis
Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis.
Hepatitis
Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Hepatitis
Pulmonary metastases from primary hepatocellular carcinoma in a 26-year-old patient: a case report.
Hepatitis
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Hepatitis
Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.
Hepatitis
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Hepatitis
Relationship of serum alpha-fetoprotein to the severity and duration of illness in patients with viral hepatitis.
Hepatitis
Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis.
Hepatitis
Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.
Hepatitis
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Hepatitis
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ).
Hepatitis
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Hepatitis
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
Hepatitis
Serum alpha-fetoprotein. A prognostic indicator of liver-cell necrosis and regeneration following experimental injury by galactosamine in rats.
Hepatitis
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.
Hepatitis
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Hepatitis
The role of alpha-fetoprotein in the differentiation of neonatal hepatitis and biliary atresia.
Hepatitis
Three cases of small hepatocellular carcinoma presenting as obstructive jaundice.
Hepatitis
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Hepatitis
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Hepatitis
Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.
Hepatitis
Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.
Hepatitis
[A case of virus B hepatitis with massive hepatic cell necrosis (funnel liver) and transient high serum alpha-fetoprotein concentration (author's transl)]
Hepatitis
[A high risk group of hepatocellular carcinoma in man, with special reference to its clinical significance for the screening of early liver cancer. Gifu Study Group for Early Liver Cancer]
Hepatitis
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
Hepatitis
[Changes in plasma values of alpha-fetoprotein in subjects with prior acute hepatitis]
Hepatitis
[Comparative study of alpha-fetoprotein and Australian antigen in viral and serum hepatitis in young children]
Hepatitis
[Fatal acute hepatic failure with hepatocarcinoma presentation in a patient with renal transplant with asymptomatic chronic B and C hepatitis]
Hepatitis
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
Hepatitis
[Occurrence of alpha-fetoprotein in various forms of hepatitis, cirrhosis and primary hepatic cancer]
Hepatitis
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
Hepatitis
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Hepatitis
[Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]
Hepatitis
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Hepatitis
[Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases]
Hepatitis
[The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma]
Hepatitis A
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Hepatitis A
Clinical significance of elevated serum alpha-fetoprotein (AFP) level in acute viral hepatitis A (AHA).
Hepatitis B
A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.
Hepatitis B
A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Hepatitis B
A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular Carcinoma.
Hepatitis B
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Hepatitis B
Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.
Hepatitis B
Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
Hepatitis B
Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein.
Hepatitis B
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Hepatitis B
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Hepatitis B
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Hepatitis B
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Hepatitis B
Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
Hepatitis B
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Hepatitis B
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Hepatitis B
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Hepatitis B
An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma.
Hepatitis B
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Hepatitis B
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival.
Hepatitis B
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Hepatitis B
Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women.
Hepatitis B
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Hepatitis B
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Hepatitis B
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Hepatitis B
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Hepatitis B
Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.
Hepatitis B
Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.
Hepatitis B
Bivariate flow cytometric analysis of p53 and DNA content in hepatocellular carcinoma.
Hepatitis B
Case report: fibrolamellar hepatocellular carcinoma in a Japanese woman: a case report and review of Japanese cases.
Hepatitis B
Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis.
Hepatitis B
Cesium Lead Bromide (CsPbBr3) Perovskite Quantum Dot-Based Photosensor for Chemiluminescence Immunoassays.
Hepatitis B
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.
Hepatitis B
Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature.
Hepatitis B
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Hepatitis B
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
Hepatitis B
Clinical biocharacterization of immunophenotype in hepatocellular carcinoma patients.
Hepatitis B
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Hepatitis B
Clinical features of treatment-naive patients with hepatitis B virus infection: A community-based survey from high- and intermediate-hepatitis B endemicity regions in Southeast China.
Hepatitis B
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Hepatitis B
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Hepatitis B
Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Hepatitis B
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Hepatitis B
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Hepatitis B
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Hepatitis B
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Hepatitis B
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Hepatitis B
Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
Hepatitis B
Combined hepato-cholangiocarcinoma arising in a gallbladder intracystic papillary neoplasm. A new view on so-called "hepatoid adenocarcinoma of the gallbladder".
Hepatitis B
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Hepatitis B
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Hepatitis B
Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.
Hepatitis B
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Hepatitis B
Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.
Hepatitis B
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Hepatitis B
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival.
Hepatitis B
Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared With Hepatocellular Carcinoma.
Hepatitis B
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Hepatitis B
Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
Hepatitis B
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Hepatitis B
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Hepatitis B
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Hepatitis B
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Hepatitis B
Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.
Hepatitis B
Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
Hepatitis B
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Hepatitis B
Diagnostic value of the ?-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma.
Hepatitis B
Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
Hepatitis B
Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
Hepatitis B
Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
Hepatitis B
Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.
Hepatitis B
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Hepatitis B
Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
Hepatitis B
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.
Hepatitis B
Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus.
Hepatitis B
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Hepatitis B
Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.
Hepatitis B
Epidemiological studies of alpha-fetoprotein and hepatitis B antigen in Tomié Town, Nagasaki, Japan.
Hepatitis B
Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection.
Hepatitis B
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.
Hepatitis B
Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients.
Hepatitis B
Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
Hepatitis B
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Hepatitis B
Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Hepatitis B
Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)-Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma.
Hepatitis B
Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study.
Hepatitis B
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Hepatitis B
Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Hepatitis B
Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors.
Hepatitis B
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Hepatitis B
Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.
Hepatitis B
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Hepatitis B
Fibrolamellar hepatocellular carcinoma: a case report with distinct radiological features.
Hepatitis B
Fine needle aspiration biopsy of hepatocellular carcinoma. Diagnostic dilemma at the ends of the spectrum.
Hepatitis B
Fixed polarizer ellipsometry for simple and sensitive detection of thin films generated by specific molecular interactions: applications in immunoassays and DNA sequence detection.
Hepatitis B
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Hepatitis B
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Hepatitis B
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Hepatitis B
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Hepatitis B
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
Hepatitis B
HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection.
Hepatitis B
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
Hepatitis B
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Hepatitis B
Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice.
Hepatitis B
Hepatitis B surface antigen, hepatitis B surface antibody and alpha-fetoprotein in urban endemic hepatitis at Aurangabad.
Hepatitis B
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
Hepatitis B
Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression.
Hepatitis B
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Hepatitis B
Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Hepatitis B
Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.
Hepatitis B
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Hepatitis B
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire.
Hepatitis B
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Hepatitis B
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.
Hepatitis B
Hepatocellular carcinoma coexisted with second malignancy--a study of 13 cases from a consecutive 440 autopsy cases of HCC.
Hepatitis B
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Hepatitis B
Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.
Hepatitis B
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.
Hepatitis B
Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
Hepatitis B
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Hepatitis B
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.
Hepatitis B
Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks.
Hepatitis B
Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
Hepatitis B
Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liver.
Hepatitis B
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Hepatitis B
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
Hepatitis B
High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
Hepatitis B
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Hepatitis B
Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Hepatitis B
Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Hepatitis B
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Hepatitis B
Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Hepatitis B
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma.
Hepatitis B
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Hepatitis B
Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine.
Hepatitis B
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Hepatitis B
Intrahepatic mass-forming cholangiocarcinoma growing in a giant hepatic hemangioma: A case report.
Hepatitis B
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Hepatitis B
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Hepatitis B
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
Hepatitis B
Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy.
Hepatitis B
Late development of hepatocellular carcinoma after viral clearance in patients with chronic hepatitis C: A need for continual surveillance.
Hepatitis B
LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Hepatitis B
Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Hepatitis B
Liver lesions detected in a hepatitis B core total antibody-positive patient masquerading as hepatocellular carcinoma: a rare case of peliosis hepatis and a review of the literature.
Hepatitis B
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Hepatitis B
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Hepatitis B
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Hepatitis B
LSA--a new liver-specific antigen in the rat. II: Immunological and biological properties.
Hepatitis B
Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Hepatitis B
Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hepatitis B
Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes.
Hepatitis B
Metastasis of hepatocellular carcinoma to Virchow's node: have the tumor cells gone astray?
Hepatitis B
Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein.
Hepatitis B
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Hepatitis B
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Hepatitis B
Natural history of compensated cirrhosis in the Child-Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections.
Hepatitis B
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Hepatitis B
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.
Hepatitis B
Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.
Hepatitis B
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
Hepatitis B
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Hepatitis B
Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Hepatitis B
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Hepatitis B
Pathologic features and patient survival in hepatocellular carcinoma in relation to age.
Hepatitis B
Patterns of antigen expression in hepatoblastoma and hepatocellular carcinoma in childhood.
Hepatitis B
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
Hepatitis B
PLC/PRF/5 (Alexander) hepatoma cell line: further characterization and studies of infectivity.
Hepatitis B
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Hepatitis B
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Hepatitis B
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Hepatitis B
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort.
Hepatitis B
Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
Hepatitis B
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Hepatitis B
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Hepatitis B
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Hepatitis B
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Hepatitis B
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Hepatitis B
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Hepatitis B
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Hepatitis B
Radical resection of hepatic polycystic echinococcosis complicated with hepatocellular carcinoma: A case report.
Hepatitis B
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Hepatitis B
Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Hepatitis B
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Hepatitis B
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Hepatitis B
Recombinant DNA and the liver: studies with albumin, alpha-fetoprotein, hepatitis B virus, and other DNA probes.
Hepatitis B
Regenerative nodule mimicking hepatocellular carcinoma in a cirrhotic child due to hepatitis B: an imaging dilemma.
Hepatitis B
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Hepatitis B
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Hepatitis B
Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver.
Hepatitis B
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Hepatitis B
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Hepatitis B
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Hepatitis B
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Hepatitis B
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.
Hepatitis B
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Hepatitis B
Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
Hepatitis B
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Hepatitis B
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Hepatitis B
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Hepatitis B
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Hepatitis B
Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Hepatitis B
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Hepatitis B
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Hepatitis B
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
Hepatitis B
Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment.
Hepatitis B
Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma.
Hepatitis B
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Hepatitis B
The acute phase protein alpha-1-antitrypsin inhibits transferrin uptake in PLC/PRF/5 cells and increases release of hepatitis B virus surface antigen and alpha-fetoprotein.
Hepatitis B
The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.
Hepatitis B
The efficacy of the immunoperoxidase technique for the detection of several antigens after destaining of stored stained sections.
Hepatitis B
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
Hepatitis B
The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood.
Hepatitis B
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients.
Hepatitis B
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Hepatitis B
The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis.
Hepatitis B
The X-gene of human hepatitis B virus transactivates the c-jun and alpha-fetoprotein genes.
Hepatitis B
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Hepatitis B
Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.
Hepatitis B
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Hepatitis B
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Hepatitis B
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Hepatitis B
Upregulation of colonic and hepatic tumor overexpressed gene is significantly associated with the unfavorable prognosis marker of human hepatocellular carcinoma.
Hepatitis B
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Hepatitis B
[A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis].
Hepatitis B
[Analysis on influencing factors that leading to nonspecific responses to indeterminate results of HIV antibodies].
Hepatitis B
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Hepatitis B
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
Hepatitis B
[Expression of ATAD2 in different liver lesions and its clinical significance].
Hepatitis B
[Importance of carcinoembryonic antigen, alpha-fetoprotein and cholylglycine in differential diagnosis of viral hepatitis B and mechanical jaundice]
Hepatitis B
[Serum alpha-fetoprotein and hepatitis B surface antigen in patients with hepatocellular carcinoma (author's transl)]
Hepatitis B
[The therapeutic value of alpha-fetoprotein and cholinesterase in patients with hepatitis B virus related acute onset chronic liver failure].
Hepatitis B
[Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver].
Hepatitis B, Chronic
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Hepatitis B, Chronic
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Hepatitis B, Chronic
Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
Hepatitis B, Chronic
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Hepatitis B, Chronic
Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection-Related Hepatocellular Carcinoma.
Hepatitis B, Chronic
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Hepatitis B, Chronic
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
Hepatitis B, Chronic
Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
Hepatitis B, Chronic
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Hepatitis B, Chronic
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Hepatitis B, Chronic
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Hepatitis B, Chronic
Effect of antiviral treatment on alfa-fetoprotein levels in HBV-related cirrhotic patients: early detection of hepatocellular carcinoma.
Hepatitis B, Chronic
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Hepatitis B, Chronic
Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.
Hepatitis B, Chronic
Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Hepatitis B, Chronic
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Hepatitis B, Chronic
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
Hepatitis B, Chronic
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Hepatitis B, Chronic
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Hepatitis B, Chronic
Monitoring of serum alpha-fetoprotein levels in children with chronic hepatitis B virus infection.
Hepatitis B, Chronic
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Hepatitis B, Chronic
Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
Hepatitis B, Chronic
Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B.
Hepatitis B, Chronic
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Hepatitis B, Chronic
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Hepatitis B, Chronic
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Hepatitis B, Chronic
Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis B.
Hepatitis B, Chronic
Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma.
Hepatitis B, Chronic
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
Hepatitis B, Chronic
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Hepatitis C
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
Hepatitis C
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Hepatitis C
Alpha-fetoprotein and highly active antiretroviral therapy in patients coinfected with HIV-1 and hepatitis C virus.
Hepatitis C
An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma.
Hepatitis C
Assessment of hepatic fibrosis by fibroscan in egyptian chronic hemodialysis patients with chronic Hepatitis C (genotype 4): A single-center study.
Hepatitis C
Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis.
Hepatitis C
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Hepatitis C
Chronological change in alpha-fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus.
Hepatitis C
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Hepatitis C
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Hepatitis C
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.
Hepatitis C
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Hepatitis C
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Hepatitis C
Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection.
Hepatitis C
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Hepatitis C
Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).
Hepatitis C
Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
Hepatitis C
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Hepatitis C
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Hepatitis C
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Hepatitis C
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.
Hepatitis C
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Hepatitis C
Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Hepatitis C
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Hepatitis C
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Hepatitis C
Efficacy of on-demand intrahepatic arterial therapy in combination with sorafenib for advanced hepatocellular carcinoma.
Hepatitis C
Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices.
Hepatitis C
Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives.
Hepatitis C
Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Hepatitis C
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
Hepatitis C
Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
Hepatitis C
Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels.
Hepatitis C
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Hepatitis C
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Hepatitis C
Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.
Hepatitis C
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Hepatitis C
Hepatocellular carcinoma with a tumour thrombus extending to the tricuspid valve: report of a successful en bloc resection.
Hepatitis C
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
Hepatitis C
Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression.
Hepatitis C
Inhibition of hepatocellular carcinoma by PegIFN?-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.
Hepatitis C
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Hepatitis C
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Hepatitis C
Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
Hepatitis C
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Hepatitis C
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Hepatitis C
Natural History of Incidental Enhancing Nodules on Cone-Beam Computed Tomography during Transarterial Therapy of Hepatocellular Carcinoma.
Hepatitis C
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Hepatitis C
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Hepatitis C
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Hepatitis C
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Hepatitis C
Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.
Hepatitis C
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Hepatitis C
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.
Hepatitis C
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Hepatitis C
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Hepatitis C
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Hepatitis C
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Hepatitis C
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Hepatitis C
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Hepatitis C
Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma.
Hepatitis C
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Hepatitis C
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Hepatitis C
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Hepatitis C
Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.
Hepatitis C
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Hepatitis C
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Hepatitis C
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.
Hepatitis C
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
Hepatitis C
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
Hepatitis C
The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
Hepatitis C
The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma.
Hepatitis C
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Hepatitis C
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Hepatitis C
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Hepatitis C
Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Hepatitis C
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
Hepatitis C
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Hepatitis C
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
Hepatitis C
[Serum alpha-fetoprotein levels in pregnant women with indeterminate result of anti hepatitis C virus antibodies analysis].
Hepatitis C
[Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without hcc development]
Hepatitis C, Chronic
A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
Hepatitis C, Chronic
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Hepatitis C, Chronic
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Hepatitis C, Chronic
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Hepatitis C, Chronic
Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
Hepatitis C, Chronic
Clinical course of chronic hepatitis C in patients with very high serum alpha-fetoprotein levels and normal hepatic imaging.
Hepatitis C, Chronic
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Hepatitis C, Chronic
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Hepatitis C, Chronic
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Hepatitis C, Chronic
Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Hepatitis C, Chronic
Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C.
Hepatitis C, Chronic
Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.
Hepatitis C, Chronic
Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study.
Hepatitis C, Chronic
Evaluation of Serum Alpha-Fetoprotein Level in Chronic Hepatitis C Patients.
Hepatitis C, Chronic
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Hepatitis C, Chronic
Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hepatitis C, Chronic
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
Hepatitis C, Chronic
Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients.
Hepatitis C, Chronic
Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following PEG-interferon and ribavirin treatment.
Hepatitis C, Chronic
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Hepatitis C, Chronic
Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment.
Hepatitis C, Chronic
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.
Hepatitis C, Chronic
Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?
Hepatitis C, Chronic
Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C.
Hepatitis C, Chronic
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: real-world results from 1716 patients in Egypt.
Hepatitis C, Chronic
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Hepatitis C, Chronic
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores.
Hepatitis C, Chronic
Serum alpha-fetoprotein levels predict early virologic response in HIV-positive subjects treated for chronic hepatitis C.
Hepatitis C, Chronic
Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.
Hepatitis C, Chronic
Spontaneous regression of a large hepatocellular carcinoma with portal vein tumor thrombi: report of a case.
Hepatitis C, Chronic
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Hepatitis C, Chronic
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
Hepatitis C, Chronic
[The laboratory evaluation of dynamics of progression of liver fibrosis under chronic hepatitis].
Hepatitis D
Isolation of Human Fetal Liver Progenitors and Their Enhanced Proliferation by Three-Dimensional Coculture with Endothelial Cells.
Hepatitis D
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.
Hepatitis D
Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey.
Hepatitis, Alcoholic
Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.
Hepatitis, Autoimmune
Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report.
Hepatitis, Autoimmune
Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.
Hepatitis, Autoimmune
Two patients with extremely elevated tumor markers: where is the malignancy?
Hepatitis, Chronic
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
Hepatitis, Chronic
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Hepatitis, Chronic
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Hepatitis, Chronic
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
Hepatitis, Chronic
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients.
Hepatitis, Chronic
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Hepatitis, Chronic
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Hepatitis, Chronic
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Hepatitis, Chronic
Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.
Hepatitis, Chronic
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
Hepatitis, Chronic
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Hepatitis, Chronic
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Hepatitis, Chronic
Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
Hepatitis, Chronic
Hepatocellular carcinoma with a sarcomatous appearance: report of a case.
Hepatitis, Chronic
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.
Hepatitis, Chronic
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Hepatitis, Chronic
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Hepatitis, Chronic
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Hepatitis, Chronic
Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Hepatitis, Chronic
Lectin-reactive patterns of markedly elevated serum alpha-fetoprotein in patients with chronic active hepatitis.
Hepatitis, Chronic
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
Hepatitis, Chronic
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Hepatitis, Chronic
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Hepatitis, Chronic
Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Hepatitis, Chronic
Post-radiation survival time in hepatocellular carcinoma based on predictors for CT-determined, transarterial embolization and various other parameters.
Hepatitis, Chronic
Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.
Hepatitis, Chronic
Report of hereditary persistence of alpha-fetoprotein in a Spanish family: molecular basis and clinical concerns.
Hepatitis, Chronic
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Hepatitis, Chronic
Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis.
Hepatitis, Chronic
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Hepatitis, Chronic
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Hepatitis, Chronic
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Hepatitis, Chronic
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Hepatitis, Chronic
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Hepatitis, Chronic
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Hepatitis, Chronic
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Hepatitis, Chronic
Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Hepatitis, Chronic
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Hepatitis, Chronic
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Hepatitis, Chronic
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Hepatitis, Chronic
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Hepatitis, Chronic
The use of tissue polypeptide specific antigen as a marker in liver diseases.
Hepatitis, Chronic
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Hepatitis, Chronic
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
Hepatitis, Chronic
[A case of hepatocellular carcinoma with survival of more than 7 years after extended right lobectomy]
Hepatitis, Chronic
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
Hepatitis, Chronic
[M2-type pyruvate kinase in the diagnosis of hepatocarcinoma--a pilot study]
Hepatitis, Chronic
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
Hepatitis, Chronic
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
Hepatitis, Chronic
[The diagnostic potentialities of determining alpha-fetoprotein in the blood of patients with mucoviscidosis]
Hepatoblastoma
A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein.
Hepatoblastoma
A Novel Method for Observing Tumor Margin in Hepatoblastoma Based on Microstructure 3D Reconstruction.
Hepatoblastoma
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
Hepatoblastoma
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
Hepatoblastoma
Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature.
Hepatoblastoma
Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
Hepatoblastoma
Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?
Hepatoblastoma
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Hepatoblastoma
Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.
Hepatoblastoma
Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.
Hepatoblastoma
Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.
Hepatoblastoma
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Hepatoblastoma
Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?
Hepatoblastoma
Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hepatoblastoma
Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
Hepatoblastoma
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Hepatoblastoma
Elevated maternal serum ?-fetoprotein level in a fetus with Beckwith-Wiedemann syndrome in the second trimester of pregnancy.
Hepatoblastoma
Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
Hepatoblastoma
Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma.
Hepatoblastoma
Establishment of a human hepatoblastoma model in athymic nude mice. Producibility of fatty acid-binding protein, alpha-fetoprotein, and alpha 1-acid glycoprotein.
Hepatoblastoma
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Hepatoblastoma
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Hepatoblastoma
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Hepatoblastoma
Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy.
Hepatoblastoma
Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature.
Hepatoblastoma
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience.
Hepatoblastoma
Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.
Hepatoblastoma
Immunocytochemical identification of human chorionic gonadotropin- and alpha-fetoprotein-producing cells of hepatoblastoma associated with precocious puberty.
Hepatoblastoma
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Hepatoblastoma
Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131-labeled anti-alpha-fetoprotein monoclonal antibody.
Hepatoblastoma
Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level.
Hepatoblastoma
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Hepatoblastoma
Intrahepatic hematoma: hepatic lesion in a newborn with high alpha-fetoprotein level.
Hepatoblastoma
Longitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith?Wiedemann Syndrome.
Hepatoblastoma
Malignant hepatic tumor occurring 10 yrs after a histocompatible sibling donor bone marrow transplantation for severe aplastic anemia.
Hepatoblastoma
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Hepatoblastoma
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Hepatoblastoma
Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
Hepatoblastoma
Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.
Hepatoblastoma
Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
Hepatoblastoma
Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Hepatoblastoma
Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.
Hepatoblastoma
Purification and characterization of Alpha-Fetoprotein from the human hepatoblastoma HepG2 cell line in serum-free medium.
Hepatoblastoma
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Hepatoblastoma
Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Hepatoblastoma
Serum Alpha-Fetoprotein Concentrations in Extremely-Low-Birth-Weight Infants.
Hepatoblastoma
Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Hepatoblastoma
Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
Hepatoblastoma
Serum vascular endothelial growth factor as a significant marker of treatment response in pediatric malignancies.
Hepatoblastoma
Strategy for hepatoblastoma management: Transplant versus nontransplant surgery.
Hepatoblastoma
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.
Hepatoblastoma
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
Hepatoblastoma
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Hepatoblastoma
Tl-201 positive, Ga-67 negative hepatoblastoma: a case report of a 12-year-old boy.
Hepatoblastoma
Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Hepatoblastoma
[Hepatoblastoma cells producing alpha-fetoprotein: morphometric, immunohistochemical and electron microscopic studies]
Hepatoblastoma
[The modulation of the phenotype of the human hepatoblastoma cell line HepG2 under the action of dimethyl sulfoxide]
Hepatomegaly
Diffuse infantile hepatic hemangiomas in a patient with Beckwith-Wiedemann syndrome: A new association?
Hepatomegaly
Disposition of epirubicin in an oily contrast medium after intravenous and intrahepato-arterial administration in liver cancer: a preliminary report.
Hepatomegaly
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
Hepatomegaly
Primary hepatocellular carcinoma in intertropical Africa: relationship between age and hepatitis B virus etiology.
Hepatomegaly
Pulmonary metastases from primary hepatocellular carcinoma in a 26-year-old patient: a case report.
Hepatomegaly
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Hepatorenal Syndrome
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons.
Hepatorenal Syndrome
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
Hernia, Umbilical
Amniotic fluid alpha-fetoprotein elevation with fetal omphalocele and a possible mechanism for its occurrence.
Hernia, Umbilical
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Hernia, Umbilical
Familial Beckwith-Wiedemann syndrome: Prenatal manifestation and a possible expansion of the phenotype.
Hernia, Umbilical
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Hernia, Umbilical
Impact of demographic factors on prenatal diagnosis and elective pregnancy termination because of abdominal wall defects, Hawaii, 1986-1997.
Hernia, Umbilical
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Hernia, Umbilical
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Hernia, Umbilical
Prenatal diagnosis and management of anterior abdominal wall defects in the west of Scotland.
Hernia, Umbilical
Raised maternal serum and amniotic fluid alpha-fetoprotein (AFP) associated with exomphalos in the fetus.
Hernia, Umbilical
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Hernia, Umbilical
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Hernia, Umbilical
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Hernia, Umbilical
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Hernia, Umbilical
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
Hernias, Diaphragmatic, Congenital
Low material serum alpha-fetoprotein levels and congenital diaphragmatic defects.
Hernias, Diaphragmatic, Congenital
Prenatal diagnosis of mosaic trisomy 16 associated with congenital diaphragmatic hernia and elevated maternal serum alpha-fetoprotein and human chorionic gonadotrophin.
Herpes Simplex
Comparison of chemiluminescence and absorptiometry in enzyme immunoassays for protein quantification.
Herpes Simplex
Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Herpes Simplex
Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Herpes Simplex
Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Herpes Simplex
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Herpes Simplex
Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Herpes Simplex
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Herpes Simplex
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Herpes Simplex
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Herpes Simplex
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Herpes Simplex
Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Herpes Simplex
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Herpes Simplex
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Herpes Zoster
Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9).
Herpes Zoster
Biochemical characterization of hamster oviductin as a sulphated zona pellucida-binding glycoprotein.
Herpes Zoster
Detection of nascent and/or mature forms of oviductin in the female reproductive tract and post-ovulatory oocytes by use of a polyclonal antibody against recombinant hamster oviductin.
Herpes Zoster
Immunolocalization of oviductin in endocytic compartments in the blastomeres of developing embryos in the golden hamster.
Herpes Zoster
Purification, sequence characterization and effect of goat oviduct-specific glycoprotein on in vitro embryo development.
Herpes Zoster
Recombinant feline oviductin--a powerful tool for functional IVF studies in the domestic cat.
Herpes Zoster
Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.
Herpes Zoster
Size variations in the mucin-type domain of hamster oviductin: identification of the polypeptide precursors and characterization of their biosynthetic maturation.
Histiocytic Sarcoma
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
HIV Infections
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Hodgkin Disease
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Hyaline Membrane Disease
Abnormal serum protein levels in infants with hyaline membrane disease--evidence of an underlying immunological disorder.
Hydatidiform Mole
Maternal serum alpha-fetoprotein in the diagnosis of hydatidiform mole. A report of two cases with elevated levels of maternal serum AFP.
Hydatidiform Mole
Radioimmunoassay of alpha-fetoprotein: a contribution to the diagnosis of choriocarcinoma and hydatidiform mole.
Hydatidiform Mole
Serum alpha-fetoprotein in hydatidiform mole, choriocarcinoma, and twin pregnancy.
Hydatidiform Mole
Triploid fetus: an important consideration in the evaluation of very high maternal serum alpha-fetoprotein.
Hydatidiform Mole
Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Hydatidiform Mole
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
Hydatidiform Mole
[The significance of alpha-fetoprotein-negativity in the interstitial area of total hydatidiform mole tissue]
Hydrocephalus
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Hydrocephalus
CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein.
Hydrocephalus
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Hydrocephalus
Increased amniotic fluid alpha-fetoprotein, familial hydrocephalus, and renal dysmorphology.
Hydrocephalus
Maternal serum alpha-fetoprotein levels in fetal hydrocephalus: a retrospective population based study.
Hydrocephalus
[Electrophoresis of cholinesterases of the amniotic fluid in the prenatal diagnosis of closure defects of the neural tube]
Hydrops Fetalis
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Hydrops Fetalis
Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection.
Hydrops Fetalis
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Hydrops Fetalis
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Hydrops Fetalis
Nonimmune hydrops fetalis caused by a massive fetomaternal hemorrhage associated with elevated maternal serum alpha-fetoprotein levels. A case report.
Hyperemesis Gravidarum
Second trimester serum alpha-fetoprotein level is a significant positive predictor for intrauterine growth restriction in pregnant women with hyperemesis gravidarum.
Hyperemesis Gravidarum
The impact of severe hyperemesis gravidarum on the triple test screening results.
Hyperprolactinemia
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Hypersensitivity
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.
Hypersensitivity
Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient.
Hypersensitivity
[Ataxia telangiectasia and characterization of its immunological disorders]
Hypertension
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Hypertension
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Hypertension
Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing.
Hypertension
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Hypertension
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Hypertension
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Hypertension
Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants.
Hypertension
Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin.
Hypertension
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Hypertension
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Hypertension
Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
Hypertension
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
Hypertension
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
Hypertension
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
Hypertension
The use of clinical, biochemical, and ultrasound parameters for the diagnosis of intrauterine growth retardation.
Hypertension
Ultrasonographic investigation of placental morphologic characteristics and size during the second trimester of pregnancy.
Hypertension
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
Hypertension, Portal
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.
Hypertension, Portal
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48?weeks in HDV-related compensated cirrhosis: A case report of 3 patients.
Hypertension, Portal
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Hypertension, Portal
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.
Hypertension, Portal
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center.
Hypertension, Portal
Personalized treatment of patients with very early hepatocellular carcinoma.
Hypertension, Portal
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Hypertension, Portal
Resection versus Ablation for Alpha-fetoprotein Positive Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis.
Hypertension, Portal
Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.
Hypertension, Pregnancy-Induced
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Hypertension, Pregnancy-Induced
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Hypertension, Pregnancy-Induced
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Hypertension, Pregnancy-Induced
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Hypertension, Pregnancy-Induced
Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict small-for-gestational-age infants.
Hypertension, Pregnancy-Induced
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Hypertension, Pregnancy-Induced
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Hyperthyroidism
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Hyperthyroidism
Chromosomal instability in a woman with infertility and two unaffected brothers: a new familial chromosomal breakage syndrome?
Hyperthyroidism
Partial hydatidiform molar pregnancy presenting with severe preeclampsia prior to twenty weeks gestation: a case report and review of the literature.
Hypervitaminosis A
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Hypoalbuminemia
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Hypoglycemia
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Hypoglycemia
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Hypoglycemia
Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
Hypoglycemia
[DGUOK-related mitochondrial DNA depletion syndrome: a case report and literature review].
Hypoglycemia
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
Hypoglycemia
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Hypogonadism
Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Hypogonadism
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Hyponatremia
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
Hyponatremia
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Hypophosphatasia
Prenatal diagnosis of hypophosphatasia; genetic, biochemical, and clinical studies.
Hypophosphatemia
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Hypoproteinemia
A new hepato-pancreato-renal disorder resembling tyrosinemia involving neuropathy and abnormal metabolism of polyunsaturated acids.
Hypoproteinemia
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
Hypospadias
A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG.
Hypothyroidism
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Hypothyroidism
Serum concentrations of alpha-fetoprotein in children with primary hypothyroidism.
IgA Deficiency
Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
IgA Deficiency
Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.
Immune System Diseases
Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.
Infections
A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients' prognosis.
Infections
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Infections
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Infections
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: immunochemical analysis of woodchuck alpha-fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay.
Infections
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Infections
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Infections
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Infections
Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.
Infections
Association between Helicobacter pylori infection and tumor markers: an observational retrospective study.
Infections
Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.
Infections
Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.
Infections
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Infections
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Infections
Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Infections
Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection.
Infections
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Infections
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Infections
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.
Infections
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Infections
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Infections
Effect of encephalomyocarditis (EMC) virus on murine foetal and placental growth monitored by quantification of maternal plasma levels of pregnancy-associated murine protein-2 and alpha-fetoprotein.
Infections
Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.
Infections
Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
Infections
Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host-parasite association.
Infections
Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection.
Infections
Elevated second trimester maternal serum alpha-fetoprotein and cytomegalovirus infection.
Infections
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.
Infections
Evaluation of Helicobacter pylori Infection in Patients with Chronic Hepatic Disease.
Infections
Evidence that alpha-fetoprotein suppresses the immunological function in transgenic mice.
Infections
First and Second Trimester Markers of Fetal Aneuploidy in Pregnant Women with HIV Infection.
Infections
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Infections
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Infections
Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.
Infections
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
Infections
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Infections
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
Infections
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
Infections
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
Infections
HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST.
Infections
Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
Infections
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Infections
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Infections
Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Infections
Maternal serum alpha-fetoprotein--a marker of fetal aplastic crisis during intrauterine human parvovirus infection.
Infections
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Infections
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Infections
p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China.
Infections
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Infections
Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Infections
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Infections
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection.
Infections
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Infections
Prognostic factors for chronic severe hepatitis and construction of a prognostic model.
Infections
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Infections
Rapid and selective shutoff of plasma protein production in herpes simplex virus type 2-infected hepatoma cells.
Infections
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Infections
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Infections
Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China.
Infections
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Infections
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Infections
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Infections
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Infections
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Infections
Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Infections
STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ?30 years.
Infections
The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy.
Infections
The hepatocyte-specific phenotype of murine liver cells correlates with high expression of connexin32 and connexin26 but very low expression of connexin43.
Infections
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Infections
[A preliminary study on the antenatal diagnosis and prevention of the fetus toxoplasmosis infection]
Infections
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Inflammatory Bowel Diseases
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Inflammatory Bowel Diseases
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Influenza, Human
Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Influenza, Human
Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Insulin Resistance
Associations between Vitamin D and ?-Cell Function and Colorectal Cancer-Associated Tumor Markers in Chinese Type 2 Diabetic Patients with Albuminuria.
Insulinoma
Malignant insulinoma with hepatoid differentiation: a unique case with alpha-fetoprotein production.
Intestinal Neoplasms
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Iron Overload
Reversing hepatocellular carcinoma progression by using networked biological therapies.
Ischemic Stroke
[The alpha-fetoprotein in prognosis of survival of and functional rehabilitation of patients with ischemic stroke].
Ischemic Stroke
[The fetal proteins in prognosis of development of pneumonia in patients with ischemic stroke].
Jaundice, Neonatal
'Idiopathic' jaundice in Sardinian full-term newborn infants: a multivariate study.
Jaundice, Neonatal
[Cord blood alpha-fetoprotein, gamma-glutamyl transpeptidase and neonatal jaundice]
Kidney Diseases
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Kidney Diseases, Cystic
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Kidney Diseases, Cystic
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Kidney Failure, Chronic
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
Kidney Failure, Chronic
Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function.
Kidney Failure, Chronic
Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Klinefelter Syndrome
Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
Klippel-Trenaunay-Weber Syndrome
Prenatal sonographic findings of Klippel-Trénaunay-Weber syndrome.
Leiomyoma
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Leukemia
Characterization of an immortalized oviduct cell line from the cynomolgus monkey (Macaca fascicularis).
Leukemia
Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes.
Leukemia
Radioimmunoassay of alpha-fetoprotein in the serum of patients with leukemia and malignant melanoma.
Leukemia
[Preparation of paraffin sections for the immunofluorescent analysis of antigens of differing chemical nature]
Leukemia
[The distribution of iodine-125 labeled alpha-fetoprotein in the animal organism and its accumulation in the tumor].
Leukemia, T-Cell
[Analysis on influencing factors that leading to nonspecific responses to indeterminate results of HIV antibodies].
Leukocytosis
Carcinosarcoma of the gallbladder producing alpha-fetoprotein and manifesting as leukocytosis with elevated serum granulocyte colony-stimulating factor: Report of a case.
Liver Abscess, Amebic
The pathogenesis of raised serum alpha-fetoprotein levels in amoebic and pyogenic hepatic abscesses.
Liver Abscess, Amebic
[Serum levels of alpha-fetoprotein in amebic liver abscess during the tissue regeneration phase]
Liver Abscess, Pyogenic
The pathogenesis of raised serum alpha-fetoprotein levels in amoebic and pyogenic hepatic abscesses.
Liver Cirrhosis
A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
Liver Cirrhosis
A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Liver Cirrhosis
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.
Liver Cirrhosis
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Liver Cirrhosis
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Liver Cirrhosis
Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
Liver Cirrhosis
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.
Liver Cirrhosis
Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
Liver Cirrhosis
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Liver Cirrhosis
Alpha-fetoprotein serum concentration in different stages of liver cirrhosis.
Liver Cirrhosis
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
Liver Cirrhosis
Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Liver Cirrhosis
Alpha-fetoprotein-producing early gastric cancer accompanying liver cirrhosis: a case report.
Liver Cirrhosis
Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
Liver Cirrhosis
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Liver Cirrhosis
Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia.
Liver Cirrhosis
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Liver Cirrhosis
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Liver Cirrhosis
Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Liver Cirrhosis
Clinical predictors of liver fibrosis in patients with chronic hepatitis B virus infection from children to adults.
Liver Cirrhosis
Clinical significance of serum alpha-fetoprotein in patients with liver cirrhosis.
Liver Cirrhosis
Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Liver Cirrhosis
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Liver Cirrhosis
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Liver Cirrhosis
Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.
Liver Cirrhosis
Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients.
Liver Cirrhosis
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Liver Cirrhosis
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Liver Cirrhosis
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein.
Liver Cirrhosis
Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort.
Liver Cirrhosis
Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
Liver Cirrhosis
Diagnosis of hepatocellular carcinoma by fine needle biopsy of portal vein thrombosis.
Liver Cirrhosis
Diagnosis of hepatocellular carcinoma in patients with liver cirrhosis using liver function assays.
Liver Cirrhosis
Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Liver Cirrhosis
Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Liver Cirrhosis
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
Liver Cirrhosis
Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
Liver Cirrhosis
Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.
Liver Cirrhosis
Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Liver Cirrhosis
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.
Liver Cirrhosis
Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Liver Cirrhosis
Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host-parasite association.
Liver Cirrhosis
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.
Liver Cirrhosis
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Liver Cirrhosis
Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
Liver Cirrhosis
Expression and prognostic value of VEGFR-2, PDGFR-?, and c-Met in advanced hepatocellular carcinoma.
Liver Cirrhosis
Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Liver Cirrhosis
Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
Liver Cirrhosis
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Liver Cirrhosis
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
Liver Cirrhosis
Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
Liver Cirrhosis
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.
Liver Cirrhosis
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.
Liver Cirrhosis
Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.
Liver Cirrhosis
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Liver Cirrhosis
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Liver Cirrhosis
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.
Liver Cirrhosis
Immunoelectron microscopic observation of alpha-fetoprotein synthesis in human non-malignant liver tissues using immunoperoxidase methods.
Liver Cirrhosis
Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume.
Liver Cirrhosis
Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial.
Liver Cirrhosis
Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas.
Liver Cirrhosis
Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: Report of a case.
Liver Cirrhosis
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Liver Cirrhosis
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Liver Cirrhosis
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.
Liver Cirrhosis
Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma.
Liver Cirrhosis
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Liver Cirrhosis
Marked hypophosphatemia with decreased serum 1,25-dihydroxyvitamin D in a patient with hepatocellular carcinoma complicating liver cirrhosis.
Liver Cirrhosis
Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease.
Liver Cirrhosis
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Liver Cirrhosis
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis.
Liver Cirrhosis
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
Liver Cirrhosis
Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma.
Liver Cirrhosis
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Liver Cirrhosis
Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liver Cirrhosis
Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
Liver Cirrhosis
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Liver Cirrhosis
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Liver Cirrhosis
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Liver Cirrhosis
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Liver Cirrhosis
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Liver Cirrhosis
RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Liver Cirrhosis
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Liver Cirrhosis
Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Liver Cirrhosis
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Liver Cirrhosis
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Liver Cirrhosis
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Liver Cirrhosis
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Liver Cirrhosis
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Liver Cirrhosis
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Liver Cirrhosis
Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Liver Cirrhosis
Serum peptide pattern differentially diagnoses Hepatitis B Virus-related hepatocellular carcinoma from liver cirrhosis.
Liver Cirrhosis
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Liver Cirrhosis
Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Liver Cirrhosis
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
Liver Cirrhosis
Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.
Liver Cirrhosis
Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection.
Liver Cirrhosis
The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
Liver Cirrhosis
The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Liver Cirrhosis
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Liver Cirrhosis
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Liver Cirrhosis
The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma.
Liver Cirrhosis
The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
Liver Cirrhosis
Three cases of small hepatocellular carcinoma presenting as obstructive jaundice.
Liver Cirrhosis
Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index.
Liver Cirrhosis
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Liver Cirrhosis
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Liver Cirrhosis
Urinary excretion of free and acetylated polyamines in hepatocellular carcinoma.
Liver Cirrhosis
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Liver Cirrhosis
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
Liver Cirrhosis
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
Liver Cirrhosis
[Analysis of prognostic factors for patients with acute-on-chronic liver failure.]
Liver Cirrhosis
[Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
Liver Cirrhosis
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.]
Liver Cirrhosis
[Capsule formation in hepatocellular carcinomas arising from liver cirrhosis]
Liver Cirrhosis
[Clinical significance of alpha-fetoprotein and carcinoembryonic antigen in the serum of patients with liver cirrhosis]
Liver Cirrhosis
[Community-based hepatocellular carcinoma screening in seven townships in Taiwan]
Liver Cirrhosis
[Development and predictive factors of hepatocellular carcinoma in patients with chronic liver disease over a long follow-up period]
Liver Cirrhosis
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
Liver Cirrhosis
[Elevated serum alpha-fetoprotein in a case of rectum carcinoma with liver cirrhosis (author's transl)]
Liver Cirrhosis
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
Liver Cirrhosis
[Expression of ATAD2 in different liver lesions and its clinical significance].
Liver Cirrhosis
[Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis]
Liver Cirrhosis
[Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer]
Liver Cirrhosis
[Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases]
Liver Cirrhosis
[Multivariate analysis of hepatic encephalopathy occurrence in patients with liver failure].
Liver Cirrhosis
[Observation on short-term therapeutic effect of zhenggan recipe in treating liver cirrhosis with alpha-feto-protein]
Liver Cirrhosis
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Liver Cirrhosis
[Role of resistin in inflammation of hepatocytes in nonalcoholic steatohepatitis.]
Liver Cirrhosis
[Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis]
Liver Cirrhosis
[Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases]
Liver Cirrhosis
[Small unilocular hepatocellular carcinoma (0 < 5 cm) in patients with liver cirrhosis. Early diagnosis, surgical indications, resection and prognosis]
Liver Cirrhosis
[The clinical significance of PIVKA-II determination in patients with hepatocellular carcinoma: a comparative study with alpha-fetoprotein]
Liver Cirrhosis
[Transcatether chemoembolization in the treatment of hepatocellular carcinoma]
Liver Cirrhosis
[Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]
Liver Cirrhosis
[Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms]
Liver Cirrhosis, Alcoholic
Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Liver Cirrhosis, Alcoholic
Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
Liver Cirrhosis, Alcoholic
Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.
Liver Cirrhosis, Alcoholic
[Spontaneous regression of hepatocellular carcinoma in a cirrhotic patient]
Liver Cirrhosis, Biliary
Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
Liver Cirrhosis, Biliary
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Liver Cirrhosis, Biliary
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Liver Diseases
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Liver Diseases
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
Liver Diseases
A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.
Liver Diseases
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Liver Diseases
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Liver Diseases
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Liver Diseases
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Liver Diseases
AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein.
Liver Diseases
AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
Liver Diseases
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Liver Diseases
Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
Liver Diseases
Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups.
Liver Diseases
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Liver Diseases
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Liver Diseases
Alpha-fetoprotein antibody-lectin enzyme immunoassay to characterize sugar chains for the study of liver diseases.
Liver Diseases
Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
Liver Diseases
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Liver Diseases
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Liver Diseases
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Liver Diseases
Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
Liver Diseases
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Liver Diseases
Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease.
Liver Diseases
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
Liver Diseases
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Liver Diseases
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Liver Diseases
Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Liver Diseases
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Liver Diseases
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study.
Liver Diseases
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Liver Diseases
Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.
Liver Diseases
Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma.
Liver Diseases
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Liver Diseases
Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Liver Diseases
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Liver Diseases
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Liver Diseases
Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Liver Diseases
Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Liver Diseases
Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.
Liver Diseases
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Liver Diseases
Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Liver Diseases
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Liver Diseases
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Liver Diseases
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Liver Diseases
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Liver Diseases
Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases.
Liver Diseases
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Liver Diseases
Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study.
Liver Diseases
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Liver Diseases
Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients.
Liver Diseases
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Liver Diseases
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
Liver Diseases
Differential reactivity of alpha-fetoprotein with lectins and its usefulness in the diagnosis of various liver diseases.
Liver Diseases
Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.
Liver Diseases
Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed.
Liver Diseases
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Liver Diseases
Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Liver Diseases
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Liver Diseases
Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Liver Diseases
Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Liver Diseases
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Liver Diseases
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Liver Diseases
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
Liver Diseases
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
Liver Diseases
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Liver Diseases
Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa.
Liver Diseases
HCC Detection on Surveillance US: Comparing Focused Liver Protocol Using US LI-RADS Technical Guidelines to a General Complete Abdominal US Protocol.
Liver Diseases
Hepatocellular Carcinoma and Liver Transplantation: A Single-Center Experience.
Liver Diseases
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
Liver Diseases
Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Liver Diseases
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein.
Liver Diseases
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Liver Diseases
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Liver Diseases
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.
Liver Diseases
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Liver Diseases
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Liver Diseases
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Liver Diseases
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Liver Diseases
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice.
Liver Diseases
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Liver Diseases
Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellular carcinoma in a tertiary referral center.
Liver Diseases
Importance of Multislice Computed Tomography in Determining the Severity of Chronic Liver Disease State.
Liver Diseases
Improved survival following transarterial radioembolization of infiltrative-appearance hepatocellular carcinoma.
Liver Diseases
Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Liver Diseases
Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes.
Liver Diseases
Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
Liver Diseases
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Liver Diseases
Lens culinaris agglutinin-A-reactive alpha-fetoprotein as a marker for liver atrophy in fulminant hepatic failure.
Liver Diseases
Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease.
Liver Diseases
Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Liver Diseases
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
Liver Diseases
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.
Liver Diseases
Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.
Liver Diseases
Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.
Liver Diseases
Marked increase in serum alpha-fetoprotein level in cirrhosis: a case report.
Liver Diseases
Meta-analysis of circulating microRNAs for the diagnosis of hepatocellular carcinoma.
Liver Diseases
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Liver Diseases
Monoclonal antibodies recognizing a recombinant portion of human alpha-fetoprotein with antigenic selectivity versus albumin.
Liver Diseases
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Liver Diseases
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Liver Diseases
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
Liver Diseases
Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
Liver Diseases
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5?cm.
Liver Diseases
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
Liver Diseases
Non-tumoral elevation of alpha-fetoprotein (AFP): a 10 year follow-up in two subjects.
Liver Diseases
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease.
Liver Diseases
Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
Liver Diseases
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Liver Diseases
Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
Liver Diseases
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Liver Diseases
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
Liver Diseases
Personalized treatment of patients with very early hepatocellular carcinoma.
Liver Diseases
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Liver Diseases
Plasminogen activator inhibitor-2 and alpha-fetoprotein in various liver disease states.
Liver Diseases
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Liver Diseases
Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Liver Diseases
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Liver Diseases
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Liver Diseases
Preliminary study of alpha-fetoprotein in nonmalignant liver diseases. A clinico-biochemical evaluation.
Liver Diseases
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Liver Diseases
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Liver Diseases
Prolonged survival after repeat resection of pulmonary metastasis from hepatocellular carcinoma.
Liver Diseases
Radioimmunoassay of alpha-fetoprotein in human serum: clinical value in patients with liver diseases.
Liver Diseases
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Liver Diseases
Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver.
Liver Diseases
Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
Liver Diseases
Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
Liver Diseases
Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Liver Diseases
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Liver Diseases
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Liver Diseases
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review.
Liver Diseases
Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Liver Diseases
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
Liver Diseases
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients.
Liver Diseases
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Liver Diseases
Serum alpha-fetoprotein levels and microheterogeneity in patients with different liver diseases.
Liver Diseases
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Liver Diseases
Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
Liver Diseases
Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Liver Diseases
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC.
Liver Diseases
Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics.
Liver Diseases
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
Liver Diseases
Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma.
Liver Diseases
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Liver Diseases
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Liver Diseases
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
Liver Diseases
Successful surgical management of pulmonary and adrenal metastases from hepatocellular carcinoma.
Liver Diseases
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Liver Diseases
Surgical Resection vs. Ablative Therapies Through a Laparoscopic Approach for Hepatocellular Carcinoma: a Comparative Study.
Liver Diseases
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
Liver Diseases
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America.
Liver Diseases
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Liver Diseases
Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Liver Diseases
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
Liver Diseases
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients.
Liver Diseases
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Liver Diseases
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Liver Diseases
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
Liver Diseases
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
Liver Diseases
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.
Liver Diseases
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
Liver Diseases
The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver.
Liver Diseases
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Liver Diseases
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Liver Diseases
Ultrasound determination of liver size and assessment of patients with malignant liver disease.
Liver Diseases
Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Liver Diseases
VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Liver Diseases
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
Liver Diseases
[A long term follow-up study in patients with chronic liver diseases with special reference to serum alpha-fetoprotein]
Liver Diseases
[Analysis of prognostic factors and construction of a logistic regression model for patients with drug-induced liver failure].
Liver Diseases
[Clinical application studies on AFP-L3 detected by micro-spin column method].
Liver Diseases
[Clinical studies on alpha-fetoprotein (AFP). Alpha-fetoprotein levels in pregnant women, newborn infants and patients with various liver diseases]
Liver Diseases
[Clinicophathological studies of alpha-fetoprotein. (1). Clinical and experimental studies of various non-malignant liver diseases]
Liver Diseases
[Diagnosis, treatment and prognosis of single-nodular minute hepatocellular carcinoma]
Liver Diseases
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
Liver Diseases
[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers]
Liver Diseases
[Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins]
Liver Diseases
[Importance of serum alpha-fetoprotein follow-up analysis in chronic liver diseases]
Liver Diseases
[Long-term course in asymptomatic carriers of HBsAg in an area of low prevalence of hepatocarcinoma]
Liver Diseases
[Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]
Liver Diseases
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Liver Diseases
[Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay]
Liver Diseases
[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency.]
Liver Diseases
[Studies on the immunosuppressive effect of alpha-fetoprotein (AFP) appeared in the serum of patients with liver disease (author's transl)]
Liver Diseases
[Surgical treatment of hepatocellular carcinoma: resection or transplantation? Results of a multivariate analysis]
Liver Diseases
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
Liver Diseases
[Value of ultrasonography in the early diagnosis of hepatocellular carcinoma]
Liver Diseases, Alcoholic
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Liver Diseases, Alcoholic
Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups.
Liver Diseases, Alcoholic
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Liver Diseases, Alcoholic
Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275.
Liver Diseases, Alcoholic
Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
Liver Diseases, Alcoholic
[Serum alpha-fetoprotein in alcoholic liver disease (author's transl)]
Liver Failure
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Liver Failure
Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure.
Liver Failure
[TRMU MUTATIONS - REVERSIBLE INFANTILE LIVER FAILURE OR MULTISYSTEM DISORDER?]
Liver Failure, Acute
Alpha-fetoprotein as a prognostic marker in acute liver failure: a pilot study.
Liver Failure, Acute
Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Liver Failure, Acute
Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B.
Liver Failure, Acute
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Liver Failure, Acute
Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure.
Liver Failure, Acute
Lens culinaris agglutinin-A-reactive alpha-fetoprotein as a marker for liver atrophy in fulminant hepatic failure.
Liver Failure, Acute
Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.
Liver Failure, Acute
Serum alpha-fetoprotein increases prior to fibrosis resolution in a patient with acute liver failure.
Liver Failure, Acute
The arterial ketone body ratio and serum alpha-fetoprotein level in patients with acute hepatic failure.
Liver Neoplasms
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.
Liver Neoplasms
A novel microfluidic co-culture system for investigation of bacterial cancer targeting.
Liver Neoplasms
A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Liver Neoplasms
A sensitive, universal and homogeneous method for determination of biomarkers in biofluids by resonance light scattering correlation spectroscopy (RLSCS).
Liver Neoplasms
A simple electrochemical immunosensor based on worm-like platinum for highly sensitive determination of alpha-fetoprotein.
Liver Neoplasms
A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
Liver Neoplasms
AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
Liver Neoplasms
Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.
Liver Neoplasms
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Liver Neoplasms
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
Liver Neoplasms
Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.
Liver Neoplasms
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Liver Neoplasms
Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
Liver Neoplasms
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Liver Neoplasms
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
Liver Neoplasms
An integrated microfluidic system for rapid screening of alpha-fetoprotein-specific aptamers.
Liver Neoplasms
An isoenzyme of 5'-nucleotide phosphodiesterase and alpha-fetoprotein in human hepatic cancer patient sera.
Liver Neoplasms
Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
Liver Neoplasms
Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
Liver Neoplasms
Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Liver Neoplasms
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Liver Neoplasms
Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer.
Liver Neoplasms
Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells.
Liver Neoplasms
Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis.
Liver Neoplasms
Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Liver Neoplasms
Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence.
Liver Neoplasms
Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
Liver Neoplasms
Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
Liver Neoplasms
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Liver Neoplasms
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
Liver Neoplasms
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Liver Neoplasms
Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.
Liver Neoplasms
Clinicopathologic features of hepatic neoplasms in explanted livers: a single institution experience.
Liver Neoplasms
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Liver Neoplasms
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Liver Neoplasms
Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Liver Neoplasms
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Liver Neoplasms
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Liver Neoplasms
Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.
Liver Neoplasms
Computed Tomography-Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival.
Liver Neoplasms
Conductometric immunoassay of alpha-fetoprotein in sera of liver cancer patients using bienzyme-functionalized nanometer-sized silica beads.
Liver Neoplasms
Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Liver Neoplasms
Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Liver Neoplasms
Dependence of the specificity of the serologic test for primary liver cancer in different areas of the world on sensitivity of the method used for detecting alpha-fetoprotein.
Liver Neoplasms
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Liver Neoplasms
Determination of plasma urokinase-type plasminogen activator antigen in patients with primary liver cancer: characterization as tumor-associated antigen and comparison with alpha-fetoprotein.
Liver Neoplasms
Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase.
Liver Neoplasms
Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
Liver Neoplasms
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Liver Neoplasms
Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
Liver Neoplasms
Efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with radiofrequency ablation versus DEB-TACE alone in Chinese hepatocellular carcinoma patients.
Liver Neoplasms
Electrochemical immunosensors with AuPt-vertical graphene/glassy carbon electrode for alpha-fetoprotein detection based on label-free and sandwich-type strategies.
Liver Neoplasms
Electrokinetic analyte transport assay for alpha-fetoprotein immunoassay integrates mixing, reaction and separation on-chip.
Liver Neoplasms
Evaluation of combined assays of serum ferritin, alpha-1-antitrypsin and alpha-fetoprotein in liver cancer.
Liver Neoplasms
Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Liver Neoplasms
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results.
Liver Neoplasms
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Liver Neoplasms
External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Liver Neoplasms
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
Liver Neoplasms
Facile and cost-effective liver cancer diagnosis by water-gated organic field-effect transistors.
Liver Neoplasms
Factors associated with compliance with recommendations for liver cancer screening in Korea: a nationwide survey in Korea.
Liver Neoplasms
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Liver Neoplasms
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Liver Neoplasms
Fluorescence and Scattering Light Cross Correlation Spectroscopy and Its Applications in Homogeneous Immunoassay.
Liver Neoplasms
Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.
Liver Neoplasms
Growth inhibition of human liver cancer cells by alpha-fetoprotein antisense strategy.
Liver Neoplasms
Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.
Liver Neoplasms
Hepatitis BS antigen, malaria titers, and primary liver cancer in South Vietnam.
Liver Neoplasms
High-Intensity Focused Ultrasound Ablation for Unresectable Primary and Metastatic Liver Cancer: Real-World Research in a Chinese Tertiary Center With 275 Cases.
Liver Neoplasms
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
Liver Neoplasms
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Liver Neoplasms
Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers.
Liver Neoplasms
Immunotherapy using Freund's adjuvant and recombinant interleukin-2 combined with transarterial chemoembolization for hepatocellular carcinoma.
Liver Neoplasms
Impact of branched-chain amino acid supplementation on the survival in patients with advanced hepatocellular carcinoma treated with sorafenib; a multicenter retrospective cohort study.
Liver Neoplasms
Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma.
Liver Neoplasms
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis--conclusion about locoregional therapy.
Liver Neoplasms
Impact of locoregional therapy and alpha-fetoprotein on outcomes in transplantation for liver cancer: a UNOS Region 6 pooled analysis.
Liver Neoplasms
Improvement of liver cancer detection with simultaneous assessment of circulating levels of free alpha-fetoprotein (AFP) and AFP-IgM complexes.
Liver Neoplasms
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Liver Neoplasms
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Liver Neoplasms
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study.
Liver Neoplasms
Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance.
Liver Neoplasms
Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Liver Neoplasms
Monoclonal antibodies recognizing a recombinant portion of human alpha-fetoprotein with antigenic selectivity versus albumin.
Liver Neoplasms
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
Liver Neoplasms
Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.
Liver Neoplasms
Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Liver Neoplasms
Photoelectrochemical immunosensor for sensitive detection of alpha-fetoprotein based on a graphene honeycomb film.
Liver Neoplasms
Polarized SERS Controlled by Anisotropic Growth on Ordered Curvature Substrate.
Liver Neoplasms
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Liver Neoplasms
Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet).
Liver Neoplasms
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Liver Neoplasms
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Liver Neoplasms
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Liver Neoplasms
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Liver Neoplasms
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Liver Neoplasms
Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma.
Liver Neoplasms
Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Liver Neoplasms
Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
Liver Neoplasms
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
Liver Neoplasms
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Liver Neoplasms
Rapid fabrication of electrode for the detection of alpha fetoprotein based on MnO2 functionalized mesoporous carbon hollow sphere.
Liver Neoplasms
Recombinant aequorin with a reactive cysteine residue for conjugation with maleimide-activated antibody.
Liver Neoplasms
Resin versus Glass Microspheres for Yttrium-90 Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma using Pretreatment Partition Model Dosimetry.
Liver Neoplasms
Risk factors for hepatocellular carcinoma among patients with chronic liver disease.
Liver Neoplasms
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Liver Neoplasms
Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma.
Liver Neoplasms
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Liver Neoplasms
Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.
Liver Neoplasms
Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Liver Neoplasms
Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein.
Liver Neoplasms
Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria.
Liver Neoplasms
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Liver Neoplasms
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Liver Neoplasms
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Liver Neoplasms
Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.
Liver Neoplasms
Serum copper, ceruloplasmin, protein thiols and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of alpha-fetoprotein.
Liver Neoplasms
Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma.
Liver Neoplasms
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Liver Neoplasms
Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell.
Liver Neoplasms
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Liver Neoplasms
Single particle technique for one-step homogeneous detection of cancer marker using gold nanoparticle probes.
Liver Neoplasms
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Liver Neoplasms
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Liver Neoplasms
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Liver Neoplasms
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
Liver Neoplasms
Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA.
Liver Neoplasms
Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer.
Liver Neoplasms
The Effect of Alpha-Fetoprotein on the Activation and Phagocytosis of Granulocytes and Monocytes.
Liver Neoplasms
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
Liver Neoplasms
The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance.
Liver Neoplasms
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution.
Liver Neoplasms
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Liver Neoplasms
The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Liver Neoplasms
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.
Liver Neoplasms
Tin Oxide Nanosheet Assembly for Hydrophobic/Hydrophilic Coating and Cancer Sensing.
Liver Neoplasms
Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
Liver Neoplasms
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Liver Neoplasms
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Liver Neoplasms
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
Liver Neoplasms
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy.
Liver Neoplasms
Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings.
Liver Neoplasms
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Liver Neoplasms
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Liver Neoplasms
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Liver Neoplasms
Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Liver Neoplasms
Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Liver Neoplasms
Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm.
Liver Neoplasms
Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.
Liver Neoplasms
[A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
Liver Neoplasms
[Alpha-fetoprotein variants and their significance in the differential diagnosis of primary liver cancer]
Liver Neoplasms
[Analysis of liver cancer screening results and influencing factors of urban residents in Zhejiang Province from 2013 to 2018].
Liver Neoplasms
[Analysis of urine metabolic profile in patients with hepatocellular carcinoma].
Liver Neoplasms
[Clinical significance of low-level alpha-fetoprotein in the diagnosis and treatment of primary liver cancer]
Liver Neoplasms
[Clinical significance of serum "hepatoma-specific" gamma-glutamyl transferase and alkaline phosphatase]
Liver Neoplasms
[Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer]
Liver Neoplasms
[Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase]
Liver Neoplasms
[Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer]
Liver Neoplasms
[Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis]
Liver Neoplasms
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
Liver Neoplasms
[Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer]
Liver Neoplasms
[Evaluation of the use of highly sensitive methods of determining alpha-fetoprotein for the diagnosis of hepatocellular cancer and teratoblastoma]
Liver Neoplasms
[Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis]
Liver Neoplasms
[Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins]
Liver Neoplasms
[Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer]
Liver Neoplasms
[Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol]
Liver Neoplasms
[Occurrence of alpha-fetoprotein in various forms of hepatitis, cirrhosis and primary hepatic cancer]
Liver Neoplasms
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Liver Neoplasms
[Possibility of detection of alpha-fetoprotein in the erythrocytes of patients with primary liver cancer]
Liver Neoplasms
[Preliminary study of the origin of alpha-fetoprotein (AFP) in the host hepatocytes of human liver cancer: immunohistochemical analysis of 48 cases]
Liver Neoplasms
[Radiofrequency thermal ablation combined with arterial embolization for primary liver cancer]
Liver Neoplasms
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.]
Liver Neoplasms
[Relation of the specificity of the serologic test for primary liver cancer in different areas of the world to the sensitivity of the method for detecting alpha-fetoprotein]
Liver Neoplasms
[Relations between the morphological characteristics and alpha-fetoprotein in primary cancer of the liver (apropos of 92 cases]
Liver Neoplasms
[Research progress in prognostic factors of hepatitis B virus-associated end-stage liver disease].
Liver Neoplasms
[Research progress of serum biomarkers for early screening of hepatocellular carcinoma].
Liver Neoplasms
[Serum alpha-fetoprotein (AFP) after primary liver cancer resection in adult value of its determination in the detection of recurrence]
Liver Neoplasms
[Significance of determination of alpha-fetoprotein in surgery of hepatic cancer]
Liver Neoplasms
[Study of Australia antigen in primary liver cancers. Correlation with alpha-fetoprotein]
Liver Neoplasms
[The prognostic value of alpha-fetoprotein (AFP) in hepatocellular cancer in chronic carriers of HBsAg and positive HBeAg]
Liver Neoplasms
[The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery]
Liver Neoplasms
[The value of methods of increased sensitivity for detecting alpha-fetoprotein in the diagnosis of primary liver cancer]
Liver Neoplasms
[Triplet anti-tumor therapy based on thymosin ?-1 attenuates incidence of hepatoma and serum alpha-fetoprotein level in rat hepatoma model].
Liver Neoplasms, Experimental
alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.
Liver Neoplasms, Experimental
Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia.
Liver Neoplasms, Experimental
Effect of glucocorticoids on the production of lactate dehydrogenase, malate dehydrogenase and alpha-fetoprotein by Morris hepatoma 7777 in vitro.
Liver Neoplasms, Experimental
No evidence for post-transcriptional control of albumin and alpha-fetoprotein gene expression in developing rat liver neoplasia.
Liver Neoplasms, Experimental
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Lordosis
Female mice deficient in alpha-fetoprotein show female-typical neural responses to conspecific-derived pheromones.
Lung Neoplasms
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
Lung Neoplasms
A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Lung Neoplasms
An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
Lung Neoplasms
Carcinoembryonic antigen, alpha 1-fetoprotein, ferritin, and alpha 2-pregnancy associated glycoprotein in the serum of lung cancer patients and its demonstration in lung tumor tissues.
Lung Neoplasms
Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure.
Lung Neoplasms
High-grade fetal adenocarcinoma of the lung with abnormal expression of alpha-fetoprotein in a female patient: Case report.
Lung Neoplasms
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Lung Neoplasms
Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.
Lung Neoplasms
[A case of alpha-fetoprotein producing lung cancer without metastasis to the liver]
Lung Neoplasms
[Alpha fetoprotein levels in the serum and bronchoalveolar lavage fluid in patients with lung cancer and other diseases of the respiratory system]
Lung Neoplasms
[Radioimmunological analysis of the carcinoembryonic antigen and alpha-fetoprotein levels in the blood of lung cancer patients]
Lupus Erythematosus, Systemic
Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report.
Lupus Erythematosus, Systemic
Elevation of maternal alpha-fetoprotein in systemic lupus erythematosus: a controlled study.
Lymphadenopathy
A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
Lymphadenopathy
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
Lymphadenopathy
Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease.
Lymphadenopathy
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Lymphadenopathy
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Lymphadenopathy
Metastatic hepatocellular carcinoma: When surgery and successive palliative treatments lead to remission.
Lymphadenopathy
Primary focal T-cell lymphoma of the liver: a case report and review of the literature.
Lymphangioma, Cystic
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Lymphangioma, Cystic
Amniotic fluid alpha-fetoprotein levels in the differential diagnosis of cystic hygroma.
Lymphangioma, Cystic
Amniotic fluid levels of alpha-fetoprotein and other proteins in a case of Turner's syndrome of the fetus.
Lymphangioma, Cystic
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Lymphangioma, Cystic
Elevated alpha-fetoprotein levels in the 45,x (Turner syndrome) fetus with cystic hygroma. Case reports.
Lymphangioma, Cystic
Etiology, prognosis and management of nuchal cystic hygroma: 25 new cases and literature review.
Lymphangioma, Cystic
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Lymphangioma, Cystic
Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha-fetoprotein.
Lymphangioma, Cystic
[Differential diagnostic procedure in sonographically detected fetal cystic hygroma]
Lymphangioma, Cystic
[Extremely high alpha-fetoprotein levels in a puncture specimen with few cells following amniocentesis and interpretation by sonography]
Lymphatic Metastasis
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
Lymphatic Metastasis
Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.
Lymphatic Metastasis
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
Lymphatic Metastasis
C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Lymphatic Metastasis
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Lymphatic Metastasis
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Lymphatic Metastasis
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Lymphatic Metastasis
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Lymphatic Metastasis
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Lymphatic Metastasis
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Lymphatic Metastasis
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Lymphatic Metastasis
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Lymphatic Metastasis
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Lymphatic Metastasis
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Lymphatic Metastasis
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Lymphatic Metastasis
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lymphatic Metastasis
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Lymphatic Metastasis
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Lymphatic Metastasis
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.
Lymphatic Metastasis
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Lymphatic Metastasis
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Lymphatic Metastasis
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
Lymphatic Metastasis
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Lymphatic Metastasis
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Lymphatic Metastasis
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Lymphatic Metastasis
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Lymphatic Metastasis
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
Lymphatic Metastasis
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Lymphoma
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Lymphoma
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Lymphoma
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Massive Hepatic Necrosis
Alcoholic liver disease. Absence of alpha-fetoprotein elevations in the recovery phase.
Massive Hepatic Necrosis
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis.
Massive Hepatic Necrosis
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
Massive Hepatic Necrosis
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Massive Hepatic Necrosis
Serum alpha-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy.
Meconium Ileus
The direct early diagnosis of cystic fibrosis by the detection of the delta F508 CFTR gene mutation in a prematurely delivered boy.
Medulloblastoma
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Melanoma
Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Melanoma
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Melanoma
Radioimmunoassay of alpha-fetoprotein in the serum of patients with leukemia and malignant melanoma.
Melanoma
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Meningitis
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Meningomyelocele
A meningomyelocele with normal intracranial signs on ultrasound and false-negative amniotic fluid alpha-fetoprotein and acetylcholinesterase.
Meningomyelocele
Effacement of the fetal cisterna magna in association with myelomeningocele.
Metabolic Diseases
Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.
Metabolic Diseases
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.
Metabolic Syndrome
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Metabolism, Inborn Errors
Detection of treatable neonatal liver disease by expanded newborn screening.
Microcephaly
A reappraisal of amniotic fluid alpha-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography.
Microcephaly
Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient.
Movement Disorders
Autosomal-Recessive Cerebellar Ataxias and Movement Disorders With Elevated Alpha-Fetoprotein.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Multiple Sclerosis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Multiple Sclerosis
The clinical course of multiple sclerosis during pregnancy and the puerperium.
Musculoskeletal Pain
Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
Myasthenia Gravis
Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
Myasthenia Gravis
Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
Myasthenia Gravis
Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
Myasthenia Gravis
Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
Myasthenia Gravis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Myasthenia Gravis
[Myasthenia gravis and pregnancy. Review of the literature and considerations on the immunoprotective effect of alpha-fetoprotein through the observation of a clinical case]
Myasthenia Gravis, Autoimmune, Experimental
Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein.
Myelodysplastic Syndromes
Clinical study on the serum carcinoembryonic antigen, CA 19-9, CA 50 and alpha-fetoprotein levels in patients with myelodysplastic syndromes.
Myocardial Infarction
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Myocarditis
Restoration of FAS-Mediated Apoptosis of Lymphocytes in Patients with Myocarditis by Specific Peptide Sequence of Human Alpha-Fetoprotein (AFP(13-19)).
Neoplasm Metastasis
A case of hepatocellular carcinoma with pulmonary metastases treated successfully with a combination of repeated hepatic arterial infusion epirubicin and Cisplatin chemotherapy and systemic low-dose infusion of 5-Fluorouracil.
Neoplasm Metastasis
A model to estimate survival in ambulatory patients with hepatocellular carcinoma.
Neoplasm Metastasis
A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Neoplasm Metastasis
A resected case of metachronous liver metastasis from lung cancer producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II).
Neoplasm Metastasis
A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.
Neoplasm Metastasis
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Neoplasm Metastasis
Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.
Neoplasm Metastasis
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Neoplasm Metastasis
Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot "Prunus mume".
Neoplasm Metastasis
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
Neoplasm Metastasis
AFP-producing adenocarcinoma of the esophagogastric junction: report of a case with atypical immunohistochemical findings responding to palliative chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT regime).
Neoplasm Metastasis
AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Neoplasm Metastasis
Aggressive excision of pulmonary metastases is warranted in the management of childhood hepatic tumors.
Neoplasm Metastasis
Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.
Neoplasm Metastasis
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Neoplasm Metastasis
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Neoplasm Metastasis
Alpha-fetoprotein in patients of gastric carcinoma with or without liver metastasis.
Neoplasm Metastasis
Alpha-fetoprotein in the serum of patients with neoplasms of the gastrointestinal tract.
Neoplasm Metastasis
Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.
Neoplasm Metastasis
Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-?B (P65) Pathway in Hepatocellular Carcinoma Cells.
Neoplasm Metastasis
Alpha-fetoprotein- and des-gamma-carboxy prothrombin-producing advanced gastric cancer.
Neoplasm Metastasis
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
Neoplasm Metastasis
An Oxygen-Concentration-Controllable Multiorgan Microfluidic Platform for Studying Hypoxia-Induced Lung Cancer-Liver Metastasis and Screening Drugs.
Neoplasm Metastasis
Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma.
Neoplasm Metastasis
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
Neoplasm Metastasis
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China.
Neoplasm Metastasis
Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.
Neoplasm Metastasis
Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports.
Neoplasm Metastasis
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Neoplasm Metastasis
Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma.
Neoplasm Metastasis
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Neoplasm Metastasis
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Neoplasm Metastasis
c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
Neoplasm Metastasis
C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
Neoplasm Metastasis
Carcino-fetal proteins and gastric cancer: the site of alpha-fetoprotein synthesis in gastric cancer.
Neoplasm Metastasis
Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan.
Neoplasm Metastasis
Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR.
Neoplasm Metastasis
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Neoplasm Metastasis
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study.
Neoplasm Metastasis
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
Neoplasm Metastasis
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Neoplasm Metastasis
Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer.
Neoplasm Metastasis
Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.
Neoplasm Metastasis
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Neoplasm Metastasis
Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Neoplasm Metastasis
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
Neoplasm Metastasis
Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Neoplasm Metastasis
Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Neoplasm Metastasis
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma.
Neoplasm Metastasis
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Neoplasm Metastasis
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Neoplasm Metastasis
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Neoplasm Metastasis
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Neoplasm Metastasis
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Neoplasm Metastasis
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Neoplasm Metastasis
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Neoplasm Metastasis
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Neoplasm Metastasis
Complete response after short-term sorafenib treatment in a patient with lymph node metastasis of hepatocellular carcinoma.
Neoplasm Metastasis
Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
Neoplasm Metastasis
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Neoplasm Metastasis
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Neoplasm Metastasis
Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
Neoplasm Metastasis
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Neoplasm Metastasis
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Neoplasm Metastasis
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Neoplasm Metastasis
Development and Identification of a Nomogram Prognostic Model for Patients with Primary Clear Cell Carcinoma of the Liver.
Neoplasm Metastasis
Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Neoplasm Metastasis
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Neoplasm Metastasis
Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Neoplasm Metastasis
Discrete nature of EpCAM(+) and CD90(+) cancer stem cells in human hepatocellular carcinoma.
Neoplasm Metastasis
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary.
Neoplasm Metastasis
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma.
Neoplasm Metastasis
Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.
Neoplasm Metastasis
Education and Imaging. Gastrointestinal: brain metastasis of alpha-fetoprotein producing gastric adenocarcinoma.
Neoplasm Metastasis
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Neoplasm Metastasis
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Neoplasm Metastasis
Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein.
Neoplasm Metastasis
Efficiency of composite laboratory tests in the diagnosis of liver malignancies.
Neoplasm Metastasis
Elevation of MAP17 enhances the malignant behavior of cells via the Akt/mTOR pathway in hepatocellular carcinoma.
Neoplasm Metastasis
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Neoplasm Metastasis
Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma.
Neoplasm Metastasis
Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Neoplasm Metastasis
Evaluation of six tumor markers in patients with carcinoma of unknown primary.
Neoplasm Metastasis
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Neoplasm Metastasis
Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.
Neoplasm Metastasis
Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Neoplasm Metastasis
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Neoplasm Metastasis
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Neoplasm Metastasis
Fifty years of discovery of alpha-fetoprotein as the first tumor marker.
Neoplasm Metastasis
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Neoplasm Metastasis
GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Neoplasm Metastasis
Gastric hepatoid adenocarcinoma: a computed tomography report of six cases.
Neoplasm Metastasis
Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.
Neoplasm Metastasis
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Neoplasm Metastasis
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Neoplasm Metastasis
Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years.
Neoplasm Metastasis
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Neoplasm Metastasis
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Neoplasm Metastasis
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Neoplasm Metastasis
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Neoplasm Metastasis
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
Neoplasm Metastasis
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Neoplasm Metastasis
High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein.
Neoplasm Metastasis
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma.
Neoplasm Metastasis
Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Neoplasm Metastasis
Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.
Neoplasm Metastasis
Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.
Neoplasm Metastasis
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Neoplasm Metastasis
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Neoplasm Metastasis
Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: a prospective study.
Neoplasm Metastasis
Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.
Neoplasm Metastasis
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Neoplasm Metastasis
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
Neoplasm Metastasis
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
Neoplasm Metastasis
Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Neoplasm Metastasis
Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases.
Neoplasm Metastasis
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Neoplasm Metastasis
Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
Neoplasm Metastasis
KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Neoplasm Metastasis
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Neoplasm Metastasis
Liver resection for hepatocellular carcinoma in patients with cirrhosis.
Neoplasm Metastasis
Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.
Neoplasm Metastasis
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Neoplasm Metastasis
Local tumor control of thoracoabdominal wall seeding tumor from hepatocellular carcinoma with ultrasound-guided interventional treatment: A summarized study.
Neoplasm Metastasis
Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.
Neoplasm Metastasis
Long-term Outcome of Chemotherapy for Advanced Testicular and Extragonadal Germ Cell Tumors: A Single-center 27-year Experience.
Neoplasm Metastasis
Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case.
Neoplasm Metastasis
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Neoplasm Metastasis
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib.
Neoplasm Metastasis
Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
Neoplasm Metastasis
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Neoplasm Metastasis
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Neoplasm Metastasis
Multidisciplinary treatment of advanced testicular tumor with bulky liver metastasis.
Neoplasm Metastasis
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
Neoplasm Metastasis
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases.
Neoplasm Metastasis
Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
Neoplasm Metastasis
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Neoplasm Metastasis
Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report.
Neoplasm Metastasis
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Neoplasm Metastasis
Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
Neoplasm Metastasis
Orchiectomy alone in clinical stage I nonseminomatous testis cancer: a critical appraisal.
Neoplasm Metastasis
Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Neoplasm Metastasis
Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report.
Neoplasm Metastasis
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Neoplasm Metastasis
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Neoplasm Metastasis
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Neoplasm Metastasis
Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulin.
Neoplasm Metastasis
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
Neoplasm Metastasis
Pediatric Liver Transplant For Hepatoblastoma: A Single-Center Experience.
Neoplasm Metastasis
Pediatric liver transplantation for hepatoblastoma: a single center experience.
Neoplasm Metastasis
Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 is a diagnostic and prognostic biomarker for hepatocellular carcinoma.
Neoplasm Metastasis
Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
Neoplasm Metastasis
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
Neoplasm Metastasis
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.
Neoplasm Metastasis
Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma.
Neoplasm Metastasis
Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Neoplasm Metastasis
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Neoplasm Metastasis
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems.
Neoplasm Metastasis
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Neoplasm Metastasis
Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Neoplasm Metastasis
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Neoplasm Metastasis
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
Neoplasm Metastasis
Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma.
Neoplasm Metastasis
Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
Neoplasm Metastasis
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Neoplasm Metastasis
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Neoplasm Metastasis
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Neoplasm Metastasis
Prognostic Importance of 18F-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT.
Neoplasm Metastasis
Prognostic model for hepatocellular carcinoma with time-dependent factors.
Neoplasm Metastasis
Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study.
Neoplasm Metastasis
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Neoplasm Metastasis
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Neoplasm Metastasis
Pulmonary atypical carcinoid tumor with marked alphafetoprotein production and features of an adenocarcinoma differentiation.
Neoplasm Metastasis
Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
Neoplasm Metastasis
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Neoplasm Metastasis
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Neoplasm Metastasis
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Neoplasm Metastasis
Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.
Neoplasm Metastasis
Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.
Neoplasm Metastasis
Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
Neoplasm Metastasis
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Neoplasm Metastasis
Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data.
Neoplasm Metastasis
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Neoplasm Metastasis
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Neoplasm Metastasis
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Neoplasm Metastasis
Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma-a cost-effectiveness analysis.
Neoplasm Metastasis
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Neoplasm Metastasis
Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
Neoplasm Metastasis
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Neoplasm Metastasis
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Neoplasm Metastasis
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Neoplasm Metastasis
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Neoplasm Metastasis
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Neoplasm Metastasis
Serum tumor markers for detection of bone metastasis in breast cancer patients.
Neoplasm Metastasis
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Neoplasm Metastasis
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Neoplasm Metastasis
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Neoplasm Metastasis
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Neoplasm Metastasis
Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors.
Neoplasm Metastasis
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Neoplasm Metastasis
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Neoplasm Metastasis
Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
Neoplasm Metastasis
Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer.
Neoplasm Metastasis
Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.
Neoplasm Metastasis
Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.
Neoplasm Metastasis
Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Neoplasm Metastasis
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
Neoplasm Metastasis
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Neoplasm Metastasis
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Neoplasm Metastasis
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
Neoplasm Metastasis
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Neoplasm Metastasis
Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
Neoplasm Metastasis
The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals.
Neoplasm Metastasis
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
Neoplasm Metastasis
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.
Neoplasm Metastasis
The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients.
Neoplasm Metastasis
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Neoplasm Metastasis
The Research of No-Touch Isolation Technique on the Prevention of Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma after Hepatectomy.
Neoplasm Metastasis
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
Neoplasm Metastasis
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Neoplasm Metastasis
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
Neoplasm Metastasis
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Neoplasm Metastasis
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Neoplasm Metastasis
Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Neoplasm Metastasis
Transesophageal echocardiography in the detection of inferior vena cava and cardiac metastasis in hepatocellular carcinoma.
Neoplasm Metastasis
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Neoplasm Metastasis
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Neoplasm Metastasis
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Neoplasm Metastasis
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Neoplasm Metastasis
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
Neoplasm Metastasis
[A case of alpha-fetoprotein producing lung cancer without metastasis to the liver]
Neoplasm Metastasis
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]
Neoplasm Metastasis
[A case of postoperative liver metastasis of alpha-fetoprotein producing gastric cancer successfully treated with intrahepatic chemotherapy (adriamycin, cisplatin, irinotecan hydrochloride)]
Neoplasm Metastasis
[A case of renal carcinoma with bone metastasis, producing alpha-fetoprotein]
Neoplasm Metastasis
[A case of stage IIIB2 infantile yolk sac tumor of testis achieved complete remission by "COMPE" chemotherapy]
Neoplasm Metastasis
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
Neoplasm Metastasis
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
Neoplasm Metastasis
[Alpha-fetoprotein secreting adrenal metastasis after hepatectomy for non-secreting hepatocarcinoma. Description of a case]
Neoplasm Metastasis
[Alpha-fetoprotein. 3. Evaluation of alpha-fetoprotein in gastric cancer and its liver metastasis]
Neoplasm Metastasis
[Bone metastases in a cirrhotic patient with normal alpha-fetoprotein levels and imaging tests: detection of hepatocarcinoma 6 months later]
Neoplasm Metastasis
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection]
Neoplasm Metastasis
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Neoplasm Metastasis
[Diagnosis of hepatocellular carcinoma with bone metastasis using fine needle aspiration biopsy: report of 2 cases]
Neoplasm Metastasis
[Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma]
Neoplasm Metastasis
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
Neoplasm Metastasis
[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]
Neoplasm Metastasis
[Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].
Neoplasm Metastasis
[Factors linked to 5-year survival after hepatectomy for hepatocellular carcinoma: univariate and multivariate analyses of 312 patients]
Neoplasm Metastasis
[Gastric cancer with liver metastasis producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II); a case report]
Neoplasm Metastasis
[Hepatic metastases from alpha-fetoprotein producing colorectal cancer that responded remarkably to transcatheter arterial chemo-embolization]
Neoplasm Metastasis
[Increase of alpha-fetoprotein in pancreatic endocrine tumors with hepatic metastases. Apropos of 2 cases]
Neoplasm Metastasis
[Liver metastasis of colon cancer with a high serum alpha-fetoprotein level: report of a case]
Neoplasm Metastasis
[Lung Metastasis from Alpha-Fetoprotein Resulting in Esophagogastric Junction Cancer-A Case Report].
Neoplasm Metastasis
[Outcome of pulmonary resection for metastases from hepatocellular carcinoma].
Neoplasm Metastasis
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
Neoplasm Metastasis
[Prognostic factors in patients with non-active treatment of hepatocellular carcinoma.]
Neoplasm Metastasis
[Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]
Neoplasm Metastasis
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
Neoplasm Metastasis
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
Neoplasm Metastasis
[Successful Treatment for Advanced Hepatocellular Carcinoma by Hepatic Arterial Infusion of CDDP Powder as Second-Line Chemotherapy.]
Neoplasm Metastasis
[The analysis of prognostic factors of primary hepatocellular carcinoma with Cox model]
Neoplasm Metastasis
[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors]
Neoplasm Metastasis
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice]
Neoplasm Metastasis
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
Neoplasm Metastasis
[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].
Neoplasm Metastasis
[Tumor thrombus arising from the superior vena cava and extending into the right atrium in a patient with advanced testicular germ cell tumor]
Neoplasm Metastasis
[Two cases of alpha-fetoprotein producing gastric cancer, showing marked response to continuous hepatic arterial infusion (HAI) chemotherapy with adriamycin]
Neoplasm Metastasis
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Neoplasm Micrometastasis
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Neoplasm Micrometastasis
Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.
Neoplasm Micrometastasis
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Neoplasm Micrometastasis
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Neoplasm Micrometastasis
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Neoplasm, Residual
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Neoplasm, Residual
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Neoplasm, Residual
Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Neoplasm, Residual
Mildly Elevated Serum Alpha-Fetoprotein (AFP) Among Patients With Testicular Cancer May Not Be Associated With Residual Cancer Or Need For Treatment.
Neoplasm, Residual
Residual pulmonary nodules after combination chemotherapy of testicular cancer.
Neoplasm, Residual
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Neoplasm, Residual
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Neoplasm, Residual
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Neoplasms
"Humors from tumors": carcinoembryonic antigen, alpha-fetoprotein, and digestive system cancer.
Neoplasms
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort.
Neoplasms
'5-5-500' - yet another extended criteria for HCC or a truly innovative development?
Neoplasms
131Iodine-DEM TACE vs. conventional TACE in cirrhotic patients with hepatocellular carcinoma: a single center experiment.
Neoplasms
240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
Neoplasms
A 35 Year Old Bangladeshi Lady with Hereditary Mucinous Ovarian Cancer, Complicated with Omental Metastasis.
Neoplasms
A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population.
Neoplasms
A 7-year history of an intratesticular mass: patient description and review of the literature about dermoid cysts of the testis.
Neoplasms
A cancer-related protein 14-3-3? is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
Neoplasms
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Neoplasms
A case of endodermal sinus tumor associated with the first pregnancy and successful management of the second pregnancy: a case report and review of the literature.
Neoplasms
A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
Neoplasms
A case of resected hepatocellular carcinoma after drug-eluting bead transarterial chemoembolization.
Neoplasms
A case of spontaneous regression of hepatocellular carcinoma with bone metastasis.
Neoplasms
A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma.
Neoplasms
A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
Neoplasms
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
Neoplasms
A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
Neoplasms
A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.
Neoplasms
A Clinicopathological Study of Paediatric Liver Tumours in a Tertiary Care Hospital.
Neoplasms
A comparative study of four serological tumor markers for the detection of breast cancer.
Neoplasms
A Comparison between Three-Dimensional Visualization Guided Hepatectomy and Ultrasonography Guided Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma within the Milan Criteria.
Neoplasms
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.
Neoplasms
A comparison of patients with hepatitis B- or hepatitis C-based advanced-stage hepatocellular carcinoma.
Neoplasms
A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.
Neoplasms
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
Neoplasms
A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene.
Neoplasms
A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia.
Neoplasms
A fluorescent molecularly-imprinted polymer gate with temperature and pH as inputs for detection of alpha-fetoprotein.
Neoplasms
A hepatic sclerosed hemangioma with significant morphological change over a period of 10 years: a case report.
Neoplasms
A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
Neoplasms
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Neoplasms
A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
Neoplasms
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Neoplasms
A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation.
Neoplasms
A long-term survival case of gastric cancer treated by continuous low-dosage 5-fluorouracil and cisplatin: a case report.
Neoplasms
A long-term survival case underwent repeated hepatic arterial infusion chemotherapy with portal branch ligation and wrapping of the liver using sheets for hepatocellular carcinoma.
Neoplasms
A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma.
Neoplasms
A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
Neoplasms
A model to estimate survival in ambulatory patients with hepatocellular carcinoma.
Neoplasms
A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.
Neoplasms
A new cancer marker: a possible cancer screening method based on the suppression of phosphofructokinase by sera from cancer patients.
Neoplasms
A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.
Neoplasms
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
Neoplasms
A Nomogram Estimation for the Risk of Microvascular Invasion in Hepatocellular Carcinoma Patients Meeting the Milan Criteria.
Neoplasms
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Neoplasms
A Nomogram Predicting Extrahepatic Metastases for Patients with Adjuvant Transarterial Chemoembolization after Hepatectomy.
Neoplasms
A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy.
Neoplasms
A novel embryological theory of autism causation involving endogenous biochemicals capable of initiating cellular gene transcription: A possible link between twelve autism risk factors and the autism 'epidemic'
Neoplasms
A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
Neoplasms
A novel microchip electrophoresis-based chemiluminescence immunoassay for the detection of alpha-fetoprotein in human serum.
Neoplasms
A novel microfluidic biosensor based on an electrical detection system for alpha-fetoprotein.
Neoplasms
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.
Neoplasms
A novel multi-array immunoassay device for tumor markers based on insert-plug model of piezoelectric immunosensor.
Neoplasms
A novel piezoelectric quartz crystal immnuosensor based on hyperbranched polymer films for the detection of alpha-Fetoprotein.
Neoplasms
A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.
Neoplasms
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
Neoplasms
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
Neoplasms
A paper-based microfluidic electrochemical immunodevice integrated with amplification-by-polymerization for the ultrasensitive multiplexed detection of cancer biomarkers.
Neoplasms
A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization.
Neoplasms
A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
Neoplasms
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
Neoplasms
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma.
Neoplasms
A piezoelectric immunosensor for the detection of alpha-fetoprotein using an interface of gold/hydroxyapatite hybrid nanomaterial.
Neoplasms
A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Neoplasms
A practical nomogram from the SEER database to predict the prognosis of hepatocellular carcinoma in patients with lymph node metastasis.
Neoplasms
A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
Neoplasms
A prognostic fingerprint in liver transplantation for hepatocellular carcinoma based on plasma metabolomics profiling.
Neoplasms
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Neoplasms
A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
Neoplasms
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Neoplasms
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up.
Neoplasms
A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.
Neoplasms
A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumour cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis.
Neoplasms
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
Neoplasms
A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage testicular cancer with poor prognostic features.
Neoplasms
A resected case of a small hepatocellular carcinoma developing within the bile duct.
Neoplasms
A sensitive fluorescent sensor for quantification of alpha-fetoprotein based on immunosorbent assay and click chemistry.
Neoplasms
A simple electrochemical immunosensor based on worm-like platinum for highly sensitive determination of alpha-fetoprotein.
Neoplasms
A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
Neoplasms
A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
Neoplasms
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Neoplasms
A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
Neoplasms
A study, by electron microscopy, of the specific uptake of alpha-fetoprotein by mouse embryonic fibroblasts in relation to in vitro aging, and by human mammary epithelial tumour cells in comparison with normal donors' cells.
Neoplasms
A synthetic peptide derived from alpha-fetoprotein inhibits the estradiol-induced proliferation of mammary tumor cells in culture through the modulation of p21.
Neoplasms
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists.
Neoplasms
A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.
Neoplasms
A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy.
Neoplasms
A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
Neoplasms
Abdominal wall metastases after surgical resection of an immature teratoma of the ovary.
Neoplasms
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Neoplasms
Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation.
Neoplasms
Abnormal prothrombin: evaluation as a tumour marker and localization in tissues of patients with hepatocellular carcinoma.
Neoplasms
Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.
Neoplasms
ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
Neoplasms
Accelerated tumor growth and changes in images concomitant with vascularization in a patient with hepatocellular carcinoma.
Neoplasms
Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors.
Neoplasms
Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Neoplasms
Acute hepatic injury after discontinuation of chemotherapy in a patient with non-Hodgkin's lymphoma and chronic hepatitis B virus infection.
Neoplasms
Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: a real-world experience.
Neoplasms
Adenocarcinoma of the uterine cervix with choriocarcinomatous and hepatoid differentiation: report of a case.
Neoplasms
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report.
Neoplasms
Adenoendocrine cell carcinoma of the gallbladder producing a high level of alpha-fetoprotein.
Neoplasms
Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Neoplasms
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer.
Neoplasms
Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials.
Neoplasms
Adriamycin coated silica microspheres as labels for cancer biomarker alpha-fetoprotein detection.
Neoplasms
Advanced extragonadal yolk sac tumor serially followed up with (18) F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein.
Neoplasms
Advanced hepatocellular carcinoma treated effectively with irinotecan via hepatic arterial infusion followed by proton beam therapy.
Neoplasms
Affinity chromatographic separation of alpha-fetoprotein variants: development of a mini-column procedure, and application to cancer patients.
Neoplasms
Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.
Neoplasms
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
Neoplasms
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
Neoplasms
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.
Neoplasms
Ag/SiO2 core-shell nanoparticle-based surface-enhanced Raman probes for immunoassay of cancer marker using silica-coated magnetic nanoparticles as separation tools.
Neoplasms
Age-dependent growth inhibition of estrogen-sensitive rat mammary tumors. Probable role of alpha-fetoprotein.
Neoplasms
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.
Neoplasms
AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Neoplasms
AGMA Score: A Novel Prognostic Score for Patients Undergoing Liver Transplant for Hepatocellular Carcinoma.
Neoplasms
Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation.
Neoplasms
Allomyrina dichotoma lectin-nonreactive alpha-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I.
Neoplasms
Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results.
Neoplasms
Alpha Fetoprotein-Secreting Gastric Cancer in the Setting of Chronic Hepatitis B: The Role of Endoscopy.
Neoplasms
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Neoplasms
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Neoplasms
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic.
Neoplasms
Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
Neoplasms
Alpha-fetoprotein (AFP) expression in clones of McA-RH 7777 rat hepatoma: correlation with the occurrence of homogeneously staining regions on chromosome 14.
Neoplasms
alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Neoplasms
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Neoplasms
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Neoplasms
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Neoplasms
Alpha-fetoprotein and albumin synthesis by heterotransplanted rat liver tumor cells.
Neoplasms
Alpha-fetoprotein and beta-human chorionic gonadotropin: their clinical significance as tumour markers.
Neoplasms
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
Neoplasms
Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
Neoplasms
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
Neoplasms
Alpha-fetoprotein and human chorionic gonadotropin in a patient with a primary intracranial germ cell tumor.
Neoplasms
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Neoplasms
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation.
Neoplasms
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Neoplasms
alpha-Fetoprotein and other serum proteins synthesized by endodermal sinus tumor transplanted into nude mice.
Neoplasms
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Neoplasms
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
Neoplasms
Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction.
Neoplasms
Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues.
Neoplasms
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Neoplasms
Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer.
Neoplasms
alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
Neoplasms
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Neoplasms
Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways.
Neoplasms
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Neoplasms
Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
Neoplasms
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Neoplasms
Alpha-fetoprotein in pericardial, peritoneal, and pleural fluids: A body fluid matrix evaluation.
Neoplasms
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Neoplasms
Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma.
Neoplasms
Alpha-fetoprotein in the serum of patients with neoplasms of the gastrointestinal tract.
Neoplasms
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.
Neoplasms
Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas.
Neoplasms
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Neoplasms
Alpha-fetoprotein molecular heterogeneity. Physiologic correlations with normal growth, carcinogenesis and tumor growth.
Neoplasms
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Neoplasms
Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation.
Neoplasms
Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
Neoplasms
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
Neoplasms
Alpha-fetoprotein production by a malignant mixed müllerian tumour of the uterus.
Neoplasms
Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor.
Neoplasms
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Neoplasms
Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis.
Neoplasms
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival.
Neoplasms
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis.
Neoplasms
alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Neoplasms
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
Neoplasms
alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Neoplasms
Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
Neoplasms
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Neoplasms
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Neoplasms
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Neoplasms
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Neoplasms
Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.
Neoplasms
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma.
Neoplasms
Alpha-fetoprotein, prealbumin, albumin, alpha-1-antitrypsin and transferrin as diagnostic and therapeutic markers for endodermal sinus tumors.
Neoplasms
Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
Neoplasms
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Neoplasms
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Neoplasms
Alpha-fetoprotein-producing Colon Carcinoma with Rapidly Increasing Liver Metastases That Resulted in Death: A Case Report.
Neoplasms
Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.
Neoplasms
Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
Neoplasms
Alpha-fetoprotein-producing early rectal carcinoma: a rare case report and review.
Neoplasms
Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case.
Neoplasms
Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1.
Neoplasms
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Neoplasms
Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics.
Neoplasms
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report.
Neoplasms
Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Neoplasms
Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Neoplasms
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Neoplasms
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Neoplasms
Alpha1-antitrypsin and alpha-fetoprotein. Protein markers in endodermal sinus (yolk sac) tumors.
Neoplasms
An abnormal elevation of serum CA72-4 rather than other tumor markers can be caused by use of colchicine.
Neoplasms
An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
Neoplasms
An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Neoplasms
An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.
Neoplasms
An apparent dimerization motif in the third domain of alpha-fetoprotein: molecular mimicry of the steroid/thyroid nuclear receptor superfamily.
Neoplasms
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Neoplasms
An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma.
Neoplasms
An icteric type hepatocellular carcinoma with no detectable tumor in the liver: report of a case.
Neoplasms
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Neoplasms
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
Neoplasms
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
Neoplasms
An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma.
Neoplasms
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
Neoplasms
An Oxygen-Concentration-Controllable Multiorgan Microfluidic Platform for Studying Hypoxia-Induced Lung Cancer-Liver Metastasis and Screening Drugs.
Neoplasms
An unusual case, in Italy, of hepatocarcinoma characterized by portal hypertension and absence of cirrhosis.
Neoplasms
Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
Neoplasms
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival.
Neoplasms
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Neoplasms
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Neoplasms
Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Neoplasms
Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients.
Neoplasms
Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
Neoplasms
Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy.
Neoplasms
Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers.
Neoplasms
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Neoplasms
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
Neoplasms
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation.
Neoplasms
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
Neoplasms
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
Neoplasms
Analysis of survival predictors in a prospective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Canadian centre.
Neoplasms
Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
Neoplasms
Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.
Neoplasms
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
Neoplasms
Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment.
Neoplasms
Angiotensin Receptor 1 Blockers Prolong Time to Recurrence after Radiofrequency Ablation in Hepatocellular Carcinoma patients: A Retrospective Study.
Neoplasms
Annona senegalensis extract demonstrates anticancer properties in N-diethylnitrosamine-induced hepatocellular carcinoma in male Wistar rats.
Neoplasms
Anti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male rats.
Neoplasms
Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Neoplasms
Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model.
Neoplasms
Antitumor activity of conjugates of the oncofetal protein alpha-fetoprotein and phthalocyanines in vitro.
Neoplasms
Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70.
Neoplasms
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.
Neoplasms
Apoptosis, redifferentiation and arresting proliferation simultaneously triggered by oxidative stress in human hepatoma cells.
Neoplasms
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients.
Neoplasms
Application of a microfluidic paper-based bioimmunosensor with laser-induced fluorescence detection in the determination of alpha-fetoprotein from serum of hepatopaths.
Neoplasms
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Neoplasms
Application of Six Sigma for evaluating the analytical quality of tumor marker assays.
Neoplasms
Are both PIVKA-II and alpha-fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma?
Neoplasms
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Neoplasms
Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.
Neoplasms
Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique.
Neoplasms
Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.
Neoplasms
Aspiration cytology of mediastinal seminoma: report of a case with emphasis on the diagnostic role of aspiration cytology, cell block and immunocytochemistry.
Neoplasms
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Neoplasms
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Neoplasms
Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
Neoplasms
Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: Results of a pilot study.
Neoplasms
Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
Neoplasms
Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis.
Neoplasms
Association between Helicobacter pylori infection and tumor markers: an observational retrospective study.
Neoplasms
Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
Neoplasms
ASSOCIATION BETWEEN MURINE DOUBLE MINUTE 2 - T309G polymorphism and recurrence of hepatocellular carcinoma after surgical treatment.
Neoplasms
Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study.
Neoplasms
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
Neoplasms
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Neoplasms
Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients.
Neoplasms
Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months.
Neoplasms
Association of reduced cell adhesion regulator messenger RNA expression with tumor progression in human hepatocellular carcinoma.
Neoplasms
Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection.
Neoplasms
Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line.
Neoplasms
Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment.
Neoplasms
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Neoplasms
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.
Neoplasms
Binding characterization of the targeting drug AIMPILA to AFP receptors in human tumor xenografts.
Neoplasms
Bioactive phytochemicals from Salvia officinalis attenuate cadmium-induced oxidative damage and genotoxicity in rats.
Neoplasms
Biochemical Evidence for the Antitumor Potential of Garcinia mangostana Linn. On Diethylnitrosamine-Induced Hepatic Carcinoma.
Neoplasms
Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil.
Neoplasms
Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation.
Neoplasms
Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
Neoplasms
Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy.
Neoplasms
Biological roles of alpha-fetoprotein during pregnancy and perinatal development.
Neoplasms
Bivariate flow cytometric analysis of p53 and DNA content in hepatocellular carcinoma.
Neoplasms
Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor.
Neoplasms
Blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic HBV hepatitis patients as hepatocellular cancer appears.
Neoplasms
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Neoplasms
Brain Metastases as Presenting Feature in 'Burned Out' Testicular Germ Cell Tumor.
Neoplasms
c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma.
Neoplasms
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
Neoplasms
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
Neoplasms
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
Neoplasms
Calcifying nested stromal-epithelial tumor of the liver: Case report of a rare primary liver tumor.
Neoplasms
Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-4 Infected Patients in Egypt.
Neoplasms
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?
Neoplasms
Cancer in Bangladesh: a model for some problems and proposed solutions in the Third World.
Neoplasms
Capillary electrochromatography immunoassay for alpha-fetoprotein based on poly(guanidinium ionic liquid) monolithic material.
Neoplasms
Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives.
Neoplasms
Capillary electrophoretic immunoassay for alpha-fetoprotein with chemiluminescence detection.
Neoplasms
Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Neoplasms
Carbohydrate structure of the concanavalin A molecular variants of alpha-fetoprotein.
Neoplasms
Carbon Nanotubes Multifunctionalized by Rolling Circle Amplification and Their Application for Highly Sensitive Detection of Cancer Markers.
Neoplasms
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Neoplasms
Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman.
Neoplasms
Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.
Neoplasms
CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma.
Neoplasms
CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Neoplasms
Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer.
Neoplasms
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Neoplasms
Central diabetes insipidus developing in a 6-year-old patient 4 years after the remission of unifocal bone Langerhans cell histiocytosis.
Neoplasms
Central nervous system germ cell tumors: controversies in diagnosis and treatment.
Neoplasms
Cesium Lead Bromide (CsPbBr3) Perovskite Quantum Dot-Based Photosensor for Chemiluminescence Immunoassays.
Neoplasms
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.
Neoplasms
Changes in expression of albumin and alpha-fetoprotein genes during rat liver development and neoplasia.
Neoplasms
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Neoplasms
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
Neoplasms
Changes in methylation pattern of albumin and alpha-fetoprotein genes in developing rat liver and neoplasia.
Neoplasms
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Neoplasms
Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma.
Neoplasms
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Neoplasms
Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma.
Neoplasms
Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.
Neoplasms
Characterization and nucleotide sequences of the variable regions of a monoclonal antibody against alpha-fetoprotein.
Neoplasms
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator.
Neoplasms
Characterization of murine hepatoma BW7756. III. Hematological profile of a tumor-associated anemia.
Neoplasms
Characterization of new human pancreatic cancer cell lines which propagate in a protein-free chemically defined medium.
Neoplasms
Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.
Neoplasms
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Neoplasms
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Neoplasms
Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.
Neoplasms
Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system.
Neoplasms
Chest wall hernia induced by high intensity focused ultrasound treatment of unresectable massive hepatocellular carcinoma: A case report.
Neoplasms
CircSMYD4 regulates proliferation, migration and apoptosis of hepatocellular carcinoma cells by sponging miR-584-5p.
Neoplasms
Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Neoplasms
Circular RNA circARPP21 Acts as a Sponge of miR-543 to Suppress Hepatocellular Carcinoma by Regulating LIFR.
Neoplasms
Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p.
Neoplasms
Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Neoplasms
Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Neoplasms
Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Neoplasms
Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
Neoplasms
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Neoplasms
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
Neoplasms
Cisplatin, etoposide, bleomycin first-line therapy and early resection of residual tumor in far-advanced germinal testis cancer.
Neoplasms
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
Neoplasms
Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor.
Neoplasms
Clinical and Computed Tomography Features of Female Pelvic Malignant Germ Cell Tumors in Children and Adolescents: A Series of 30 Cases.
Neoplasms
Clinical and contrast-enhanced image features in the prediction model for the detection of small hepatocellular carcinomas.
Neoplasms
Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours.
Neoplasms
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Neoplasms
Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the Prepubertal Testis Tumor Registry.
Neoplasms
Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy.
Neoplasms
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Neoplasms
Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
Neoplasms
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Neoplasms
Clinical Efficacy and Prognosis Factors for Advanced Hepatoblastoma in Children: A 6-year Retrospective Study.
Neoplasms
Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
Neoplasms
Clinical evaluation of a monoclonal antibody to serum KM01 for the diagnosis of hepatocellular carcinoma.
Neoplasms
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
Neoplasms
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Neoplasms
Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases.
Neoplasms
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Neoplasms
Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Neoplasms
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
Neoplasms
Clinical features of small hepatocellular carcinomas as assessed by histologic grades.
Neoplasms
Clinical features of three girls with mosaic genome-wide paternal uniparental isodisomy.
Neoplasms
Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma.
Neoplasms
Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection.
Neoplasms
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.
Neoplasms
Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.
Neoplasms
Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Neoplasms
Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI-based Assays.
Neoplasms
Clinical performance of LOCI-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Neoplasms
Clinical relevance of HER-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor.
Neoplasms
Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma.
Neoplasms
Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Neoplasms
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.
Neoplasms
Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.
Neoplasms
Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Neoplasms
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.
Neoplasms
Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases.
Neoplasms
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.
Neoplasms
Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation.
Neoplasms
Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Neoplasms
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Neoplasms
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Neoplasms
Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation.
Neoplasms
Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Neoplasms
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Neoplasms
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Neoplasms
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Neoplasms
Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
Neoplasms
Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Neoplasms
Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma.
Neoplasms
Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.
Neoplasms
Clinicopathological and Prognostic Role of Programmed Cell Death-1 in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Neoplasms
Clinicopathological comparison of resectable hepatocellular carcinoma between the young and the elderly patients.
Neoplasms
Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Neoplasms
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Neoplasms
Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.
Neoplasms
Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Neoplasms
Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Neoplasms
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Neoplasms
Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.
Neoplasms
Clinicopathological studies of minute hepatocellular carcinoma. Analysis of 20 cases, including 4 with hepatic resection.
Neoplasms
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
Neoplasms
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Neoplasms
Combination chemotherapy of hepatocellular carcinoma with doxorubicin and streptozotocin.
Neoplasms
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up.
Neoplasms
Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.
Neoplasms
Combination of alpha-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence.
Neoplasms
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation.
Neoplasms
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Neoplasms
Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells.
Neoplasms
Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Neoplasms
Combination of PAPPA, fhCG?, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.
Neoplasms
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Neoplasms
Combination treatment for advanced hepatocellular carcinoma with portal vein tumour thrombus: A case report.
Neoplasms
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
Neoplasms
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Neoplasms
Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct.
Neoplasms
Combined hepatocellular-cholangiocarcinoma after tetralogy of Fallot repair: a case report and review of literature.
Neoplasms
Combined hepatocellular-cholangiocarcinoma with stem cell features, cholangiolocellular subtype after inferior vena cava stent placement for a patient with Budd-Chiari syndrome.
Neoplasms
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.
Neoplasms
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Neoplasms
Combined measurement of preoperative ?-fetoprotein and des-?-carboxyprothrombin predicts recurrence after curative resection in patients with hepatitis-B related hepatocellular carcinoma.
Neoplasms
Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
Neoplasms
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Neoplasms
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Neoplasms
Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization.
Neoplasms
Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Neoplasms
Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy.
Neoplasms
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Neoplasms
Comparative analysis of certain metals and tumor markers in bronchopulmonary cancer and colorectal cancers. Metals and tumor markers in the neoplastic process.
Neoplasms
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Neoplasms
Comparative morphology of endodermal sinus tumor (Teilum) to human yolk sac and a proposal of endodermal cell tumor.
Neoplasms
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Neoplasms
Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Neoplasms
Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
Neoplasms
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Neoplasms
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Neoplasms
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Neoplasms
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Neoplasms
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Neoplasms
Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis.
Neoplasms
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
Neoplasms
Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients.
Neoplasms
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
Neoplasms
Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Neoplasms
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Neoplasms
Comparison of the effects of postoperative prophylactic transcatheter arterial chemoembolization (TACE) and transhepatic arterial infusion (TAI) after hepatectomy for primary liver cancer.
Neoplasms
Comparison of the outcomes of hepatocellular carcinoma after hepatectomy between two regional medical centers in China and Japan.
Neoplasms
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.
Neoplasms
Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma.
Neoplasms
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma.
Neoplasms
Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.
Neoplasms
Complete disappearance of unresectable hepatoblastoma by continuous infusion therapy through hepatic artery.
Neoplasms
Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Neoplasms
Complete necrotization of hepatocellular carcinoma by chemotherapy and subsequent intravascular coagulation: a case report.
Neoplasms
Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Neoplasms
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.
Neoplasms
Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma.
Neoplasms
Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
Neoplasms
Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.
Neoplasms
Computed tomography imaging and clinical features of congenital hepatoblastoma: A retrospective analysis.
Neoplasms
Computed Tomography-Guided High-Dose-Rate Brachytherapy in Hepatocellular Carcinoma: Safety, Efficacy, and Effect on Survival.
Neoplasms
Concentrations of alpha-fetoprotein, insulin-like growth factor binding protein-3, c-erbB-2, and epidermal growth factor in serum of patients with endometriosis.
Neoplasms
Congenital ependymoblastoma presenting as a sacrococcygeal mass in a newborn: an immunohistochemical, light and electron microscopic study.
Neoplasms
Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Neoplasms
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Neoplasms
Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
Neoplasms
Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: Clinical and biological significance.
Neoplasms
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.
Neoplasms
Controlling data quality and reproducibility of a high-sensitivity immunoassay using isotachophoresis in a microchip.
Neoplasms
Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.
Neoplasms
Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma.
Neoplasms
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma.
Neoplasms
Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?
Neoplasms
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
Neoplasms
Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation.
Neoplasms
CT arterial portography and CT hepatic arteriography in detection of micro liver cancer.
Neoplasms
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Neoplasms
Cushing's syndrome due to ovarian serous adenocarcinoma secreting multiple endocrine substances: a case report and immunohistochemical analysis.
Neoplasms
Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival.
Neoplasms
Cytopathologic and clinicopathologic features of ovarian hepatoid carcinoma. A case report.
Neoplasms
Cytopathologic findings and differential diagnostic considerations of primary clear cell carcinoma of the lung.
Neoplasms
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma.
Neoplasms
Datura stramonium agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors.
Neoplasms
Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.
Neoplasms
Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
Neoplasms
Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.
Neoplasms
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Neoplasms
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Neoplasms
Des-?-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.
Neoplasms
Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer.
Neoplasms
Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.
Neoplasms
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Neoplasms
Detection of a metastatic lesion and tiny yolk sac tumors in two teenage patients by FDG-PET: report of two cases.
Neoplasms
Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Neoplasms
Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Neoplasms
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Neoplasms
Detection of craniospinal dissemination of intracranial germ cell tumours based on serum and cerebrospinal fluid levels of tumour markers.
Neoplasms
Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Neoplasms
Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.
Neoplasms
Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
Neoplasms
Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Neoplasms
Detection of serum alpha-fetoprotein in dogs with naturally occurring malignant neoplasia.
Neoplasms
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Neoplasms
Determinants of survival after sorafenib failure in patients with BCLC-C hepatocellular carcinoma in real-world practice.
Neoplasms
Determination of alpha-fetoprotein by radioimmunoassay. Ten year experience in applying a locally produced kit.
Neoplasms
Developing a prediction rule to assess hepatic malignancy in patients with cirrhosis.
Neoplasms
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Neoplasms
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
Neoplasms
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Neoplasms
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study.
Neoplasms
Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study.
Neoplasms
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Neoplasms
Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
Neoplasms
Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Neoplasms
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection.
Neoplasms
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Neoplasms
Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma.
Neoplasms
Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.
Neoplasms
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.
Neoplasms
Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer.
Neoplasms
Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Neoplasms
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Neoplasms
Developmental alterations of alpha-fetoprotein sugar chain in amniotic fluids analyzed by lectin affinity electrophoresis.
Neoplasms
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Neoplasms
Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase.
Neoplasms
Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases.
Neoplasms
Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
Neoplasms
Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review.
Neoplasms
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Neoplasms
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Neoplasms
Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC).
Neoplasms
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors.
Neoplasms
Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.
Neoplasms
Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors: An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3.
Neoplasms
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Neoplasms
Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer.
Neoplasms
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Neoplasms
Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Neoplasms
Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
Neoplasms
Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Neoplasms
Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro.
Neoplasms
Different transformation of mature teratoma in a patient with mixed germ cell tumor of the testis.
Neoplasms
Differential gene alteration among hepatoma cell lines demonstrated by cDNA microarray-based comparative genomic hybridization.
Neoplasms
Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique.
Neoplasms
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Neoplasms
Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
Neoplasms
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Neoplasms
Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
Neoplasms
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Neoplasms
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.
Neoplasms
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas.
Neoplasms
Distinguishing Tumor from Bland Portal Vein Thrombus in Liver Transplant Candidates with Hepatocellular Carcinoma: The "A-VENA" Criteria.
Neoplasms
Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis.
Neoplasms
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice.
Neoplasms
Do We Need to Be Limited by Matching Milan Criteria for Survival in Living Donor Liver Transplantation?
Neoplasms
Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?
Neoplasms
Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
Neoplasms
Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?--Results of a study in 50 patients.
Neoplasms
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Neoplasms
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Neoplasms
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
Neoplasms
Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Neoplasms
Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Neoplasms
Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+.
Neoplasms
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
Neoplasms
Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesis.
Neoplasms
Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1 beta production and gene expression in human monocytic cells by human alpha-fetoprotein.
Neoplasms
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Neoplasms
Doxorubicin, L-arginine, or their combination as a prophylactic agent against hepatic carcinoma in mice.
Neoplasms
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma.
Neoplasms
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Neoplasms
Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Neoplasms
Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Neoplasms
Early increase of serum alpha-fetoprotein in spontaneous hepatocarcinogenesis in mice.
Neoplasms
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Neoplasms
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Neoplasms
Early Recurrence after Curative Resection in Oligonodular Hepatocellular Carcinoma.
Neoplasms
Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome.
Neoplasms
Ectopic hepatocellular carcinoma mimicking a retroperitoneal tumor: A case report.
Neoplasms
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Neoplasms
Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Neoplasms
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.
Neoplasms
Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.
Neoplasms
Effect of horse antibody to rat alpha-fetoprotein upon the growth of AH-66 in Donryu rats.
Neoplasms
Effect of mid-late mouse fetus' microenvironment on the growth of tumor cells after intrauterine transplantation.
Neoplasms
Effect of pre- and post-treatment ?-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Neoplasms
Effect of selenium-enriched malt on hepatocarcinogenesis, paraneoplastic syndrome and the hormones regulating blood glucose in rats treated by diethylnitrosamine.
Neoplasms
Effective relief of obstructive jaundice in a patient with nonresectable icteric-type hepatocellular carcinoma by external beam radiation therapy: case report.
Neoplasms
Effectiveness and feasibility of external beam radiotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium involvement: a multicenter trial in Korea (KROG 17-10).
Neoplasms
Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Neoplasms
Effects of ascorbic acid and DL-alpha-tocopherol on human hepatoma cell proliferation and redifferentiation.
Neoplasms
Effects of ascorbic acid and sodium selenite on growth and redifferentiation in human hepatoma cells and its mechanisms.
Neoplasms
Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation.
Neoplasms
Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.
Neoplasms
Effects of exercise type on estrogen, tumor markers, immune function, antioxidant function, and physical fitness in postmenopausal obese women.
Neoplasms
Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Neoplasms
Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.
Neoplasms
Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture.
Neoplasms
Effects of the irreversible ornithine decarboxylase inhibitor, alpha-difluoromethylornithine, aflatoxin B1, and choline deficiency on hepatocarcinogenesis.
Neoplasms
Efficacy and Safety of Drug Eluting Bead TACE with Microspheres <150 ?m for the Treatment of Hepatocellular Carcinoma.
Neoplasms
Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China.
Neoplasms
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial.
Neoplasms
Efficacy of argon-helium cryosurgical ablation on primary hepatocellular carcinoma: a pilot clinical study.
Neoplasms
Efficacy of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with radiofrequency ablation versus DEB-TACE alone in Chinese hepatocellular carcinoma patients.
Neoplasms
Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Neoplasms
Efficacy of neuroendoscopic procedures in minimally invasive preferential management of pineal region tumors: a prospective study.
Neoplasms
Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Neoplasms
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Neoplasms
Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.
Neoplasms
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
Neoplasms
Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.
Neoplasms
Elevated maternal serum ?-fetoprotein level in a fetus with Beckwith-Wiedemann syndrome in the second trimester of pregnancy.
Neoplasms
Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.
Neoplasms
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Neoplasms
Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Neoplasms
Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.
Neoplasms
Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.
Neoplasms
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Neoplasms
Elevated serum alpha-fetoprotein in Wilms tumor may follow the same pattern of other fetal neoplasms after treatment: evidence from three cases.
Neoplasms
Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation.
Neoplasms
Elevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the Tumor.
Neoplasms
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Neoplasms
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Neoplasms
Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis.
Neoplasms
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Neoplasms
Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
Neoplasms
Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis.
Neoplasms
Endodermal sinus (yolk sac) tumour of the liver. A case report and review of the literature.
Neoplasms
Endodermal sinus tumor (yolk sac tumor), seminoma and hemangiopericytoma. Rare primary mediastinal tumors. A report on the course of the disease in nine patients.
Neoplasms
Endodermal sinus tumor in pregnancy: report of a case and review of the literature.
Neoplasms
Endodermal sinus tumor of the infant vagina treated exclusively with chemotherapy.
Neoplasms
Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases.
Neoplasms
Endodermal sinus tumor of the pineal region. Metastases through a ventriculoperitoneal shunt.
Neoplasms
Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report.
Neoplasms
Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar Region.
Neoplasms
Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization.
Neoplasms
Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
Neoplasms
Enhancement of tumor-specific T cell responses by transcatheter arterial embolization with dendritic cell infusion for hepatocellular carcinoma.
Neoplasms
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
Neoplasms
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
Neoplasms
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Neoplasms
Epidemiologic study of 230 cases of testicular/paratesticular tumors or masses: 15-year experience of a single center.
Neoplasms
Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah.
Neoplasms
Errors in measurement and reporting of serum markers in patients with germ cell tumors.
Neoplasms
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Neoplasms
Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater.
Neoplasms
Establishment and characterization of a cancer cell line derived from an aggressive childhood liver tumor.
Neoplasms
Establishment and characterization of a cell line from a chemically-induced mouse hepatoblastoma.
Neoplasms
Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.
Neoplasms
Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis.
Neoplasms
Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.
Neoplasms
Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma.
Neoplasms
Establishment of a human hepatoblastoma model in athymic nude mice. Producibility of fatty acid-binding protein, alpha-fetoprotein, and alpha 1-acid glycoprotein.
Neoplasms
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.
Neoplasms
Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
Neoplasms
Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.
Neoplasms
Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors.
Neoplasms
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Neoplasms
Evaluation of Circulating miRNA Biomarkers of Testicular Germ Cell Tumors during Therapy and Follow-up-A Copenhagen Experience.
Neoplasms
Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias.
Neoplasms
Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
Neoplasms
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Neoplasms
Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Neoplasms
Evaluation of Recurrence Predictors and Survival Probability After Liver Transplantation for Hepatocellular Carcinoma: Analysis From a Single Center.
Neoplasms
Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Neoplasms
Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Neoplasms
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.
Neoplasms
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.
Neoplasms
Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+? in epithelial ovarian cancer patients.
Neoplasms
Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
Neoplasms
Evaluation of the UniCel DxI 800 immunoassay analyzer in measuring five tumor markers.
Neoplasms
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
Neoplasms
Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Neoplasms
Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
Neoplasms
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Neoplasms
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Neoplasms
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study.
Neoplasms
Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to Sorafenib.
Neoplasms
Excellent response to Anti-PD-1 therapy in a patient with hepatocellular carcinoma: case report and review of literature.
Neoplasms
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report.
Neoplasms
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.
Neoplasms
Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
Neoplasms
Expanded Milan criteria on pathological examination after liver transplantation: analysis of preoperative data.
Neoplasms
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Neoplasms
Experience with the management of primary endodermal sinus tumor of the mediastinum.
Neoplasms
Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
Neoplasms
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Neoplasms
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Neoplasms
Expression and prognostic value of VEGFR-2, PDGFR-?, and c-Met in advanced hepatocellular carcinoma.
Neoplasms
Expression and Significance of LncRNA-MINCR and CDK2 mRNA in Primary Hepatocellular Carcinoma.
Neoplasms
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Neoplasms
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Neoplasms
Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature.
Neoplasms
Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
Neoplasms
Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Neoplasms
Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Neoplasms
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Neoplasms
Expression of FOXO6 is Associated With Oxidative Stress Level and Predicts the Prognosis in Hepatocellular Cancer: A Comparative Study.
Neoplasms
Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study.
Neoplasms
Expression of human regenerating gene mRNA and its product in normal and neoplastic human pancreas.
Neoplasms
Expression of insulin-like growth factor II, alpha-fetoprotein and hepatitis B virus transcripts in human primary liver cancer.
Neoplasms
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Neoplasms
Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates with Early Recurrence and Aggressive Features of HBV-Associated HCC.
Neoplasms
Expression of P-glycoprotein in rat hepatocarcinogenesis by diethylnitrosamine and the modulation by anticancer drugs.
Neoplasms
Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
Neoplasms
Expression of Src and FAK in Hepatocellular Carcinoma and the Effect of Src Inhibitors on Hepatocellular Carcinoma In Vitro.
Neoplasms
Expression of transforming growth factor-beta 1 mRNA in human hepatocellular carcinoma.
Neoplasms
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Neoplasms
Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma.
Neoplasms
External validation of an individual prognostic calculator after trans-arterial chemo-embolization for hepatocellular carcinoma.
Neoplasms
Extragonadal germ cell tumor in the retrovesical region associated with Klinefelter's syndrome: a case report and review of the literature.
Neoplasms
Extragonadal germ cell tumor of the prostate associated with Klinefelter's syndrome.
Neoplasms
Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
Neoplasms
Extraneural metastasis of choriocarcinomatous element in pineal germ-cell tumor. Case report.
Neoplasms
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Neoplasms
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Neoplasms
Fabrication of a simple and sensitive QDs-based electrochemiluminescence immunosensor using a nanostructured composite material for the detection of tumor markers alpha-fetoprotein.
Neoplasms
Fabrication of Gold Nanoparticle-Embedded Metal-Organic Framework for Highly Sensitive Surface-Enhanced Raman Scattering Detection.
Neoplasms
Fabrication of stable antibody-modified field effect transistors using electrical activation of Schiff base cross-linkages for tumor marker detection.
Neoplasms
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Neoplasms
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Neoplasms
Factors Associated With Ovarian Preservation in Children and Adolescents With Primary Tumors of Ovary.
Neoplasms
Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
Neoplasms
Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.
Neoplasms
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
Neoplasms
Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.
Neoplasms
False elevation of human chorionic gonadotropin in a patient with testicular cancer.
Neoplasms
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
Neoplasms
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Neoplasms
Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
Neoplasms
Favorable outcome in children with Beckwith-Wiedemann syndrome and intraabdominal malignant tumors.
Neoplasms
Feasibility and diagnostic impact of fluorescence-based diagnostic laparoscopy in hepatocellular carcinoma: a case report.
Neoplasms
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma.
Neoplasms
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.
Neoplasms
Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence.
Neoplasms
Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Neoplasms
Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Neoplasms
Fine needle aspiration diagnosis of necrotizing eosinophilic abscess clinically mimicking hepatic neoplasia: a case report.
Neoplasms
Fine-needle aspiration biopsy of hepatic angiosarcoma: report of a case with immunocytochemical findings.
Neoplasms
Fine-needle aspiration cytology of pulmonary adenocarcinoma of fetal type: report of a case with immunohistochemical and ultrastructural studies.
Neoplasms
First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients.
Neoplasms
Focal nodular hyperplasia masquerading as malignancy in an infant with elevated alpha-fetoprotein: A case report with literature review.
Neoplasms
Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.
Neoplasms
Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time.
Neoplasms
Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
Neoplasms
Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.
Neoplasms
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.
Neoplasms
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
Neoplasms
GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Neoplasms
Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, CEA and alpha-fetoprotein.
Neoplasms
Gallium-67-citrate scanning in primary cancer of the liver: diagnostic value in the presence of cirrhosis and relation to alpha-fetoprotein.
Neoplasms
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Neoplasms
Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.
Neoplasms
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Neoplasms
Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
Neoplasms
Generalized intraperitoneal seeding of hepatocellular carcinoma after microwave coagulation therapy: a case report.
Neoplasms
Genetic correction improves prediction efficiency of serum tumor biomarkers on digestive cancer risk in the elderly Chinese cohort study.
Neoplasms
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
Neoplasms
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
Neoplasms
Germ cell neoplasms of head and neck soft tissues: a pathologic spectrum of teratomatous and endodermal sinus tumors.
Neoplasms
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Neoplasms
Germ cell tumor in the basal ganglia: immunohistochemical demonstration of alpha-fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen.
Neoplasms
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Neoplasms
Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
Neoplasms
Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.
Neoplasms
Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
Neoplasms
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Neoplasms
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Neoplasms
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Neoplasms
Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Neoplasms
Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection.
Neoplasms
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.
Neoplasms
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
Neoplasms
Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
Neoplasms
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
Neoplasms
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Neoplasms
Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Neoplasms
Growth inhibition of estrogen-sensitive tumor cells in newborn rats. Probable role of alpha-fetoprotein.
Neoplasms
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications.
Neoplasms
Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
Neoplasms
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Neoplasms
Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells.
Neoplasms
H1(0) histones of normal and cancer human cells. Amino acid composition of H1 purified by polyacrylamide gel electrophoresis.
Neoplasms
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Neoplasms
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Neoplasms
Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.
Neoplasms
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
Neoplasms
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
Neoplasms
Hepatic Epithelioid Hemangioendothelioma as a Rare Indication for Liver Transplantation.
Neoplasms
Hepatic Epithelioid Hemangioendothelioma Presenting Synchronously with Hepatocellular Carcinoma.
Neoplasms
Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report.
Neoplasms
Hepatic mesenchymal hamartoma combined with infantile hepatic hemangioendothelioma in an infant.
Neoplasms
Hepatic perfusion index: a new and useful factor in predicting survival among patients with hepatocellular carcinoma.
Neoplasms
Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.
Neoplasms
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.
Neoplasms
Hepatic Resection Is Associated With Improved Long-Term Survival Compared to Radio-Frequency Ablation in Patients With Multifocal Hepatocellular Carcinoma.
Neoplasms
Hepatic resection is not enough for hepatocellular carcinoma. A follow-up study of 92 patients.
Neoplasms
Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary.
Neoplasms
Hepatitis B surface antigen and alpha-fetoprotein secreting human primary liver cell cancer in athymic mice.
Neoplasms
Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression.
Neoplasms
Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
Neoplasms
Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis.
Neoplasms
Hepatoblastoma presenting as isosexual precocity. The clinical importance of histologic and serologic parameters.
Neoplasms
Hepatoblastoma with pure fetal epithelial differentiation in a 10-year-old boy: A rare case report and review of the literature.
Neoplasms
Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
Neoplasms
Hepatocellular Carcinoma and High Grade Neuroendocrine Carcinoma: A Case Report and Review of the Literature.
Neoplasms
Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
Neoplasms
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Neoplasms
Hepatocellular carcinoma complicating biliary cirrhosis caused by biliary atresia: report of a case.
Neoplasms
Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
Neoplasms
Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis.
Neoplasms
Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Neoplasms
Hepatocellular carcinoma in patients with autoimmune liver diseases: two case reports and literature review.
Neoplasms
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Neoplasms
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Neoplasms
Hepatocellular carcinoma in the noncirrhotic liver: Clinical features and outcomes in Veracruz, Mexico.
Neoplasms
Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Neoplasms
Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Neoplasms
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Neoplasms
Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation.
Neoplasms
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
Neoplasms
Hepatocellular Carcinoma that Relapsed 54 Months after Living Donor Liver Transplantation.
Neoplasms
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Neoplasms
Hepatocellular carcinoma with peritoneal dissemination which was regressed during vitamin K2 and vitamin E administration.
Neoplasms
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
Neoplasms
Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients.
Neoplasms
Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Neoplasms
Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
Neoplasms
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Neoplasms
Hepatocyte nuclear factor 1? is a novel prognostic marker independent of the milan criteria in transplantable hepatocellular carcinoma: A retrospective analysis based on tissue microarrays.
Neoplasms
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Neoplasms
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Neoplasms
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.
Neoplasms
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
Neoplasms
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Neoplasms
Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor.
Neoplasms
Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis.
Neoplasms
Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.
Neoplasms
Hepatoid adenocarcinoma of the stomach with liver metastasis mimicking hepatocellular carcinoma: a case report.
Neoplasms
Hepatoid adenocarcinoma of the stomach: Thirteen case reports and review of literature.
Neoplasms
Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
Neoplasms
Hepatoid adenocarcinoma: computed tomographic imaging findings with histopathologic correlation in 6 cases.
Neoplasms
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Neoplasms
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Neoplasms
Hepatoid carcinoma of the pancreas penetrating into the gastric cavity: a case report and literature review.
Neoplasms
Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma.
Neoplasms
Hepatoid carcinoma of the stomach: is it still an unusual anatomo-clinical entity? Six cases-report.
Neoplasms
Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case.
Neoplasms
Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases.
Neoplasms
Hepatoid yolk sac tumors of the mediastinum: a clinicopathologic and immunohistochemical study of four cases.
Neoplasms
Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Neoplasms
Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.
Neoplasms
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Neoplasms
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
Neoplasms
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016.
Neoplasms
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Neoplasms
High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Neoplasms
High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma.
Neoplasms
High Hepatitis B Viral Load Predicts Recurrence of Small Hepatocellular Carcinoma after Curative Resection.
Neoplasms
High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Neoplasms
High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma.
Neoplasms
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.
Neoplasms
High-efficient expression, refolding and purification of functional recombinant C-terminal fragment of human alpha-fetoprotein.
Neoplasms
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Neoplasms
Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer.
Neoplasms
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Neoplasms
Highly sensitive, label-free and real-time detection of alpha-fetoprotein using a silicon nanowire biosensor.
Neoplasms
Histochemical studies of dense-core granulated tumors of the lung. Neuron-specific enolase as a marker for granulated cells.
Neoplasms
Histologic Grade and Mitotic Index as Predictors of Microvascular Invasion in Hepatocellular Carcinoma.
Neoplasms
Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.
Neoplasms
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Neoplasms
HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study.
Neoplasms
Hodgkin's disease--a histochemical study with special emphasis on the character of Hodgkin's cell and Reed-Sternberg cell.
Neoplasms
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Neoplasms
Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFP-L3).
Neoplasms
Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors.
Neoplasms
Human CD4+ T Cells Recognize an Epitope within {alpha}-Fetoprotein Sequence and Develop into TGF-{beta}-Producing CD4+ T Cells.
Neoplasms
Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.
Neoplasms
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Neoplasms
Human chorionic gonadotropin and alpha-fetoprotein in cholangiocarcinoma in relation to the expression of ras p21: an immunohistochemical study.
Neoplasms
Human chorionic gonadotropin and alpha-fetoprotein in sera and tumor cells of a patient with pure dysgerminoma of the ovary. A case report with radio-immunoassay and immunoperoxidase.
Neoplasms
Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
Neoplasms
Human endodermal sinus tumour in nude mice and its markers for diagnosis and management.
Neoplasms
Human fetal and tumor alpha-fetoproteins differ in conformationally dependent epitope variants expression.
Neoplasms
Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration.
Neoplasms
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Neoplasms
Human mammary tumor cell proliferation: primary role of platelet-derived growth factor and possible synergism with human alpha-fetoprotein.
Neoplasms
Human seminal plasma analysis of five tumor markers: CA 125, alpha-fetoprotein, CA 50, CA 19.9, and CA 195.
Neoplasms
HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
Neoplasms
Hyaline globules and papillary fragments in cytologic smears from two intra-abdominal tumors (ovarian and hepatic) in female patients: A diagnostic pitfall with histologic correlation.
Neoplasms
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Neoplasms
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Neoplasms
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.
Neoplasms
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
Neoplasms
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Neoplasms
Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.
Neoplasms
Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.
Neoplasms
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Neoplasms
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Neoplasms
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Neoplasms
Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group.
Neoplasms
Immune monitoring of surgical colorectal malignancies through carcinoembryonic antigen and alpha-fetoprotein serum levels, flow-cytometric blood lymphocyte phenotyping and tumor DNA analysis.
Neoplasms
Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Neoplasms
Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
Neoplasms
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Neoplasms
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary.
Neoplasms
Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
Neoplasms
Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors.
Neoplasms
Immunodevice for simultaneous detection of two relevant tumor markers based on separation of different microparticles by dielectrophoresis.
Neoplasms
Immunofluorescent demonstration of alpha- fetoprotein and other plasma proteins in yolk sac tumor.
Neoplasms
Immunofluorescent localization of alpha-fetoprotein synthesis in endodermal sinus tumor (yolk sac tumor).
Neoplasms
Immunohistochemical and affinity electrophoretic studies of alpha-fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space.
Neoplasms
Immunohistochemical and ultrastructural study on erythropoiesis in hepatoblastoma.
Neoplasms
Immunohistochemical demonstration of alpha-fetoprotein in testicular germ cell tumors.
Neoplasms
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Neoplasms
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Neoplasms
Immunohistochemical differentiation of yolk sac-type alpha-fetoprotein from hepatic-type alpha-fetoprotein.
Neoplasms
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Neoplasms
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Neoplasms
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Neoplasms
Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
Neoplasms
Immunohistochemical study of P53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases.
Neoplasms
Immunohistochemical type distinction of alpha-fetoprotein in various alpha-fetoprotein-secreting tumors.
Neoplasms
Immunohistochemistry of ovarian granulosa cell tumours. The value of tissue specific proteins and tumour markers.
Neoplasms
Immunoradioautography test for alpha-fetoprotein in the differential diagnosis of germinogenic tumours of the testis and in the evaluation of effectiveness of their treatment.
Neoplasms
Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume.
Neoplasms
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience.
Neoplasms
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Neoplasms
Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B.
Neoplasms
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Neoplasms
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.
Neoplasms
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Neoplasms
Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
Neoplasms
Impairment of Spermatogenesis in Rats by Mercuric Chloride: Involvement of Low 17beta-Estradiol Level in Induction of Acute Oxidative Stress.
Neoplasms
Importance of achieving complete necrosis during the first treatment for hepatocellular carcinoma to prevent bone metastasis: a prospective study.
Neoplasms
Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.
Neoplasms
Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
Neoplasms
Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass.
Neoplasms
In silico and in vivo characterization of cabralealactone, solasodin and salvadorin in a rat model: potential anti-inflammatory agents.
Neoplasms
Inappropriate practice in tumor marker requests at a university hospital in Western Saudi Arabia: A 3-year retrospective study.
Neoplasms
Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000.
Neoplasms
Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study.
Neoplasms
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
Neoplasms
Increase of serum beta2-microglobulin in patients affected by HCV correlated hepatocellular carcinoma.
Neoplasms
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Neoplasms
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
Neoplasms
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Neoplasms
Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma.
Neoplasms
Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
Neoplasms
Increased serum levels of monosialo-alpha-fetoprotein in hepatocellular carcinoma and other malignancies.
Neoplasms
Increased Serum Levels of Trypsin Inhibitor Kazal1 in Patients with HBV-Related Hepatocellular Carcinoma Predict a Poor Prognosis.
Neoplasms
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Neoplasms
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Neoplasms
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.
Neoplasms
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Neoplasms
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Neoplasms
Infantile hemangioendothelioma of the liver: ultrastructural study of a type II case.
Neoplasms
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
Neoplasms
Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome.
Neoplasms
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Neoplasms
Inflammatory pseudotumor of the liver masquerading as hepatocellular carcinoma after a hepatitis B virus infection: Report of a case.
Neoplasms
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Neoplasms
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
Neoplasms
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells.
Neoplasms
Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.
Neoplasms
Inhibition of normal allogenic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma.
Neoplasms
Inhibition of rat hepatocellular carcinoma tumor growth after multiple infusions of recombinant Ad.AFPtk followed by ganciclovir treatment.
Neoplasms
Inhibitory Effect of Nelumbo nucifera Leaf Extract on 2-Acetylaminofluorene-induced Hepatocarcinogenesis Through Enhancing Antioxidative Potential and Alleviating Inflammation in Rats.
Neoplasms
Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
Neoplasms
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Neoplasms
Integrated microfluidic device for serum biomarker quantitation using either standard addition or a calibration curve.
Neoplasms
Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Neoplasms
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Neoplasms
Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Neoplasms
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.
Neoplasms
Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Neoplasms
Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
Neoplasms
Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol.
Neoplasms
Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma.
Neoplasms
Interstitial deletion of the long arm of chromosome 4 [del(4)(q21.22q23)] and a liver tumor.
Neoplasms
Intra arterial treatment of hepatocellular carcinoma: Comparison of MELD score variations between radio-embolization and chemo-embolization.
Neoplasms
Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants.
Neoplasms
Intraarterial injection of anti-tumor drugs dispersed in lipid contrast medium: a choice for initially unresectable hepatoblastoma in infants.
Neoplasms
Intracranial germ cell tumours. A review with special reference to endocrine manifestations.
Neoplasms
Intracranial multiple midline germinomas: is histological verification crucial for therapy?
Neoplasms
Intrahepatic arterial injections of cisplatin-phosphatidylcholine-Lipiodol suspension in two unresectable hepatoblastoma cases.
Neoplasms
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
Neoplasms
Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. A clinicopathologic study.
Neoplasms
Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors.
Neoplasms
Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Neoplasms
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.
Neoplasms
Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
Neoplasms
Investigation of Alpha-Fetoprotein Antibody Modified Fluorescent Magnetic Probe on HepG? Cell and Cancer Model Mouse.
Neoplasms
Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
Neoplasms
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Neoplasms
Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Neoplasms
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Neoplasms
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Neoplasms
Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?
Neoplasms
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
Neoplasms
Is laparatomy the first step in treatment of childhood liver tumors?--The experience from the German Cooperative Pediatric Liver Tumor Study HB-89.
Neoplasms
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.
Neoplasms
Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.
Neoplasms
Juvenile Granulosa Cell Tumor of the Testicle - Report of a Neonatal Case with Positive Alpha-fetoprotein Immunohistochemical Staining.
Neoplasms
Juvenile granulosa cell tumor of the testis:: contemporary clinical management and pathological diagnosis.
Neoplasms
Juvenile granulosa cell tumour with hepatocyte-like cells and raised serum alpha-fetoprotein.
Neoplasms
KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases.
Neoplasms
Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen.
Neoplasms
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
Neoplasms
Krukenberg tumor with concomitant ipsilateral hydronephrosis and spermatic cord metastasis in a man: A case report.
Neoplasms
Label-free immunosensing for alpha-fetoprotein in human plasma using surface plasmon resonance.
Neoplasms
Label-free immunosensor based on Pd nanoplates for amperometric immunoassay of alpha-fetoprotein.
Neoplasms
Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Neoplasms
Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Neoplasms
Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy.
Neoplasms
Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma.
Neoplasms
Large acinar cell carcinoma of the pancreas in a patient with elevated serum AFP level.
Neoplasms
Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene.
Neoplasms
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
Neoplasms
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Neoplasms
Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.
Neoplasms
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications.
Neoplasms
Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers.
Neoplasms
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Neoplasms
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Neoplasms
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Neoplasms
Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.
Neoplasms
Letter: Comparison of plasma carcinoembryonic antigen and alpha-fetoprotein in various tumours.
Neoplasms
Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states.
Neoplasms
Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.
Neoplasms
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival.
Neoplasms
Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity.
Neoplasms
Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis.
Neoplasms
Lipopolysaccharide Enhances Beta2-Glycoprotein I Activation of Nuclear Factor ?B in Liver Cancer Cells.
Neoplasms
Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Neoplasms
Liver resection associated with better outcomes for single large hepatocellular carcinoma located in the same section.
Neoplasms
Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries.
Neoplasms
Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.
Neoplasms
Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
Neoplasms
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Neoplasms
Liver transplantation for biliary atresia associated with malignant hepatic tumors.
Neoplasms
Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?
Neoplasms
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Neoplasms
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.
Neoplasms
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Neoplasms
Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.
Neoplasms
Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
Neoplasms
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
Neoplasms
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
Neoplasms
Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.
Neoplasms
Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors.
Neoplasms
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Neoplasms
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
Neoplasms
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Neoplasms
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China.
Neoplasms
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Neoplasms
Living donor liver transplantation for a child with recurrent pediatric adult-type hepatocellular carcinoma.
Neoplasms
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.
Neoplasms
Living donor liver transplantation in a pediatric patient with preexisting yolk sac tumor.
Neoplasms
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
Neoplasms
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p.
Neoplasms
Local tumor control of thoracoabdominal wall seeding tumor from hepatocellular carcinoma with ultrasound-guided interventional treatment: A summarized study.
Neoplasms
Localisation of malignant germ-cell tumours by external scanning after injection of radiolabelled anti-alpha-fetoprotein.
Neoplasms
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Neoplasms
Localization of alpha-fetoprotein by immunofluorescent method during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
Neoplasms
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?
Neoplasms
Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Neoplasms
Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Neoplasms
Long-term functional outcome of sacrococcygeal teratoma in a UK regional center (1993 to 2006).
Neoplasms
Long-term impact of a restrictive laboratory test ordering form on tumor marker prescriptions.
Neoplasms
Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment.
Neoplasms
Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source.
Neoplasms
Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma.
Neoplasms
Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Neoplasms
Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy.
Neoplasms
Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy.
Neoplasms
Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients.
Neoplasms
Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study.
Neoplasms
Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Neoplasms
Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma.
Neoplasms
Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9.
Neoplasms
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Neoplasms
Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
Neoplasms
Low cyclin F expression in hepatocellular carcinoma associates with poor differentiation and unfavorable prognosis.
Neoplasms
Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
Neoplasms
Low metallothionein 1M expression association with poor hepatocellular carcinoma prognosis after curative resection.
Neoplasms
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.
Neoplasms
Lymphoepithelioma-like hepatocellular carcinoma without Epstein-Barr virus infection: A case report and a review of the literature.
Neoplasms
Lymphoid hyperplasia detected as a single mass in the gallbladder: report of a case.
Neoplasms
Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
Neoplasms
Machine Learning Can Predict Total Death After Radiofrequency Ablation in Liver Cancer Patients.
Neoplasms
Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection.
Neoplasms
Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Neoplasms
Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.
Neoplasms
Malignant hepatic tumor occurring 10 yrs after a histocompatible sibling donor bone marrow transplantation for severe aplastic anemia.
Neoplasms
Malignant müllerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor.
Neoplasms
Malignant mixed Mullerian tumor of the uterine corpus with alpha-fetoprotein-producing hepatoid adenocarcinoma component.
Neoplasms
Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
Neoplasms
Malignant ovarian germ cell tumours: experience in the National University Hospital of Singapore.
Neoplasms
Malignant sacrococcygeal germ cell tumors in childhood: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
Neoplasms
Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series.
Neoplasms
Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
Neoplasms
Management of advanced endodermal sinus tumor of the ovary with preservation of reproductive function.
Neoplasms
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Neoplasms
Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Neoplasms
Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
Neoplasms
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Neoplasms
Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
Neoplasms
Matrix metalloproteinase 12 expression is associated with tumor FOXP3+ regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma.
Neoplasms
Mature and immature extracranial teratomas in children: the UK Children's Cancer Study Group Experience.
Neoplasms
Mature teratoma of the pineal region in the paediatric age group: A case report and review of the literature.
Neoplasms
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Neoplasms
Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects.
Neoplasms
Mediastinal growing teratoma syndrome succesfully treated by multiple modality therapies.
Neoplasms
Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome.
Neoplasms
Mediastinal yolk sac tumors associated with prominent multilocular cystic changes of thymic epithelium: a clinicopathologic and immunohistochemical study of five cases.
Neoplasms
Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.
Neoplasms
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms.
Neoplasms
Metastatic hepatocellular carcinoma of the breast, simulating gynecomastia: diagnosis by fine-needle aspiration biopsy.
Neoplasms
Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens.
Neoplasms
Metastatic neuroendocrine carcinoma presenting as multifocal liver lesions with elevated alpha-fetoprotein.
Neoplasms
Metastatic pancreatic acinar cell carcinoma in a younger male with marked AFP production: A potential pitfall on fine needle aspiration biopsy.
Neoplasms
Metastatic Recurrent Hepatocellular Carcinoma Post Liver Transplant With Marked Pretransplant Elevation of Alpha Fetoprotein and No Evidence of Primary Neoplasm.
Neoplasms
Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Neoplasms
Microchip-based multiplex electro-immunosensing system for the detection of cancer biomarkers.
Neoplasms
MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
Neoplasms
MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
Neoplasms
MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Neoplasms
microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.
Neoplasms
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Neoplasms
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Neoplasms
Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma.
Neoplasms
Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.
Neoplasms
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Neoplasms
Microvascular invasion of single small hepatocellular carcinoma ?3 cm: Predictors and optimal treatments.
Neoplasms
Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
Neoplasms
Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps.
Neoplasms
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Neoplasms
miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma.
Neoplasms
Misleading leads: don't assume an alpha-fetoprotein secreting tumour is of germ cell or hepatic origin.
Neoplasms
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Neoplasms
Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach.
Neoplasms
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Neoplasms
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.
Neoplasms
Monocyte chemotaxis in patients with nonseminomatous testicular carcinoma. Effect of chemotherapy.
Neoplasms
Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
Neoplasms
Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
Neoplasms
Mouse hepatoblastomas: a histologic, ultrastructural, and immunohistochemical study.
Neoplasms
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
Neoplasms
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Neoplasms
Multidisciplinary treatment in children with non-metastatic hepatoblastoma: treatment results at the National Cancer Institute, Cairo University.
Neoplasms
Multifunctional nanocatalyst-based ultrasensitive detection of human tissue transglutaminase 2.
Neoplasms
Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker.
Neoplasms
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center.
Neoplasms
Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Neoplasms
Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
Neoplasms
Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene asconductingbridge.
Neoplasms
Multiplexed determination of protein biomarkers using metal-tagged antibodies and size exclusion chromatography--inductively coupled plasma mass spectrometry.
Neoplasms
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
Neoplasms
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases.
Neoplasms
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Neoplasms
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.
Neoplasms
Nanobody medicated immunoassay for ultrasensitive detection of cancer biomarker alpha-fetoprotein.
Neoplasms
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Neoplasms
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
Neoplasms
Necrotic Hepatocellular Carcinoma Occurring within an Inflammatory Pseudotumor-like Nodule.
Neoplasms
Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre.
Neoplasms
Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma.
Neoplasms
Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma.
Neoplasms
Neonatal hepatoblastoma in a newborn with severe phenotype of Beckwith-Wiedemann syndrome.
Neoplasms
Neuroendoscopic anatomy and surgery in pineal region tumors: role of neuroendoscopic procedure in the 'minimally-invasive preferential' management.
Neoplasms
Neurohypophyseal granulomatous germinoma invading the right cavernous sinus: case report and review of the literature.
Neoplasms
Neutrophil-to-Lymphocyte Ratio Predicts High-Risk Explant Features and Waitlist Survival But Is Not Independently Associated With Recurrence or Survival Following Liver Transplantation for Hepatocellular Carcinoma.
Neoplasms
NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
Neoplasms
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
Neoplasms
Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
Neoplasms
Nimesulide-induced fatal acute liver failure in an elderly woman with metastatic biliary adenocarcinoma. A case report.
Neoplasms
Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinoma.
Neoplasms
No association exists between E-cadherin gene polymorphism and tumor recurrence in patients with hepatocellular carcinoma after transplantation.
Neoplasms
No evidence for post-transcriptional control of albumin and alpha-fetoprotein gene expression in developing rat liver neoplasia.
Neoplasms
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5?cm.
Neoplasms
Nodal gliomatosis and alpha-fetoprotein production. Two unusual facets of grade I ovarian teratoma.
Neoplasms
Nodular hepatocellular carcinoma. Treatment with subsegmental intraarterial injection of iodine 131-labeled iodized oil.
Neoplasms
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
Neoplasms
Nomogram Based on Systemic Immune Inflammation Index and Prognostic Nutrition Index Predicts Recurrence of Hepatocellular Carcinoma After Surgery.
Neoplasms
Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Neoplasms
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
Neoplasms
Non-tumoral elevation of alpha-fetoprotein (AFP): a 10 year follow-up in two subjects.
Neoplasms
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Neoplasms
Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Neoplasms
Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
Neoplasms
Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Neoplasms
Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
Neoplasms
Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study.
Neoplasms
Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer.
Neoplasms
Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study.
Neoplasms
Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer.
Neoplasms
Occurrence of Vascular Lake Phenomenon as a Predictor of Improved Tumor Response in HCC Patients That Underwent DEB-TACE.
Neoplasms
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Neoplasms
Oncocytic biliary cystadenocarcinoma: a case report and review of the literature.
Neoplasms
Oncodevelopmental alpha-fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit.
Neoplasms
Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L.
Neoplasms
Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma.
Neoplasms
Optimal tailored screening protocol after living donor liver transplantation for hepatocellular carcinoma.
Neoplasms
Optoelectrofluidic sandwich immunoassays for detection of human tumor marker using surface-enhanced Raman scattering.
Neoplasms
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.
Neoplasms
Orthotopic Liver Transplantation After Stereotactic Body Radiotherapy for Pediatric Hepatocellular Carcinoma with Central Biliary Obstruction and Nodal Involvement.
Neoplasms
Outcome after curative resection for a huge (>/=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification.
Neoplasms
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Neoplasms
Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.
Neoplasms
Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma.
Neoplasms
Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation.
Neoplasms
Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Neoplasms
Ovarian clear cell carcinoma associated with endometriosis: a case report with immunohistochemical study.
Neoplasms
Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Neoplasms
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Neoplasms
Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Neoplasms
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Neoplasms
Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
Neoplasms
Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
Neoplasms
Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Neoplasms
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Neoplasms
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Neoplasms
Ovarian yolk sac tumor with virilization during pregnancy: immunohistochemical demonstration of Leydig cells as functioning stroma.
Neoplasms
Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Neoplasms
Overexpression of centromere protein K (CENP-K) gene in hepatocellular carcinoma promote cell proliferation by activating AKT/TP53 signal pathway.
Neoplasms
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
Neoplasms
Overexpression of lncRNA MT1JP Mediates Apoptosis and Migration of Hepatocellular Carcinoma Cells by Regulating miR-24-3p.
Neoplasms
Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Neoplasms
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Neoplasms
Overexpression of p53 in hepatocellular carcinomas: a clinicopathological and prognostic correlation.
Neoplasms
Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma.
Neoplasms
Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
Neoplasms
p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo.
Neoplasms
Paclitaxel: an effective antineoplastic agent in the treatment of xenotransplanted hepatoblastoma.
Neoplasms
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Neoplasms
Paper-based colorimetric spot test utilizing smartphone sensing for detection of biomarkers.
Neoplasms
PARP-1 serves as a novel molecular marker for hepatocellular carcinoma in a Southern Chinese Zhuang population.
Neoplasms
Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report.
Neoplasms
Pathobiology of intracranial germ-cell tumors: immunochemical, immunohistochemical, and electron microscopic investigations.
Neoplasms
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of response.
Neoplasms
Pathologic features and patient survival in hepatocellular carcinoma in relation to age.
Neoplasms
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma.
Neoplasms
Patient-derived xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.
Neoplasms
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Neoplasms
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation.
Neoplasms
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Neoplasms
Pediatric HBsAg chronic liver disease and adult asymptomatic carrier status: two stages of the same entity.
Neoplasms
Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
Neoplasms
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Neoplasms
Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma.
Neoplasms
Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.
Neoplasms
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.
Neoplasms
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver.
Neoplasms
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
Neoplasms
Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
Neoplasms
Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Neoplasms
Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
Neoplasms
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
Neoplasms
Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Neoplasms
Peritoneal implantation of endodermal sinus tumor of the pineal region via a ventriculoperitoneal shunt. Cytodiagnosis with immunocytochemical demonstration of alpha-fetoprotein.
Neoplasms
Periventricular metastases of a primary intracranial alpha-fetoprotein-producing germ cell tumor.
Neoplasms
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Neoplasms
Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
Neoplasms
Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.
Neoplasms
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Neoplasms
Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma.
Neoplasms
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Neoplasms
Plasma B-cell activating factor levels and polymorphisms in hepatitis B-related hepatocellular carcinoma: Clinical correlation and prognosis.
Neoplasms
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Neoplasms
Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.
Neoplasms
Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Neoplasms
Plasma nitrite/nitrate concentrations as a tumor marker for hepatocellular carcinoma.
Neoplasms
Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Neoplasms
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Neoplasms
Poorly differentiated hepatocellular carcinoma accompanied by anti-Hu antibody-positive paraneoplastic peripheral neuropathy.
Neoplasms
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal Liver.
Neoplasms
Population-level utilization of anatomic resection in early hepatocellular carcinoma (?5 cm): post-operative, middle- and long-term outcomes.
Neoplasms
Positive feedback loop of AKR1B10P1/miR-138/SOX4 promotes cell growth in hepatocellular carcinoma cells.
Neoplasms
Possible common origin of alpha-fetoprotein- and human chorionic gonadotropin--secreting cells in intracranial germ cell tumor. Case report.
Neoplasms
Post-operative blood tests and multicentric recurrence of hepatocellular carcinoma.
Neoplasms
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Neoplasms
Postchemotherapy sarcoma as a somatic-type malignancy derived from the gonadal yolk sac tumor in a patient with 46, XY pure gonadal dysgenesis.
Neoplasms
Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis.
Neoplasms
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.
Neoplasms
Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Neoplasms
Postoperative Transarterial Chemoembolization Benefits Patients with High ?-Glutamyl Transferase Levels after Curative Hepatectomy for Hepatocellular Carcinoma: A Survival Stratification Analysis.
Neoplasms
Potential function of amniotic fluid in fetal development---novel insights by comparing the composition of human amniotic fluid with umbilical cord and maternal serum at mid and late gestation.
Neoplasms
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area.
Neoplasms
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Neoplasms
Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.
Neoplasms
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Neoplasms
Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.
Neoplasms
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.
Neoplasms
Predicting survival time of Korean hepatocellular carcinoma patients using the Cox proportional hazards model: a retrospective study based on big data analysis.
Neoplasms
Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin.
Neoplasms
Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images.
Neoplasms
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
Neoplasms
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Neoplasms
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Neoplasms
Prediction of Tumor Recurrence by 18F-FDG PET in Liver Transplantation for Hepatocellular Carcinoma.
Neoplasms
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Neoplasms
Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.
Neoplasms
Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Neoplasms
Predictive factors for the histologic nature of residual tumor mass after chemotherapy in patients with advanced testicular cancer.
Neoplasms
Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis.
Neoplasms
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies.
Neoplasms
Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Neoplasms
Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE).
Neoplasms
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Neoplasms
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Neoplasms
Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.
Neoplasms
Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
Neoplasms
Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.
Neoplasms
Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Neoplasms
Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Neoplasms
Predictors of tumor-free survival after liver transplant in patient with hepatocellular carcinoma.
Neoplasms
Pregnancy following treatment of endodermal sinus tumor of the ovary with combination chemotherapy, including cis-platinum.
Neoplasms
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Neoplasms
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.
Neoplasms
Preoperative Albumin-to-Globulin Ratio Predicts Prognosis in Hepatocellular Carcinoma: A Cohort Study Including Non-Hepatitis Virus-Infected Patients.
Neoplasms
Preoperative Alpha-Fetoprotein Has No Prognostic Role in Small Hepatocellular Carcinoma in Non-Cirrhotic Patients After Surgical Resection.
Neoplasms
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Neoplasms
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Neoplasms
Preoperative Assessment for Event-Free Survival With Hepatoblastoma in Pediatric Patients by Developing a CT-Based Radiomics Model.
Neoplasms
Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Neoplasms
Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.
Neoplasms
Preoperative investigation and indication for operation in hepatocellular carcinoma.
Neoplasms
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Neoplasms
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study.
Neoplasms
Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis.
Neoplasms
Preoperative prediction of microvascular invasion of hepatocellular carcinoma using
Neoplasms
Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.
Neoplasms
Preoperative predictors of survival after resection of small hepatocellular carcinomas.
Neoplasms
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
Neoplasms
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
Neoplasms
Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation.
Neoplasms
Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
Neoplasms
Presacral epidermal cyst found in an adult male with a high CEA content: report of an unusual case.
Neoplasms
Presence of alpha-1-antitrypsin in pancreatic carcinoma. Report of four cases in association with hepatic storage of the protease inhibitor.
Neoplasms
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Neoplasms
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Neoplasms
Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.
Neoplasms
Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Neoplasms
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.
Neoplasms
Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine.
Neoplasms
Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.
Neoplasms
Primary culture of liver cancer tissues with or without transcatheter arterial embolization and establishment of a cell strain.
Neoplasms
Primary extragonadal germ cell tumors of the retroperitoneum: differentiation of primary and secondary tumors.
Neoplasms
Primary focal T-cell lymphoma of the liver: a case report and review of the literature.
Neoplasms
Primary gastric choriocarcinoma. Report of an autopsy case with immunohistochemical study.
Neoplasms
Primary hepatic lymphoma diagnosed using endoscopic ultrasound-guided liver biopsy: a case report.
Neoplasms
Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
Neoplasms
Primary Hepatic Lymphoma Mimicking a Hepatocellular Carcinoma in a Cirrhotic Patient: Case Report and Systematic Review of the Literature.
Neoplasms
Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature.
Neoplasms
Primary intracranial yolk sac tumor: immunofluorescent demonstration of alpha-fetoprotein synthesis.
Neoplasms
Primary intratesticular rhabdomyosarcoma in children: a case report and review of the literature.
Neoplasms
Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology.
Neoplasms
Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
Neoplasms
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Neoplasms
Primary neuroendocrine carcinoma coexisting with hemangioma in the liver: report of a case.
Neoplasms
Primary neuroendocrine tumor of the testis: a study of clinicopathological features.
Neoplasms
Primary pulmonary hepatoid adenocarcinoma: A case report and review of the literature.
Neoplasms
Primary vs metastatic hepatic carcinoma. An immunohistochemical study of 34 cases.
Neoplasms
Primary yolk sac tumor concomitant with carcinosarcoma originating from the endometrium: Case report.
Neoplasms
Primary yolk sac tumor of the endometrium: a case report and review of the literature.
Neoplasms
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Neoplasms
Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case.
Neoplasms
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis.
Neoplasms
Production of 13 plasma proteins by human testicular yolk sac tumor transplanted into nude mice.
Neoplasms
Production of immunoreactive calcitonin and some other tumor markers by established human carcinoma cell lines.
Neoplasms
Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapy.
Neoplasms
Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment.
Neoplasms
Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients.
Neoplasms
Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Neoplasms
Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Neoplasms
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma.
Neoplasms
Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Neoplasms
Prognostic and clinicopathological significance of hypoxia-inducible factors 1? and 2? in hepatocellular carcinoma: a systematic review with meta-analysis.
Neoplasms
Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Neoplasms
Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Neoplasms
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.
Neoplasms
Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Neoplasms
Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
Neoplasms
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.
Neoplasms
Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma.
Neoplasms
Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation.
Neoplasms
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma.
Neoplasms
Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy.
Neoplasms
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
Neoplasms
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Neoplasms
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival.
Neoplasms
Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
Neoplasms
Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases.
Neoplasms
Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients.
Neoplasms
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Neoplasms
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Neoplasms
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Neoplasms
Prognostic Impact of Alpha Fetoprotein at Diagnosis on Overall Survival of Single Small Hepatocellular Carcinomas.
Neoplasms
Prognostic impact of des-?-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Neoplasms
Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
Neoplasms
Prognostic Importance of 18F-FDG Uptake Pattern of Hepatocellular Cancer Patients Who Received SIRT.
Neoplasms
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Neoplasms
Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France.
Neoplasms
Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study.
Neoplasms
Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Neoplasms
Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
Neoplasms
Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
Neoplasms
Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.
Neoplasms
Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.
Neoplasms
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Neoplasms
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.
Neoplasms
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Neoplasms
Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.
Neoplasms
Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
Neoplasms
Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma.
Neoplasms
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.
Neoplasms
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.
Neoplasms
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Neoplasms
Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.
Neoplasms
Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma.
Neoplasms
Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Neoplasms
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Neoplasms
Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.
Neoplasms
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma.
Neoplasms
Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Neoplasms
Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation.
Neoplasms
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Neoplasms
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Neoplasms
Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
Neoplasms
Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation.
Neoplasms
Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
Neoplasms
Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy.
Neoplasms
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Neoplasms
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Neoplasms
Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Neoplasms
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.
Neoplasms
Prolonged survival after repeat resection of pulmonary metastasis from hepatocellular carcinoma.
Neoplasms
Promotion of growth and differentiation of rat ductular oval cells in primary culture.
Neoplasms
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Neoplasms
Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Neoplasms
Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan.
Neoplasms
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Neoplasms
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Neoplasms
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Neoplasms
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery.
Neoplasms
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma.
Neoplasms
Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Neoplasms
Protein composition of cyst fluids from mature teratoma in patients with nonseminomatous germ cell tumors of the testis.
Neoplasms
Proteomic prediction of disease outcome in cancer : clinical framework and current status.
Neoplasms
Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Neoplasms
Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature.
Neoplasms
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Neoplasms
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
Neoplasms
Pure Primary Extragonadal Retroperitoneal Yolk Sac Tumour in a Young Child: A Case Report.
Neoplasms
Pure yolk sac tumors in genital and extragenital sites: study on three pedriatic cases, with cytological findings on two.
Neoplasms
Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells.
Neoplasms
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Neoplasms
Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
Neoplasms
Quantitative, label-free detection of five protein biomarkers using multiplexed arrays of silicon photonic microring resonators.
Neoplasms
Rabbit alpha-fetoprotein: normal levels and breakage tolerance with haptenated homologous alpha-fetoprotein.
Neoplasms
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival.
Neoplasms
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Neoplasms
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Neoplasms
Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
Neoplasms
Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
Neoplasms
Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival.
Neoplasms
Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis.
Neoplasms
Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up.
Neoplasms
Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.
Neoplasms
Radiographic features of hepatocellular carcinoma and their relation to prognosis in Canada.
Neoplasms
Radioimmunoassay of serum alpha-fetoprotein in patients with different maliganant tumors.
Neoplasms
Radioimmunodetection of cancer using antibodies to alpha-fetoprotein and carcinoembryonic antigen.
Neoplasms
Radioimmunodetection of cancers containing carcinoembryonic antigen and alpha-fetoprotein.
Neoplasms
Radioimmunodetection of primary and metastatic germ cell tumors containing alpha-fetoprotein.
Neoplasms
Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary results.
Neoplasms
Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
Neoplasms
Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases.
Neoplasms
Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
Neoplasms
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.
Neoplasms
Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial.
Neoplasms
Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes.
Neoplasms
Raised maternal serum alpha-fetoprotein levels during pregnancy following treatment of an endodermal sinus tumour. Case report.
Neoplasms
Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Neoplasms
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Neoplasms
Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
Neoplasms
Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers.
Neoplasms
Rapid and sensitive lateral flow immunoassay method for determining alpha fetoprotein in serum using europium (III) chelate microparticles-based lateral flow test strips.
Neoplasms
Rapid and simple immunosensing system for simultaneous detection of tumor markers based on negative-dielectrophoretic manipulation of microparticles.
Neoplasms
Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Neoplasms
Rapid progression of hepatocellular carcinoma in a patient with autoimmune hepatitis.
Neoplasms
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Neoplasms
Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C.
Neoplasms
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (? 2 cm, Barcelona stage 0) - assessment with large number of cases.
Neoplasms
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Neoplasms
Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.
Neoplasms
Recombinant alpha-fetoprotein C-terminal fragment: the new recombinant vector for targeted delivery.
Neoplasms
Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report.
Neoplasms
Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
Neoplasms
Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy.
Neoplasms
Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation.
Neoplasms
Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment.
Neoplasms
Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
Neoplasms
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
Neoplasms
Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma.
Neoplasms
Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan.
Neoplasms
Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Neoplasms
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Neoplasms
Regulation of Anti-Tumor Activity Using Monoclonal Antibodies to Alpha-Fetoprotein Receptor and after Immunization with This Protein.
Neoplasms
Reimbursements and frequency of tests in privately insured testicular cancer patients in the United States: Implications to national guidelines.
Neoplasms
Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Neoplasms
Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Neoplasms
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
Neoplasms
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Neoplasms
Relationship between polymorphism of angiotensin-converting enzyme gene insertion/deletion and risk of hepatocellular carcinoma in a Chinese Dai population.
Neoplasms
Relationship Between Serum Tumor-related Markers and Dietary Intakes in Korean Healthy Adults.
Neoplasms
Relationship between the serum CA-125 level and bone mineral density in healthy pre- and post-menopausal women.
Neoplasms
Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
Neoplasms
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Neoplasms
Remission, relapse, and metastasis/death of small hepatocellular carcinoma treated with percutaneous ethanol injection.
Neoplasms
Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Neoplasms
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
Neoplasms
Resection after intraarterial chemotherapy of a hepatoblastoma originating in the caudate lobe.
Neoplasms
Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer.
Neoplasms
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases.
Neoplasms
Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis.
Neoplasms
Residual retroperitoneal mass following chemotherapy for infantile yolk sac tumor.
Neoplasms
Resin versus Glass Microspheres for Yttrium-90 Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma using Pretreatment Partition Model Dosimetry.
Neoplasms
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version).
Neoplasms
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Neoplasms
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Neoplasms
Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa.
Neoplasms
Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
Neoplasms
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
Neoplasms
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Neoplasms
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Neoplasms
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
Neoplasms
Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis.
Neoplasms
Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.
Neoplasms
Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data.
Neoplasms
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Neoplasms
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Neoplasms
Risk factors for early death due to recurrence after resection of large hepatocellular carcinomas.
Neoplasms
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.
Neoplasms
Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Neoplasms
Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma.
Neoplasms
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Neoplasms
Risk factors for intraocular metastasis of primary liver cancer in diabetic patients: Alpha-fetoprotein and cancer antigen 125.
Neoplasms
Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Neoplasms
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Neoplasms
Risk factors of delay in restoration of hepatic reserve capacity and local recurrence after radiofrequency ablation therapy for hepatocellular carcinoma (HCC).
Neoplasms
Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy.
Neoplasms
Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation.
Neoplasms
Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.
Neoplasms
Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein.
Neoplasms
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Neoplasms
Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Neoplasms
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Neoplasms
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Neoplasms
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Neoplasms
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Neoplasms
Role of serum alpha-fetoprotein in pre- and post-orthotopic liver transplantation (OLT) for malignant disease.
Neoplasms
Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Neoplasms
Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
Neoplasms
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Neoplasms
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.
Neoplasms
Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer.
Neoplasms
Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver.
Neoplasms
Schistosoma mansoni infection and the occurrence, characteristics, and survival of patients with hepatocellular carcinoma: an observational study over a decade.
Neoplasms
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.
Neoplasms
Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.
Neoplasms
Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Neoplasms
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Neoplasms
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Neoplasms
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.
Neoplasms
Selection and characterization of a novel affibody peptide and its application in a two-site ELISA for the detection of cancer biomarker alpha-fetoprotein.
Neoplasms
Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit.
Neoplasms
Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation.
Neoplasms
Selective in vitro and in vivo growth inhibition against human yolk sac tumor cell lines by purified antibody against human alpha-fetoprotein conjugated with mitomycin C via human serum albumin.
Neoplasms
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Neoplasms
Self-healing mechanism and bioelectrochemical interface properties of core-shell guanosine-borate hydrogels.
Neoplasms
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Neoplasms
Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma.
Neoplasms
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood.
Neoplasms
Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.
Neoplasms
Sensitive immunosensor for cancer biomarker based on dual signal amplification strategy of graphene sheets and multienzyme functionalized carbon nanospheres.
Neoplasms
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Neoplasms
Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Neoplasms
Separation of circulating cancer cells by unique microfluidic chip in colorectal cancer.
Neoplasms
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Neoplasms
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Neoplasms
Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Neoplasms
Serial serum determination on alpha-fetoprotein as a marker of the effect of postoperative chemotherapy in ovarian endodermal sinus tumor.
Neoplasms
Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
Neoplasms
Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.
Neoplasms
Sertoli-Leydig cell tumor - a rare androgen secreting ovarian tumor in postmenopausal women. Case report and review of literature.
Neoplasms
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Neoplasms
Serum alpha-fetoprotein (AFP) in benign and malignant gastrointestinal diseases: evaluation of an immunoenzymatic assay.
Neoplasms
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Neoplasms
Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour.
Neoplasms
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Neoplasms
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Neoplasms
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Neoplasms
Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Neoplasms
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Neoplasms
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Neoplasms
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Neoplasms
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
Neoplasms
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Neoplasms
Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
Neoplasms
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
Neoplasms
Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
Neoplasms
Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.
Neoplasms
Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Neoplasms
Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Neoplasms
Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
Neoplasms
Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma.
Neoplasms
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Neoplasms
Serum insulin-like growth factor-II as a serologic marker of small hepatocellular carcinoma.
Neoplasms
Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients.
Neoplasms
Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
Neoplasms
Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Neoplasms
Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
Neoplasms
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Neoplasms
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Neoplasms
Serum prolactin, gonadotropins, androgens, estrogens, and gestagens in patients with malignant testicular germ cell tumor.
Neoplasms
Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Neoplasms
Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma.
Neoplasms
Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Neoplasms
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Neoplasms
Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Neoplasms
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Neoplasms
Serum type IV collagen-degrading enzyme in hepatocellular carcinoma with metastasis.
Neoplasms
Serum type-2 macro-creatine kinase isoenzyme is not a useful marker of severe liver diseases or neoplasia.
Neoplasms
Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma.
Neoplasms
Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Neoplasms
Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Neoplasms
Shadows Behind Using Simple Risk Models in Selection of Hepatocellular Carcinoma Patients for Liver Transplantation.
Neoplasms
Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
Neoplasms
Short- and Long-term Outcomes between Young and Older HCC Patients Exceeding The Milan Criteria after Hepatectomy.
Neoplasms
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Neoplasms
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Neoplasms
Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
Neoplasms
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Neoplasms
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Neoplasms
Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Neoplasms
Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Neoplasms
Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
Neoplasms
Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-?/Smad signal pathway in hepatocellular carcinoma.
Neoplasms
SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
Neoplasms
Small hepatocellular carcinoma presenting as intrabiliary pedunculated polyp and obstructive jaundice.
Neoplasms
Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation.
Neoplasms
Somatostatin Receptor in Human Hepatocellular Carcinomas: Biological, Patient and Tumor Characteristics.
Neoplasms
Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma.
Neoplasms
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Neoplasms
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
Neoplasms
Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.
Neoplasms
Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma.
Neoplasms
Specific immunoreaction-induced controlled release strategy for sensitive impedance immunoassay of a cancer marker.
Neoplasms
Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
Neoplasms
Spindle cell tumors resected from male patients with germ cell tumors. A clinicopathologic study of 14 cases.
Neoplasms
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer.
Neoplasms
Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.
Neoplasms
Spontaneous regression of germinoma in the pineal region before endoscopic surgery: a pitfall of modern strategy for pineal germ cell tumors.
Neoplasms
Spontaneous Regression of Hepatocellular Carcinoma due to Disruption of the Feeding Artery.
Neoplasms
Spontaneous rupture of immature gastric teratoma with hemoperitoneum in a newborn with 3-year follow-up.
Neoplasms
Spontaneous rupture of metastatic alpha-fetoprotein-producing gastric cancer of the liver.
Neoplasms
Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Neoplasms
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Neoplasms
Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Neoplasms
Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse.
Neoplasms
Striking differences between the mouse and the human alpha-fetoprotein enhancers.
Neoplasms
STROBE-clinical characteristics and prognosis factors of gastric cancer in young patients aged ?30 years.
Neoplasms
Study of Fe?O?-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients.
Neoplasms
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Neoplasms
Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
Neoplasms
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.
Neoplasms
Submandibular endodermal sinus (yolk sac) tumor in a female infant. A case report.
Neoplasms
Subnormal albumin gene expression is associated with weight loss in immunodeficient/DNA-repair-impaired wasted mice.
Neoplasms
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Neoplasms
Successful Embolization of Hepatocelluar Carcinoma With Yttrium-90 Glass Microspheres Prior to Liver Transplantation.
Neoplasms
Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
Neoplasms
Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.
Neoplasms
Successful surgical management of pulmonary and adrenal metastases from hepatocellular carcinoma.
Neoplasms
Successful therapy of subcutaneously growing human hepatoblastoma xenografts with topotecan.
Neoplasms
Successful treatment of an endodermal sinus tumor of the vagina by chemotherapy alone: a rare case of an infant diagnosed by pathological examination of discharged tumor fragment.
Neoplasms
Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study.
Neoplasms
Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation.
Neoplasms
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
Neoplasms
Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation.
Neoplasms
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
Neoplasms
Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.
Neoplasms
Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
Neoplasms
Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma.
Neoplasms
Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
Neoplasms
Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
Neoplasms
Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen.
Neoplasms
Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
Neoplasms
Suppression of Zinc Finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients.
Neoplasms
Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
Neoplasms
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Neoplasms
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Neoplasms
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography.
Neoplasms
Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter.
Neoplasms
Surgical treatment of Epstein-Barr virus-associated lymphoepithelioma-like carcinoma occurring in both the posterior mediastinum and liver: Case report.
Neoplasms
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
Neoplasms
Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Neoplasms
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Neoplasms
Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.
Neoplasms
Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience.
Neoplasms
Survival and Tolerability of Transarterial Chemoembolization in Greater Versus less than 70 Years of Age Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score Analysis.
Neoplasms
Survival of Patients with Advanced Hepatocellular Carcinoma: Sorafenib versus Other Treatments.
Neoplasms
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
Neoplasms
Synergistic action of purified alpha-fetoprotein and growth factors on the proliferation of porcine granulosa cells in monolayer culture.
Neoplasms
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma.
Neoplasms
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
Neoplasms
Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantation.
Neoplasms
Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer.
Neoplasms
Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model.
Neoplasms
Technical considerations for fractionated stereotactic radiotherapy of hepatocellular carcinoma.
Neoplasms
Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
Neoplasms
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates.
Neoplasms
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Neoplasms
Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
Neoplasms
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
Neoplasms
Testicular tumours in infancy and childhood--a review of 10 germ cell tumours and 10 non germ cell tumours.
Neoplasms
Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
Neoplasms
The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
Neoplasms
The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.
Neoplasms
The Carcinogenic Agent Diethylnitrosamine Induces Early Oxidative Stress, Inflammation and Proliferation in Rat Liver, Stomach and Colon: Protective Effect of Ginger Extract.
Neoplasms
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Neoplasms
The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study.
Neoplasms
The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
Neoplasms
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
Neoplasms
The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study.
Neoplasms
The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT).
Neoplasms
The development of laboratory tests for cancer in Japan with special reference to carcinoembryonic proteins.
Neoplasms
The diagnostic and prognostic value of tumor markers in giant mediastinal endodermal sinus tumor with prolonged survival: Twelve-year follow up after radical resection.
Neoplasms
The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis.
Neoplasms
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
Neoplasms
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Neoplasms
The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.
Neoplasms
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
Neoplasms
The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), alpha-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules.
Neoplasms
The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Neoplasms
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
Neoplasms
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
Neoplasms
The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells.
Neoplasms
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
Neoplasms
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Neoplasms
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
Neoplasms
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
Neoplasms
The impact of filtered water-pipe smoke on healthy versus cancer cells and their neurodegenerative role on AMPA receptor.
Neoplasms
The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
Neoplasms
The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
Neoplasms
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Neoplasms
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
Neoplasms
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Neoplasms
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma.
Neoplasms
The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.
Neoplasms
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.
Neoplasms
The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.
Neoplasms
The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.
Neoplasms
The potential value of immunohistologic techniques in the classification of ovarian and testicular tumors.
Neoplasms
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
Neoplasms
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Neoplasms
The Predictive Power of Serum ?-Fetoprotein and Des-?-Carboxy Prothrombin for Survival Varies by Tumor Size in Hepatocellular Carcinoma.
Neoplasms
The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.
Neoplasms
The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients.
Neoplasms
The Prognostic Correlation of Heart Rate Variability at Diagnosis with Survival of Patients with Hepatocellular Carcinoma.
Neoplasms
The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
Neoplasms
The prognostic significance of serum HBeAg on the recurrence and long-term survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis.
Neoplasms
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Neoplasms
The protective role of etoricoxib against diethylnitrosamine/2-acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: The impact of NF-?B/COX-2/PGE2 signaling.
Neoplasms
The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Neoplasms
The receptor binding fragment of alpha-fetoprotein is a promising new vector for the selective delivery of antineoplastic agents.
Neoplasms
The role of abdominal surgery in the treatment of advanced testicular germ cell tumours.
Neoplasms
The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
Neoplasms
The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice.
Neoplasms
The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection.
Neoplasms
The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.
Neoplasms
The role of second-look surgery in the management of advanced germ cell malignancies.
Neoplasms
The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
Neoplasms
The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.
Neoplasms
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
Neoplasms
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
Neoplasms
The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.
Neoplasms
The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
Neoplasms
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Neoplasms
The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
Neoplasms
The Spatial Distribution Characteristics of the Tumor Biomarker Alpha-fetoprotein: A Cross-section Study.
Neoplasms
The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.
Neoplasms
The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.
Neoplasms
The treatment of intermediate stage tumour beyond TACE: from surgery to systemic therapy.
Neoplasms
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
Neoplasms
The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy.
Neoplasms
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Neoplasms
The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Neoplasms
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
Neoplasms
The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: Comparison with contrast-enhanced CT/MRI.
Neoplasms
The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
Neoplasms
The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors. 1976.
Neoplasms
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
Neoplasms
The Value of TTPVI in Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
Neoplasms
Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice.
Neoplasms
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Neoplasms
Therapeutic use of human alpha-fetoprotein in clinical patients : Is a cancer risk involved?
Neoplasms
Three cases of extrapulmonary small cell carcinoma occurring in the prostate, stomach, and pancreas.
Neoplasms
Three different types of alpha-fetoprotein in the diagnosis of malignant solid tumors: use of a sensitive lectin-affinity immunoelectrophoresis.
Neoplasms
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Neoplasms
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Neoplasms
Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns.
Neoplasms
Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Neoplasms
Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors.
Neoplasms
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Neoplasms
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Neoplasms
Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
Neoplasms
Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study.
Neoplasms
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
Neoplasms
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Neoplasms
Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China.
Neoplasms
Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis.
Neoplasms
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
Neoplasms
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.
Neoplasms
Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.
Neoplasms
Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.
Neoplasms
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Neoplasms
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Neoplasms
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Neoplasms
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Neoplasms
Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study.
Neoplasms
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Neoplasms
Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
Neoplasms
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
Neoplasms
Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.
Neoplasms
Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride.
Neoplasms
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.
Neoplasms
Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.
Neoplasms
Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Neoplasms
Transformation of cultured fetal rat liver cells by MDAB and phenobarbital. Morphological, biochemical and immunocytochemical characterization of cell lines.
Neoplasms
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Neoplasms
Transient therapy-related surge in serum tumor biomarkers: Characterizing behavior and postulating its biologic role.
Neoplasms
Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.
Neoplasms
Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Neoplasms
Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution.
Neoplasms
Treatment of intracranial nongerminomatous malignant germ cell tumors producing alpha-fetoprotein.
Neoplasms
Treatment of mediastinal immature teratoma in a child with precocious puberty and Klinefelter's syndrome.
Neoplasms
Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Neoplasms
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients.
Neoplasms
Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature.
Neoplasms
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Neoplasms
Triple Positive Tumor Markers for Hepatocellular Carcinoma Are Useful Predictors of a Poor Survival.
Neoplasms
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Neoplasms
Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases.
Neoplasms
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.
Neoplasms
Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis.
Neoplasms
Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Neoplasms
Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma.
Neoplasms
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
Neoplasms
Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma.
Neoplasms
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Neoplasms
Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC.
Neoplasms
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma.
Neoplasms
Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases.
Neoplasms
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Neoplasms
Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes.
Neoplasms
Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Neoplasms
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
Neoplasms
Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection.
Neoplasms
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Neoplasms
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Neoplasms
Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Neoplasms
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
Neoplasms
Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Neoplasms
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Neoplasms
Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms.
Neoplasms
Two-step selection criteria for living donor liver transplantation in patients with hepatocellular carcinoma.
Neoplasms
Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
Neoplasms
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.
Neoplasms
Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma.
Neoplasms
Ultrasound determination of liver size and assessment of patients with malignant liver disease.
Neoplasms
Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma.
Neoplasms
Ultrastructure and immunohistochemical staining of a transplanted endodermal sinus tumor.
Neoplasms
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma.
Neoplasms
Undifferentiated (embryonal) sarcoma of the liver. Epithelial features as shown by immunohistochemical analysis and electron microscopic examination.
Neoplasms
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Neoplasms
Unique clinicopathological features of patients with primary malignant hepatic tumors who are seropositive for lectin-reactive alpha-fetoprotein alone: report of five cases.
Neoplasms
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Neoplasms
Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
Neoplasms
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Neoplasms
Unsuspected primary malignancy in the setting of elevated serum alpha-fetoprotein.
Neoplasms
Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Neoplasms
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.
Neoplasms
Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Neoplasms
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Neoplasms
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Neoplasms
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Neoplasms
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Neoplasms
Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
Neoplasms
Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Neoplasms
Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma.
Neoplasms
Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies.
Neoplasms
Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.
Neoplasms
Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Neoplasms
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Neoplasms
Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.
Neoplasms
Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma.
Neoplasms
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Neoplasms
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.
Neoplasms
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review.
Neoplasms
Uterine retiform sertoli-leydig cell tumor: report of a case providing additional evidence that uterine tumors resembling ovarian sex cord tumors have a histologic and immunohistochemical phenotype of genuine sex cord tumors.
Neoplasms
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
Neoplasms
Vaginal yolk sac (endodermal sinus) tumors in infancy presenting persistent vaginal bleeding.
Neoplasms
Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population.
Neoplasms
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
Neoplasms
Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples.
Neoplasms
Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.
Neoplasms
Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Neoplasms
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
Neoplasms
Validity of MR imaging for monitoring effects of percutaneous ethanol injection for HCC.
Neoplasms
Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
Neoplasms
Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Neoplasms
Value of tumor markers in the treatment of endodermal sinus tumors and choriocarcinomas in the pineal region.
Neoplasms
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
Neoplasms
Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Neoplasms
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
Neoplasms
Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocols.
Neoplasms
Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Neoplasms
Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
Neoplasms
Vimentin-positive and Alpha-fetoprotein-elevated Nuclear Protein of the Testis Midline Carcinoma: A Case Report and Review of the Literature.
Neoplasms
Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.
Neoplasms
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Neoplasms
What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B?
Neoplasms
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
Neoplasms
Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
Neoplasms
Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study.
Neoplasms
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients.
Neoplasms
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.
Neoplasms
Yolk sac tumor (endodermal sinus tumor) and alpha-fetoprotein. A report of three cases.
Neoplasms
Yolk sac tumor of the anterior mediastinum. Case report with light- and electron-microscopic examination and immunohistochemical study of alpha-fetoprotein.
Neoplasms
Yolk sac tumor of the stomach with an adenocarcinomatous component: a case report with immunohistochemical analysis.
Neoplasms
Yolk sac tumor of the testicle: is retroperitoneal lymph node dissection necessary?
Neoplasms
Yolk sac tumors of the mediastinum with prominent spindle cell features: a clinicopathologic study of three cases.
Neoplasms
Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.
Neoplasms
Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Neoplasms
Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: A case report and literature review.
Neoplasms
[131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells]
Neoplasms
[A case of advanced gastric cancer showing pylorus stenosis with multiple liver metastases, that respond remarkably to neoadjuvant chemotherapy of combined TXL and low-dose FP]
Neoplasms
[A case of alpha-fetoprotein producing mediastinal germ cell tumor treated with preoperative chemotherapy]
Neoplasms
[A case of alpha-fetoprotein strongly positive cholecystic cancer associated with porcelain gallbladder (author's transl)]
Neoplasms
[A case of hepatocarcinoma preceded by several years by "isolated" increase in alphafetoprotein]
Neoplasms
[A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration]
Neoplasms
[A case of primary mediastinal germ cell tumor with production of alpha-fetoprotein, successfully treated with chemotherapy (cis-platinum, vinblastine, peplomycin), and curative resection]
Neoplasms
[A case of primary retroperitoneal tumor with combined histologic features of embryonal carcinoma and yolk sac tumor]
Neoplasms
[A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases.]
Neoplasms
[A case report of advanced hepatocellular carcinoma successfully treated with surgical multi-ablation therapy based on radio-frequency thermal ablation]
Neoplasms
[A case report of distal gastrectomy with thrombectomy after NAC for Gastric cancer].
Neoplasms
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
Neoplasms
[A new method of preparation of doxorubicin-in-oil suspension using ultrasonificator attached with Cuphorn]
Neoplasms
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report]
Neoplasms
[A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1]
Neoplasms
[A suspected case of extra-gonadal germ cell tumor complicated with choriocarcinoma syndrome].
Neoplasms
[Abdominal metastasis of a pineal region tumor through ventriculoperitoneal shunt. Case report]
Neoplasms
[Accumulation of doxorubicin conjugates with dendritic polymer and vector protein in normal and tumor cells in vitro].
Neoplasms
[Alpha-fetoprotein and human chorionic gonadotropin as tumor markers in intracranial and intraspinal germ cell tumors]
Neoplasms
[Alpha-fetoprotein immunotherapy as a stage of combined treatment of cancer patients]
Neoplasms
[Alpha-fetoprotein, an indicator of malignancy in hepatic tissue (author's transl)]
Neoplasms
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
Neoplasms
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
Neoplasms
[An experimental study on alpha-fetoprotein producing yolk sac tumor (author's transl)]
Neoplasms
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
Neoplasms
[Analysis of risk factors of recurrence in patients with BCLC 0-A hepatocellular carcinoma after surgical resection].
Neoplasms
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]
Neoplasms
[Anti-tumor activity of an anti-human alpha-fetoprotein antibody-human serum albumin-mitomycin C conjugate against human yolk sac tumor maintained in vitro and in nude mice in vivo]
Neoplasms
[Antitumor effects of human interferon on human tumors heterotransplanted into nude mice]
Neoplasms
[Assay of chorionic gonadotrophin, follicle-stimulating hormone and alpha-fetoprotein in the efferent blood in germinal tumors of the testis]
Neoplasms
[Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein]
Neoplasms
[Biphasic pulmonary blastoma with germ cell differentiation: a challenge in diagnosis and treatment].
Neoplasms
[Carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in malignant female genital neoplasms]
Neoplasms
[Carcinoembryonic antigen and alpha-fetoprotein in patients with intraocular neoplasms (author's transl)]
Neoplasms
[Case of germ cell tumor of the pineal region with elevation of serum and csf alpha-fetoprotein levels following histological change]
Neoplasms
[Case of yolk sac tumor decreasing in size and the normalizing of alph-fetoprotein level by anticancer chemotherapy]
Neoplasms
[Case of yolk sac tumor of the anterior mediastinum with superior vena cava syndrome]
Neoplasms
[Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)]
Neoplasms
[Changes in the rhythms of the alpha-fetoprotein content of the blood serum of mice with hepatoma 22A and of tumor cell proliferation depending on the time of cyclophosphane administration]
Neoplasms
[Chemical modification of anti-cancer drugs to increase their affinity to tumor antigens]
Neoplasms
[Chemoembolization combined with hepatic arterial induction of endogenous TNF and anticancer agents for hepatocellular carcinoma--a case report]
Neoplasms
[Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session]
Neoplasms
[Clinical and ultrasonographic features of testis tumor in children of different ages].
Neoplasms
[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)]
Neoplasms
[Clinical significance of cysteinyl leukotriene receptor expression in primary hepatocellular carcinoma].
Neoplasms
[Clinical studies of testicular tumor. I. Analysis of 27 patients with seminoma: the clinical significance of hCG-beta determination and of retroperitoneal lymph node dissection for stage I patients]
Neoplasms
[Clinical study on serum 5'-nucleotide phosphodiesterase isoenzyme-V as a predictor of liver metastases in patients with gastric and colorectal cancers]
Neoplasms
[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]
Neoplasms
[Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid]
Neoplasms
[Combination chemotherapy and chemoembolization in the treatment of primary inoperable hepatoblastoma]
Neoplasms
[Combined treatment with resection, intraoperative hypotonic and post-operative systemic chemotherapy using cis-platinum for a mediastinal yolk sac tumor: a case report]
Neoplasms
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]
Neoplasms
[Conventional serum tumor markers in liver cancer. Retrospective analysis of 118 patients].
Neoplasms
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Neoplasms
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
Neoplasms
[Correlation between the expression profile of cytokeratin 19/glypican 3 and recurrence of hepatocellular carcinoma after interventional therapy].
Neoplasms
[Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract]
Neoplasms
[Current considerations on the behavior of serum alpha-fetoprotein as a tumor marker]
Neoplasms
[Detection of alpha-fetoprotein in the blood serum postoperatively in cancer patients]
Neoplasms
[Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]
Neoplasms
[Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)]
Neoplasms
[Diagnostic possibilities of combining liver scintigraphy with the alpha-fetoprotein test in cancer patients]
Neoplasms
[Diagnostic significance of the study of alpha-fetoprotein in liver cirrhosis and primary cancer of the liver]
Neoplasms
[Diagnostic value of serum alpha-fetoprotein determinations in malignant tumors of the testes]
Neoplasms
[Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
Neoplasms
[Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system]
Neoplasms
[Differentiation antigens in tumors: dependence on carcinogenesis mechanisms and progression (a hypothesis)]
Neoplasms
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
Neoplasms
[Early diagnosis and rational therapy of primary carcinoma of the liver. Principles of secondary prevention]
Neoplasms
[Effect of a conjugate of adriamycin and an antibody to human alpha-fetoprotein (AFP) on AFP-producing hepatic tumors]
Neoplasms
[Effect of anti-human alpha-fetoprotein serum on human endodermal sinus tumor transplanted in nude mice (author's transl)]
Neoplasms
[Effect of cyclophosphamide on alpha-fetoprotein content in the blood serum of mice with hepatoma 22a depending upon the period of tumor development]
Neoplasms
[Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]
Neoplasms
[Effects of alpha-fetoprotein on the expression of TRAIL death receptor-2 and its role on resisting the cytotoxicity of TRAIL in hepatoma cells].
Neoplasms
[Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases]
Neoplasms
[Evaluation of alpha-fetoprotein concentration in patients with chronic liver diseases].
Neoplasms
[Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer]
Neoplasms
[Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up].
Neoplasms
[Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers]
Neoplasms
[Experimental chemotherapy of human testicular carcinoma transplanted in nude mice]
Neoplasms
[Experimental studies on the tumor imaging using antibodies to human alpha-fetoprotein. 1. Fluctuations in the iodine-labeled antibody activities]
Neoplasms
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
Neoplasms
[Expression and significance of c-jun-activation-domain binding protein (JAB1) in hepatocellular carcinoma]
Neoplasms
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
Neoplasms
[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma]
Neoplasms
[Expression of the Fra-1 gene in the peripheral blood of children with Wilms tumor].
Neoplasms
[Extraneural metastasis of pineal germinoma through a ventriculoperitoneal shunt, following histological change]
Neoplasms
[False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer]
Neoplasms
[Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea]
Neoplasms
[General concepts of alpha-fetoprotein (AFP)-secreting tumors, with special reference to the histogenesis]
Neoplasms
[Germ cell tumor in the basal ganglia with elevated serum and CSF alpha-fetoprotein levels]
Neoplasms
[Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients]
Neoplasms
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]
Neoplasms
[Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]
Neoplasms
[High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group]
Neoplasms
[High-efficient renaturation of immobilized recombinant C-terminal fragment of human alpha-fetoprotein].
Neoplasms
[Highly metastatic model of human hepatocellular carcinoma established in nude mice using orthotopic organ selection of metastatic variant from patient specimens]
Neoplasms
[Increase of alpha-fetoprotein in pancreatic endocrine tumors with hepatic metastases. Apropos of 2 cases]
Neoplasms
[Laboratory diagnosis of tumors of the pancreato-biliary area in patients with mechanical jaundice]
Neoplasms
[Lectin binding in immunohistologically AFP/HCG positive and negative testicular carcinoma]
Neoplasms
[Levels of serum alpha-fetoprotein before and after transcatheter embolization of hepatocellular tumors with Lipiodol]
Neoplasms
[Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors]
Neoplasms
[Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases]
Neoplasms
[Loss of p53 gene and amplification of HER-2 oncogene in primary hepatocellular carcinoma and their clinical significance]
Neoplasms
[Molecular heterogeneity of alpha-fetoprotein in ovarian or extragonadal yolk sac tumor]
Neoplasms
[Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes]
Neoplasms
[New protein vectors based on an alpha-fetoprotein fragment for targeted DNA delivery into cancer cells]
Neoplasms
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Neoplasms
[Ovarian serous adenocarcinoma with functioning stroma and production of estrogen and alpha-fetoprotein]
Neoplasms
[Pancreatic endocrine tumor with metastases and increase of alpha-fetoprotein. A case report]
Neoplasms
[Plasma levels of alpha-fetoprotein and carcinoembryonic antigen in patients with malignant gastrointestinal tumors]
Neoplasms
[Practical value of alpha-fetoprotein in the diagnosis and postoperative surveillance of embryonal tumors of the testicle]
Neoplasms
[Predictive Value of Platelet to Lymphocyte Ratio and Prognostic Nutritional Index on Prognosis of Hepatocellular Carcinoma after Liver Resection].
Neoplasms
[Preparation of conjugates of adriamycin with antibodies to alpha-fetoprotein and their properties]
Neoplasms
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]
Neoplasms
[Primary intracranial germ cell tumor with abnormal high value of alpha-fetoprotein after the radiation therapy]
Neoplasms
[Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin]
Neoplasms
[Primary mediastinal germ cell tumor with marked elevation of HCG and alpha-fetoprotein]
Neoplasms
[Prognostic significance of albumin/globulin ratio on postoperative survival of patients with hepatocellular carcinoma].
Neoplasms
[Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]
Neoplasms
[Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]
Neoplasms
[Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]
Neoplasms
[Radiofrequency ablation: a new approach in the treatment of hepatocellular carcinoma]
Neoplasms
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.]
Neoplasms
[Radioimmunoimaging of hepatic tumors with 131I labeled polyclonal antibody against alpha-fetoprotein (AFP)]
Neoplasms
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
Neoplasms
[Radioimmunological determination of the carcinoembryonic antigen, alpha-fetoprotein and other tumor antigens in oncological patients before and after radiation therapy]
Neoplasms
[Radioimmunological monitoring of the treatment of malignant neoplasms in childhood]
Neoplasms
[Relations between the morphological characteristics and alpha-fetoprotein in primary cancer of the liver (apropos of 92 cases]
Neoplasms
[Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma]
Neoplasms
[Relationship between structure and function of alpha-fetoprotein: conformational status and biological activity]
Neoplasms
[Relationship between testicular microcalcifications and clinical characteristics in patients with testicular cancer].
Neoplasms
[Research progress in prognostic factors of hepatitis B virus-associated end-stage liver disease].
Neoplasms
[Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update]
Neoplasms
[Retroperitoneal surgery in the treatment of germ-cell tumors of the testis: retroperitoneal lymph node dissection (RPLND).]
Neoplasms
[Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]
Neoplasms
[Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma]
Neoplasms
[Serum alpha-fetoprotein in patients with hepatic malignancies. I. Subfractions identified by Con A crossed-line affinity immunoelectrophoresis]
Neoplasms
[Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)]
Neoplasms
[Small hepatocellular carcinoma. New concepts on intrahepatic recurrence after hepatectomy in orthotopic liver transplantation]
Neoplasms
[Solid tumours of human primary hepatocellular carcinoma cell-lines in hypothymic mice: a model for biochemical and therapeutic studies (author's transl)]
Neoplasms
[Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses]
Neoplasms
[Structure and expression of alpha-fetoprotein gene--current progress in research]
Neoplasms
[Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method]
Neoplasms
[Studies on tissue-localization of various tumormarkers in ovarian tumors by immunoperoxidase method]
Neoplasms
[Study on the clinical significance and correlation of arginase-1 and inducible nitric oxide synthase expression in hepatocellular carcinoma].
Neoplasms
[Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]
Neoplasms
[Study on the value of serum des-?-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
Neoplasms
[Synthesis of alpha-fetoprotein, albumin and transferrin by long-term cultured cells of murine hepatoma]
Neoplasms
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Neoplasms
[The analysis of prognostic factors of primary hepatocellular carcinoma with Cox model]
Neoplasms
[The distribution of iodine-125 labeled alpha-fetoprotein in the animal organism and its accumulation in the tumor].
Neoplasms
[The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]
Neoplasms
[The evaluation of ratio of oncomarkers in search of initial focus of tumor: on the occasion of fiftieth anniversary of discovery of alpha-fetoprotein as an oncomarker].
Neoplasms
[The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma]
Neoplasms
[The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients]
Neoplasms
[The role of tumour markers in diagnosis and management of testicular germ cell tumours.]
Neoplasms
[The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers]
Neoplasms
[The study of RNA markers in blood of patients with malignant tumors of gastrointestinal tract].
Neoplasms
[The Value of Diffusion Kurtosis Imaging in Predicting Post-surgery Early Recurrence of Hepatocellular Carcinoma].
Neoplasms
[Treatment of patients with stage I-II non-seminoma germ-cell tumors of the testis]
Neoplasms
[Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)]
Neoplasms
[Two patients with liver cirrhosis who presented with alpha-fetoprotein values diagnostic of hepatocarcinoma but without evidence of neoplasms]
Neoplasms
[Ultrasonographic and clinical features of common testicular germ cell tumors in children].
Neoplasms
[Use of a lipid lymphographic agent, lipiodol, as a carrier of high molecular weight antitumor agent, smancs, for hepatocellular carcinoma]
Neoplasms
[Usefulness of carcinoembryonic antigen and other markers in patients with hemoptysis]
Neoplasms
[Utility of measurement of tumor markers for preoperative staging of gastric cancer]
Neoplasms
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Neoplasms
[Value of determinations of serum levels of carcino-embryonic antigen (CEA) and alpha-fetoprotein (AFP) for early detection of malignant tumours (author's transl)]
Neoplasms
[Yolk sac tumor by fetectomy in the rat: histopathological characteristics and histogenesis (author's transl)]
Neoplasms
¹?F-fluorodeoxyglucose PET/CT findings of a solitary primary hepatic lymphoma: a case report.
Neoplasms, Germ Cell and Embryonal
A case of endodermal sinus tumor associated with the first pregnancy and successful management of the second pregnancy: a case report and review of the literature.
Neoplasms, Germ Cell and Embryonal
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Neoplasms, Germ Cell and Embryonal
A personalized approach to cancer treatment: how biomarkers can help.
Neoplasms, Germ Cell and Embryonal
A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein (AFP) in germ cell tumors of the testis.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein and human chorionic gonadotropin in a patient with a primary intracranial germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein in germ cell tumors. An immunohistochemical study.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein in malignant germ cell tumors of the ovary.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein in plasma and serum of healthy adults: preanalytical, analytical and biological sources of variation and construction of age-dependent reference intervals.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein secretion in a craniopharyngioma. Are craniopharyngiomas part of the germ cell tumor family?
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein surge following high-dose chemotherapy in germ cell tumours.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.
Neoplasms, Germ Cell and Embryonal
Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Neoplasms, Germ Cell and Embryonal
An Unusual Case of Primary Retroperitoneal Germ Cell Tumour in a Young Man.
Neoplasms, Germ Cell and Embryonal
Cardiac metastasis from yolk sac tumor: case report and review.
Neoplasms, Germ Cell and Embryonal
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Neoplasms, Germ Cell and Embryonal
Central diabetes insipidus developing in a 6-year-old patient 4 years after the remission of unifocal bone Langerhans cell histiocytosis.
Neoplasms, Germ Cell and Embryonal
Central nervous system germ cell tumors: controversies in diagnosis and treatment.
Neoplasms, Germ Cell and Embryonal
Cerebrospinal fluid alpha-fetoprotein in germ cell neoplasms.
Neoplasms, Germ Cell and Embryonal
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Neoplasms, Germ Cell and Embryonal
Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology.
Neoplasms, Germ Cell and Embryonal
Clinical study of intracranial nongerminomatous germ cell tumors producing alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Clinical use of tumor markers in childhood malignancies.
Neoplasms, Germ Cell and Embryonal
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Concanavalin A affinity of alpha-fetoprotein. Its use in differentiating tumors.
Neoplasms, Germ Cell and Embryonal
Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Neoplasms, Germ Cell and Embryonal
Development of testicular alpha-fetoprotein-secreting germ cell tumor 3 years after treatment of intracranial lesion identified as non-secreting germ cell tumor on the basis of clinical data--case report.
Neoplasms, Germ Cell and Embryonal
Diagnostic difficulties before definitive treatment of an extragonadal retroperitoneal germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
Neoplasms, Germ Cell and Embryonal
Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Neoplasms, Germ Cell and Embryonal
Distribution of tumor-associated antigens in the various histologic components of germ cell tumors of the testis.
Neoplasms, Germ Cell and Embryonal
Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Neoplasms, Germ Cell and Embryonal
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Neoplasms, Germ Cell and Embryonal
Drug-resistance patterns assessed from tumor marker analysis.
Neoplasms, Germ Cell and Embryonal
Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence.
Neoplasms, Germ Cell and Embryonal
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Elevated alpha-fetoprotein secondary to Hodgkin's lymphoma.
Neoplasms, Germ Cell and Embryonal
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
Neoplasms, Germ Cell and Embryonal
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Neoplasms, Germ Cell and Embryonal
Epidemiologic study of 230 cases of testicular/paratesticular tumors or masses: 15-year experience of a single center.
Neoplasms, Germ Cell and Embryonal
Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors.
Neoplasms, Germ Cell and Embryonal
Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report.
Neoplasms, Germ Cell and Embryonal
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Neoplasms, Germ Cell and Embryonal
Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.
Neoplasms, Germ Cell and Embryonal
False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features.
Neoplasms, Germ Cell and Embryonal
Gastric cancer with adenocarcinoma and yolk sac tumor components: A rare entity.
Neoplasms, Germ Cell and Embryonal
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Neoplasms, Germ Cell and Embryonal
Germ cell tumor in the basal ganglia: immunohistochemical demonstration of alpha-fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen.
Neoplasms, Germ Cell and Embryonal
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Neoplasms, Germ Cell and Embryonal
Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
Neoplasms, Germ Cell and Embryonal
Germinoma with malignant transformation to nongerminomatous germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Neoplasms, Germ Cell and Embryonal
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells.
Neoplasms, Germ Cell and Embryonal
Hepatoid carcinoma of the ovary: characteristics of its immunoreactivity. A case report.
Neoplasms, Germ Cell and Embryonal
Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!
Neoplasms, Germ Cell and Embryonal
Hereditary persistence of alpha-fetoprotein. Case report and review of the literature.
Neoplasms, Germ Cell and Embryonal
High alpha-fetoprotein level in HCV-related nodular liver cell dysplasia.
Neoplasms, Germ Cell and Embryonal
Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.
Neoplasms, Germ Cell and Embryonal
Human chorionic gonadotropin and alpha-fetoprotein in testicular germ cell tumors. An immunohistochemical study in comparison with tissue concentrations.
Neoplasms, Germ Cell and Embryonal
Imaging in gynecological disease (22): clinical?and?ultrasound characteristics of ovarian embryonal carcinomas, non-gestational choriocarcinomas and malignant mixed germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Neoplasms, Germ Cell and Embryonal
Immunohistochemical demonstration of alpha-fetoprotein in testicular germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Immunohistochemical localisation of alpha-fetoprotein (AFP) in germ cell tumours: evidence for AFP production by tissues different from endodermal sinus tumour.
Neoplasms, Germ Cell and Embryonal
Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Intracranial germ cell tumor indicating a high level of alpha-fetoprotein (AFP).
Neoplasms, Germ Cell and Embryonal
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Neoplasms, Germ Cell and Embryonal
Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Lens Culinaris Agglutinin-reactive Fraction of Alpha-fetoprotein as a Tumor Marker in a Patient With Nonseminomatous Germ Cell Tumor With Normal Alpha-fetoprotein Level.
Neoplasms, Germ Cell and Embryonal
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Neoplasms, Germ Cell and Embryonal
Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Malignant ganglioneuroma arising from mediastinal mixed germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Mediastinal growing teratoma syndrome succesfully treated by multiple modality therapies.
Neoplasms, Germ Cell and Embryonal
Mediastinal teratoma and precocious puberty in a boy with mosaic Klinefelter syndrome.
Neoplasms, Germ Cell and Embryonal
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms.
Neoplasms, Germ Cell and Embryonal
Metastatic pancreatic acinar cell carcinoma in a younger male with marked AFP production: A potential pitfall on fine needle aspiration biopsy.
Neoplasms, Germ Cell and Embryonal
MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.
Neoplasms, Germ Cell and Embryonal
Mixed germ cell malignancy of the ovary concurrent with pregnancy.
Neoplasms, Germ Cell and Embryonal
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Neoplasms, Germ Cell and Embryonal
Morphologic features of human chorionic gonadotropin- or alpha-fetoprotein-producing germ cell tumors of the central nervous system: histological heterogeneity and surgical meaning.
Neoplasms, Germ Cell and Embryonal
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Neoplasms, Germ Cell and Embryonal
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Neoplasms, Germ Cell and Embryonal
NUT midline carcinoma mimicking a germ cell tumor: a case report.
Neoplasms, Germ Cell and Embryonal
Observations on reliability of commercial assay for alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Neoplasms, Germ Cell and Embryonal
Ovarian mixed germ cell tumor composed of polyembryoma and immature teratoma.
Neoplasms, Germ Cell and Embryonal
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Neoplasms, Germ Cell and Embryonal
Persistently elevated alpha-fetoprotein associated with chronic hepatitis B during chemotherapy for malignant ovarian germ cell tumors: a case series and a review of the literature.
Neoplasms, Germ Cell and Embryonal
Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
Neoplasms, Germ Cell and Embryonal
Possible common origin of alpha-fetoprotein- and human chorionic gonadotropin--secreting cells in intracranial germ cell tumor. Case report.
Neoplasms, Germ Cell and Embryonal
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Neoplasms, Germ Cell and Embryonal
Potential role of ventricular tumor markers in CNS germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Neoplasms, Germ Cell and Embryonal
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.
Neoplasms, Germ Cell and Embryonal
Primary endodermal sinus tumor of the penis: a case report.
Neoplasms, Germ Cell and Embryonal
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Neoplasms, Germ Cell and Embryonal
Primary mediastinal pleomorphic rhabdomyosarcoma: a case report.
Neoplasms, Germ Cell and Embryonal
Primary pulmonary alpha-fetoprotein-producing malignant germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Primary yolk sac tumor originating from the endometrium: A case report and literature review.
Neoplasms, Germ Cell and Embryonal
Production of alpha-fetoprotein by human germ cell tumors in vivo and in vitro.
Neoplasms, Germ Cell and Embryonal
Prognostic factors of patients with yolk sac tumors of the ovary.
Neoplasms, Germ Cell and Embryonal
Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Neoplasms, Germ Cell and Embryonal
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Radioimmunoassay of alpha-fetoprotein in children with primary intracranial tumors.
Neoplasms, Germ Cell and Embryonal
Radioimmunodetection of primary and metastatic germ cell tumors containing alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa.
Neoplasms, Germ Cell and Embryonal
Retroperitoneal lymph node dissection in the setting of elevated markers.
Neoplasms, Germ Cell and Embryonal
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Neoplasms, Germ Cell and Embryonal
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Secretion of human chorionic gonadotropin and alpha-fetoprotein by an ovarian germ cell tumor of apparent yolk sac origin.
Neoplasms, Germ Cell and Embryonal
Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Neoplasms, Germ Cell and Embryonal
Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Serum lactic dehydrogenase as a tumor marker in dysgerminoma.
Neoplasms, Germ Cell and Embryonal
Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Serum prolactin, gonadotropins, androgens, estrogens, and gestagens in patients with malignant testicular germ cell tumor.
Neoplasms, Germ Cell and Embryonal
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Neoplasms, Germ Cell and Embryonal
Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Structures of disease-specific serum alpha-fetoprotein isoforms.
Neoplasms, Germ Cell and Embryonal
Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.
Neoplasms, Germ Cell and Embryonal
Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Neoplasms, Germ Cell and Embryonal
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Neoplasms, Germ Cell and Embryonal
Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
Neoplasms, Germ Cell and Embryonal
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
Neoplasms, Germ Cell and Embryonal
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Neoplasms, Germ Cell and Embryonal
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Neoplasms, Germ Cell and Embryonal
The role of second-look surgery in the management of advanced germ cell malignancies.
Neoplasms, Germ Cell and Embryonal
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Neoplasms, Germ Cell and Embryonal
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
Neoplasms, Germ Cell and Embryonal
The value of surveillance testing in childhood brain tumors.
Neoplasms, Germ Cell and Embryonal
Treatment of intracranial nongerminomatous malignant germ cell tumors producing alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Tumor markers at the time of recurrence in patients with germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Neoplasms, Germ Cell and Embryonal
Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Neoplasms, Germ Cell and Embryonal
Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Neoplasms, Germ Cell and Embryonal
Value of tumor markers in nonseminomatous germ cell tumor of the testis.
Neoplasms, Germ Cell and Embryonal
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
Neoplasms, Germ Cell and Embryonal
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
Neoplasms, Germ Cell and Embryonal
[A case of alpha-fetoprotein producing mediastinal germ cell tumor treated with preoperative chemotherapy]
Neoplasms, Germ Cell and Embryonal
[A case of primary mediastinal germ cell tumor with production of alpha-fetoprotein, successfully treated with chemotherapy (cis-platinum, vinblastine, peplomycin), and curative resection]
Neoplasms, Germ Cell and Embryonal
[Alpha-fetoprotein and human chorionic gonadotropin as tumor markers in intracranial and intraspinal germ cell tumors]
Neoplasms, Germ Cell and Embryonal
[Alpha-fetoprotein as a marker in cases of infantile germ cell tumors]
Neoplasms, Germ Cell and Embryonal
[An Abnormal Alpha-Fetoprotein Fractionation Provides Additional Information: A Case of Retroperitoneal Germ Cell Tumor Accompanied by Liver Cirrhosis Type C].
Neoplasms, Germ Cell and Embryonal
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
Neoplasms, Germ Cell and Embryonal
[Case of germ cell tumor of the pineal region with elevation of serum and csf alpha-fetoprotein levels following histological change]
Neoplasms, Germ Cell and Embryonal
[Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)]
Neoplasms, Germ Cell and Embryonal
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
Neoplasms, Germ Cell and Embryonal
[Germ cell tumor in the basal ganglia with elevated serum and CSF alpha-fetoprotein levels]
Neoplasms, Germ Cell and Embryonal
[Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes]
Neoplasms, Germ Cell and Embryonal
[Primary intracranial germ cell tumor with abnormal high value of alpha-fetoprotein after the radiation therapy]
Neoplasms, Germ Cell and Embryonal
[Primary intracranial malignant germ cell tumor associated with abnormal high value of alpha-fetoprotein and human chorionic gonadotropin]
Neoplasms, Germ Cell and Embryonal
[Primary mediastinal germ cell tumor with marked elevation of HCG and alpha-fetoprotein]
Neoplasms, Germ Cell and Embryonal
[Structure and expression of alpha-fetoprotein gene--current progress in research]
Neoplasms, Germ Cell and Embryonal
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Neoplasms, Germ Cell and Embryonal
[The role of tumour markers in diagnosis and management of testicular germ cell tumours.]
Neoplasms, Germ Cell and Embryonal
[Usefulness of tumor markers in the treatment of germ cell tumors]
Neoplastic Cells, Circulating
A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma.
Neoplastic Cells, Circulating
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Neoplastic Cells, Circulating
Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Neoplastic Cells, Circulating
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Neoplastic Cells, Circulating
Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
Neoplastic Cells, Circulating
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
Nephrosis
Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
Nephrosis
Congenital nephrosis: detection of index cases through maternal serum alpha-fetoprotein screening.
Nephrosis
CRB2 mutations produce a phenotype resembling congenital nephrosis, Finnish type, with cerebral ventriculomegaly and raised alpha-fetoprotein.
Nephrosis
Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.
Nephrosis
Elevated maternal serum alpha-fetoprotein levels: what is the risk of fetal aneuploidy?
Nephrosis
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Nephrosis
Genetic and preimplantation diagnosis of cystic kidney disease with ventriculomegaly.
Nephrosis
Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA analysis.
Nephrosis
Maternal serum alpha-fetoprotein levels peak at 19-21?weeks' gestation and subsequently decline in a NPHS1 sequence variant heterozygote; implications for prenatal diagnosis of congenital nephrosis of the Finnish type.
Nephrosis
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Nephrotic Syndrome
Amniotic alpha-fetoprotein in the prenatal diagnosis of congenital nephrotic syndrome of the Finnish type.
Nephrotic Syndrome
Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein.
Nephrotic Syndrome
Maternal serum alpha-fetoprotein levels in congenital nephrotic syndrome carrier pregnancies.
Nephrotic Syndrome
Normalization of maternal serum alpha-fetoprotein levels after 23 weeks' gestation in an NPHS1 nephrotic syndrome carrier pregnancy.
Nephrotic Syndrome
Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations.
Nephrotic Syndrome
Why is congenital nephrotic syndrome associated with a rise in the concentration of alpha-fetoprotein in the amniotic fluid?
Nervous System Diseases
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Nervous System Diseases
Immunomodulation by alpha-fetoprotein in neurological disorders may involve.
Neural Tube Defects
A co-twin fetus papyraceus as a cause of elevated AFP and acetylcholinesterase in the amniotic fluid of the normal co-twin.
Neural Tube Defects
A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
Neural Tube Defects
A study of the value of measuring maternal serum alpha-fetoprotein for the antenatal diagnosis of neural tube defects.
Neural Tube Defects
Abnormal US appearance of the cerebellum (banana sign): indirect sign of spina bifida.
Neural Tube Defects
Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.
Neural Tube Defects
Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Neural Tube Defects
All MoMs are not equal: some statistical properties associated with reporting results in the form of multiples of the median.
Neural Tube Defects
Alpha-fetoprotein and acetylcholinesterase in twins discordant for neural tube defect.
Neural Tube Defects
Alpha-fetoprotein and albumin in experimentally-induced exencephaly in the rat.
Neural Tube Defects
Alpha-fetoprotein and the prenatal diagnosis of neural tube defects.
Neural Tube Defects
Alpha-fetoprotein concanavalin A-binding variants in the diagnosis of neural tube defects and other communicating fetal abnormalities.
Neural Tube Defects
Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
Neural Tube Defects
Alpha-fetoprotein in antenatal diagnosis of neural tube defects.
Neural Tube Defects
Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
Neural Tube Defects
Alpha-fetoprotein levels in amniotic fluid and maternal serum as determined by radioimmunoassay: implications for prenatal diagnosis of fetal neural tube defects.
Neural Tube Defects
Alpha-fetoprotein: an enhanced-sensitivity assay for neural tube defect and Down syndrome evaluation.
Neural Tube Defects
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.
Neural Tube Defects
alpha-Fetoprotein: relationship between maternal serum and amniotic fluid levels.
Neural Tube Defects
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Neural Tube Defects
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Neural Tube Defects
Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein elevation with fetal omphalocele and a possible mechanism for its occurrence.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein in the antenatal diagnosis of neural tube defects.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein in the prenatal diagnosis of fetal neural tube defects.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Neural Tube Defects
Amniotic fluid alpha-fetoprotein levels in antenatal diagnosis of neural tube defects.
Neural Tube Defects
Amniotic fluid analysis in prenatal diagnosis of neural tube defects: a comparison between six biochemical tests supplementary to the measurement of amniotic fluid alpha-fetoprotein.
Neural Tube Defects
Amniotic fluid and maternal serum alpha-fetoprotein determination in neural tube defects.
Neural Tube Defects
Amniotic fluid concentrations of alpha-fetoprotein (AFP) in early normal pregnancy, and pregnancy complicated by neural tube defects. A review of 18 months experience.
Neural Tube Defects
Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
Neural Tube Defects
Amniotic fluid levels of fibrin(ogen) degradation fragment E and alpha-fetoprotein in normal pregnancy and with fetal neural tube defect.
Neural Tube Defects
Analysis of maternal alpha-fetoprotein: a comparison of three radioimmunoassays.
Neural Tube Defects
Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein.
Neural Tube Defects
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Neural Tube Defects
Antepartum screening in the office-based practice: findings from the collaborative Ambulatory Research Network.
Neural Tube Defects
Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Neural Tube Defects
Between-pregnancy biological variability of maternal serum alpha-fetoprotein and free beta hCG: implications for Down syndrome screening in subsequent pregnancies.
Neural Tube Defects
Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Neural Tube Defects
Cholinesterase evaluation in the prenatal diagnosis of open neural tube defects.
Neural Tube Defects
Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
Neural Tube Defects
Clinical interpretation of maternal serum alpha-fetoprotein concentrations.
Neural Tube Defects
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Neural Tube Defects
Comparison of an ELISA with a RIA method for serum alpha-fetoprotein determination in screening for fetal neural tube defects.
Neural Tube Defects
Complement factors and alpha-fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects.
Neural Tube Defects
Con A non-reactive fractions of human amniotic fluid alpha-fetoprotein in prenatal diagnosis of fetal neural tube defects and fetal abdominal wall defects. Predictive values, sensitivity, and specificity, and comparison to acetylcholinesterase and ultrasound scanning.
Neural Tube Defects
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Neural Tube Defects
Concanavalin A reactivity pattern of human amniotic fluid AFP examined by crossed affino-immunoelectrophoresis. A definite test for neural tube defect?
Neural Tube Defects
Congenital nephrosis of the Finnish type: overview of placental pathology and literature review.
Neural Tube Defects
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery.
Neural Tube Defects
Cut-off levels for maternal plasma alpha-fetoprotein in the diagnosis of neural tube defects: validation of the use of multiples of the normal median.
Neural Tube Defects
Detection of neural tube defects with alpha-fetoprotein measurement in amniotic fluid. A protocol for managing elevated values.
Neural Tube Defects
Diagnosis of fetal acrania during the first trimester nuchal translucency screening for Down syndrome.
Neural Tube Defects
Diagnostic effectiveness of ultrasound in detection of neural tube defect. The South Wales experience of 2509 scans (1977-1982) in high-risk mothers.
Neural Tube Defects
Effect of normal MSAFP screening on maternal age for genetic amniocentesis.
Neural Tube Defects
Effects of antenatal diagnosis and selective abortion on frequencies of genetic disorders.
Neural Tube Defects
Elevated levels of midtrimester maternal serum alpha-fetoprotein are associated with preterm delivery but not with fetal growth retardation.
Neural Tube Defects
Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
Neural Tube Defects
Elevated maternal serum alpha-fetoprotein, second-trimester oligohydramnios, and pregnancy outcome.
Neural Tube Defects
Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Neural Tube Defects
Establishment of a collaborative university-commercial maternal serum alpha-fetoprotein screening program: a model for tertiary center outreach.
Neural Tube Defects
Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps.
Neural Tube Defects
Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing. Fourth report of the UK collaborative study on alpha-fetoprotein in relation to neural tube defects.
Neural Tube Defects
Evaluating health and maturation of the unborn: the role of the clinical laboratory.
Neural Tube Defects
Evaluation of a commercial immunoenzymometric assay for alpha-fetoprotein.
Neural Tube Defects
Evaluation of measurement of maternal plasma alpha-fetoprotein levels as a screening test for fetal neural tube defects.
Neural Tube Defects
Experience with 8 cases of prenatally diagnosed sacrococcygeal teratomas.
Neural Tube Defects
Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody.
Neural Tube Defects
Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
Neural Tube Defects
False-positive amniotic fluid acetylcholinesterase results: the need for a multifacet approach to the prenatal diagnosis of neural tube defects.
Neural Tube Defects
Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
Neural Tube Defects
First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects.
Neural Tube Defects
First-Trimester Screening for Neural Tube Defects Using Alpha-Fetoprotein.
Neural Tube Defects
Four years' experience of maternal alpha-fetoprotein screening and its effect on the pattern of antenatal care.
Neural Tube Defects
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
Neural Tube Defects
High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole.
Neural Tube Defects
Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.
Neural Tube Defects
Immunocytochemical characterization of amniotic fluid macrophages in cases of fetal neural tube defects.
Neural Tube Defects
Implementation of a screening program for diagnosing open neural tube defects: selection, evaluation, and utilization of alpha-fetoprotein methodology.
Neural Tube Defects
Increased amnionic fluid alpha-fetoprotein due to a holoacardium amorphous twin.
Neural Tube Defects
Increased levels of apo-transcobalamins I and II in amniotic fluid from pregnant women with previous neural tube defect offspring.
Neural Tube Defects
Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome.
Neural Tube Defects
Influence of provider characteristics and insurance status on maternal serum alpha-fetoprotein screening.
Neural Tube Defects
Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
Neural Tube Defects
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Neural Tube Defects
Isoelectric focusing of amniotic fluid alpha-fetoprotein to improve diagnosis of neural tube defects.
Neural Tube Defects
Levels of alpha-fetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects.
Neural Tube Defects
Life without amniocentesis: elevated maternal serum alpha-fetoprotein in the Manitoba program 1986-91.
Neural Tube Defects
Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
Neural Tube Defects
Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
Neural Tube Defects
Maternal serum alpha-fetoprotein in presence of both neural tube defects and chromosome anomalies.
Neural Tube Defects
Maternal serum alpha-fetoprotein in the first trimester cannot predict neural tube defects.
Neural Tube Defects
Maternal serum alpha-fetoprotein in twin pregnancies uncomplicated by neural tube defect.
Neural Tube Defects
Maternal serum alpha-fetoprotein level and the relationship to ventriculomegaly in fetal neural tube defect: A retrospective cohort study.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for neural tube defects and other disorders using an ultramicro-ELISA. Collaborative study in Cuba and in the German Democratic Republic.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a combined study in Germany and short overview on screening in populations with low birth prevalence of neural tube defects.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for neural tube defects. Results of a consensus meeting.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening for the early antenatal detection of neural tube defects.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening in a provincial Health District.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening in Natal. Results of over 12 000 tests.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening. III. Pitfalls in evaluating black gravid women.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening: low and high values for detection of genetic abnormalities.
Neural Tube Defects
Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
Neural Tube Defects
Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling.
Neural Tube Defects
Maternal smoking during pregnancy and false positive maternal serum alpha-fetoprotein (MSAFP) screening for open neural tube defects.
Neural Tube Defects
Maternal zinc and selenium status in pregnancies with a neural tube defect or elevated plasma alpha-fetoprotein.
Neural Tube Defects
Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups.
Neural Tube Defects
Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Neural Tube Defects
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects.
Neural Tube Defects
Neural tube defects and maternal serum zinc and copper concentrations in mid-pregnancy: a case-control study.
Neural Tube Defects
Origin of amniotic fluid alpha-fetoprotein in normal and defective pregnancies.
Neural Tube Defects
Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Neural Tube Defects
Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening.
Neural Tube Defects
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Neural Tube Defects
Prenatal biochemical screening for Down's syndrome and neural tube defects.
Neural Tube Defects
Prenatal detection of neural tube defects by maternal serum alphafetoprotein assay.
Neural Tube Defects
Prenatal detection of neural tube defects. Comparison between alpha-fetoprotein and beta-trace protein assays.
Neural Tube Defects
Prenatal detection of neural tube defects: experience with alpha-fetoprotein assays of amniotic fluid.
Neural Tube Defects
Prenatal diagnosis of neural tube defects by measurement of serum alpha-fetoprotein in Havana City.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. I. Problems and pitfalls: analysis of 2495 cases using the alpha-fetoprotein assay.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. II. Analysis of false positive and false negative alpha-fetoprotein results.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. III. A reevaluation of the alpha-fetoprotein assay.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. V. The value of amniotic fluid cholinesterase studies.
Neural Tube Defects
Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
Neural Tube Defects
Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population.
Neural Tube Defects
Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
Neural Tube Defects
Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
Neural Tube Defects
Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
Neural Tube Defects
Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
Neural Tube Defects
Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis.
Neural Tube Defects
Quantification of the D2-glycoprotein in amniotic fluid and serum from pregnancies with fetal neural tube defects.
Neural Tube Defects
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Neural Tube Defects
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Neural Tube Defects
Regional variations in neural tube defects and alfa-fetoprotein screening in Denmark 1983-88.
Neural Tube Defects
Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
Neural Tube Defects
Risk-benefit assessment of anticonvulsants in women of child-bearing potential.
Neural Tube Defects
Routine amniotic fluid alpha-fetoprotein measurement in 34,000 pregnancies.
Neural Tube Defects
Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Neural Tube Defects
Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
Neural Tube Defects
S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus.
Neural Tube Defects
Sacral meningocele with conotruncal heart defects: a possible autosomal recessive trait.
Neural Tube Defects
Screening for congenital dislocation of the hip, scoliosis, and other abnormalities affecting the musculoskeletal system.
Neural Tube Defects
Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
Neural Tube Defects
Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
Neural Tube Defects
Screening for fetal neural tube defects by maternal plasma alpha-fetoprotein determination.
Neural Tube Defects
Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk.
Neural Tube Defects
Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects.
Neural Tube Defects
Second-trimester placental changes associated with elevated maternal serum alpha-fetoprotein.
Neural Tube Defects
Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population.
Neural Tube Defects
Serum alpha-fetoprotein and neural tube defects in the first trimester of pregnancy. MRC Vitamin Study Research Group.
Neural Tube Defects
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Neural Tube Defects
Sonography as a procedure complementary to alpha-fetoprotein testing for neural tube defects.
Neural Tube Defects
Sonography, a complementary examination to alpha-fetoprotein testing for fetal neural tube defects.
Neural Tube Defects
Stage II ultrasound examination for the diagnosis of fetal abnormalities with an elevated amniotic fluid alpha-fetoprotein concentration.
Neural Tube Defects
Studies of an alpha-fetoprotein assay using dry blood-spot samples to be used for the detection of fetal neural tube defects.
Neural Tube Defects
Study of alpha-fetoprotein in amniotic fluid and its application in the prenatal diagnosis of neural tube defects.
Neural Tube Defects
The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects.
Neural Tube Defects
The effect of gestational age on the detection rate of Down's syndrome by maternal serum alpha-fetoprotein screening.
Neural Tube Defects
The effect of private attitudes on public policy. Prenatal screening for neural tube defects as a prototype.
Neural Tube Defects
The effects of analytical factors on second trimester risk estimations.
Neural Tube Defects
The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
Neural Tube Defects
The relation between maternal plasma alpha-fetoprotein and birth weight in twin pregnancies.
Neural Tube Defects
The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects.
Neural Tube Defects
The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review.
Neural Tube Defects
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Neural Tube Defects
The value of alpha-fetoprotein in the prenatal diagnosis of neural tube defects.
Neural Tube Defects
Triploid fetus: an important consideration in the evaluation of very high maternal serum alpha-fetoprotein.
Neural Tube Defects
Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Neural Tube Defects
Ultrasonography and alpha-fetoprotein determination for antenatal detection of neural tube defects.
Neural Tube Defects
Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
Neural Tube Defects
Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein.
Neural Tube Defects
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Neural Tube Defects
Use of patients' data to control alpha-fetoprotein assays when screening for neural tube defects.
Neural Tube Defects
[Acrania and spina bifida diagnosed by alpha-fetoprotein determination in 16th week of pregnancy]
Neural Tube Defects
[Determination of alpha-fetoprotein, cholinesterase and alpha 2-macroglobulin in the amniotic fluid in the diagnosis of neural tube defects]
Neural Tube Defects
[Electrophoresis of cholinesterases of the amniotic fluid in the prenatal diagnosis of closure defects of the neural tube]
Neural Tube Defects
[Genetic amniocentesis: technique and results in 1,000 first trimester amniocenteses (author's transl)]
Neural Tube Defects
[Hepatocellular carcinoma as a rare cause of excessive rise in alpha-fetoprotein in pregnancy]
Neural Tube Defects
[Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]
Neural Tube Defects
[Percentage of concanavalin-A non-conjugating alpha-fetoprotein in amniotic fluid in the prenatal diagnosis of neural tube defects]
Neural Tube Defects
[Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum]
Neural Tube Defects
[Prenatal diagnosis of congenital defects through the determination of alpha fetoprotein]
Neural Tube Defects
[Prenatal diagnosis of Meckel-Gruber's syndrome by ultrasound (author's transl(]
Neural Tube Defects
[Quantitative acetylcholinesterase (AChE)--determination in amniotic fluid--potential for differential diagnosis in consistently high AFP levels during general AFP screening for prenatal diagnosis of open neural tube defects]
Neural Tube Defects
[Report on 8 years' experience in prenatal diagnosis of genetic defects. I. Indications and methods]
Neural Tube Defects
[Screening for neural tube defects. Determination of serum alpha-fetoprotein in women in the 16th to 18th weeks of pregnancy]
Neural Tube Defects
[The alpha-fetoprotein level analysis in open neural tube defects and chromosomal aberrations in the fetus]
Neural Tube Defects
[The determination of acetylcholinesterase activity in amniotic fluid as a further possibility for the prenatal diagnosis of open neural tube defects]
Neurodegenerative Diseases
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Neuroectodermal Tumor, Melanotic
Melanotic neuroectodermal tumor of infancy with high serum levels of alpha-fetoprotein. Ultrastructural study and immunological evidence of glial fibrillary protein and alpha-fetoprotein.
Neuroectodermal Tumors
Pigmented neuroectodermal tumor of infancy. A light microscopic and immunohistochemical study.
Neuroendocrine Tumors
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.
Neuroendocrine Tumors
Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin.
Neuroendocrine Tumors
Pure alpha-fetoprotein-producing neuroendocrine carcinoma of the pancreas: a case report.
Neuroinflammatory Diseases
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Neurologic Manifestations
[Ataxia telangiectasia. Clinical and biological study in 17 cases]
Neuronal Ceroid-Lipofuscinoses
Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease.
Neuronal Ceroid-Lipofuscinoses
Identification of alpha-fetoprotein as an autoantigen in juvenile Batten disease.
Non-alcoholic Fatty Liver Disease
Abnormal fucosylation of alpha-fetoprotein in patients with non-alcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination.
Non-alcoholic Fatty Liver Disease
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
Non-alcoholic Fatty Liver Disease
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Non-alcoholic Fatty Liver Disease
Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease.
Obesity
Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.
Obesity
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals.
Obesity
Maternal thyroid function does not alter maternal serum alpha-fetoprotein interpretation.
Obstetric Labor, Premature
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Obstetric Labor, Premature
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Obstetric Labor, Premature
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Obstetric Labor, Premature
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Obstetric Labor, Premature
Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations.
Obstetric Labor, Premature
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Obstetric Labor, Premature
Transformed alpha-fetoprotein (t-AFP) levels in women with threatened preterm labor.
Obstetric Labor, Premature
Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk.
Oculocerebrorenal Syndrome
Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Oligohydramnios
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Oligohydramnios
Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester?
Oligohydramnios
Elevated maternal serum alpha-fetoprotein levels and oligohydramnios: poor prognosis for pregnancy outcome.
Oligohydramnios
Elevated maternal serum alpha-fetoprotein with oligohydramnios: ultrasound evaluation and outcome.
Oligohydramnios
Elevated maternal serum alpha-fetoprotein, second-trimester oligohydramnios, and pregnancy outcome.
Oligohydramnios
Maternal serum alpha-fetoprotein levels and fetal outcome in early second-trimester oligohydramnios.
Oligohydramnios
Midtrimester diagnosis and anomalies in the dup(22q) syndrome: correlation of aneuploidy with low maternal serum alpha-fetoprotein and oligohydramnios.
Oligohydramnios
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
Oligohydramnios
Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios.
Oligohydramnios
Outcome of mid-trimester pregnancies complicated by oligohydramnios. Quantitative evaluation of the prognostic value of maternal serum alpha-fetoprotein level.
Oligohydramnios
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Oligohydramnios
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
Oligohydramnios
Sonography of placental abnormalities and oligohydramnios in women with elevated alpha-fetoprotein levels: comparison with control subjects.
Oligohydramnios
The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
Oligohydramnios
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Oligohydramnios
The branchio-oto-renal (BOR) syndrome: report of bilateral renal agenesis in three sibs.
Osteogenesis Imperfecta
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Ovarian Cysts
Maternal serum alpha-fetoprotein levels in ectopic pregnancy. A prospective study.
Ovarian Cysts
Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Ovarian Neoplasms
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Ovarian Neoplasms
Diagnostic accuracy of preoperative alpha-fetoprotein as an ovarian tumor marker in children and adolescents: not as good as we thought?
Ovarian Neoplasms
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Ovarian Neoplasms
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Ovarian Neoplasms
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.
Pancoast Syndrome
Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: a case report.
Pancreatic Neoplasms
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Pancreatic Neoplasms
Alpha-fetoprotein-producing pancreatic cancer cells possess cancer stem cell characteristics.
Pancreatic Neoplasms
Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
Pancreatic Neoplasms
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Pancreatic Neoplasms
Intra- and postoperative radiation therapy for an alpha-fetoprotein-producing pancreatic carcinoma.
Pancreatic Neoplasms
Mesoporous TiO2-based architectures as promising sensing materials towards next-generation biosensing applications.
Pancreatic Neoplasms
Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
Pancreatic Neoplasms
Serum pancreatic oncofetal antigen: its clinical usefulness for screening pancreatic cancer in combination with tests for other tumor markers.
Pancreatic Neoplasms
Successful resection of a liver metastasis from AFP-producing pancreatic cancer resulting in long-term survival: a case report and review of literature.
Pancreatitis
Alpha-fetoprotein producing carcinoma of the gallbladder associated with anomalous arrangement of the pancreaticobiliary ductal system--early detection through an attack of acute pancreatitis.
Pancreatitis
Primary Pancreatic Yolk Sac Tumor Presenting as Diffusely Enlarged Pancreas in Initial 18F-FDG PET/CT.
Pancreatitis, Chronic
Carcinoembryonic antigen, alpha 1-antitrypsin, and alpha-fetoprotein in the pancreas of patients with cystic fibrosis.
Pancreatitis, Chronic
[The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer]
Papilloma
Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.
Paraneoplastic Syndromes
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Parkinson Disease
Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: report of a case.
Pelvic Inflammatory Disease
Alpha-fetoprotein and the acute phase response. A study using acute pelvic inflammatory disease as a model system.
Perinatal Death
Maternal serum alpha-fetoprotein, birthweight and perinatal death in twin pregnancy.
Perinatal Death
Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Perinatal Death
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Perinatal Death
Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk.
Perinatal Death
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Peripheral Nervous System Diseases
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia.
Peripheral Nervous System Diseases
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Peripheral Nervous System Diseases
Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
Peripheral Nervous System Diseases
Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein.
Peripheral Nervous System Diseases
Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
Peripheral Nervous System Diseases
Cognitive functions in ataxia with oculomotor apraxia type 2.
Peripheral Nervous System Diseases
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Peritoneal Diseases
Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience.
Peritoneal Neoplasms
Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease.
Peritonitis
The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Perivascular Epithelioid Cell Neoplasms
Contrast-enhanced ct and angiographic findings in hepatic perivascular epithelioid cell tumor.
Persistent Infection
A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician's Choice in a New Therapeutic Scenario.
Persistent Infection
[Incidence and natural history of hepatocellular carcinoma in patients with chronic hepatitis C virus infection]
Pinealoma
Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
Pituitary Neoplasms
Estrogen induction of progestophilins in rat estrogen-sensitive cells grown in media supplemented with sera from castrated rats and from rats bearing an alpha-fetoprotein-secreting hepatoma.
Placenta Accreta
Elevated maternal serum alpha-fetoprotein associated with placenta accreta.
Placenta Accreta
Life-threatening obstetric haemorrhage in second trimester from a placenta percreta with raised alpha-fetoprotein levels.
Placenta Accreta
Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
Placenta Accreta
Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
Placenta Accreta
Second Trimester Biochemical Markers as Possible Predictors of Pathological Placentation: A Retrospective Case-Control Study.
Placenta Accreta
Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
Placenta Previa
Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa.
Placenta Previa
Association of maternal serum alpha-fetoprotein with persistent placenta previa.
Placental Insufficiency
Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Plasmacytoma
[A case of IgA-lambda producing gastric plasmacytoma associated with alpha-fetoprotein producing gastric carcinoma]
Pleural Effusion
[Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival]
Pleural Effusion
[Clinical usefulness of tumor markers in the diagnosis of pleural effusions. Carcinoembryonic antigen, alpha-fetoprotein and orosomucoid]
Pneumonia
A Case Report: Can Citrin Deficiency Lead to Hepatocellular Carcinoma in Children?
Pneumonia
[The fetal proteins in prognosis of development of pneumonia in patients with ischemic stroke].
Polycystic Kidney Diseases
A case of recurrent infantile polycystic kidney associated with hydrops fetalis.
Polycystic Kidney Diseases
Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein.
Polycystic Kidney, Autosomal Recessive
Sonographic identification of autosomal recessive polycystic kidney disease associated with increased maternal serum/amniotic fluid alpha-fetoprotein.
Polycythemia
Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Polycythemia
Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Polycythemia
Hepatocellular carcinoma associated with erythrocytosis and hypoglycemia in a yearling filly.
Polyhydramnios
A case of umbilical cord hemangioma: doppler studies and review of the literature.
Polyhydramnios
Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
Polyhydramnios
Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases.
Polyhydramnios
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Polyhydramnios
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Polyhydramnios
Cystic adenomatoid malformation of the lung: an obstetric and ultrasound perspective.
Polyhydramnios
Open neural tube defects: immunocytochemical demonstration of neuroepithelial cells in amniotic fluid.
Polyhydramnios
Polyhydramnios and elevated amniotic fluid alpha-fetoprotein caused by fetal supraventricular tachycardia.
Polyhydramnios
Polyhydramnios associated with a ring chromosome and low maternal serum alpha-fetoprotein levels managed with indomethacin.
Polyhydramnios
Prenatal findings in epidermolysis bullosa with pyloric atresia in a family not known to be at risk.
Polyhydramnios
Raised alpha-fetoprotein levels in amniotic fluid and maternal serum associated with distension of the fetal bladder caused by absence of urethra.
Polyhydramnios
The importance of investigating for uniparental disomy in prenatally identified balanced acrocentric rearrangements.
Polyhydramnios
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
Polyhydramnios
[Hydramnios and fetal malformations. Use of estimating the level of alpha-fetoprotein and of bilirubin in the amniotic fluid during the last trimester of pregnancy (author's transl)]
Porphyria, Erythropoietic
The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein.
Pre-Eclampsia
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Pre-Eclampsia
Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia.
Pre-Eclampsia
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Pre-Eclampsia
Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?
Pre-Eclampsia
Combination of PAPPA, fhCG?, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.
Pre-Eclampsia
Diverse maternal and fetal pathology associated with absent diastolic flow in the umbilical artery of high-risk fetuses.
Pre-Eclampsia
Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Pre-Eclampsia
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome.
Pre-Eclampsia
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Pre-Eclampsia
Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Pre-Eclampsia
Mean arterial pressure, pregnancy induced hypertension, and preeclampsia. Evaluation as independent risk factors and as surrogates for high maternal serum alpha-protein in estimating breast cancer risk.
Pre-Eclampsia
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Pre-Eclampsia
Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Pre-Eclampsia
Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia.
Pre-Eclampsia
Midtrimester triple test levels in women with severe preeclampsia and HELLP syndrome.
Pre-Eclampsia
Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Pre-Eclampsia
Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Pre-Eclampsia
Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Pre-Eclampsia
Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility.
Pre-Eclampsia
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Pre-Eclampsia
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Pre-Eclampsia
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case-control study in China.
Pre-Eclampsia
The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
Pre-Eclampsia
The association of early-onset fetal growth restriction, elevated maternal serum alpha-fetoprotein, and the development of severe pre-eclampsia.
Pre-Eclampsia
The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Pre-Eclampsia
Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
Pregnancy Complications
Alterations of Circulating Biomarkers During Late Term Pregnancy Complications in the Horse Part II: Steroid Hormones and Alpha-Fetoprotein.
Pregnancy Complications
Amniotic fluid alpha-fetoprotein is not a useful biological marker of pregnancy outcome.
Pregnancy Complications
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Pregnancy Complications
Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies.
Pregnancy Complications
Does unexplained second-trimester (15 to 20 weeks' gestation) maternal serum alpha-fetoprotein elevation presage adverse perinatal outcome? Pitfalls and preliminary studies with late second- and third-trimester maternal serum alpha-fetoprotein.
Pregnancy Complications
Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications.
Pregnancy Complications
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Pregnancy Complications
Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Pregnancy Complications
Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
Pregnancy Complications
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Pregnancy Complications
Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Pregnancy Complications
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Pregnancy Complications
Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Pregnancy Complications
The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.
Pregnancy Complications
Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Pregnancy Complications
Velamentous umbilical cord insertion may be suspected from maternal serum alpha-fetoprotein and hCG.
Pregnancy Complications
[Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death]
Pregnancy Complications
[Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype]
Pregnancy, Abdominal
Abdominal pregnancy associated with extremely elevated serum alpha-fetoprotein. Case report.
Pregnancy, Abdominal
Advanced abdominal pregnancy complicated by bilateral ureteral obstruction. A case report.
Pregnancy, Ectopic
hCG, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy.
Pregnancy, Ectopic
Maternal serum alpha-fetoprotein levels in ectopic pregnancy. A prospective study.
Pregnancy, High-Risk
Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Pregnancy, High-Risk
Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Pregnancy, High-Risk
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Pregnancy, High-Risk
Screening for high-risk pregnancies with maternal serum alpha-fetoprotein (MSAFP). The Canadian Society of Clinical Chemists' Task Force on MSAFP Screening.
Pregnancy, High-Risk
Serum alpha-fetoprotein: I. Evaluation of quantitative assays adapted to automated immunoassay systems.
Pregnancy, High-Risk
Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies.
Pregnancy, Tubal
Elevated maternal serum alpha-fetoprotein associated with an asymptomatic tubal pregnancy at 20 weeks' gestation.
Pregnancy, Tubal
Midtrimester tubal pregnancy with markedly elevated maternal serum alpha-fetoprotein. A case report.
Premature Birth
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Premature Birth
Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
Premature Birth
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Premature Birth
Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome.
Premature Birth
Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis.
Premature Birth
Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity.
Premature Birth
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Premature Birth
The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
Premature Birth
The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth.
Premature Birth
The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth.
Prostatic Neoplasms
Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Prostatic Neoplasms
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Prostatic Neoplasms
Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Prostatic Neoplasms
Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Protein Deficiency
The expression of growth-arrest genes in the liver and kidney of the protein-restricted rat fetus.
Proteinuria
Fetal proteinuria in diagnosis of congenital nephrosis detected by raised alpha-fetoprotein in maternal serum.
Proteinuria
Mechanisms by which amniotic-fluid alpha-fetoprotein may be increased in fetal abnormalities.
Proteinuria
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Pruritus
LPAC syndrome associated with deletion of the full exon 4 in a ABCB4 genetic mutation in a patient with hepatitis C.
Psoriasis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Puberty, Precocious
An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin.
Puberty, Precocious
Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein.
Puberty, Precocious
Pediatric germ cell and human chorionic gonadotropin-producing tumors. Clinical and laboratory features.
Pulmonary Blastoma
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
Pulmonary Blastoma
Pulmonary blastoma with germ cell (yolk sac) differentiation: report of two cases.
Pulmonary Blastoma
[An autopsied case of pulmonary blastoma with high serum alpha-fetoprotein and carcinoembryonic antigen levels]
Rectal Neoplasms
Alpha-fetoprotein-producing early rectal carcinoma: a rare case report and review.
Rectal Neoplasms
Alpha-fetoprotein-producing rectal cancer: calculated tumor marker doubling time.
Rectal Neoplasms
[A case with rectal cancer showing a high level of serum alpha-fetoprotein]
Rectal Neoplasms
[Establishment of alpha-fetoprotein producing human rectal cancer cell line (RKK-YK) and its features]
Respiratory Distress Syndrome
[Alpha-fetoprotein and neonatology: Postnatal estimation of gestational age and idiopathic respiratory distress syndrome (author's transl)]
Rh Isoimmunization
Alpha-fetoprotein in amniotic fluid and serum from pregnant women with severe rhesus isoimmunization.
Rh Isoimmunization
Alpha-fetoprotein levels in amniotic fluid in pregnancies complicated by rhesus isoimmunization.
Rh Isoimmunization
Midtrimester Rh sensitization associated with circulating anticardiolipin antibodies and elevated maternal serum alpha-fetoprotein. A case report.
Rh Isoimmunization
[Alpha-fetoprotein in the amniotic fluid in pregnancies at high risk for congenital fetal defect and Rh isoimmunization]
Rhabdomyosarcoma
Testicular sex cord-stromal tumors in children: clinicopathologic study of sixteen children with review of the literature.
Sarcoma
Carcinogenicity of aflatoxin B1 in rhesus monkeys: two additional cases of primary liver cancer.
Sarcoma
Increased production of alpha-fetoprotein by cyclic 3',5'-adenosine monophosphate-treated Yoshida ascites sarcoma cells in vitro.
Sarcoma
The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
Sarcoma, Avian
Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.
Sarcoma, Avian
Nitric Oxide Synthase Type III Overexpression By Gene Therapy Exerts Antitumoral Activity In Mouse Hepatocellular Carcinoma.
Sarcoma, Endometrial Stromal
[A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production]
Sarcoma, Kaposi
Eosinophilic globules in Kaposi's sarcoma. A histochemical, immunohistochemical, and ultrastructural study.
Sarcoma, Yoshida
alpha-Fetoprotein detected in rat transplantable hepatomas by radioimmunoassay.
Sarcoma, Yoshida
Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro.
Sarcopenia
Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Sarcopenia
Sarcopenia and Alpha-fetoprotein Level in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: In Response.
Sarcopenia
Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy.
Scleroderma, Systemic
Alpha-fetoprotein producing pulmonary blastoma in a patient with systemic sclerosis: pathogenetic analysis.
Seizures
Interstitial deletion of the long arm of chromosome 4 [del(4)(q21.22q23)] and a liver tumor.
Seminoma
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Seminoma
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Seminoma
Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A prospective immunohistochemical study.
Seminoma
Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.
Seminoma
Biochemical markers for testicular germ-cell tumors in relation to histology and stage: some experiences from the Danish testicular cancer (DATECA) Study from 1976 through 1981.
Seminoma
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Seminoma
Elevated lactate dehydrogenase isoenzyme 1 as a tumour marker in patients with germ cell testicular tumours.
Seminoma
False positivity with one-step and conventional ELISA for alpha-fetoprotein in seminoma.
Seminoma
Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
Seminoma
Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Seminoma
Immunohistochemical and radioimmunological determination of beta-HCG and pregnancy-specific beta 1-protein in seminomas.
Seminoma
Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
Seminoma
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Seminoma
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Seminoma
Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
Seminoma
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Seminoma
Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma.
Seminoma
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Seminoma
Retroperitoneal Histologic Findings of Patients With Elevated Serum Alpha-fetoprotein and Pure Seminoma at Orchiectomy.
Seminoma
Retroperitoneal Metastatic Germ Cell Tumor Presenting as a Psoas Abscess: A Diagnostic Pitfall.
Seminoma
Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma.
Seminoma
Seminoma with conspicuous signet ring cells: a rare, previously uncharacterized morphologic variant.
Seminoma
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Seminoma
The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions.
Seminoma
Tubular seminoma. An immunohistochemical and DNA flow-cytometric study of four cases.
Seminoma
Tumor markers and 18F-FDG PET/CT after orchiectomy in seminoma: Is there any correlation?
Seminoma
Tumor markers and18F-FDG PET/CT after orchiectomy in seminoma:Is there any correlation?
Seminoma
When is a seminoma not a seminoma? The incidence, risk factors and management of patients with testicular seminoma with discordant elevated serum alpha-fetoprotein.
Seminoma
[A Clinicopathologic Study of 6 Patients with Histologically Pure Seminoma But Elevated Serum Alpha-Fetoprotein].
Seminoma
[Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase]
Seminoma
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
Seminoma
[Testicular tumors: association between preoperative clinical, radiological and immuno-serological factors, and histology and stage]
Sepsis
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Sepsis
The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.
Sertoli-Leydig Cell Tumor
Androblastoma and raised serum alpha-fetoprotein with familial multinodular goitre. Case report.
Sertoli-Leydig Cell Tumor
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor.
Sertoli-Leydig Cell Tumor
Elevated serum alpha-fetoprotein associated with Sertoli-Leydig cell tumors of the ovary.
Sertoli-Leydig Cell Tumor
Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors. Case report and review of the literature.
Sertoli-Leydig Cell Tumor
Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases.
Sertoli-Leydig Cell Tumor
Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.
Sertoli-Leydig Cell Tumor
Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein.
Sertoli-Leydig Cell Tumor
Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.
Sertoli-Leydig Cell Tumor
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Sertoli-Leydig Cell Tumor
Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein.
Sertoli-Leydig Cell Tumor
Raised serum alpha-fetoprotein in Sertoli-Leydig cell tumor (androblastoma) of ovary: report of two cases.
Sertoli-Leydig Cell Tumor
Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation.
Sertoli-Leydig Cell Tumor
Sertoli Leydig cell tumor with malignant heterologous elements and raised alpha-fetoprotein: a case report.
Sertoli-Leydig Cell Tumor
Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein.
Sertoli-Leydig Cell Tumor
Sertoli-Leydig cell tumor of the ovary with alpha-fetoprotein production.
Sertoli-Leydig Cell Tumor
Sertoli-Leydig cell tumor of the ovary: a rare cause of amenorrhea.
Sertoli-Leydig Cell Tumor
[A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration]
Sex Chromosome Aberrations
Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Single Umbilical Artery
Prenatal diagnosis of omphalocele associated with umbilical cord cyst.
Skin Diseases
Role of elevated alpha-fetoprotein in prenatal diagnosis of junctional epidermolysis bullosa and pyloric atresia.
Small Cell Lung Carcinoma
Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Solitary Pulmonary Nodule
The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), alpha-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules.
Spina Bifida Cystica
Alpha-fetoprotein screening for open spina bifida: effect of routine biparietal diameter measurement to estimate gestational age.
Spina Bifida Cystica
Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
Spina Bifida Cystica
Amniotic fluid alpha-fetoprotein levels in anencephaly and open spina bifida: validation of median cut-off limits.
Spina Bifida Cystica
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Spina Bifida Cystica
Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?
Spina Bifida Cystica
Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.
Spina Bifida Cystica
Estimating an individual's risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing. Fourth report of the UK collaborative study on alpha-fetoprotein in relation to neural tube defects.
Spina Bifida Cystica
First trimester maternal serum alpha-fetoprotein is not raised in pregnancies with open spina bifida.
Spina Bifida Cystica
Levels of alpha-fetoprotein in amniotic fluids of mice (curly-tail) with neural tube defects.
Spina Bifida Cystica
Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
Spina Bifida Cystica
Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Spina Bifida Cystica
Nomogram for estimating an individual's risk of having a fetus with open spina bifida.
Spina Bifida Cystica
Prenatal diagnosis of diastematomyelia: presentation of eight cases and review of the literature.
Spina Bifida Cystica
Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
Spina Bifida Cystica
Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis.
Spina Bifida Cystica
Ratio of immunochemically determined amniotic fluid acetylcholinesterase to butyrylcholinesterase in the differential diagnosis of fetal abnormalities.
Spina Bifida Cystica
Should maternal alpha-fetoprotein estimation be carried out in centers where ultrasound screening is routine? A sensitivity analysis approach.
Spina Bifida Cystica
Survival of infants with open spina bifida in relation to maternal serum alpha-fetoprotein level. Third report of the UK collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Spina Bifida Cystica
Tables for estimation of individual risks of fetal neural tube and ventral wall defects, incorporating prior probability, maternal serum alpha-fetoprotein levels, and ultrasonographic examination results.
Spina Bifida Cystica
The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida.
Spina Bifida Cystica
The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
Spina Bifida Cystica
[Prenatal diagnosis of anencephaly and open spina bifida by combined use of amniotic or maternal serum alpha-fetoprotein and maternal urine estrogen/creatinine ratio (author's transl)]
Spinal Dysraphism
A G-->A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP).
Spinal Dysraphism
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Spinal Dysraphism
Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.
Spinal Dysraphism
Alpha-fetoprotein testing: opinions of parents of children with spina bifida.
Spinal Dysraphism
Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Spinal Dysraphism
Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida.
Spinal Dysraphism
Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
Spinal Dysraphism
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.
Spinal Dysraphism
Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein.
Spinal Dysraphism
Determination of subfractions of amniotic fluid alpha-fetoprotein in diagnosing spina bifida and congenital nephrosis.
Spinal Dysraphism
Early antenatal diagnosis of spina bifida in a twin fetus by ultrasonic examination and alpha-fetoprotein estimation.
Spinal Dysraphism
Early prenatal diagnosis of neural-tube defects by ultrasound-guided fetoscopy.
Spinal Dysraphism
Impact on spina bifida screening of shifting prenatal Down syndrome maternal serum screening from the second trimester to the first.
Spinal Dysraphism
Maternal serum alpha-fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation.
Spinal Dysraphism
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Spinal Dysraphism
Polyacrylamide gel electrophoresis of amniotic fluid cholinesterases: a good prenatal test for neural tube defects.
Spinal Dysraphism
Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Spinal Dysraphism
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Spinal Dysraphism
Relationship between some obstetric landmarks and the concentration of alpha-fetoprotein in maternal blood.
Spinal Dysraphism
Role of Maternal Serum Alpha-Fetoprotein and Ultrasonography in Contemporary Detection of Spina Bifida.
Spinal Dysraphism
Should maternal alpha-fetoprotein estimation be carried out in centers where ultrasound screening is routine? A sensitivity analysis approach.
Spinal Dysraphism
Spina bifida: early antenatal diagnosis using amniotic fluid alpha-fetoprotein heterogeneity.
Spinal Dysraphism
Spinal Hamartoma with Severe Kyphoscoliosis - A Rare Case of Spinal Mass in a Fetus.
Spinal Dysraphism
The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida.
Spinal Dysraphism
The improvement of the antenatal detection of fetal neural tube defects using discriminant analysis.
Spinal Dysraphism
The molecular nature of alpha-fetoprotein in anencephaly and spina bifida.
Spinal Dysraphism
The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Spinal Dysraphism
Trends in clinical characteristics of infants with spina bifida--Atlanta, 1972-1979.
Spinal Dysraphism
Ultrasound and amniotic fluid alpha-fetoprotein in the prenatal diagnosis of spina bifida.
Spinal Dysraphism
[Acrania and spina bifida diagnosed by alpha-fetoprotein determination in 16th week of pregnancy]
Spinal Dysraphism
[Contents of alpha-fetoprotein in the blood of pregnant women as a criterion of the presence of congenital heart defects in the fetus]
Spinal Dysraphism
[Unusual course of alpha-fetoprotein levels in a case of spina bifida detected by prenatal diagnosis]
Spinocerebellar Ataxias
Autosomal recessive spinocerebellar ataxia and peripheral neuropathy with raised alpha-fetoprotein.
Spinocerebellar Ataxias
Exome analysis reveals a Japanese family with spinocerebellar ataxia, autosomal recessive 1.
Spinocerebellar Ataxias
Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein.
Spinocerebellar Degenerations
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Spinocerebellar Degenerations
Identification and characterisation of a large Senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Stillbirth
A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Stillbirth
First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Stillbirth
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Stillbirth
Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.
Stillbirth
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Stillbirth
Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome.
Stillbirth
Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Stillbirth
Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome.
Stomach Neoplasms
A case of alpha-fetoprotein-producing gastric cancer showing an exogastric growth pattern.
Stomach Neoplasms
A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein.
Stomach Neoplasms
A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Stomach Neoplasms
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Stomach Neoplasms
Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
Stomach Neoplasms
Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1.
Stomach Neoplasms
Alpha-fetoprotein- and des-gamma-carboxy prothrombin-producing advanced gastric cancer.
Stomach Neoplasms
Alpha-fetoprotein-producing early gastric cancer accompanying liver cirrhosis: a case report.
Stomach Neoplasms
Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis.
Stomach Neoplasms
Alteration of the AT motif binding factor-1 expression in alpha-fetoprotein producing gastric cancer: is it an event for differentiation and proliferation of the tumors?
Stomach Neoplasms
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease.
Stomach Neoplasms
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.
Stomach Neoplasms
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Stomach Neoplasms
c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.
Stomach Neoplasms
Carcino-fetal proteins and gastric cancer: the site of alpha-fetoprotein synthesis in gastric cancer.
Stomach Neoplasms
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Stomach Neoplasms
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Stomach Neoplasms
Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer.
Stomach Neoplasms
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Stomach Neoplasms
Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Stomach Neoplasms
Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients.
Stomach Neoplasms
Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
Stomach Neoplasms
Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
Stomach Neoplasms
Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.
Stomach Neoplasms
Combined Detection of Exosome Concentration and Tumor Markers in Gastric Cancer.
Stomach Neoplasms
Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Stomach Neoplasms
Des-gamma carboxy prothrombin (PIVKA-II) and alpha-fetoprotein producing gastric cancer with multiple liver metastases.
Stomach Neoplasms
Des-gamma carboxy prothrombin (PIVKA-II)- and alpha-fetoprotein (AFP)-producing gastric cancer.
Stomach Neoplasms
Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
Stomach Neoplasms
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Stomach Neoplasms
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas.
Stomach Neoplasms
Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Stomach Neoplasms
Establishment of an alpha-fetoprotein-producing gastric cancer cell line in serum-free media.
Stomach Neoplasms
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.
Stomach Neoplasms
Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.
Stomach Neoplasms
Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Stomach Neoplasms
Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Stomach Neoplasms
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Stomach Neoplasms
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Stomach Neoplasms
High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein.
Stomach Neoplasms
High level of expression of alpha-fetoprotein receptor in gastric cancers.
Stomach Neoplasms
Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.
Stomach Neoplasms
Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer.
Stomach Neoplasms
Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients.
Stomach Neoplasms
Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.
Stomach Neoplasms
Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case.
Stomach Neoplasms
Measurements of serum C-reactive protein levels in patients with gastric cancer and quantification using silicon nanowire arrays.
Stomach Neoplasms
miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.
Stomach Neoplasms
Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer.
Stomach Neoplasms
Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer.
Stomach Neoplasms
Overexpression of P-glycoprotein in untreated AFP-producing gastric carcinoma.
Stomach Neoplasms
Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Stomach Neoplasms
Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer.
Stomach Neoplasms
Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases.
Stomach Neoplasms
Prognostic significance of tumour markers in Chinese patients with gastric cancer.
Stomach Neoplasms
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Stomach Neoplasms
Prognostic value of serum alpha-fetoprotein levels in patients with gastric cancer: a meta-analysis.
Stomach Neoplasms
Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Stomach Neoplasms
Prolonged Survival in a Case of Chemotherapy-Sensitive Gastric Cancer That Produced Alpha-Fetoprotein and Protein Induced by Vitamin K Antagonist-II.
Stomach Neoplasms
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer-report of 4 cases.
Stomach Neoplasms
Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.
Stomach Neoplasms
Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer.
Stomach Neoplasms
Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Stomach Neoplasms
Serum alpha-fetoprotein subfractions in hepatic malignancies identified by different reactivities with concanavalin A, lentil lectin or phytohemagglutinin-E.
Stomach Neoplasms
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Stomach Neoplasms
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.
Stomach Neoplasms
Study of Fe?O?-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients.
Stomach Neoplasms
Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.
Stomach Neoplasms
Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.
Stomach Neoplasms
Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report.
Stomach Neoplasms
The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.
Stomach Neoplasms
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Stomach Neoplasms
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.
Stomach Neoplasms
Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy.
Stomach Neoplasms
[A case of postoperative liver metastasis of alpha-fetoprotein producing gastric cancer successfully treated with intrahepatic chemotherapy (adriamycin, cisplatin, irinotecan hydrochloride)]
Stomach Neoplasms
[Alpha-fetoprotein producing gastric cancer responding to combined chemotherapy with UFT and adriamycin]
Stomach Neoplasms
[Alpha-fetoprotein producing gastric cancer transplanted into athymic nude mice (author's transl)]
Stomach Neoplasms
[Alpha-fetoprotein. 3. Evaluation of alpha-fetoprotein in gastric cancer and its liver metastasis]
Stomach Neoplasms
[Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer]
Stomach Neoplasms
[Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer].
Stomach Neoplasms
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]
Stomach Neoplasms
[Gastric cancer with liver metastasis producing alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist II (PIVKA-II); a case report]
Stomach Neoplasms
[The effect of anti-human AFP serum for AFP producing stomach cancer xenotransplanted nude mice]
Stomach Neoplasms
[The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
Stomach Neoplasms
[Two cases of alpha-fetoprotein producing gastric cancer, showing marked response to continuous hepatic arterial infusion (HAI) chemotherapy with adriamycin]
Stomach Neoplasms
[Utility of measurement of tumor markers for preoperative staging of gastric cancer]
Superior Vena Cava Syndrome
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
Superior Vena Cava Syndrome
Characteristics of thymoma successfully resected by videothoracoscopic surgery.
Tachycardia, Supraventricular
Polyhydramnios and elevated amniotic fluid alpha-fetoprotein caused by fetal supraventricular tachycardia.
Telangiectasis
Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.
Telangiectasis
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia-Like Disorders.
Telangiectasis
Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia.
Telangiectasis
Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.
Telangiectasis
Mutation analysis of the ATM gene in two Chinese patients with ataxia telangiectasia.
Telangiectasis
Six Novel ATM Gene Variants in Sri Lankan Patients with Ataxia Telangiectasia.
Teratocarcinoma
alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Teratocarcinoma
Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
Teratocarcinoma
Endogenous and transfected mouse alpha-fetoprotein genes in undifferentiated F9 cells are activated in transient heterokaryons.
Teratocarcinoma
Immunocytochemical quantitative study of alpha-fetoprotein in normal and neoplastic neural development.
Teratocarcinoma
Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation.
Teratocarcinoma
Localization of alpha-fetoprotein in transplantable murine teratocarcinomas.
Teratocarcinoma
Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes.
Teratocarcinoma
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
Teratocarcinoma
Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
Teratocarcinoma
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Teratocarcinoma
The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene.
Teratocarcinoma
[Comparative analysis of expression of TGFbeta family factors and their receptors in mouse embryonic stem and embryonic teratocarcinoma cells]
Teratocarcinoma
[Immunological localization of alpha-fetoprotein in the proximal endoderm and its significance in extra-embryonic differentiation of teratocarcinomas in the mouse]
Teratocarcinoma
[Radioimmunologic serum determinations of alpha-fetoprotein in patients with tumors of the testis (author's transl)]
Teratoma
A preterm infant with an extradural myxopapillary ependymona component of a teratoma and high levels of alpha-fetoprotein.
Teratoma
AFP in yolk sac tumor and solid teratoma of the ovary: significance of postoperative serum AFP.
Teratoma
Alpha-fetoprotein levels correlate with the pathologic grade and surgical outcomes of pediatric retroperitoneal teratomas.
Teratoma
Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases.
Teratoma
Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma.
Teratoma
Alpha-fetoprotein subfractions in germ cell tumors identified by Con A or LCH crossed-line affinity immunoelectrophoresis.
Teratoma
An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma.
Teratoma
Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum.
Teratoma
Benign metachronous bilateral ovarian and mediastinal teratomas with an elevated alpha-fetoprotein.
Teratoma
Case report: a preterm infant with an extradural myxopapillary ependymoma component of a teratoma and high levels of alpha-fetoprotein.
Teratoma
Combined cystic teratoma and hepatoblastoma of the liver. Probable divergent differentiation of an uncommitted hepatic precursor cell.
Teratoma
Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.
Teratoma
Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review.
Teratoma
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Teratoma
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
Teratoma
Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
Teratoma
Extreme levels of alpha-fetoprotein in a newborn with a benign intrapericardial teratoma.
Teratoma
Factors affecting functional prognosis in survivors of primary central nervous system germinal tumors.
Teratoma
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts.
Teratoma
Germ cell tumor in an adolescent with extensive testicular microlithiasis: concerns regarding future management.
Teratoma
Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma.
Teratoma
Immature endodermal teratoma of the ovary: embryologic correlations and immunohistochemistry.
Teratoma
Immature teratoma of the ovary. Correlation between serum alpha-fetoprotein value and immunohistochemical analysis.
Teratoma
Immature teratoma producing alpha-fetoprotein without components of yolk sac tumor in the pineal region.
Teratoma
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary.
Teratoma
Immunocytochemical localization of neuroendocrine hormones and oncofetal antigens in ovarian teratomas.
Teratoma
Improved staging for testicular cancer using biologic tumor markers: a prospective study.
Teratoma
Long-term survival in malignant intracranial germ-cell tumors: a report of two cases and a review of the literature.
Teratoma
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
Teratoma
Management of pineal non-germinoma germ cell tumor with residual teratoma and normal alpha-fetoprotein.
Teratoma
Maternal serum alpha-fetoprotein and epithelial tumour marker concentrations are not increased by fetal sacrococcygeal teratoma.
Teratoma
Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in a pregnancy complicated by fetal sacrococcygeal teratoma.
Teratoma
Nasopharyngeal teratoma. Report of a case with prenatal diagnosis and postnatal management.
Teratoma
Nodal gliomatosis and alpha-fetoprotein production. Two unusual facets of grade I ovarian teratoma.
Teratoma
Ovarian mixed germ cell tumor composed of dysgerminoma, endodermal sinus tumor, choriocarcinoma and mature teratoma in a 44-year-old woman: case report and literature review.
Teratoma
Ovarian tumors in the pediatric age group: 37 cases treated over an 8-year period.
Teratoma
Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Teratoma
Progression from an immature teratoma with miliary gliomatosis peritonei to growing teratoma syndrome with nodular gliomatosis peritonei.
Teratoma
Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein level.
Teratoma
Rapid growth of congenital diffuse brain tumor considered to be teratoma: case report.
Teratoma
Recurrent immature teratoma: lack of correlation between serum level and immunohistochemical detection of serum alpha-fetoprotein.
Teratoma
Recurrent yolk sac tumor following resection of a neonatal immature gastric teratoma.
Teratoma
Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Teratoma
Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Teratoma
Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
Teratoma
Robb-Smith type malignant histiocytosis associated with a mediastinal germ cell tumor.
Teratoma
Sacrococcygeal Teratoma: Clinical Characteristics, Management, and Long-term Outcomes in a Prospective Study from a Tertiary Care Center.
Teratoma
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Teratoma
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Teratoma
Testicular teratoma demanded in-depth pathological exploration to rule out malignancy: A pediatric case report.
Teratoma
The diagnostic value of alpha-fetoprotein in an infant with sacrococcygeal teratoma.
Teratoma
The diagnostic value of alpha-fetoprotein in infants and children with teratomas: a questionnaire survey in Japan.
Teratoma
The histogenetic-embryologic basis for reappearance of alpha-fetoprotein in endodermal sinus tumors (yolk sac tumors) and teratomas.
Teratoma
The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Teratoma
Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors.
Teratoma
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
Teratoma
[Sacrococcygeal teratoma and normal alpha-fetoprotein levels in the amniotic fluid]
Teratoma
[Serological examinations in children with hepatoma and teratoma of alpha-fetoprotein and alpha-2-H-globulin and the diagnostic and prognostic value (author's transl)]
Teratoma
[Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)]
Testicular Neoplasms
A case report of retroperitoneal extrahepatic hepatocellular carcinoma presented with elevated level of Alpha fetoprotein.
Testicular Neoplasms
A presumed extragonadal germ cell tumor that turned out to be a gastric cancer-a case report.
Testicular Neoplasms
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Testicular Neoplasms
Alpha-fetoprotein half-life as a predictor of residual testicular tumor. Effect of the analytic strategy on test sensitivity and specificity.
Testicular Neoplasms
Alpha-fetoprotein synthesis in tissue culture of human testicular tumors and an examination of experimental yolk sac tumors in the rat.
Testicular Neoplasms
Beta-human chorionic gonadotropin and alpha-fetoprotein in central and peripheral venous blood of patients with testicular tumors.
Testicular Neoplasms
Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy.
Testicular Neoplasms
Chorionic gonadotrophin and alpha-fetoprotein markers for testicular cancer.
Testicular Neoplasms
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
Testicular Neoplasms
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors.
Testicular Neoplasms
Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer.
Testicular Neoplasms
Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.
Testicular Neoplasms
Embryonal carcinoma of the testis associated with prostate cancer in a 72-year-old man.
Testicular Neoplasms
Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
Testicular Neoplasms
Errors in measurement and reporting of serum markers in patients with germ cell tumors.
Testicular Neoplasms
Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
Testicular Neoplasms
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Testicular Neoplasms
Hereditary persistence of alpha-fetoprotein mimicking testicular cancer in a patient with acute epididymitis.
Testicular Neoplasms
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Testicular Neoplasms
Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Testicular Neoplasms
Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
Testicular Neoplasms
In vitro synthesis of alpha-fetoprotein and human chorionic gonadotropin in testicular cancer.
Testicular Neoplasms
Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Testicular Neoplasms
Late relapse of testicular cancer 21 years after first complete remission: a case report.
Testicular Neoplasms
Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
Testicular Neoplasms
Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Testicular Neoplasms
Mildly Elevated Serum Alpha-Fetoprotein (AFP) Among Patients With Testicular Cancer May Not Be Associated With Residual Cancer Or Need For Treatment.
Testicular Neoplasms
Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Testicular Neoplasms
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Testicular Neoplasms
Neopterin as tumour marker serum and urinary neopterin concentrations in malignant diseases.
Testicular Neoplasms
Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer.
Testicular Neoplasms
Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
Testicular Neoplasms
Re: alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Testicular Neoplasms
Re: Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer. Sophie D. Fosså and M. Mason. Br. J. Urol., 69, 108, 1992.
Testicular Neoplasms
Residual pulmonary nodules after combination chemotherapy of testicular cancer.
Testicular Neoplasms
Retroperitoneal lymph node dissection in the setting of elevated markers.
Testicular Neoplasms
Retroperitoneal mass and elevation of alpha-fetoprotein following lymphadenectomy and adjuvant chemotherapy for nonseminomatous testicular cancer.
Testicular Neoplasms
Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
Testicular Neoplasms
Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Testicular Neoplasms
Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Testicular Neoplasms
Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
Testicular Neoplasms
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.
Testicular Neoplasms
Serum and cellular biologic tumor markers in patients with urologic cancer.
Testicular Neoplasms
Synthesis of alpha-fetoprotein and some other serum proteins in testicular tumors.
Testicular Neoplasms
Testicular Germ Cell Tumors: Serological and Immunohistochemical Diagnosis.
Testicular Neoplasms
Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
Testicular Neoplasms
Testicular mixed germ cell tumor with polyembryoma component in brothers.
Testicular Neoplasms
The role of radioimmunodetection in the management of testicular cancer.
Testicular Neoplasms
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
Testicular Neoplasms
The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Testicular Neoplasms
The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
Testicular Neoplasms
Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Testicular Neoplasms
VAB-6 chemotherapy causes spurious elevation of alpha-fetoprotein associated with liver dysfunctions.
Testicular Neoplasms
Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
Testicular Neoplasms
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.
Testicular Neoplasms
[A case report of infantile testicular cancer: dissection of paraaortic lymph node involvement indicated by gradual rise in serum alpha-fetoprotein after orchiectomy]
Testicular Neoplasms
[A giant testicular tumor detected with dyspnea due to lung metastases: a case report]
Testicular Neoplasms
[Early changes in serum alpha-fetoprotein after chemotherapy in advanced testicular tumors]
Testicular Neoplasms
[False-positive elevation of alpha-fetoprotein during induction chemotherapy in patients with testicular cancer]
Testicular Neoplasms
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]
Testicular Neoplasms
[High alpha-fetoprotein persistence after orchiectomy. On a case of uncommon etiology].
Testicular Neoplasms
[Immunohistochemical study of testicular tumor on cellular localization of HCG beta-subunit, alpha-fetoprotein and beta 1-pregnancy specific glycoprotein (author's transl)]
Testicular Neoplasms
[Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase]
Testicular Neoplasms
[Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors]
Testicular Neoplasms
[Significance of current bio- and molecular-markers in urological cancers]
Testicular Neoplasms
[Significance of tumor markers in the treatment of urological malignancies]
Testicular Neoplasms
[Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method]
Testicular Neoplasms
[The current concept of tumor markers in oncologic urology--cytoplasmic markers]
Testicular Neoplasms
[The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors]
Testicular Neoplasms
[Tissue concentrations of alpha-fetoprotein in various testicular tumors]
Testicular Neoplasms
[Two cases of testicular tumors with high alpha-fetoprotein levels: a case report]
Testicular Neoplasms
[Value and problems of alpha-fetoprotein determinations in testicular neoplasms]
Thrombocytopenia
Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Thrombocytopenia
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
Thrombocytopenia
Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Thrombocytopenia
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thrombocytosis
A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
Thrombocytosis
Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band.
Thrombocytosis
Patterns of hepatoblastoma and hepatocellular carcinoma in children after universal hepatitis B vaccination in taiwan: a report from a single institution in southern Taiwan.
Thrombocytosis
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Thrombocytosis
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Thrombophilia
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophilias.
Thrombosis
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators.
Thrombosis
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Thrombosis
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Thrombosis
A single-center retrospective analysis of liver transplantation on 255 patients with hepatocellular carcinoma.
Thrombosis
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Thrombosis
Alpha-fetoprotein and 18F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: Preliminary experience.
Thrombosis
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Thrombosis
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation.
Thrombosis
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Thrombosis
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
Thrombosis
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
Thrombosis
Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
Thrombosis
Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Thrombosis
Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
Thrombosis
Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
Thrombosis
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Thrombosis
Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma.
Thrombosis
Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients.
Thrombosis
Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.
Thrombosis
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Thrombosis
Combined Chemoembolization and Radiotherapy Versus Chemoembolization Alone for Hepatocellular Carcinoma Invading the Hepatic Vein or Inferior Vena Cava.
Thrombosis
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Thrombosis
Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Thrombosis
Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Thrombosis
Complete remission of unresectable hepatocellular carcinoma on healthy liver by the combination of aggressive surgery and high-dose-intensity chemotherapy by CPT-11.
Thrombosis
CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.
Thrombosis
Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation.
Thrombosis
Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Thrombosis
Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Thrombosis
Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Thrombosis
Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.
Thrombosis
Feasibility of SBRT for hepatocellular carcinoma in Brazil - a prospective pilot study.
Thrombosis
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Thrombosis
Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.
Thrombosis
Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.
Thrombosis
High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Thrombosis
High serum alpha-fetoprotein concentration associated with pseudoinfarction of a cirrhotic liver: report of a case.
Thrombosis
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Thrombosis
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Thrombosis
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Thrombosis
Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
Thrombosis
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Thrombosis
Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
Thrombosis
Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Thrombosis
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Thrombosis
Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.
Thrombosis
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Thrombosis
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Thrombosis
Management and patient survival in hepatocellular carcinoma: does the physician's level of experience matter?
Thrombosis
MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.
Thrombosis
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival.
Thrombosis
Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration.
Thrombosis
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Thrombosis
PLZF and PLZF-MAPK10 can predict the prognosis of postoperative patients with hepatocellular carcinoma.
Thrombosis
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma.
Thrombosis
Predictors of Futile Liver Resection for Patients with Barcelona Clinic Liver Cancer Stage B/C Hepatocellular Carcinoma.
Thrombosis
Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Thrombosis
Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.
Thrombosis
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
Thrombosis
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Thrombosis
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.
Thrombosis
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study.
Thrombosis
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease.
Thrombosis
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.
Thrombosis
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma.
Thrombosis
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Thrombosis
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Thrombosis
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Thrombosis
Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Thrombosis
Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital.
Thrombosis
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
Thrombosis
Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
Thrombosis
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Thrombosis
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
Thrombosis
Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
Thrombosis
Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
Thrombosis
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
Thrombosis
Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Thrombosis
Successful resection for advanced hepatoblastoma, combined with perioperative chemotherapy.
Thrombosis
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Thrombosis
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Thrombosis
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.
Thrombosis
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Thrombosis
The MAAPE score in intermediate and advanced hepatocellular carcinoma treated with Yttrium-90 resin microsphere radioembolization.
Thrombosis
Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
Thrombosis
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Thrombosis
Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study.
Thrombosis
Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma.
Thrombosis
Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
Thrombosis
Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Thrombosis
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study.
Thrombosis
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Thrombosis
Ultrasonographic diagnosis of a large placental intervillous thrombosis associated with elevated maternal serum alpha-fetoprotein level.
Thrombosis
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Thrombosis
Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Thrombosis
Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma.
Thrombosis
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Thrombosis
Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
Thrombosis
[A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization]
Thrombosis
[A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma]
Thrombosis
[Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Thrombosis
[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma]
Thrombosis
[Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea]
Thrombosis
[Massive venous thrombosis with cardiac invasion as primary manifestation of hepatocarcinoma]
Thrombosis
[Tumor thrombus arising from the superior vena cava and extending into the right atrium in a patient with advanced testicular germ cell tumor]
Thymoma
Induction of CD4+ murine natural killer T-like cells by immunization with syngeneic thymoma expressing embryonic alpha-fetoprotein.
Thyroid Diseases
Maternal thyroid function does not alter maternal serum alpha-fetoprotein interpretation.
Thyroiditis, Autoimmune
Modulation of T cell function by alpha-fetoprotein: An in vivo study on porcine thyroid peroxidase-induced experimental autoimmune thyroiditis in transgenic mice producing human alpha-fetoprotein.
Toxemia
CGH in the detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies.
Toxemia
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
Toxemia
Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
Toxoplasmosis, Congenital
[A preliminary study on the antenatal diagnosis and prevention of the fetus toxoplasmosis infection]
transaldolase deficiency
Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Tricuspid Valve Insufficiency
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Trisomy 13 Syndrome
Amniotic fluid acetylcholinesterase activity and alpha-fetoprotein in chromosomal anomalies and neural tube defects.
Trisomy 13 Syndrome
Decreased levels of amniotic fluid alpha-fetoprotein associated with Down syndrome.
Trisomy 13 Syndrome
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Trisomy 13 Syndrome
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Trisomy 18 Syndrome
A maternal serum screen for trisomy 18: an extension of maternal serum screening for Down syndrome.
Trisomy 18 Syndrome
A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Trisomy 18 Syndrome
A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories.
Trisomy 18 Syndrome
Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
Trisomy 18 Syndrome
An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.
Trisomy 18 Syndrome
Effectiveness of alpha-fetoprotein variants L2 and L3 as substitutes of alpha-fetoprotein in screening for fetal Trisomy 18.
Trisomy 18 Syndrome
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Trisomy 18 Syndrome
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Trisomy 18 Syndrome
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Trisomy 18 Syndrome
Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Trisomy 18 Syndrome
Maternal serum screening for trisomy 18: assessing different statistical models to optimize detection rates.
Trisomy 18 Syndrome
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
Trisomy 18 Syndrome
Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Trisomy 18 Syndrome
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Trisomy 18 Syndrome
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Trisomy 18 Syndrome
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
Trisomy 18 Syndrome
Second trimester two-step trisomy 18 screening using maternal serum markers.
Trisomy 18 Syndrome
Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
Trisomy 18 Syndrome
Significance of a false-positive trisomy 18 multiple-marker screening test.
Trisomy 18 Syndrome
The advantages of using triple-marker screening for chromosomal abnormalities.
Trisomy 18 Syndrome
The effects of analytical factors on second trimester risk estimations.
Trisomy 18 Syndrome
Weights of fetuses with autosomal trisomies at termination of pregnancy: an investigation of the etiologic factors of low serum alpha-fetoprotein values.
Trisomy 18 Syndrome
[Concanavalin A reactivity of alpha-fetoprotein in the amniotic fluid in autosomal trisomies of the fetus]
Trisomy 18 Syndrome
[Prenatal diagnosis of trisomy 18 via hydramnion detected by echosonography (author's transl)]
Trophoblastic Neoplasms
A rare case of combined placental site trophoblastic tumour with mature cystic teratoma and mixed germ cell tumour in the testis.
Trophoblastic Neoplasms
CSF and serum AFP in patients without gestational or neoplastic AFP-secretion.
Trophoblastic Neoplasms
Testicular germ cell tumor composed of placental site trophoblastic tumor and teratoma.
Trophoblastic Tumor, Placental Site
A rare case of combined placental site trophoblastic tumour with mature cystic teratoma and mixed germ cell tumour in the testis.
Trophoblastic Tumor, Placental Site
Testicular germ cell tumor composed of placental site trophoblastic tumor and teratoma.
Turner Syndrome
Alpha-fetoprotein and ultrasound scanning in the prenatal diagnosis of Turner's syndrome.
Turner Syndrome
Amniotic fluid levels of alpha-fetoprotein and other proteins in a case of Turner's syndrome of the fetus.
Turner Syndrome
Elevated second-trimester maternal serum ?-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Turner Syndrome
First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21.
Turner Syndrome
Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnancies.
Turner Syndrome
Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome.
Turner Syndrome
Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Turner Syndrome
Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha-fetoprotein.
Turner Syndrome
Reactivity of amniotic fluid alpha-fetoprotein with concanavallin A in diagnosis of neural tube defects.
Turner Syndrome
[Cause for increased alpha-fetoprotein values in amniotic fluid in prenatal diagnosis of genetic defects (author's transl)]
Tyrosinemias
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Tyrosinemias
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Tyrosinemias
Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I.
Tyrosinemias
The efficacy of liver transplantation in malignant liver tumors associated with tyrosinemia: clinical and laboratory findings of five cases.
Tyrosinemias
[Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia]
Tyrosinemias
[Hereditary tyrosinemia and alpha-1-fetoprotein. II. Comparative tissue levels of alpha-fetoprotein in 2 cases of hereditary tyrosinemia. Considerations on the ontogenesis of human fetoprotein]
Tyrosinemias
[Infantile cirrhosis associated with neoproduction of alpha-fetoprotein. Further perspectives in hereditary tyrosinemia]
Uremia
Tumor markers in uremia: carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein.
Urinary Bladder Neoplasms
Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type.
Urinary Bladder Neoplasms
Triple primary cancers involving kidney, urinary bladder, and liver in a dye worker.
Urinary Bladder Neoplasms
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Urogenital Diseases
Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Uterine Cervical Neoplasms
Elevated serum alpha-fetoprotein levels as a presenting sign of epidural recurrence from cervical cancer.
Uterine Hemorrhage
Alpha-fetoprotein (AFP) in maternal serum and human gonadotropin (hCG) in urine in 77 patients with vaginal bleeding in early pregnancy.
Uterine Hemorrhage
Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Uterine Hemorrhage
Endodermal sinus tumor of the infant vagina treated exclusively with chemotherapy.
Uterine Hemorrhage
Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Uterine Hemorrhage
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Uterine Neoplasms
Significance of serum tumor markers in patients with carcinoma of the ovary.
Uveitis
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Vaginal Discharge
Alpha-fetoprotein as a tool to distinguish amniotic fluid from urine, vaginal discharge, and semen.
Varicose Veins
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Varicose Veins
Elevated maternal serum alpha-fetoprotein, umbilical vein varix, and mesenchymal dysplasia: are they related?
Varicose Veins
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan.
Varicose Veins
Hepatocellular carcinoma in Taiwan: clinicopathological study of 440 cases from a consecutive 6000 autopsies.
Varicose Veins
Importance of Multislice Computed Tomography in Determining the Severity of Chronic Liver Disease State.
Varicose Veins
Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis.
Varicose Veins
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma.
Varicose Veins
Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Varicose Veins
[Successful Treatment for Advanced Hepatocellular Carcinoma by Hepatic Arterial Infusion of CDDP Powder as Second-Line Chemotherapy.]
Venous Thrombosis
Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma.
Venous Thrombosis
Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002.
Venous Thrombosis
Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.
Viremia
Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
Viremia
Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.
Virus Diseases
A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Virus Diseases
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Virus Diseases
Characteristics of hepatocellular carcinoma in hemodialysis patients in hepatitis B endemic area.
Virus Diseases
Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma.
Virus Diseases
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Virus Diseases
Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).
Virus Diseases
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
Virus Diseases
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Virus Diseases
Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Virus Diseases
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Virus Diseases
Efficacy of on-demand intrahepatic arterial therapy in combination with sorafenib for advanced hepatocellular carcinoma.
Virus Diseases
Fibrolamellar variant of hepatocellular carcinoma presenting during pregnancy: management dilemmas.
Virus Diseases
Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Virus Diseases
Hepatocellular carcinoma with right atrial extension in a young patient with congenitally unguarded tricuspid orifice.
Virus Diseases
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Virus Diseases
Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining.
Virus Diseases
Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?
Virus Diseases
Isolation of Human Fetal Liver Progenitors and Their Enhanced Proliferation by Three-Dimensional Coculture with Endothelial Cells.
Virus Diseases
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.
Virus Diseases
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers.
Virus Diseases
Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production.
Virus Diseases
Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.
Virus Diseases
Prognostic significance of E-cadherin expression in hepatocellular carcinoma: correlations with clinical features.
Virus Diseases
Role of Matrix Metallopeptidase 12 in the Development of Hepatocellular Carcinoma.
Virus Diseases
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis.
Virus Diseases
Upregulation of heat shock factor 1 transcription activity is associated with hepatocellular carcinoma progression.
Virus Diseases
[Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]
Vision Disorders
Puberty due to a mixed germ cell tumour of the hypothalamus secreting BhCG and alpha-fetoprotein.
Vitamin D Deficiency
Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC.
Vitamin E Deficiency
Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia.
Vitamin K Deficiency
A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases.
Vitamin K Deficiency
Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review.
Vitamin K Deficiency
[Large hepatocellular carcinoma successfully treated with transarterial chemoembolization using cisplatin]
Wilms Tumor
Elevated serum alpha-fetoprotein in Wilms tumor may follow the same pattern of other fetal neoplasms after treatment: evidence from three cases.
Wilms Tumor
Familial synchronous bilateral teratoid Wilms tumor with elevated alpha-fetoprotein level.
Wilms Tumor
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
Wilms Tumor
[An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein]
html completed